{"items": "715", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "What Analyst Projections for Key Metrics Reveal About Intuitive Surgical, Inc.  ( ISRG )  Q4 Earnings", "url": "https://www.zacks.com/stock/news/2212396/what-analyst-projections-for-key-metrics-reveal-about-intuitive-surgical-inc-isrg-q4-earnings", "time_published": "20240118T183100", "authors": ["Zacks Equity Research"], "summary": "Get a deeper insight into the potential performance of Intuitive Surgical, Inc. (ISRG) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default295.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999981"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.183852, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.342803", "ticker_sentiment_score": "0.233075", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why This Robotic Surgery's Looming Rivals Are 'Unlikely To Derail' It", "url": "https://www.investors.com/news/technology/isrg-stock-hits-record-high-with-looming-rivals-unlikely-to-derail-it/", "time_published": "20240118T171600", "authors": ["ALLISON GATLIN", "Investor's Business Daily"], "summary": "ISRG Stock Hits Record High With Looming Rivals 'Unlikely To Derail' It Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/01/stock-Intuitive-Surgical-04-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.998356"}], "overall_sentiment_score": 0.271774, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.825924", "ticker_sentiment_score": "0.435002", "ticker_sentiment_label": "Bullish"}]}, {"title": "Reasons to Retain Intuitive Surgical  ( ISRG )  in Your Portfolio Now", "url": "https://www.zacks.com/stock/news/2211214/reasons-to-retain-intuitive-surgical-isrg-in-your-portfolio-now", "time_published": "20240117T112800", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/2297.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.337863, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MMSI", "relevance_score": "0.098862", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.196212", "ticker_sentiment_score": "0.173649", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.380736", "ticker_sentiment_score": "0.353433", "ticker_sentiment_label": "Bullish"}, {"ticker": "DVA", "relevance_score": "0.098862", "ticker_sentiment_score": "0.060057", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bitcoin ETFs, the Gig Economy, and Robotic Surgery", "url": "https://www.fool.com/investing/2024/01/16/bitcoin-etfs-the-gig-economy-and-robotic-surgery/", "time_published": "20240117T004600", "authors": ["Motley Fool Staff"], "summary": "These investors have a lot to talk about. And Burford Capital CEO Chris Bogart drops in to talk about the world of legal financing, his company's competitive advantages, and a high-stakes case with Argentina.", "banner_image": "https://g.foolcdn.com/editorial/images/760957/mfm_0110.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}, {"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.197701, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MFCSF", "relevance_score": "0.009461", "ticker_sentiment_score": "0.100329", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.009461", "ticker_sentiment_score": "0.100312", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.009461", "ticker_sentiment_score": "0.157209", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GS", "relevance_score": "0.009461", "ticker_sentiment_score": "0.157209", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DASH", "relevance_score": "0.009461", "ticker_sentiment_score": "-0.061485", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.028377", "ticker_sentiment_score": "0.076737", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.075575", "ticker_sentiment_score": "0.088299", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.01892", "ticker_sentiment_score": "0.141714", "ticker_sentiment_label": "Neutral"}, {"ticker": "BUR", "relevance_score": "0.01892", "ticker_sentiment_score": "0.035684", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.047278", "ticker_sentiment_score": "0.049846", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Suffers a Larger Drop Than the General Market: Key Insights", "url": "https://www.zacks.com/stock/news/2211107/intuitive-surgical-inc-isrg-suffers-a-larger-drop-than-the-general-market-key-insights", "time_published": "20240116T230018", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) reachead $362.33 at the closing of the latest trading day, reflecting a -0.38% change compared to its last close.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default300.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928769"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.201813, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.598621", "ticker_sentiment_score": "0.279967", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical Unusual Options Activity For January 16 - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/24/01/36648780/intuitive-surgical-unusual-options-activity-for-january-16", "time_published": "20240116T194603", "authors": ["Benzinga Insights"], "summary": "Investors with a lot of money to spend have taken a bearish stance on Intuitive Surgical ISRG. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}], "overall_sentiment_score": 0.147763, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.819198", "ticker_sentiment_score": "0.268435", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Earnings Expected to Grow: Should You Buy?", "url": "https://www.zacks.com/stock/news/2210809/intuitive-surgical-inc-isrg-earnings-expected-to-grow-should-you-buy", "time_published": "20240116T150033", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default79.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.189137, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.296463", "ticker_sentiment_score": "0.24676", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Should You Buy Intuitive Surgical  ( ISRG )  Ahead of Earnings?", "url": "https://www.zacks.com/stock/news/2210552/should-you-buy-intuitive-surgical-isrg-ahead-of-earnings", "time_published": "20240116T121700", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical (ISRG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e8/547.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99237"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.463457, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.89699", "ticker_sentiment_score": "0.604501", "ticker_sentiment_label": "Bullish"}]}, {"title": "The Zacks Analyst Blog Highlights Advanced Micro Devices, Abbott Laboratories, Qualcomm, Morgan Stanley and Intuitive Surgical", "url": "https://www.zacks.com/stock/news/2210521/the-zacks-analyst-blog-highlights-advanced-micro-devices-abbott-laboratories-qualcomm-morgan-stanley-and-intuitive-surgical", "time_published": "20240116T113600", "authors": ["Zacks Investment Research"], "summary": "Advanced Micro Devices, Abbott Laboratories, Qualcomm, Morgan Stanley and Intuitive Surgical are included in this Analyst Blog.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/0d/701.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.177829, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AMD", "relevance_score": "0.341857", "ticker_sentiment_score": "0.202679", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.276648", "ticker_sentiment_score": "0.110714", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.140485", "ticker_sentiment_score": "0.040143", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.276648", "ticker_sentiment_score": "0.161938", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.140485", "ticker_sentiment_score": "0.040143", "ticker_sentiment_label": "Neutral"}]}, {"title": "1 Top AI and Robotics Stock Closed Out 2023 With a Bang -- Is It a Buy for 2024?", "url": "https://www.fool.com/investing/2024/01/15/1-top-ai-and-robotics-stock-closed-out-2023-with-a/", "time_published": "20240115T103700", "authors": ["Nicholas Rossolillo"], "summary": "Intuitive Surgical just closed out 2023 in tip-top shape.", "banner_image": "https://media.ycharts.com/charts/c1bc4d0256082492d854b4780c2618a9.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.98396"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.262182, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.1331", "ticker_sentiment_score": "0.315945", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "These 9 Stocks Are Running To Start 2024", "url": "https://www.investors.com/news/sp-500-these-9-stocks-are-running-to-start-2024/", "time_published": "20240114T130000", "authors": ["ED CARSON", "Investor's Business Daily"], "summary": "The S&P 500 index is up just a fraction in 2024 so far, but a number of big caps are off to a strong start. Nvidia ( NVDA ) , the No. 1 S&P 500 stock performer in 2023, is leading the way again. That is, excluding Juniper Networks ( JNPR ) , which spiked last week as Hewlett Packard Enterprise ( ...", "banner_image": "https://www.investors.com/wp-content/uploads/2021/05/Stock-nvidia-hq-01-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.172108, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.500753", "ticker_sentiment_score": "0.177567", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANET", "relevance_score": "0.31482", "ticker_sentiment_score": "0.109733", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNPR", "relevance_score": "0.160633", "ticker_sentiment_score": "0.128431", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTLT", "relevance_score": "0.213048", "ticker_sentiment_score": "0.149398", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTRS", "relevance_score": "0.264515", "ticker_sentiment_score": "0.098631", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPQ", "relevance_score": "0.05387", "ticker_sentiment_score": "0.096737", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.31482", "ticker_sentiment_score": "0.107239", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPE", "relevance_score": "0.107495", "ticker_sentiment_score": "0.105371", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.31482", "ticker_sentiment_score": "0.246327", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PANW", "relevance_score": "0.213048", "ticker_sentiment_score": "0.028285", "ticker_sentiment_label": "Neutral"}]}, {"title": "Market Rebounds As Nvidia Leads; Bitcoin ETFs, Tesla Fall: Weekly Review", "url": "https://www.investors.com/news/stock-market-rally-rebounds-nvidia-tesla-jpmorgan-bitcoin-etfs-in-focus/", "time_published": "20240112T191300", "authors": ["Investor's Business Daily", "IBD STAFF"], "summary": "Market Rebounds As Nvidia Leads. Bitcoin ETFs, Tesla Fall: Weekly Review Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/11/Stock-bounce-05-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.99489"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.007321, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALK", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.11938", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.068371", "ticker_sentiment_score": "0.028338", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.11938", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.091075", "ticker_sentiment_score": "0.060214", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.136242", "ticker_sentiment_score": "0.010052", "ticker_sentiment_label": "Neutral"}, {"ticker": "CROX", "relevance_score": "0.068371", "ticker_sentiment_score": "0.189572", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.022883", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPQ", "relevance_score": "0.022815", "ticker_sentiment_score": "-0.000921", "ticker_sentiment_label": "Neutral"}, {"ticker": "BK", "relevance_score": "0.068371", "ticker_sentiment_score": "0.028338", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.045612", "ticker_sentiment_score": "0.128458", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.113705", "ticker_sentiment_score": "0.011467", "ticker_sentiment_label": "Neutral"}, {"ticker": "URBN", "relevance_score": "0.068371", "ticker_sentiment_score": "0.131736", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBH", "relevance_score": "0.068371", "ticker_sentiment_score": "-0.140846", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.022815", "ticker_sentiment_score": "0.001816", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGTX", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.022883", "ticker_sentiment_label": "Neutral"}, {"ticker": "EADSF", "relevance_score": "0.022815", "ticker_sentiment_score": "-0.111175", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.136242", "ticker_sentiment_score": "-0.148914", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPR", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.11938", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.045612", "ticker_sentiment_score": "0.027908", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.022883", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.068371", "ticker_sentiment_score": "0.002016", "ticker_sentiment_label": "Neutral"}, {"ticker": "WT", "relevance_score": "0.022815", "ticker_sentiment_score": "0.120065", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.091075", "ticker_sentiment_score": "0.027513", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXNX", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.022883", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARA", "relevance_score": "0.045612", "ticker_sentiment_score": "0.128458", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.068371", "ticker_sentiment_score": "0.087256", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.136242", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.045612", "ticker_sentiment_score": "0.027908", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNPR", "relevance_score": "0.068371", "ticker_sentiment_score": "-0.001011", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.022883", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEO", "relevance_score": "0.045612", "ticker_sentiment_score": "0.185014", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SWN", "relevance_score": "0.068371", "ticker_sentiment_score": "0.150164", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DAL", "relevance_score": "0.136242", "ticker_sentiment_score": "-0.020069", "ticker_sentiment_label": "Neutral"}, {"ticker": "LULU", "relevance_score": "0.045612", "ticker_sentiment_score": "0.185014", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GCO", "relevance_score": "0.045612", "ticker_sentiment_score": "0.185014", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANF", "relevance_score": "0.068371", "ticker_sentiment_score": "0.131736", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXEL", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.022883", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPE", "relevance_score": "0.180967", "ticker_sentiment_score": "-0.001504", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.022883", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.068371", "ticker_sentiment_score": "0.026257", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.091075", "ticker_sentiment_score": "-0.023423", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.246923", "ticker_sentiment_score": "0.097548", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why Regeneron Just Hit A Record High - Again", "url": "https://www.investors.com/news/technology/regn-stock-hits-a-record-high-again-as-it-tacks-on-new-wins/", "time_published": "20240112T182200", "authors": ["ALLISON GATLIN", "Investor's Business Daily"], "summary": "REGN Stock Hits A Record High - Again - As It Tacks On New Wins Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2020/08/Stock-regeneron-01-shutt.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}], "overall_sentiment_score": 0.259275, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ALNY", "relevance_score": "0.123844", "ticker_sentiment_score": "0.02857", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.303175", "ticker_sentiment_score": "0.346108", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AZN", "relevance_score": "0.123844", "ticker_sentiment_score": "0.02857", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.06211", "ticker_sentiment_score": "0.115369", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.06211", "ticker_sentiment_score": "0.337735", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SNY", "relevance_score": "0.06211", "ticker_sentiment_score": "0.190789", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Intuitive Surgical, Inc.  ( ISRG )  is Poised to Beat Earnings Estimates Again", "url": "https://www.zacks.com/stock/news/2209683/why-intuitive-surgical-inc-isrg-is-poised-to-beat-earnings-estimates-again", "time_published": "20240112T171010", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default79.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99989"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.31112, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.407844", "ticker_sentiment_score": "0.47206", "ticker_sentiment_label": "Bullish"}]}, {"title": "Lung Cancer Surgery Market Projected to Reach USD 20.2 billion with Registering at a CAGR of 5.6% by 2031| Transparency Market Research Inc.", "url": "https://www.benzinga.com/pressreleases/24/01/g36613349/lung-cancer-surgery-market-projected-to-reach-usd-20-2-billion-with-registering-at-a-cagr-of-5-6-b", "time_published": "20240112T161947", "authors": ["Globe Newswire"], "summary": "Wilmington, Delaware, United States, Jan. 12, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global lung cancer surgery market is estimated to flourish at a CAGR of 5.6% from 2023 to 2031.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.195235, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.034233", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.136306", "ticker_sentiment_score": "0.140847", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.034233", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFX", "relevance_score": "0.068404", "ticker_sentiment_score": "0.014449", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.068404", "ticker_sentiment_score": "0.105458", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCPNF", "relevance_score": "0.102449", "ticker_sentiment_score": "0.233034", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.034233", "ticker_sentiment_score": "0.178081", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WMGTF", "relevance_score": "0.102449", "ticker_sentiment_score": "0.023021", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical (ISRG) Preliminary Q4 Revenues Improve Y/Y", "url": "https://www.zacks.com/stock/news/2208995/intuitive-surgical-isrg-preliminary-q4-revenues-improve-yy", "time_published": "20240111T162500", "authors": [], "summary": "Intuitive Surgical's (ISRG) fourth-quarter revenues reflect a strong demand in procedure volume as China recovers following the resurgence of COVID-19 in early 2023.", "banner_image": null, "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.239137, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MMSI", "relevance_score": "0.121037", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.239305", "ticker_sentiment_score": "0.195358", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.506832", "ticker_sentiment_score": "0.106492", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.121037", "ticker_sentiment_score": "0.105658", "ticker_sentiment_label": "Neutral"}]}, {"title": "Strength Seen in Intuitive Surgical, Inc.  ( ISRG ) : Can Its 10.3% Jump Turn into More Strength?", "url": "https://www.zacks.com/stock/news/2208841/strength-seen-in-intuitive-surgical-inc-isrg-can-its-103-jump-turn-into-more-strength", "time_published": "20240111T141900", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default254.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.233742, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.572601", "ticker_sentiment_score": "0.269634", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HOLX", "relevance_score": "0.572601", "ticker_sentiment_score": "-0.087397", "ticker_sentiment_label": "Neutral"}]}, {"title": "Investor Optimism Rises Ahead Of Key Inflation Reports; Nasdaq Surges Over 100 Points - Concrete Pumping Holdings  ( NASDAQ:BBCP ) , Infosys  ( NYSE:INFY ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36588551/investor-optimism-rises-ahead-of-key-inflation-reports-nasdaq-surges-over-100-points", "time_published": "20240111T080513", "authors": ["Avi Kapoor"], "summary": "The CNN Money Fear and Greed index showed further improvement in overall market sentiment, but the index remained in the \"Greed\" zone on Wednesday. U.S. stocks closed higher on Wednesday before inflation data and earnings were released.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/11/image_4.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": -0.154908, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "WBD", "relevance_score": "0.124809", "ticker_sentiment_score": "-0.180469", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BBCP", "relevance_score": "0.246582", "ticker_sentiment_score": "-0.387413", "ticker_sentiment_label": "Bearish"}, {"ticker": "INFY", "relevance_score": "0.246582", "ticker_sentiment_score": "-0.387413", "ticker_sentiment_label": "Bearish"}, {"ticker": "LEN", "relevance_score": "0.246582", "ticker_sentiment_score": "0.444106", "ticker_sentiment_label": "Bullish"}, {"ticker": "NTIC", "relevance_score": "0.246582", "ticker_sentiment_score": "-0.387413", "ticker_sentiment_label": "Bearish"}, {"ticker": "ISRG", "relevance_score": "0.246582", "ticker_sentiment_score": "0.444106", "ticker_sentiment_label": "Bullish"}]}, {"title": "Company News for Jan 11, 2024", "url": "https://www.zacks.com/stock/news/2208610/company-news-for-jan-11-2024", "time_published": "20240111T080400", "authors": ["Zacks Equity Research"], "summary": "Companies In The News Are: WDFC, ETWO, LEN, ISRG.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d3/848.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.283527, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "WDFC", "relevance_score": "0.56415", "ticker_sentiment_score": "0.417545", "ticker_sentiment_label": "Bullish"}, {"ticker": "LEN", "relevance_score": "0.56415", "ticker_sentiment_score": "0.368709", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.56415", "ticker_sentiment_score": "0.371639", "ticker_sentiment_label": "Bullish"}, {"ticker": "ETWO", "relevance_score": "0.56415", "ticker_sentiment_score": "0.439785", "ticker_sentiment_label": "Bullish"}]}, {"title": "Stock Upgrades: Intuitive Surgical Shows Rising Relative Strength", "url": "https://www.investors.com/ibd-data-stories/stock-upgrades-intuitive-surgical-shows-rising-relative-strength-2/", "time_published": "20240111T080000", "authors": ["INVESTOR'S BUSINESS DAILY", "Investor's Business Daily"], "summary": "When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Intuitive Surgical ( ISRG ) , which saw a welcome improvement to its Relative Strength ( RS ) Rating on Thursday, rising from 77 to 90.", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.341787, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.546745", "ticker_sentiment_score": "0.467744", "ticker_sentiment_label": "Bullish"}]}, {"title": "Learning From Motley Fool Rule Breakers History", "url": "https://www.fool.com/investing/2024/01/10/learning-from-motley-fool-rule-breakers-history/", "time_published": "20240111T031000", "authors": ["Motley Fool Staff"], "summary": "\"The lessons we really learn, and earn, are a consequence of observing and living through history measured in years, not hours or days,\" Motley Fool co-founder David Gardner.", "banner_image": "https://g.foolcdn.com/editorial/images/760348/image.jpeg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Macro", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.201952, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.005823", "ticker_sentiment_score": "0.073862", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.005823", "ticker_sentiment_score": "0.105208", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.023287", "ticker_sentiment_score": "0.10873", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.023287", "ticker_sentiment_score": "0.114014", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.005823", "ticker_sentiment_score": "0.105208", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMG", "relevance_score": "0.081374", "ticker_sentiment_score": "0.089015", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.029106", "ticker_sentiment_score": "0.102727", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTSC", "relevance_score": "0.005823", "ticker_sentiment_score": "0.200814", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Markets Trade Higher Ahead of Thursday's CPI", "url": "https://www.zacks.com/stock/news/2208516/markets-trade-higher-ahead-of-thursdays-cpi", "time_published": "20240110T225500", "authors": ["Mark Vickery"], "summary": "Core CPI year over year looks to shed 20 bps to +3.8%, which would be the lowest print since the latter half of 2021.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6e/54381.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.769861"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.273603, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KBH", "relevance_score": "0.188193", "ticker_sentiment_score": "0.140712", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.188193", "ticker_sentiment_score": "0.229438", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVDA", "relevance_score": "0.188193", "ticker_sentiment_score": "0.229438", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.188193", "ticker_sentiment_score": "0.229438", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "V", "relevance_score": "0.188193", "ticker_sentiment_score": "0.229438", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical leads S&P 500 gainers after guidance that handily topped analyst estimates", "url": "https://www.marketwatch.com/story/intuitive-surgical-leads-s-p-500-gainers-as-analysts-welcome-bullish-guidance-for-2024-8b019845", "time_published": "20240110T194100", "authors": ["Ciara Linnane"], "summary": "Stock soared 9.5% to put it on track for biggest one-day gain in almost a year.", "banner_image": "https://images.mktw.net/im-40684020/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}], "overall_sentiment_score": 0.223432, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.24289", "ticker_sentiment_score": "0.366742", "ticker_sentiment_label": "Bullish"}, {"ticker": "JPM", "relevance_score": "0.163354", "ticker_sentiment_score": "0.258399", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Stocks Edge Higher, Bitcoin Holds Steady Awaiting SEC's Decision: What's Driving Markets Wednesday? - Boeing  ( NYSE:BA ) ", "url": "https://www.benzinga.com/markets/cryptocurrency/24/01/36582327/stocks-edge-higher-bitcoin-holds-steady-awaiting-secs-decision-whats-driving-markets-wedne", "time_published": "20240110T191853", "authors": ["Piero Cingari"], "summary": "Wednesday's session is one of modest gains on Wall Street, with all major large-cap stock indices in the green. Market attention is focused on the long-awaited decision by the Securities and Exchange Commission regarding the approval of Bitcoin ETFs.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Wall-Street-sign.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.961735"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.238487, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.193465", "ticker_sentiment_score": "0.125099", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.097457", "ticker_sentiment_score": "0.172582", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IVZ", "relevance_score": "0.097457", "ticker_sentiment_score": "0.204602", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.193465", "ticker_sentiment_score": "0.225808", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.097457", "ticker_sentiment_score": "0.172582", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PANW", "relevance_score": "0.193465", "ticker_sentiment_score": "0.245164", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FOREX:USD", "relevance_score": "0.193465", "ticker_sentiment_score": "0.092232", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.28664", "ticker_sentiment_score": "0.143862", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.193465", "ticker_sentiment_score": "0.179363", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Stock Market Struggles For Gains; Bitcoin Stocks See More Drama; Chip Equipment Stock Tanks", "url": "https://www.investors.com/market-trend/stock-market-today/stock-market-struggles-for-gains-bitcoin-stocks-see-more-drama/", "time_published": "20240110T155600", "authors": ["KIMBERLEY KOENIG", "Investor's Business Daily"], "summary": "Stock Market Struggles For Gains. Bitcoin Stocks See More Drama. Chip Equipment Stock Tanks Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2021/04/Stock-bitcoindrop-01a-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.190638, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MARA", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.065335", "ticker_sentiment_label": "Neutral"}, {"ticker": "BE", "relevance_score": "0.057215", "ticker_sentiment_score": "0.31806", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNPR", "relevance_score": "0.170475", "ticker_sentiment_score": "0.036653", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.114137", "ticker_sentiment_score": "0.071308", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPQ", "relevance_score": "0.057215", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.057215", "ticker_sentiment_score": "-0.17599", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IVZ", "relevance_score": "0.057215", "ticker_sentiment_score": "-0.055178", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.065335", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEHR", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.082001", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.170475", "ticker_sentiment_score": "0.162602", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LEN", "relevance_score": "0.114137", "ticker_sentiment_score": "0.258958", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ETSY", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.1961", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GCT", "relevance_score": "0.114137", "ticker_sentiment_score": "0.004738", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOST", "relevance_score": "0.114137", "ticker_sentiment_score": "0.245489", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HPE", "relevance_score": "0.170475", "ticker_sentiment_score": "0.036653", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.170475", "ticker_sentiment_score": "0.065931", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stock market today: Wall Street nears record high as markets prep for an inflation report", "url": "https://apnews.com/article/stock-market-rates-tokyo-67e003dd6d80b57d63c8455f03030708", "time_published": "20240110T144845", "authors": ["STAN CHOE"], "summary": "Stock market today: Wall Street stays in neutral as markets wait for inflation report The Associated Press ...", "banner_image": "https://dims.apnews.com/dims4/default/b26b199/2147483647/strip/true/crop/3381x2252+0+1/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2Fbb%2Fb1%2Fd7a7bc8a1315ef92c7043ba57938%2Fb11172ae40a14d53b214b0a838af754a", "source": "Associated Press", "category_within_source": "Markets", "source_domain": "apnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Economy - Monetary", "relevance_score": "0.9545"}, {"topic": "Financial Markets", "relevance_score": "0.998962"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": -0.009806, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "WDFC", "relevance_score": "0.049019", "ticker_sentiment_score": "0.313384", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BAC", "relevance_score": "0.049019", "ticker_sentiment_score": "0.198044", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LEN", "relevance_score": "0.049019", "ticker_sentiment_score": "0.045457", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.049019", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.049019", "ticker_sentiment_score": "-0.21608", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ISRG", "relevance_score": "0.049019", "ticker_sentiment_score": "0.045457", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAL", "relevance_score": "0.049019", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.049019", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:JPY", "relevance_score": "0.146321", "ticker_sentiment_score": "0.059072", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.049019", "ticker_sentiment_score": "-0.013995", "ticker_sentiment_label": "Neutral"}]}, {"title": "What's Going On With Robotics Focused Intuitive Surgical Stock Today? - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36574286/whats-going-on-with-robotics-focused-intuitive-surgical-stock-today", "time_published": "20240110T144033", "authors": ["Vandana Singh"], "summary": "Tuesday, Intuitive Surgical Inc ISRG reported preliminary fourth-quarter revenue of approximately $1.93 billion, up 17% Y/Y, versus the consensus estimates of $1.87 billion. The company expects FY23 revenue of approximately $7.12 billion, up 14% Y/Y versus estimates of $7.07 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/10/isrg.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.281177, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.419733", "ticker_sentiment_score": "0.192027", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Three Stocks: The Buyers Are Back, Analysts Are Running, So Should You, and An AI Healthcare Stock? Yup!", "url": "https://moneymorning.com/2024/01/10/three-stocks-the-buyers-are-back-analysts-are-running-so-should-you-and-an-ai-healthcare-stock-yup/", "time_published": "20240110T141218", "authors": ["Chris Johnson"], "summary": "As we've spoken about for the past month, you should invest in the transactions in real estate in 2024, not the house. What I mean by that is don't buy the homebuilders in 2024, they've got excess inventory coming online which could put them in a spot.", "banner_image": "https://moneymorning.com/wp-content/blogs.dir/1/files/2018/11/Retina_Headshots_ChrisJohnson.jpg", "source": "Money Morning", "category_within_source": "RSS", "source_domain": "moneymorning.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.053029, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GS", "relevance_score": "0.13459", "ticker_sentiment_score": "-0.238626", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RDFN", "relevance_score": "0.265378", "ticker_sentiment_score": "0.27027", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ETSY", "relevance_score": "0.388879", "ticker_sentiment_score": "0.041098", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.388879", "ticker_sentiment_score": "0.448441", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bitcoin, Ethereum, Dogecoin Dip Following False ETF Approval Report, Triggering $200M In Liquidations; Biden Trails Trump In Key Michigan Poll, But Democrats May Have A Workaround - Top Headlines Today While US Was Sleeping", "url": "https://www.benzinga.com/markets/cryptocurrency/24/01/36574351/bitcoin-ethereum-dogecoin-dip-following-false-etf-approval-report-triggering-200m-in-liqui", "time_published": "20240110T135929", "authors": ["Akanksha Bakshi"], "summary": "MicroStrategy's Bitcoin Paper Gains Swell To $840M In 2024 Dogecoin Sees $2.4M In Liquidations Amid Rumor Of Mascot's Death Apple Boots Binance, Others From App Store in India After Government Crack Down Gensler's 'SEC Twitter Account Was Compromised' Tweet Is Now An Ordinal 'Immortalized On ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/10/news-image_by_piro_from_pixabay.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.187457, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.065327", "ticker_sentiment_score": "-0.133832", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.065327", "ticker_sentiment_score": "-0.133832", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.065327", "ticker_sentiment_score": "-0.321336", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NVDA", "relevance_score": "0.065327", "ticker_sentiment_score": "-0.100132", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.130217", "ticker_sentiment_score": "-0.047903", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNPR", "relevance_score": "0.065327", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGH", "relevance_score": "0.065327", "ticker_sentiment_score": "0.15831", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HPQ", "relevance_score": "0.065327", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPE", "relevance_score": "0.065327", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.065327", "ticker_sentiment_score": "0.15831", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PSMT", "relevance_score": "0.065327", "ticker_sentiment_score": "0.15831", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.433877", "ticker_sentiment_score": "-0.093449", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.065327", "ticker_sentiment_score": "-0.09336", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:DOGE", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.294659", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "ISRG Stock Jumps On Q4 Revision, New Buy Point In Play", "url": "https://www.investors.com/news/technology/isrg-stock-jumps-on-q4-revision-new-buy-point-in-play/", "time_published": "20240110T131200", "authors": ["ALAN R. ELLIOTT", "Investor's Business Daily"], "summary": "Robotic surgical instruments innovator Intuitive Surgical ( ISRG ) on Tuesday guided fourth-quarter revenue expectations to $1.93 billion, vs. consensus views for $1.87 billion. ISRG stock rose more than 5% in Wednesday's premarket trade, pacing the early action on the Nasdaq and S&P 500 ...", "banner_image": "https://www.investors.com/wp-content/uploads/2017/10/stock-IntuitiveSurgical-01-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.164471, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.454174", "ticker_sentiment_score": "0.199584", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JPM", "relevance_score": "0.159569", "ticker_sentiment_score": "0.097443", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket - Aehr Test Systems  ( NASDAQ:AEHR ) , AERWINS Technologies  ( NASDAQ:AWIN ) ", "url": "https://www.benzinga.com/news/24/01/36574594/why-aehr-test-systems-shares-are-trading-lower-by-15-here-are-20-stocks-moving-premarket", "time_published": "20240110T130259", "authors": ["Avi Kapoor"], "summary": "Shares of Aehr Test Systems AEHR shares fell sharply in pre-market trading after the company lowered its full-year revenue guidance. The company said revenue will likely be impacted by an anticipated delay in the timing of new orders from current and new customers.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/10/image39_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.882182"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.928769"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.092257, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "XCUR", "relevance_score": "0.206392", "ticker_sentiment_score": "-0.110928", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGE", "relevance_score": "0.138464", "ticker_sentiment_score": "-0.053305", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWIN", "relevance_score": "0.206392", "ticker_sentiment_score": "-0.046709", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRYU", "relevance_score": "0.138464", "ticker_sentiment_score": "0.043453", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICCT", "relevance_score": "0.206392", "ticker_sentiment_score": "0.191412", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NEXI", "relevance_score": "0.138464", "ticker_sentiment_score": "-0.053305", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLDS", "relevance_score": "0.138464", "ticker_sentiment_score": "-0.331772", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SSL", "relevance_score": "0.138464", "ticker_sentiment_score": "-0.238639", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GRTX", "relevance_score": "0.138464", "ticker_sentiment_score": "-0.057457", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.138464", "ticker_sentiment_score": "0.223379", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PSMT", "relevance_score": "0.138464", "ticker_sentiment_score": "0.313697", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AEHR", "relevance_score": "0.206392", "ticker_sentiment_score": "0.107891", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGTX", "relevance_score": "0.206392", "ticker_sentiment_score": "0.096526", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.069495", "ticker_sentiment_score": "0.061204", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZCAR", "relevance_score": "0.138464", "ticker_sentiment_score": "0.146913", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGH", "relevance_score": "0.138464", "ticker_sentiment_score": "0.40098", "ticker_sentiment_label": "Bullish"}, {"ticker": "ELEV", "relevance_score": "0.206392", "ticker_sentiment_score": "0.064242", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEXPF", "relevance_score": "0.069495", "ticker_sentiment_score": "-0.041971", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.206392", "ticker_sentiment_score": "0.139318", "ticker_sentiment_label": "Neutral"}]}, {"title": "US Stocks Set For Mixed Open, Cryptos Slip As Bitcoin ETF Decision Day Arrives: Analyst Says S&P 500 Was 'Due For A Break' After Red-Hot 2023 Finish - Biglari Holdings  ( NYSE:BH ) ", "url": "https://www.benzinga.com/markets/equities/24/01/36574043/us-stocks-set-for-mixed-open-cryptos-slip-as-bitcoin-etf-decision-day-arrives-analyst-says-s-p-5", "time_published": "20240110T123618", "authors": ["Shanthi Rexaline"], "summary": "The market mood may continue to be lackluster, with index futures indicating a mixed opening on Wednesday. The potential approval of a spot Bitcoin BTC/USD exchange-traded fund is the major event traders are likely anticipating, and a green light from the SEC could spark a rally in both crypto ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/data-charts_0.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.998947"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.03888, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KBH", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNPR", "relevance_score": "0.110209", "ticker_sentiment_score": "0.020522", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPQ", "relevance_score": "0.055236", "ticker_sentiment_score": "0.018022", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPE", "relevance_score": "0.110209", "ticker_sentiment_score": "0.020522", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.055236", "ticker_sentiment_score": "0.219949", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.110209", "ticker_sentiment_score": "0.29228", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "COIN", "relevance_score": "0.110209", "ticker_sentiment_score": "0.044396", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:JPY", "relevance_score": "0.055236", "ticker_sentiment_score": "-0.107846", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:CAD", "relevance_score": "0.055236", "ticker_sentiment_score": "-0.107846", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.110209", "ticker_sentiment_score": "-0.042375", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.322374", "ticker_sentiment_score": "0.009572", "ticker_sentiment_label": "Neutral"}]}, {"title": "Futures Mixed; Tesla Launches Updated Model 3 In North America", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-updated-tesla-model-3-launched-in-north-america/", "time_published": "20240110T121400", "authors": ["ED CARSON", "Investor's Business Daily"], "summary": "Dow Jones Futures Fall. Updated Tesla Model 3 Launched In North America Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2017/02/stock-wallStreet-1-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.214378"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.069254, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MARA", "relevance_score": "0.147818", "ticker_sentiment_score": "-0.167722", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GOOG", "relevance_score": "0.049526", "ticker_sentiment_score": "0.144115", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.098862", "ticker_sentiment_score": "0.215036", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AAPL", "relevance_score": "0.098862", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNPR", "relevance_score": "0.147818", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPQ", "relevance_score": "0.098862", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.147818", "ticker_sentiment_score": "-0.167722", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AEHR", "relevance_score": "0.243864", "ticker_sentiment_score": "-0.218294", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MSFT", "relevance_score": "0.049526", "ticker_sentiment_score": "0.20116", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.423843", "ticker_sentiment_score": "0.070716", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEN", "relevance_score": "0.243864", "ticker_sentiment_score": "0.187585", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HPE", "relevance_score": "0.243864", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.243864", "ticker_sentiment_score": "0.143496", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.243864", "ticker_sentiment_score": "0.038118", "ticker_sentiment_label": "Neutral"}]}, {"title": "PriceSmart Posts Upbeat Earnings, Joins SMART Global, Intuitive Surgical And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session - Fox Factory Hldg  ( NASDAQ:FOXF ) , Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/24/01/36571973/pricesmart-posts-upbeat-earnings-joins-smart-global-intuitive-surgical-and-other-big-stocks-moving-h", "time_published": "20240110T101854", "authors": ["Avi Kapoor"], "summary": "U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 60 points on Wednesday. Shares of PriceSmart, Inc. PSMT rose sharply in pre-market trading as the company reported better-than-expected earnings for its first quarter.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/10/pricesmart_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.904684"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.259316, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SNEJF", "relevance_score": "0.337811", "ticker_sentiment_score": "0.217264", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TGTX", "relevance_score": "0.337811", "ticker_sentiment_score": "0.143059", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.115787", "ticker_sentiment_score": "0.06791", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGH", "relevance_score": "0.229149", "ticker_sentiment_score": "0.449554", "ticker_sentiment_label": "Bullish"}, {"ticker": "FOXF", "relevance_score": "0.229149", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOST", "relevance_score": "0.229149", "ticker_sentiment_score": "0.409881", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.337811", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.229149", "ticker_sentiment_score": "0.065989", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSMT", "relevance_score": "0.439786", "ticker_sentiment_score": "0.371959", "ticker_sentiment_label": "Bullish"}]}, {"title": "KB Home, PriceSmart And 3 Stocks To Watch Heading Into Wednesday - KB Home  ( NYSE:KBH ) , Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36570989/kb-home-pricesmart-and-3-stocks-to-watch-heading-into-wednesday", "time_published": "20240110T082031", "authors": ["Avi Kapoor"], "summary": "With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects KB Home KBH to report quarterly earnings at $1.69 per share on revenue of $1.62 billion after the closing bell.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/10/kb_home_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.341249, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KBH", "relevance_score": "0.518022", "ticker_sentiment_score": "0.568136", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.360752", "ticker_sentiment_score": "0.307407", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RELL", "relevance_score": "0.518022", "ticker_sentiment_score": "0.335238", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SGH", "relevance_score": "0.518022", "ticker_sentiment_score": "0.795647", "ticker_sentiment_label": "Bullish"}, {"ticker": "PSMT", "relevance_score": "0.518022", "ticker_sentiment_score": "0.644906", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Surgical  ( NASDAQ:ISRG )  Upgraded to Buy by StockNews.com", "url": "https://www.defenseworld.net/2024/01/10/intuitive-surgical-nasdaqisrg-upgraded-to-buy-by-stocknews-com.html", "time_published": "20240110T075643", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of Intuitive Surgical ( NASDAQ:ISRG - Free Report ) from a hold rating to a buy rating in a research note published on Tuesday.", "banner_image": "https://www.marketbeat.com/logos/intuitive-surgical-inc-logo.png?v=20231227090315", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.922939"}, {"topic": "Earnings", "relevance_score": "0.976913"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.301508, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TFC", "relevance_score": "0.041181", "ticker_sentiment_score": "0.074767", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.041181", "ticker_sentiment_score": "0.074767", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.744032", "ticker_sentiment_score": "0.472448", "ticker_sentiment_label": "Bullish"}, {"ticker": "MS", "relevance_score": "0.041181", "ticker_sentiment_score": "0.074767", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Stock Is Rising After Hours: What's Going On? - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/24/01/36567607/intuitive-surgical-stock-is-rising-after-hours-whats-going-on", "time_published": "20240109T223459", "authors": ["Adam Eckert"], "summary": "Intuitive Surgical Inc ISRG shares are trading higher in Tuesday's after-hours session after the company reported preliminary financial results. What Happened: Intuitive Surgical said it expects fourth-quarter revenue of approximately $1.93 billion versus estimates of $1.87 billion, according to ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/intuitive-da-vinci-or-staff-with-vision-.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.132544, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.944494", "ticker_sentiment_score": "0.252129", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JPM", "relevance_score": "0.16849", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Announces Preliminary Fourth Quarter and Full Year 2023 Results", "url": "https://www.globenewswire.com/news-release/2024/01/09/2806665/7637/en/Intuitive-Announces-Preliminary-Fourth-Quarter-and-Full-Year-2023-Results.html", "time_published": "20240109T210500", "authors": ["Inc.", "Intuitive Surgical"], "summary": "SUNNYVALE, Calif., Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- Intuitive ( the \"Company\" ) ( Nasdaq: ISRG ) , a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2023 financial ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/db89f2a9-76ed-4743-84d3-a7ac75605b6c", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}, {"topic": "Earnings", "relevance_score": "0.459462"}], "overall_sentiment_score": 0.111646, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "FOSUF", "relevance_score": "0.022536", "ticker_sentiment_score": "-0.011175", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.067536", "ticker_sentiment_score": "0.140823", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFOSF", "relevance_score": "0.022536", "ticker_sentiment_score": "-0.011175", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Beats Stock Market Upswing: What Investors Need to Know", "url": "https://www.zacks.com/stock/news/2207230/intuitive-surgical-inc-isrg-beats-stock-market-upswing-what-investors-need-to-know", "time_published": "20240108T225017", "authors": ["Zacks Equity Research"], "summary": "In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $328.86, marking a +1.97% move from the previous day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default281.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.28786, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.546745", "ticker_sentiment_score": "0.376546", "ticker_sentiment_label": "Bullish"}]}, {"title": "AAMI and FDA Co-Sponsor Medtech Conference, 'AAMI and FDA neXus'", "url": "https://www.benzinga.com/pressreleases/24/01/g36535042/aami-and-fda-co-sponsor-medtech-conference-aami-and-fda-nexus", "time_published": "20240108T143700", "authors": ["Globe Newswire"], "summary": "Arlington, VA, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- The Association for the Advancement of Medical Instrumentation ( AAMI ) is delighted to welcome the U.S. Food and Drug Administration as an official co-sponsor of its upcoming medical device standards conference, AAMI and FDA neXus 2024.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.144866, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.075397", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "STE", "relevance_score": "0.075397", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.075397", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Is a Trending Stock: Facts to Know Before Betting on It", "url": "https://www.zacks.com/stock/news/2206892/intuitive-surgical-inc-isrg-is-a-trending-stock-facts-to-know-before-betting-on-it", "time_published": "20240108T140006", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default297.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.237299, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.507331", "ticker_sentiment_score": "0.16549", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Inogen  ( INGN )  Soars 15.4%: Is Further Upside Left in the Stock?", "url": "https://www.zacks.com/stock/news/2206766/inogen-ingn-soars-154-is-further-upside-left-in-the-stock", "time_published": "20240108T121000", "authors": ["Zacks Equity Research"], "summary": "Inogen (INGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default136.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.219018, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.542261", "ticker_sentiment_score": "-0.08472", "ticker_sentiment_label": "Neutral"}, {"ticker": "INGN", "relevance_score": "0.627119", "ticker_sentiment_score": "0.42456", "ticker_sentiment_label": "Bullish"}]}, {"title": "What That Famous Investing Quote About Bulls, Bears, and Pigs Gets Wrong", "url": "https://www.fool.com/investing/2024/01/06/what-that-famous-quote-about-bulls-bears-and-pigs/", "time_published": "20240106T150400", "authors": ["Motley Fool Staff"], "summary": "Motley Fool co-founder David Gardner responds to comments and questions from \"Rule Breaker Investing\" listeners.", "banner_image": "https://g.foolcdn.com/editorial/images/759873/image.jpeg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}], "overall_sentiment_score": 0.247416, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.00915", "ticker_sentiment_score": "0.032336", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.018299", "ticker_sentiment_score": "0.034471", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.018299", "ticker_sentiment_score": "0.034471", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.00915", "ticker_sentiment_score": "0.032336", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.018299", "ticker_sentiment_score": "0.178122", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BKNG", "relevance_score": "0.00915", "ticker_sentiment_score": "0.032336", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.00915", "ticker_sentiment_score": "0.032336", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.027445", "ticker_sentiment_score": "0.036153", "ticker_sentiment_label": "Neutral"}]}, {"title": "Big Players' Recent Trades in ISRG Options - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/24/01/36477896/big-players-recent-trades-in-isrg-options", "time_published": "20240103T204622", "authors": ["Benzinga Insights"], "summary": "Whales with a lot of money to spend have taken a noticeably bearish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ISRG we detected 44 trades. If we consider the specifics of each trade, it is accurate to state that 43% of the investors opened trades with bullish ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}], "overall_sentiment_score": 0.203281, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.800874", "ticker_sentiment_score": "0.244027", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "$1000 Invested In Intuitive Surgical 15 Years Ago Would Be Worth This Much Today - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/24/01/36471888/1000-invested-in-intuitive-surgical-15-years-ago-would-be-worth-this-much-today", "time_published": "20240103T153024", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 15 years by 12.79% on an annualized basis producing an average annual return of 24.35%. Currently, Intuitive Surgical has a market capitalization of $115.50 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "3 Top Stocks to Buy for the Long Haul", "url": "https://www.fool.com/investing/2024/01/03/3-top-stocks-to-buy-for-the-long-haul/", "time_published": "20240103T124500", "authors": ["Selena Maranjian"], "summary": "These three investments are poised to perform well over many years to come.", "banner_image": "https://g.foolcdn.com/editorial/images/759642/getty-happy-feet-on-desk-smiling-tattoos.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.998311"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.87644"}], "overall_sentiment_score": 0.279618, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.427597", "ticker_sentiment_score": "0.287772", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOOG", "relevance_score": "0.064276", "ticker_sentiment_score": "0.088068", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.128135", "ticker_sentiment_score": "0.10255", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.064276", "ticker_sentiment_score": "0.088068", "ticker_sentiment_label": "Neutral"}, {"ticker": "COST", "relevance_score": "0.064276", "ticker_sentiment_score": "0.088068", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.064276", "ticker_sentiment_score": "0.088068", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.128135", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.19117", "ticker_sentiment_score": "0.14513", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why Intuitive Surgical, Inc.  ( ISRG )  Fell More Than Broader Market", "url": "https://www.zacks.com/stock/news/2204669/heres-why-intuitive-surgical-inc-isrg-fell-more-than-broader-market", "time_published": "20240102T225017", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $330.98, signifying a -1.89% move from its prior day's close.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default46.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.218603, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.661658", "ticker_sentiment_score": "0.324202", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": " ( ISRG )  - Analyzing Intuitive Surgical's Short Interest - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/short-sellers/24/01/36450045/isrg-analyzing-intuitive-surgicals-short-interest", "time_published": "20240102T131512", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical's ISRG short percent of float has fallen 11.0% since its last report. The company recently reported that it has 3.11 million shares sold short, which is 0.89% of all regular shares that are available for trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.259737, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.221819", "ticker_sentiment_score": "0.110774", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Time-Tested Stocks to Buy Right Now That Could Make You Richer in 2024", "url": "https://www.fool.com/investing/2023/12/29/2-time-tested-stocks-to-buy-right-now-that-could/", "time_published": "20231229T140000", "authors": ["Rachel Warren"], "summary": "These companies serve constant consumer needs, lending resilience to their businesses.", "banner_image": "https://g.foolcdn.com/editorial/images/759425/investing-woman-wall-street-suit-stocks-finance.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.98396"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": 0.234508, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.098255", "ticker_sentiment_score": "0.149847", "ticker_sentiment_label": "Neutral"}, {"ticker": "COST", "relevance_score": "0.33433", "ticker_sentiment_score": "0.182554", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Which Mutual Funds Are Positioned Perfectly For 2024?", "url": "https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-funds-are-positioned-perfectly-for-2024/", "time_published": "20231229T120000", "authors": ["Investor's Business Daily", "ADAM SHELL"], "summary": "Best Mutual Funds: Which Are Positioned Perfectly For 2024? Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2021/04/Stock-marketBoard-29-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.838487"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.266261, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ENPH", "relevance_score": "0.038314", "ticker_sentiment_score": "0.276091", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "META", "relevance_score": "0.038314", "ticker_sentiment_score": "0.143593", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.057444", "ticker_sentiment_score": "0.142039", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.057444", "ticker_sentiment_score": "0.206", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SWK", "relevance_score": "0.038314", "ticker_sentiment_score": "0.182612", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SWKH", "relevance_score": "0.019163", "ticker_sentiment_score": "0.17269", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "USEG", "relevance_score": "0.019163", "ticker_sentiment_score": "0.116482", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADMA", "relevance_score": "0.038314", "ticker_sentiment_score": "0.198468", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UNH", "relevance_score": "0.038314", "ticker_sentiment_score": "0.1224", "ticker_sentiment_label": "Neutral"}, {"ticker": "DEO", "relevance_score": "0.019163", "ticker_sentiment_score": "0.099371", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.07654", "ticker_sentiment_score": "0.187525", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CECO", "relevance_score": "0.038314", "ticker_sentiment_score": "0.297189", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ASHTF", "relevance_score": "0.038314", "ticker_sentiment_score": "0.293549", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.038314", "ticker_sentiment_score": "0.044768", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEDG", "relevance_score": "0.038314", "ticker_sentiment_score": "0.276091", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.038314", "ticker_sentiment_score": "0.143593", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNR", "relevance_score": "0.038314", "ticker_sentiment_score": "0.1224", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.057444", "ticker_sentiment_score": "0.160299", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MORN", "relevance_score": "0.038314", "ticker_sentiment_score": "0.143593", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.038314", "ticker_sentiment_score": "0.044768", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.057444", "ticker_sentiment_score": "0.142039", "ticker_sentiment_label": "Neutral"}, {"ticker": "STLD", "relevance_score": "0.038314", "ticker_sentiment_score": "0.293549", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Stocks Showing Improved Relative Strength: Axonics", "url": "https://www.investors.com/ibd-data-stories/stocks-showing-improved-relative-strength-axonics/", "time_published": "20231229T080000", "authors": ["Investor's Business Daily", "INVESTOR'S BUSINESS DAILY"], "summary": "On Friday, Axonics ( AXNX ) received a positive adjustment to its Relative Strength ( RS ) Rating, from 67 to 71. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.322937, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IDXX", "relevance_score": "0.318897", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.318897", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXNX", "relevance_score": "0.588876", "ticker_sentiment_score": "0.334266", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Investors Heavily Search Intuitive Surgical, Inc.  ( ISRG ) : Here is What You Need to Know", "url": "https://www.zacks.com/stock/news/2203106/investors-heavily-search-intuitive-surgical-inc-isrg-here-is-what-you-need-to-know", "time_published": "20231228T140006", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default182.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.230367, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.509136", "ticker_sentiment_score": "0.168919", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Myriam J. Curet, M.D. to its Board of Directors", "url": "https://www.globenewswire.com/news-release/2023/12/28/2801688/0/en/Inspire-Medical-Systems-Inc-Announces-Appointment-of-Seasoned-Medical-Device-Executive-Myriam-J-Curet-M-D-to-its-Board-of-Directors.html", "time_published": "20231228T130000", "authors": ["Inspire Medical Systems"], "summary": "Company adds further expertise in medical device industry R&D, regulatory affairs and commercialization Company adds further expertise in medical device industry R&D, regulatory affairs and commercialization ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/7298e8ee-9586-47cb-8af2-4d8d50ddbf8e", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.180749, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "INSP", "relevance_score": "0.221481", "ticker_sentiment_score": "0.16128", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.074692", "ticker_sentiment_score": "0.038884", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.074692", "ticker_sentiment_score": "0.172903", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Myriam J. Curet, M.D. to its Board of Directors - Inspire Medical Systems  ( NYSE:INSP ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36409718/inspire-medical-systems-inc-announces-appointment-of-seasoned-medical-device-executive-myriam-j-cu", "time_published": "20231228T130000", "authors": ["Globe Newswire"], "summary": "MINNEAPOLIS, Dec. 28, 2023 ( GLOBE NEWSWIRE ) -- Inspire Medical Systems, Inc. INSP ( Inspire ) , a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea ( OSA ) , today announced the ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.171486, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "INSP", "relevance_score": "0.210579", "ticker_sentiment_score": "0.181415", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.070935", "ticker_sentiment_score": "0.038628", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.070935", "ticker_sentiment_score": "0.172145", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "2 Magnificent Growth Stocks to Buy With $1,000 Right Now for 2024", "url": "https://www.fool.com/investing/2023/12/28/2-magnificent-growth-stocks-to-buy-with-1000-right/", "time_published": "20231228T103200", "authors": ["Rachel Warren"], "summary": "These growth stocks have tons of room left to run.", "banner_image": "https://g.foolcdn.com/editorial/images/759424/father-and-daughter-doing-homework-at-dinner-table.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.266143"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.967645"}], "overall_sentiment_score": 0.140008, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "FVRR", "relevance_score": "0.346884", "ticker_sentiment_score": "0.29727", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.263942", "ticker_sentiment_score": "0.129456", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Rises But Trails Market: What Investors Should Know", "url": "https://www.zacks.com/stock/news/2202882/intuitive-surgical-inc-isrg-rises-but-trails-market-what-investors-should-know", "time_published": "20231227T230021", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $337.47, signifying a +0.02% move from its prior day's close.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default218.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.976913"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.212582, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.527969", "ticker_sentiment_score": "0.225188", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "3 Stocks I Want to Buy if the Market Crashes Again", "url": "https://www.fool.com/investing/2023/12/27/3-stocks-i-want-to-buy-if-the-market-crashes-again/", "time_published": "20231227T140000", "authors": ["Bradley Guichard"], "summary": "You never know when opportunity will knock. You need a plan.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F758956%2Fnvda-infographic.png&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999612"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.236831, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.050148", "ticker_sentiment_score": "0.051996", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.246832", "ticker_sentiment_score": "0.211714", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.100099", "ticker_sentiment_score": "-0.043199", "ticker_sentiment_label": "Neutral"}, {"ticker": "PANW", "relevance_score": "0.100099", "ticker_sentiment_score": "0.101158", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 MedTech Stocks With Potential to Benefit From AI Boom in 2024", "url": "https://www.zacks.com/stock/news/2200918/3-medtech-stocks-with-potential-to-benefit-from-ai-boom-in-2024", "time_published": "20231221T123700", "authors": ["Indrajit Bandyopadhyay"], "summary": "Investors looking to tap the budding prospects in the lucrative AI market in 2024 can count on Medtronic (MDT), GE HealthCare Technologies (GEHC) and Hologic (HOLX).", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a9/50721.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.402997, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "GEHC", "relevance_score": "0.099614", "ticker_sentiment_score": "0.15323", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MSFT", "relevance_score": "0.033282", "ticker_sentiment_score": "0.121679", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.066506", "ticker_sentiment_score": "0.183557", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HOLX", "relevance_score": "0.165258", "ticker_sentiment_score": "0.27633", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDT", "relevance_score": "0.165258", "ticker_sentiment_score": "0.191", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.033282", "ticker_sentiment_score": "0.214994", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical  ( NASDAQ:ISRG )  Downgraded to \"Hold\" at StockNews.com", "url": "https://www.defenseworld.net/2023/12/20/intuitive-surgical-nasdaqisrg-downgraded-to-hold-at-stocknews-com.html", "time_published": "20231220T082044", "authors": ["Defense World Staff"], "summary": "StockNews.com downgraded shares of Intuitive Surgical ( NASDAQ:ISRG - Free Report ) from a buy rating to a hold rating in a research note released on Tuesday morning. Other research analysts have also recently issued reports about the stock.", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&Symbol=ISRG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.897321"}, {"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.305372, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TFC", "relevance_score": "0.040969", "ticker_sentiment_score": "0.111064", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBCPF", "relevance_score": "0.040969", "ticker_sentiment_score": "0.111064", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.040969", "ticker_sentiment_score": "0.05256", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.719308", "ticker_sentiment_score": "0.472256", "ticker_sentiment_label": "Bullish"}, {"ticker": "FL", "relevance_score": "0.040969", "ticker_sentiment_score": "0.05256", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.040969", "ticker_sentiment_score": "0.111064", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Laps the Stock Market: Here's Why", "url": "https://www.zacks.com/stock/news/2199645/intuitive-surgical-inc-isrg-laps-the-stock-market-heres-why", "time_published": "20231218T225017", "authors": ["Zacks Equity Research"], "summary": "The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $328.42, representing a +1.25% change from its previous close.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default189.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.213431, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.656549", "ticker_sentiment_score": "0.367234", "ticker_sentiment_label": "Bullish"}]}, {"title": "$1000 Invested In This Stock 20 Years Ago Would Be Worth $180 Thousand Today - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/23/12/36291256/1000-invested-in-this-stock-20-years-ago-would-be-worth-180-thousand-today", "time_published": "20231218T210025", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 20 years by 21.99% on an annualized basis producing an average annual return of 29.56%. Currently, Intuitive Surgical has a market capitalization of $115.91 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "Spotlight on Intuitive Surgical: Analyzing the Surge in Options Activity - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/12/36284868/spotlight-on-intuitive-surgical-analyzing-the-surge-in-options-activity", "time_published": "20231218T153200", "authors": ["Benzinga Insights"], "summary": "Financial giants have made a conspicuous bullish move on Intuitive Surgical. Our analysis of options history for Intuitive Surgical ISRG revealed 9 unusual trades. Delving into the details, we found 66% of traders were bullish, while 33% showed bearish tendencies.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.157674, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.7414", "ticker_sentiment_score": "0.131936", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.09989", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Meet the top fund managers of 2023: How they outsmarted their peers, and their big bets for 2024", "url": "https://www.businessinsider.com/best-mutual-funds-managers-stock-market-portfolios-strategies-2023-12", "time_published": "20231216T110800", "authors": ["Laila Maidan", "James Faris", "Mark Reeth", "William Edwards"], "summary": "Top Mutual Fund Managers Share Strategy, Stock Picks for 2024 - Business Insider ...", "banner_image": null, "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "www.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.999897"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.875462"}], "overall_sentiment_score": 0.328251, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.016796", "ticker_sentiment_score": "0.125313", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.050359", "ticker_sentiment_score": "0.141633", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.263764", "ticker_sentiment_score": "0.287637", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRWD", "relevance_score": "0.016796", "ticker_sentiment_score": "0.125094", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.050359", "ticker_sentiment_score": "0.086909", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.016796", "ticker_sentiment_score": "0.089377", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.199447", "ticker_sentiment_score": "0.225823", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MELI", "relevance_score": "0.033585", "ticker_sentiment_score": "0.119605", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.117159", "ticker_sentiment_score": "0.143011", "ticker_sentiment_label": "Neutral"}, {"ticker": "MA", "relevance_score": "0.033585", "ticker_sentiment_score": "0.097551", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOW", "relevance_score": "0.083833", "ticker_sentiment_score": "0.121947", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORN", "relevance_score": "0.016796", "ticker_sentiment_score": "0.19906", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VALU", "relevance_score": "0.016796", "ticker_sentiment_score": "0.181596", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.016796", "ticker_sentiment_score": "0.099722", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.033585", "ticker_sentiment_score": "0.195263", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "How the Invesco QQQ ETF Could Turn You Into a Millionaire", "url": "https://www.fool.com/investing/2023/12/15/how-the-invesco-qqq-etf-could-turn-you-into-a-mill/", "time_published": "20231215T122700", "authors": ["Stefon Walters"], "summary": "With some of the world's top companies leading the way, this exchange-traded fund should have sustained, impressive growth for some time.", "banner_image": "https://media.ycharts.com/charts/af73dbbd3655c0682ab99b62be9bb87b.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.998932"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.252744, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LULU", "relevance_score": "0.068112", "ticker_sentiment_score": "0.166664", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IVZ", "relevance_score": "0.450354", "ticker_sentiment_score": "0.396025", "ticker_sentiment_label": "Bullish"}, {"ticker": "KO", "relevance_score": "0.068112", "ticker_sentiment_score": "0.190836", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.068112", "ticker_sentiment_score": "0.166664", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "4 Sector ETFs to Win Despite Slowing November Inflation Data", "url": "https://www.zacks.com/stock/news/2197222/4-sector-etfs-to-win-despite-slowing-november-inflation-data", "time_published": "20231213T133500", "authors": ["Sanghamitra Saha"], "summary": "The annual inflation rate in the United States slowed to 3.1% in November 2023, the lowest reading in five months.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default240.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.988787"}, {"topic": "Earnings", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.131051, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.100729", "ticker_sentiment_score": "0.045646", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.100729", "ticker_sentiment_score": "0.045646", "ticker_sentiment_label": "Neutral"}]}, {"title": "A Look Into Intuitive Surgical Inc's Price Over Earnings - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/23/12/36201592/a-look-into-intuitive-surgical-incs-price-over-earnings", "time_published": "20231212T164647", "authors": ["Benzinga Insights"], "summary": "In the current session, the stock is trading at $315.87, after a 0.14% spike. Over the past month, Intuitive Surgical Inc. ISRG stock increased by 8.81%, and in the past year, by 13.06%.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.250388, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.43789", "ticker_sentiment_score": "0.349782", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Outperforms Broader Market: What You Need to Know", "url": "https://www.zacks.com/stock/news/2196444/intuitive-surgical-inc-isrg-outperforms-broader-market-what-you-need-to-know", "time_published": "20231211T225015", "authors": ["Zacks Equity Research"], "summary": "The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $315.43, representing a +1.61% change from its previous close.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default11.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.237437, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.545136", "ticker_sentiment_score": "0.317265", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here is What to Know Beyond Why Intuitive Surgical, Inc.  ( ISRG )  is a Trending Stock", "url": "https://www.zacks.com/stock/news/2195395/here-is-what-to-know-beyond-why-intuitive-surgical-inc-isrg-is-a-trending-stock", "time_published": "20231208T140005", "authors": ["Zacks Equity Research"], "summary": "Zacks.com users have recently been watching Intuitive Surgical, Inc. (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default110.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.22863, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.510952", "ticker_sentiment_score": "0.157266", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "2 Healthcare Stocks to Buy Hand Over Fist in December", "url": "https://www.fool.com/investing/2023/12/08/2-healthcare-stocks-to-buy-hand-over-fist-december/", "time_published": "20231208T134500", "authors": ["Prosper Junior Bakiny"], "summary": "These stocks are great options now -- and most any month.", "banner_image": "https://g.foolcdn.com/editorial/images/757033/elderly-person-sitting-on-a-bed.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.316726"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}], "overall_sentiment_score": 0.280805, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.306325", "ticker_sentiment_score": "0.264226", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.207127", "ticker_sentiment_score": "0.142283", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stock Upgrades: PROCEPT BioRobotics Shows Rising Relative Strength", "url": "https://www.investors.com/ibd-data-stories/stock-upgrades-procept-biorobotics-shows-rising-relative-strength-2/", "time_published": "20231208T080000", "authors": ["INVESTOR'S BUSINESS DAILY", "Investor's Business Daily"], "summary": "On Friday, PROCEPT BioRobotics ( PRCT ) cleared a noteworthy technical benchmark, seeing its Relative Strength ( RS ) Rating jump into the 80-plus percentile with an improvement to 82, up from 74 the day before. X When looking for the best stocks to buy and watch, one factor to watch closely ...", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.354381, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.343279", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCT", "relevance_score": "0.495015", "ticker_sentiment_score": "0.519481", "ticker_sentiment_label": "Bullish"}]}, {"title": "IDEXX Laboratories Stock Earns IBD Stock Rating Upgrade", "url": "https://www.investors.com/news/idexx-laboratories-stock-earns-ibd-stock-rating-upgrade/", "time_published": "20231206T202500", "authors": ["JULIE MAK", "Investor's Business Daily", "INVESTOR'S BUSINESS DAILY"], "summary": "One important metric to look for in a stock is an 80 or higher Relative Strength Rating. IDEXX Laboratories ( IDXX ) stock now clears that threshold, with a jump from 79 to 83 Wednesday. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.", "banner_image": "https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.989041"}], "overall_sentiment_score": 0.380039, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "IDXX", "relevance_score": "0.736438", "ticker_sentiment_score": "0.405424", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.290607", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stock Upgrades: IDEXX Laboratories Shows Rising Relative Strength", "url": "https://www.investors.com/ibd-data-stories/stock-upgrades-idexx-laboratories-shows-rising-relative-strength-4/", "time_published": "20231206T080000", "authors": ["Investor's Business Daily", "INVESTOR'S BUSINESS DAILY"], "summary": "One important metric to look for in a stock is an 80 or higher Relative Strength Rating. IDEXX Laboratories ( IDXX ) now clears that threshold, with a jump from 79 to 83 Wednesday. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.386752, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "IDXX", "relevance_score": "0.784902", "ticker_sentiment_score": "0.472481", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.380012", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why the Global X Robotics and Artificial Intelligence ETF Gained 16% in November", "url": "https://www.fool.com/investing/2023/12/05/why-the-global-x-robotics-artificial-intelligence/", "time_published": "20231206T021457", "authors": ["Jeremy Bowman"], "summary": "The AI-focused ETF benefited from bullish macroeconomic data.", "banner_image": "https://media.ycharts.com/charts/4d93b998fa4afd1fdd20b287fd6afa44.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.976671"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.402935, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.198221", "ticker_sentiment_score": "0.234132", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SPGI", "relevance_score": "0.09989", "ticker_sentiment_score": "0.280252", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KYCCF", "relevance_score": "0.09989", "ticker_sentiment_score": "0.04657", "ticker_sentiment_label": "Neutral"}, {"ticker": "FANUF", "relevance_score": "0.09989", "ticker_sentiment_score": "0.04657", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.198221", "ticker_sentiment_score": "0.159863", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Registers a Bigger Fall Than the Market: Important Facts to Note", "url": "https://www.zacks.com/stock/news/2193854/intuitive-surgical-inc-isrg-registers-a-bigger-fall-than-the-market-important-facts-to-note", "time_published": "20231205T225005", "authors": ["Zacks Equity Research"], "summary": "In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $309.52, indicating a -0.74% shift from the previous trading day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default250.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.976913"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.204485, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.527969", "ticker_sentiment_score": "0.185002", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "$1000 Invested In This Stock 10 Years Ago Would Be Worth $7,400 Today - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/23/12/36102233/1000-invested-in-this-stock-10-years-ago-would-be-worth-7-400-today", "time_published": "20231205T213017", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 10 years by 12.35% on an annualized basis producing an average annual return of 22.06%. Currently, Intuitive Surgical has a market capitalization of $109.04 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "PROCEPT BioRobotics Stock Scores Rising Relative Strength", "url": "https://www.investors.com/news/procept-biorobotics-stock-scores-rising-relative-strength/", "time_published": "20231205T194400", "authors": ["Investor's Business Daily", "INVESTOR'S BUSINESS DAILY", "JULIE MAK"], "summary": "The Relative Strength ( RS ) Rating for PROCEPT BioRobotics ( PRCT ) stock headed into a new percentile Tuesday, as it got a lift from 70 to 77. When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength.", "banner_image": "https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}], "overall_sentiment_score": 0.395598, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "IDXX", "relevance_score": "0.29234", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.29234", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCT", "relevance_score": "0.651499", "ticker_sentiment_score": "0.425293", "ticker_sentiment_label": "Bullish"}]}, {"title": "Nvidia and Microsoft CEOs say industrial companies will benefit most from AI. Here are stocks to put on your watch list.", "url": "https://www.marketwatch.com/story/nvidia-and-microsoft-ceos-say-industrial-companies-will-benefit-most-from-ai-here-are-stocks-to-put-on-your-watch-list-b427ab86", "time_published": "20231205T120200", "authors": ["Philip van Doorn"], "summary": "Money managers name stocks of companies that can benefit from the \"third wave\" of artificial-intelligence deployment described by Nvidia CEO Jensen Huang.", "banner_image": "https://images.mktw.net/im-04212103/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.961735"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.157088, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BABA", "relevance_score": "0.042685", "ticker_sentiment_score": "0.105656", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.02135", "ticker_sentiment_score": "0.096155", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.042685", "ticker_sentiment_score": "0.037888", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.211007", "ticker_sentiment_score": "0.15381", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AXON", "relevance_score": "0.042685", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MU", "relevance_score": "0.042685", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAH", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.019388", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.085249", "ticker_sentiment_score": "0.038902", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.106446", "ticker_sentiment_score": "0.1083", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.042685", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "VWAGY", "relevance_score": "0.02135", "ticker_sentiment_score": "0.080939", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADBE", "relevance_score": "0.06399", "ticker_sentiment_score": "0.039014", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.042685", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GD", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.019388", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.042685", "ticker_sentiment_score": "0.051568", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks With Rising Relative Strength: PROCEPT BioRobotics", "url": "https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-strength-procept-biorobotics/", "time_published": "20231205T080000", "authors": ["Investor's Business Daily", "INVESTOR'S BUSINESS DAILY"], "summary": "The Relative Strength ( RS ) Rating for PROCEPT BioRobotics ( PRCT ) headed into a new percentile Tuesday, as it got a lift from 70 to 77. X When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength.", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.389406, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "IDXX", "relevance_score": "0.325208", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.325208", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCT", "relevance_score": "0.705799", "ticker_sentiment_score": "0.454726", "ticker_sentiment_label": "Bullish"}]}, {"title": "Medical Robotic Systems Market Size to be Worth USD 21.3 billion by 2031, with Notable CAGR of 11.2%| Transparency Market Research, Inc.", "url": "https://www.benzinga.com/pressreleases/23/12/g36074527/medical-robotic-systems-market-size-to-be-worth-usd-21-3-billion-by-2031-with-notable-cagr-of-11-2", "time_published": "20231204T173000", "authors": ["Globe Newswire"], "summary": "Wilmington, Delaware, United States, Dec. 04, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global medical robotic systems market is estimated to flourish at a CAGR of 11.2% from 2023 to 2031.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.371048, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.063425", "ticker_sentiment_score": "0.043136", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.063425", "ticker_sentiment_score": "0.043136", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.063425", "ticker_sentiment_score": "0.190472", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "5 Top Stocks to Buy Before 2024", "url": "https://www.fool.com/investing/2023/12/02/5-top-stocks-to-buy-before-2024/", "time_published": "20231202T100000", "authors": ["Adria Cimino"], "summary": "These stocks have room to run -- next year and over the long term.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F756622%2Fgettyimages-1323758599.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}], "overall_sentiment_score": 0.309374, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.223522", "ticker_sentiment_score": "0.23701", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VRTX", "relevance_score": "0.075397", "ticker_sentiment_score": "0.147665", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.075397", "ticker_sentiment_score": "0.285192", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.259529", "ticker_sentiment_score": "0.252343", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Inari Medical, Inc.  ( NARI )  Up 17.1% Since Last Earnings Report: Can It Continue?", "url": "https://www.zacks.com/stock/news/2192444/inari-medical-inc-nari-up-171-since-last-earnings-report-can-it-continue", "time_published": "20231201T163143", "authors": ["Zacks Equity Research"], "summary": "Inari Medical, Inc. (NARI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default320.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999162"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}], "overall_sentiment_score": 0.181538, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.193852", "ticker_sentiment_score": "0.055725", "ticker_sentiment_label": "Neutral"}, {"ticker": "NARI", "relevance_score": "0.500227", "ticker_sentiment_score": "0.333471", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Reasons to Add Intuitive Surgical  ( ISRG )  to Your Portfolio Now", "url": "https://www.zacks.com/stock/news/2192025/reasons-to-add-intuitive-surgical-isrg-to-your-portfolio-now", "time_published": "20231201T124700", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/2297.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.290796, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BDSX", "relevance_score": "0.149038", "ticker_sentiment_score": "0.042318", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.197816", "ticker_sentiment_score": "0.073814", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.38366", "ticker_sentiment_score": "0.414113", "ticker_sentiment_label": "Bullish"}, {"ticker": "DVA", "relevance_score": "0.149038", "ticker_sentiment_score": "0.117534", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stock Upgrades: PROCEPT BioRobotics Shows Rising Relative Strength", "url": "https://www.investors.com/ibd-data-stories/stock-upgrades-procept-biorobotics-shows-rising-relative-strength/", "time_published": "20231201T080000", "authors": ["Investor's Business Daily", "INVESTOR'S BUSINESS DAILY"], "summary": "Stock Upgrades: PROCEPT BioRobotics Shows Rising Relative ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.451796, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.334008", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZJYL", "relevance_score": "0.334008", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCT", "relevance_score": "0.804667", "ticker_sentiment_score": "0.699326", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Stock Moves -0.06%: What You Should Know", "url": "https://www.zacks.com/stock/news/2191147/intuitive-surgical-inc-isrg-stock-moves--006-what-you-should-know", "time_published": "20231129T225005", "authors": ["Zacks Equity Research"], "summary": "In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $310.76, denoting a -0.06% change from the preceding trading day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default351.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.188371, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.592095", "ticker_sentiment_score": "0.220408", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": " ( ISRG )  - Analyzing Intuitive Surgical's Short Interest - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/short-sellers/23/11/36007771/isrg-analyzing-intuitive-surgicals-short-interest", "time_published": "20231129T174512", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical's ISRG short percent of float has risen 19.28% since its last report. The company recently reported that it has 3.45 million shares sold short, which is 0.99% of all regular shares that are available for trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.287384, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.221819", "ticker_sentiment_score": "0.184023", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Should You Invest in the iShares U.S. Medical Devices ETF  ( IHI ) ?", "url": "https://www.zacks.com/stock/news/2190656/should-you-invest-in-the-ishares-us-medical-devices-etf-ihi", "time_published": "20231129T112005", "authors": ["Zacks Equity Research"], "summary": "Sector ETF report for IHI ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default316.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.223565, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.064973", "ticker_sentiment_score": "0.031018", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEM", "relevance_score": "0.129516", "ticker_sentiment_score": "0.026807", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.129516", "ticker_sentiment_score": "0.070142", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.129516", "ticker_sentiment_score": "0.070142", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.129516", "ticker_sentiment_score": "0.070142", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical  ( NASDAQ:ISRG )  Upgraded by StockNews.com to \"Buy\"", "url": "https://www.defenseworld.net/2023/11/28/intuitive-surgical-nasdaqisrg-upgraded-by-stocknews-com-to-buy.html", "time_published": "20231128T082045", "authors": ["Defense World Staff"], "summary": "Intuitive Surgical ( NASDAQ:ISRG ) Upgraded by StockNews.com to ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&Symbol=ISRG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.938793"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.25854, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "C", "relevance_score": "0.041181", "ticker_sentiment_score": "0.008773", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.744032", "ticker_sentiment_score": "0.410398", "ticker_sentiment_label": "Bullish"}, {"ticker": "WFC", "relevance_score": "0.041181", "ticker_sentiment_score": "0.008773", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTHM", "relevance_score": "0.041181", "ticker_sentiment_score": "0.015887", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRBR", "relevance_score": "0.041181", "ticker_sentiment_score": "0.015887", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is Trending Stock Intuitive Surgical, Inc.  ( ISRG )  a Buy Now?", "url": "https://www.zacks.com/stock/news/2189640/is-trending-stock-intuitive-surgical-inc-isrg-a-buy-now", "time_published": "20231127T140005", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default44.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.623304"}], "overall_sentiment_score": 0.261359, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.505538", "ticker_sentiment_score": "0.177403", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying?", "url": "https://www.fool.com/investing/2023/11/26/johnson-johnson-and-intuitive-surgical-might-becom/", "time_published": "20231126T113000", "authors": ["Alex Carchidi"], "summary": "With retailers worrying about Ozempic's impact, healthcare stocks could be next.", "banner_image": "https://g.foolcdn.com/editorial/images/755827/stressed-investor-sitting-in-dark-at-computer.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.090999, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.135347", "ticker_sentiment_score": "0.120203", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.223659", "ticker_sentiment_score": "0.065413", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Is Integra  ( IART )  Up 10.2% Since Last Earnings Report?", "url": "https://www.zacks.com/stock/news/2189144/why-is-integra-iart-up-102-since-last-earnings-report", "time_published": "20231124T163124", "authors": ["Zacks Equity Research"], "summary": "Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default258.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999816"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}], "overall_sentiment_score": 0.103977, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IART", "relevance_score": "0.131643", "ticker_sentiment_score": "0.140099", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.174903", "ticker_sentiment_score": "0.050289", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.04406", "ticker_sentiment_score": "0.094149", "ticker_sentiment_label": "Neutral"}]}, {"title": "Wall Street Analysts Think Intuitive Surgical, Inc.  ( ISRG )  Is a Good Investment: Is It?", "url": "https://www.zacks.com/stock/news/2188998/wall-street-analysts-think-intuitive-surgical-inc-isrg-is-a-good-investment-is-it", "time_published": "20231124T143005", "authors": ["Zacks Equity Research"], "summary": "Based on the average brokerage recommendation (ABR), Intuitive Surgical, Inc. (ISRG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?", "banner_image": "https://staticx-tuner.zacks.com/images/yesopchart/brokerage_bar/ISRG_11242023.png", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}], "overall_sentiment_score": 0.277688, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.348452", "ticker_sentiment_score": "0.196727", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical's Options: A Look at What the Big Money is Thinking - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/11/35921609/intuitive-surgicals-options-a-look-at-what-the-big-money-is-thinking", "time_published": "20231122T174640", "authors": ["Benzinga Insights"], "summary": "High-rolling investors have positioned themselves bullish on Intuitive Surgical ISRG, and it's important for retail traders to take note. \\This activity came to our attention today through Benzinga's tracking of publicly available options data.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.187906, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.695399", "ticker_sentiment_score": "0.294097", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's How Much You Would Have Made Owning Intuitive Surgical Stock In The Last 15 Years - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/23/11/35895817/heres-how-much-you-would-have-made-owning-intuitive-surgical-stock-in-the-last-15-years", "time_published": "20231121T143024", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 15 years by 10.95% on an annualized basis producing an average annual return of 22.42%. Currently, Intuitive Surgical has a market capitalization of $109.44 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Surgical Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark", "url": "https://www.investors.com/news/intuitive-surgical-stock-earns-relative-strength-rating-upgrade-hits-key-benchmark/", "time_published": "20231117T194400", "authors": ["JULIE MAK", "INVESTOR'S BUSINESS DAILY", "Investor's Business Daily"], "summary": "Intuitive Surgical Stock Earns Relative Strength Rating Upgrade ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}], "overall_sentiment_score": 0.437446, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.31282", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.772973", "ticker_sentiment_score": "0.648361", "ticker_sentiment_label": "Bullish"}]}, {"title": "Johnson & Johnson Is Eyeing Intuitive Surgical's Market, But Can It Win?", "url": "https://www.fool.com/investing/2023/11/17/johnson-johnson-eyeing-intuitive-surgicals-market/", "time_published": "20231117T110300", "authors": ["Alex Carchidi"], "summary": "The healthcare company's entry into the market will be a major test for Intuitive Surgical.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.136741, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.045139", "ticker_sentiment_score": "-0.103775", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.265859", "ticker_sentiment_score": "0.022151", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.222838", "ticker_sentiment_score": "0.08142", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Earns Relative Strength Rating Upgrade; Hits Key Benchmark", "url": "https://www.investors.com/ibd-data-stories/intuitive-surgical-earns-relative-strength-rating-upgrade-hits-key-benchmark/", "time_published": "20231117T080000", "authors": ["INVESTOR'S BUSINESS DAILY", "Investor's Business Daily"], "summary": "Intuitive Surgical Earns Relative Strength Rating Upgrade. Hits Key ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.402163, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.374312", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.77735", "ticker_sentiment_score": "0.644725", "ticker_sentiment_label": "Bullish"}]}, {"title": "Stocks Showing Improving Market Leadership: Haemonetics Earns 81 RS Rating", "url": "https://www.investors.com/ibd-data-stories/stocks-showing-improving-market-leadership-haemonetics-earns-81-rs-rating/", "time_published": "20231117T080000", "authors": ["Investor's Business Daily", "INVESTOR'S BUSINESS DAILY"], "summary": "Stocks Showing Improving Market Leadership: Haemonetics Earns ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.390125, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.801457", "ticker_sentiment_score": "0.538392", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.331765", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "GE HealthCare Techs Shows Improved Relative Strength; Still Shy Of Benchmark", "url": "https://www.investors.com/ibd-data-stories/ge-healthcare-techs-shows-improved-relative-strength-still-shy-of-benchmark/", "time_published": "20231117T080000", "authors": ["INVESTOR'S BUSINESS DAILY", "Investor's Business Daily"], "summary": "GE HealthCare Techs Shows Improved Relative Strength. Still Shy ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.314925, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.31482", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.31482", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.160633", "ticker_sentiment_score": "0.145717", "ticker_sentiment_label": "Neutral"}]}, {"title": "Decoding Intuitive Surgical's Options Activity: What's the Big Picture? - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/11/35813237/decoding-intuitive-surgicals-options-activity-whats-the-big-picture", "time_published": "20231115T193058", "authors": ["Benzinga Insights"], "summary": "Whales with a lot of money to spend have taken a noticeably bullish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ISRG we detected 10 trades. If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.146184, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.782378", "ticker_sentiment_score": "0.172688", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WFC", "relevance_score": "0.08183", "ticker_sentiment_score": "-0.118377", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.08183", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Healthcare Stocks That Could Make You Richer", "url": "https://www.fool.com/investing/2023/11/15/2-healthcare-stocks-that-could-make-you-richer/", "time_published": "20231115T143700", "authors": ["Prosper Junior Bakiny"], "summary": "Merck and Intuitive Surgical both still have bright futures ahead.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.839681"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.275158, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.05133", "ticker_sentiment_score": "0.167044", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.393462", "ticker_sentiment_score": "0.325566", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical Earns Relative Strength Rating Upgrade", "url": "https://www.investors.com/ibd-data-stories/intuitive-surgical-earns-relative-strength-rating-upgrade/", "time_published": "20231115T080000", "authors": ["Investor's Business Daily", "INVESTOR'S BUSINESS DAILY"], "summary": "On Wednesday, Intuitive Surgical ( ISRG ) earned an upgrade to its Relative Strength ( RS ) Rating, from 68 to 71. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.337693, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.343279", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.92456", "ticker_sentiment_score": "0.508726", "ticker_sentiment_label": "Bullish"}]}, {"title": "Haemonetics Sees Relative Strength Rating Rise To 71", "url": "https://www.investors.com/ibd-data-stories/haemonetics-sees-relative-strength-rating-rise-to-71/", "time_published": "20231115T080000", "authors": ["INVESTOR'S BUSINESS DAILY", "Investor's Business Daily"], "summary": "On Wednesday, Haemonetics ( HAE ) earned an upgrade to its Relative Strength ( RS ) Rating, from 68 to 71. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.361556, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.93718", "ticker_sentiment_score": "0.510492", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.358152", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Director at Intuitive Surgical Acquires Company Stock Options Worth 722 Shares - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/23/11/35778516/director-at-intuitive-surgical-acquires-company-stock-options-worth-722-shares", "time_published": "20231114T150025", "authors": ["Benzinga Insights"], "summary": "Kolli Sreelakshmi, Director at Intuitive Surgical ISRG, reported a large acquisition of company stock options on November 13, according to a new SEC filing. What Happened: A Form 4 filing from the U.S.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/insider_image_2.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99393"}], "overall_sentiment_score": 0.245853, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.52706", "ticker_sentiment_score": "0.552281", "ticker_sentiment_label": "Bullish"}]}, {"title": "Is Most-Watched Stock Intuitive Surgical, Inc.  ( ISRG )  Worth Betting on Now?", "url": "https://www.zacks.com/stock/news/2183889/is-most-watched-stock-intuitive-surgical-inc-isrg-worth-betting-on-now", "time_published": "20231114T140006", "authors": ["Zacks Equity Research"], "summary": "Zacks.com users have recently been watching Intuitive Surgical, Inc. (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default325.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}], "overall_sentiment_score": 0.2152, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.51278", "ticker_sentiment_score": "0.11724", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Cathie Wood Bargain Buys That Should Be on Your List Too", "url": "https://www.fool.com/investing/2023/11/13/3-cathie-wood-buys-that-should-be-on-your-list/", "time_published": "20231113T100000", "authors": ["Adria Cimino"], "summary": "Wood just picked up shares of these companies recently.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F754792%2Fgettyimages-three-business-people-use-tablets.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.98396"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.989041"}], "overall_sentiment_score": 0.30049, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.384608", "ticker_sentiment_score": "0.294376", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.170475", "ticker_sentiment_score": "0.280953", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DNA", "relevance_score": "0.170475", "ticker_sentiment_score": "0.190203", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.057215", "ticker_sentiment_score": "0.079944", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Revolutionary Stocks I'd Buy Right Now Without Hesitation", "url": "https://www.fool.com/investing/2023/11/12/3-revolutionary-stocks-id-buy-right-now-without-he/", "time_published": "20231112T105000", "authors": ["Keith Speights"], "summary": "Most stocks aren't truly revolutionary. These really are.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.144753, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.106541", "ticker_sentiment_score": "0.206734", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.211191", "ticker_sentiment_score": "0.125834", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMDX", "relevance_score": "0.26224", "ticker_sentiment_score": "-0.065665", "ticker_sentiment_label": "Neutral"}]}, {"title": "Fosun Pharma to deliver China-made surgical robots in key medical milestone", "url": "https://www.scmp.com/business/china-business/article/3241245/fosun-pharma-prepares-deliver-da-vinci-surgical-robots-make-advanced-medical-treatment-affordable", "time_published": "20231112T081406", "authors": ["Daniel Ren"], "summary": "The Fosun Group is looking to make another major leap in the healthcare industry as it prepares to deliver locally-made surgical robots to hospitals.", "banner_image": "https://cdn.i-scmp.com/sites/default/files/d8/images/canvas/2023/11/12/b53b0b69-dd22-4e24-8057-5215d3549ce1_800c4d68.jpg", "source": "South China Morning Post", "category_within_source": "Economy", "source_domain": "www.scmp.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.232756, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "FOSUF", "relevance_score": "0.279015", "ticker_sentiment_score": "0.200829", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DOMO", "relevance_score": "0.056943", "ticker_sentiment_score": "0.078004", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.113597", "ticker_sentiment_score": "0.1186", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFOSF", "relevance_score": "0.056943", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GE", "relevance_score": "0.056943", "ticker_sentiment_score": "-0.090936", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.056943", "ticker_sentiment_score": "0.082934", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.056943", "ticker_sentiment_score": "0.235", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "IBD Rating Upgrades: Intuitive Surgical Shows Improved Price Strength", "url": "https://www.investors.com/ibd-data-stories/ibd-rating-upgrades-intuitive-surgical-shows-improved-price-strength/", "time_published": "20231109T080000", "authors": ["Investor's Business Daily", "INVESTOR'S BUSINESS DAILY"], "summary": "IBD Rating Upgrades: Intuitive Surgical Shows Improved Price ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.401142, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.350564", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.827318", "ticker_sentiment_score": "0.378294", "ticker_sentiment_label": "Bullish"}, {"ticker": "AWON", "relevance_score": "0.179788", "ticker_sentiment_score": "0.23138", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Corporate America weighs business impact of new weight-loss drugs", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/corporate-america-weighs-business-impact-new-weight-loss-drugs-2023-11-08/", "time_published": "20231108T181900", "authors": ["Reuters"], "summary": "[1/3] A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/BDRWR7ZSR5JSXIAJL2GP24IQY4.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.110954, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KO", "relevance_score": "0.054114", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.054114", "ticker_sentiment_score": "-0.009037", "ticker_sentiment_label": "Neutral"}, {"ticker": "COR", "relevance_score": "0.054114", "ticker_sentiment_score": "0.033123", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMD", "relevance_score": "0.054114", "ticker_sentiment_score": "0.004", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAH", "relevance_score": "0.054114", "ticker_sentiment_score": "0.033123", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.054114", "ticker_sentiment_score": "0.036002", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.054114", "ticker_sentiment_score": "0.178815", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FSNUF", "relevance_score": "0.054114", "ticker_sentiment_score": "0.083764", "ticker_sentiment_label": "Neutral"}, {"ticker": "KDP", "relevance_score": "0.054114", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEP", "relevance_score": "0.054114", "ticker_sentiment_score": "0.128764", "ticker_sentiment_label": "Neutral"}, {"ticker": "PODD", "relevance_score": "0.054114", "ticker_sentiment_score": "-0.048816", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.054114", "ticker_sentiment_score": "0.025012", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.054114", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.054114", "ticker_sentiment_score": "0.264935", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Johnson & Johnson to submit application to start trials for surgical robot", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-submit-application-start-trials-its-robotic-surgical-system-2023-11-07/", "time_published": "20231107T131200", "authors": ["Reuters"], "summary": "Johnson & Johnson to submit application to start trials for its robotic surgical system ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/4L7SJNLFZJJ65BIEBCLWLVUH2M.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.126574, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.282234", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.282234", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.282234", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Best Stocks to Invest $20,000 in Right Now", "url": "https://www.fool.com/investing/2023/11/03/the-best-stocks-to-invest-20000-in-right-now/", "time_published": "20231103T135300", "authors": ["Rachel Warren"], "summary": "These companies are all highly profitable on top of being industry leaders.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.955357"}, {"topic": "Earnings", "relevance_score": "0.839681"}], "overall_sentiment_score": 0.199538, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.129516", "ticker_sentiment_score": "0.094834", "ticker_sentiment_label": "Neutral"}, {"ticker": "COST", "relevance_score": "0.214177", "ticker_sentiment_score": "0.10077", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABNB", "relevance_score": "0.172097", "ticker_sentiment_score": "0.151572", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  is Attracting Investor Attention: Here is What You Should Know", "url": "https://www.zacks.com/stock/news/2177972/intuitive-surgical-inc-isrg-is-attracting-investor-attention-here-is-what-you-should-know", "time_published": "20231103T130006", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default327.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}], "overall_sentiment_score": 0.224255, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.511864", "ticker_sentiment_score": "0.117109", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rule Breaker Investing: 9 Foolish Truths", "url": "https://www.fool.com/investing/2023/11/01/rule-breaker-investing-9-foolish-truths/", "time_published": "20231102T024700", "authors": ["Motley Fool Staff"], "summary": "What are the eternal verities in the world of money?", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.213781, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.019158", "ticker_sentiment_score": "0.037637", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.031924", "ticker_sentiment_score": "0.080803", "ticker_sentiment_label": "Neutral"}, {"ticker": "MELI", "relevance_score": "0.006386", "ticker_sentiment_score": "0.075526", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.006386", "ticker_sentiment_score": "0.037099", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUBS", "relevance_score": "0.012772", "ticker_sentiment_score": "0.02492", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.019158", "ticker_sentiment_score": "0.018462", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.006386", "ticker_sentiment_score": "0.219614", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.019158", "ticker_sentiment_score": "0.018462", "ticker_sentiment_label": "Neutral"}]}, {"title": "Prostate Cancer Minimally Invasive Surgery Market Size is Envisioned to Grow at a CAGR of 3.6% and reach USD 3.9 billion by 2031|Report by TMR", "url": "https://www.benzinga.com/pressreleases/23/11/g35543727/prostate-cancer-minimally-invasive-surgery-market-size-is-envisioned-to-grow-at-a-cagr-of-3-6-and-", "time_published": "20231101T170000", "authors": ["Globe Newswire"], "summary": "Wilmington, Delaware, United States, Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. The global prostate cancer minimally invasive surgery market stood at US$ 2.9 billion in 2022 and is projected to reach US$ 3.9 billion in 2031.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.074333, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.040484", "ticker_sentiment_score": "0.254161", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BDX", "relevance_score": "0.040484", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.040484", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFX", "relevance_score": "0.040484", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's How Much You Would Have Made Owning Intuitive Surgical Stock In The Last 15 Years - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/23/11/35538301/heres-how-much-you-would-have-made-owning-intuitive-surgical-stock-in-the-last-15-years", "time_published": "20231101T140023", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 15 years by 8.27% on an annualized basis producing an average annual return of 19.0%. Currently, Intuitive Surgical has a market capitalization of $92.32 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Appoints Sreelakshmi Kolli to its Board of Directors", "url": "https://www.globenewswire.com/news-release/2023/10/31/2770646/7637/en/Intuitive-Appoints-Sreelakshmi-Kolli-to-its-Board-of-Directors.html", "time_published": "20231031T201500", "authors": ["Intuitive Surgical", "Inc."], "summary": "Intuitive announces new board member ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/db89f2a9-76ed-4743-84d3-a7ac75605b6c", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.319829, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ZBH", "relevance_score": "0.088799", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACN", "relevance_score": "0.088799", "ticker_sentiment_score": "0.139044", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGN", "relevance_score": "0.262052", "ticker_sentiment_score": "0.177332", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.262052", "ticker_sentiment_score": "0.370693", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Appoints Sreelakshmi Kolli to its Board of Directors - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35524665/intuitive-appoints-sreelakshmi-kolli-to-its-board-of-directors", "time_published": "20231031T201500", "authors": ["Globe Newswire"], "summary": "SUNNYVALE, Calif., Oct. 31, 2023 ( GLOBE NEWSWIRE ) -- Intuitive ISRG, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the appointment of Sreelakshmi Kolli, executive vice president and chief digital officer at Align Technology, ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.313135, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ZBH", "relevance_score": "0.086556", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACN", "relevance_score": "0.086556", "ticker_sentiment_score": "0.138299", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGN", "relevance_score": "0.255641", "ticker_sentiment_score": "0.171929", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.255641", "ticker_sentiment_score": "0.364161", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Surgical Unusual Options Activity - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/10/35520888/intuitive-surgical-unusual-options-activity", "time_published": "20231031T173151", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bullish stance on Intuitive Surgical ISRG. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.207912, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.735253", "ticker_sentiment_score": "0.204582", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.088799", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.088799", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Robotics Market size to grow by USD 22.26 billion from 2022 to 2027, Market driven by stringent health and safety ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/robotics-market-size-to-grow-by-usd-22-26-billion-from-2022-to-2027--market-driven-by-stringent-health-and-safety-regulations---technavio-301971640.html", "time_published": "20231031T020000", "authors": [], "summary": "Robotics Market size to grow by USD 22.26 billion from 2022 to 2027, Market driven by stringent health and safety ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.187841, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TER", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABLZF", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNZOF", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "HON", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEAGF", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "KWHIF", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMRNF", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIGRY", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYBQF", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "FANUF", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHX", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBRA", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.046724", "ticker_sentiment_score": "0.01885", "ticker_sentiment_label": "Neutral"}]}, {"title": "Big Banks and Big Rates", "url": "https://www.fool.com/investing/2023/10/27/big-banks-and-big-rates/", "time_published": "20231027T172800", "authors": ["the Motley Fool Staff"], "summary": "The major banks are cashing in on high interest rates, but cracks continue to show in the picture of the consumer.", "banner_image": "https://g.foolcdn.com/editorial/images/751475/mfm_20231013.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Blockchain", "relevance_score": "0.682689"}, {"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "IPO", "relevance_score": "0.576289"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.999995"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.057687, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.028463", "ticker_sentiment_score": "-0.019049", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.011387", "ticker_sentiment_score": "0.023049", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.03984", "ticker_sentiment_score": "0.026526", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.028463", "ticker_sentiment_score": "0.070144", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.022772", "ticker_sentiment_score": "0.051095", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZM", "relevance_score": "0.011387", "ticker_sentiment_score": "0.040067", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.011387", "ticker_sentiment_score": "0.063418", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATVI", "relevance_score": "0.022772", "ticker_sentiment_score": "0.065893", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEP", "relevance_score": "0.01708", "ticker_sentiment_score": "0.070455", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEAM", "relevance_score": "0.068242", "ticker_sentiment_score": "0.004058", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.005694", "ticker_sentiment_score": "-0.048225", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.022772", "ticker_sentiment_score": "0.006486", "ticker_sentiment_label": "Neutral"}, {"ticker": "OM", "relevance_score": "0.022772", "ticker_sentiment_score": "-0.069138", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIRK", "relevance_score": "0.045525", "ticker_sentiment_score": "0.065356", "ticker_sentiment_label": "Neutral"}]}, {"title": "Weight-Loss Beating Continues For Devices Makers; Why It's Overdone", "url": "https://www.investors.com/news/technology/weight-loss-drugs-spook-medical-device-stocks-an-overreaction/", "time_published": "20231027T130000", "authors": ["ALLISON GATLIN", "Investor's Business Daily"], "summary": "Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2023/10/IT2c103023-300x171.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.997405"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.093424, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "INSP", "relevance_score": "0.034907", "ticker_sentiment_score": "-0.017925", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBH", "relevance_score": "0.034907", "ticker_sentiment_score": "0.125221", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.017458", "ticker_sentiment_score": "-0.108231", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.087122", "ticker_sentiment_score": "0.080517", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMD", "relevance_score": "0.034907", "ticker_sentiment_score": "0.125221", "ticker_sentiment_label": "Neutral"}, {"ticker": "MASI", "relevance_score": "0.034907", "ticker_sentiment_score": "0.23697", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMGN", "relevance_score": "0.034907", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.087122", "ticker_sentiment_score": "0.002112", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.034907", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.034907", "ticker_sentiment_score": "0.23697", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FSNUF", "relevance_score": "0.017458", "ticker_sentiment_score": "0.047327", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.069748", "ticker_sentiment_score": "0.111489", "ticker_sentiment_label": "Neutral"}, {"ticker": "PODD", "relevance_score": "0.034907", "ticker_sentiment_score": "0.099119", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLNO", "relevance_score": "0.017458", "ticker_sentiment_score": "0.014131", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.05234", "ticker_sentiment_score": "0.026937", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.121738", "ticker_sentiment_score": "0.072049", "ticker_sentiment_label": "Neutral"}]}, {"title": "Global Medical Robotics Market is Forecast to Reach a Value of USD 28.77 Billion By 2030 with a Growing CAGR of 14.94% | Infinium Global Research", "url": "https://www.prnewswire.com/news-releases/global-medical-robotics-market-is-forecast-to-reach-a-value-of-usd-28-77-billion-by-2030-with-a-growing-cagr-of-14-94--infinium-global-research-301970015.html", "time_published": "20231027T100300", "authors": ["Infinium Global Research"], "summary": "Global Medical Robotics Market is Forecast to Reach a Value of USD 28.77 Billion By 2030 with a Growing CAGR of ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2244132/Infinium_Global_Research_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.305753, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ZBH", "relevance_score": "0.038101", "ticker_sentiment_score": "0.066226", "ticker_sentiment_label": "Neutral"}, {"ticker": "EKSO", "relevance_score": "0.038101", "ticker_sentiment_score": "0.066226", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.038101", "ticker_sentiment_score": "0.066226", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.038101", "ticker_sentiment_score": "0.066226", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.038101", "ticker_sentiment_score": "0.066226", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.038101", "ticker_sentiment_score": "0.066226", "ticker_sentiment_label": "Neutral"}, {"ticker": "III", "relevance_score": "0.038101", "ticker_sentiment_score": "0.164249", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDT", "relevance_score": "0.038101", "ticker_sentiment_score": "0.066226", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.038101", "ticker_sentiment_score": "0.066226", "ticker_sentiment_label": "Neutral"}]}, {"title": "Analysis: Healthcare companies counter investor worries over Wegovy effect", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-companies-counter-investor-worries-over-wegovy-effect-2023-10-27/", "time_published": "20231027T050020", "authors": ["Manas Mishra", "David Gaffen"], "summary": "A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File Photo Acquire Licensing Rights", "banner_image": "https://s3.amazonaws.com/arc-authors/reuters/64c98ae2-82dc-4c80-b81f-dc010b8de5de.png", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.040704, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RMD", "relevance_score": "0.049221", "ticker_sentiment_score": "0.003987", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.049221", "ticker_sentiment_score": "0.018908", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.049221", "ticker_sentiment_score": "0.052759", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.049221", "ticker_sentiment_score": "0.016001", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.098255", "ticker_sentiment_score": "0.124991", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.049221", "ticker_sentiment_score": "-0.129072", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Top Healthcare Stocks Defying the Bear Market", "url": "https://www.fool.com/investing/2023/10/26/2-top-healthcare-stocks-defying-the-bear-market/", "time_published": "20231026T140000", "authors": ["Rachel Warren"], "summary": "These companies are building out their revenue and profit streams, and the proof is in the pudding.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.232862, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.107255", "ticker_sentiment_score": "0.248954", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.21258", "ticker_sentiment_score": "0.109427", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Healthcare Stocks to Buy and Hold for the Next 10 Years", "url": "https://www.fool.com/investing/2023/10/26/healthcare-stocks-buy-and-hold-for-decade/", "time_published": "20231026T092000", "authors": ["Rachel Warren"], "summary": "Great healthcare businesses are out there and their stocks are ripe for the picking.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.986714"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.079124, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.088472", "ticker_sentiment_score": "0.113", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.175859", "ticker_sentiment_score": "0.143021", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDOC", "relevance_score": "0.088472", "ticker_sentiment_score": "-0.168834", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "HCA Healthcare's  ( HCA )  Q3 Earnings Miss on High Expense Level", "url": "https://www.zacks.com/stock/news/2170994/hca-healthcares-hca-q3-earnings-miss-on-high-expense-level", "time_published": "20231024T161100", "authors": ["Zacks Equity Research"], "summary": "HCA Healthcare's (HCA) Q3 results were hurt by an increase in salaries and benefits expenses. Management presently estimates 2023 EPS to be within $17.80-$18.50, compared with the prior-view of $17.70-$18.90 per share.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/07/49005.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.998947"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.146034, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.159569", "ticker_sentiment_score": "0.078563", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.159569", "ticker_sentiment_score": "0.107786", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.19871", "ticker_sentiment_score": "0.135342", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCA", "relevance_score": "0.385286", "ticker_sentiment_score": "0.1858", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "4 Hot Penny Stocks To Watch With Big News This Week", "url": "https://pennystocks.com/featured/2023/10/24/4-hot-penny-stocks-to-watch-with-big-news-this-week/", "time_published": "20231024T130245", "authors": ["J. Samuel"], "summary": "Whether you're trading penny stocks or stocks over $100, the goal is the same. You want to find opportunities as early as possible and capitalize. In the stock market today, there are plenty of factors affecting the way investors approach both long-term and short-term opportunities.", "banner_image": "https://pennystocks.com/wp-content/uploads/2022/06/best-penny-stocks-to-buy-this-week.jpg", "source": "PennyStocks.com", "category_within_source": "n/a", "source_domain": "pennystocks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.714479"}], "overall_sentiment_score": 0.159037, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LIAN", "relevance_score": "0.155201", "ticker_sentiment_score": "0.254259", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LMT", "relevance_score": "0.039033", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLAP", "relevance_score": "0.039033", "ticker_sentiment_score": "-0.06548", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.039033", "ticker_sentiment_score": "0.016585", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.039033", "ticker_sentiment_score": "0.026811", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFTR", "relevance_score": "0.039033", "ticker_sentiment_score": "0.08789", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Is a Trending Stock: Facts to Know Before Betting on It", "url": "https://www.zacks.com/stock/news/2170165/intuitive-surgical-inc-isrg-is-a-trending-stock-facts-to-know-before-betting-on-it", "time_published": "20231023T130007", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default185.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.226535, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.513698", "ticker_sentiment_score": "0.129956", "ticker_sentiment_label": "Neutral"}]}, {"title": "Robotics Market size to grow by USD 22.26 billion from 2022 to 2027, ABB Ltd., Clearpath Robotics Inc., Cyberdyne Inc ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/robotics-market-size-to-grow-by-usd-22-26-billion-from-2022-to-2027--abb-ltd-clearpath-robotics-inc-cyberdyne-inc-denso-corp-are-among-the-major-companies-in-the-market---technavio-301963363.html", "time_published": "20231023T020000", "authors": [], "summary": "Robotics Market size to grow by USD 22.26 billion from 2022 to 2027, ABB Ltd., Clearpath Robotics Inc., Cyberdyne Inc ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.192332, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TER", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABLZF", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNZOF", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "HON", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEAGF", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "KWHIF", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMRNF", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIGRY", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYBQF", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "FANUF", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHX", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBRA", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.048327", "ticker_sentiment_score": "0.078482", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Downgrades Intuitive Surgical  ( NASDAQ:ISRG )  to Hold", "url": "https://www.defenseworld.net/2023/10/22/stocknews-com-downgrades-intuitive-surgical-nasdaqisrg-to-hold.html", "time_published": "20231022T061641", "authors": ["Defense World Staff"], "summary": "StockNews.com Downgrades Intuitive Surgical ( NASDAQ:ISRG ) to ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&Symbol=ISRG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.993856"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.278833, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TFC", "relevance_score": "0.044634", "ticker_sentiment_score": "0.043164", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.737032", "ticker_sentiment_score": "0.438096", "ticker_sentiment_label": "Bullish"}, {"ticker": "WFC", "relevance_score": "0.044634", "ticker_sentiment_score": "0.043164", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical's Revenue Dipped: Is It Time to Sell?", "url": "https://www.fool.com/investing/2023/10/21/intuitive-surgicals-revenue-dipped-is-it-time-to-s/", "time_published": "20231021T092700", "authors": ["Cory Renauer"], "summary": "A stagnating top line isn't what investors want to see, but things might not be as bad as the surgical robot specialist's stock price performance would suggest.", "banner_image": "https://media.ycharts.com/charts/09f0b390f8557b76ff486827a070b862.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.891286"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.15853, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.274628", "ticker_sentiment_score": "0.082722", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.326643", "ticker_sentiment_score": "0.297294", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.111747", "ticker_sentiment_score": "0.027716", "ticker_sentiment_label": "Neutral"}]}, {"title": "SolarEdge Technologies, Regions Financial fall; Autoliv, Euronet rise, Friday, 10/20/2023", "url": "https://apnews.com/article/financial-markets-stocks-wall-street-ef19b9af0ac575fb077362a6bf1b72a0", "time_published": "20231020T202000", "authors": [], "summary": "SolarEdge Technologies, Regions Financial fall. Autoliv, Euronet rise, Friday, 10/20/2023 The Associated Press ...", "banner_image": "https://dims.apnews.com/dims4/default/dcac1a4/2147483647/strip/true/crop/700x394+0+28/resize/1440x810!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2F90%2F29%2F4e3c1cc7446089a9101a7bdff4c8%2Fdefaultshareimage-copy.png", "source": "Associated Press", "category_within_source": "Markets", "source_domain": "apnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.268236, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SEDG", "relevance_score": "0.355588", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNX", "relevance_score": "0.355588", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RF", "relevance_score": "0.355588", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAZZ", "relevance_score": "0.355588", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPQ", "relevance_score": "0.355588", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPE", "relevance_score": "0.355588", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.355588", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EEFT", "relevance_score": "0.355588", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Analysts React To Intuitive Surgical Q3 Performance, Slash Price Targets - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/equities/23/10/35354393/analysts-react-to-intuitive-surgical-q3-performance-slash-price-targets", "time_published": "20231020T191449", "authors": ["Lekha Gupta"], "summary": "Intuitive Surgical Inc ISRG shares fell by around 3%. Several analysts lowered estimates post Q3 FY23 earnings. ISRG reported quarterly earnings of $1.46 per share, which beat the analyst consensus estimate of $1.41, and sales of $1.74 billion, which missed the analyst consensus estimate of $1.77 ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/20/isrg.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997405"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.038312, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CNICF", "relevance_score": "0.082393", "ticker_sentiment_score": "0.015391", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.395012", "ticker_sentiment_score": "-0.124682", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Jones Falls As Gold Jumps; Solar Stocks Melt As Student Loan Repayment Misfires", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-as-gold-rises-trump-ally-jordan-fails-speaker-bid-as-student-loans-repayment-misfires/", "time_published": "20231020T165000", "authors": ["Investor's Business Daily", "VIDYA RAMAKRISHNAN"], "summary": "Dow Jones Falls As Gold Rises. Trump Ally Jordan Fails Speaker Bid Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/02/stock-capital-hill-redSky-01-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.999862"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.972476"}], "overall_sentiment_score": -0.118879, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.127119", "ticker_sentiment_score": "-0.205204", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ENPH", "relevance_score": "0.127119", "ticker_sentiment_score": "-0.215069", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AAPL", "relevance_score": "0.127119", "ticker_sentiment_score": "-0.205204", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FSLR", "relevance_score": "0.127119", "ticker_sentiment_score": "-0.215069", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SEDG", "relevance_score": "0.127119", "ticker_sentiment_score": "-0.215069", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INTC", "relevance_score": "0.127119", "ticker_sentiment_score": "-0.205204", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DDOG", "relevance_score": "0.127119", "ticker_sentiment_score": "0.057891", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADBE", "relevance_score": "0.18967", "ticker_sentiment_score": "0.07525", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKR", "relevance_score": "0.127119", "ticker_sentiment_score": "0.045158", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLB", "relevance_score": "0.18967", "ticker_sentiment_score": "-0.003284", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.127119", "ticker_sentiment_score": "-0.034407", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.18967", "ticker_sentiment_score": "-0.003284", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks Struggle As Yields Soar; Tesla Tumbles: Weekly Review", "url": "https://www.investors.com/news/stock-market-struggles-as-treasury-yields-soar-tesla-nvidia-among-notable-losers/", "time_published": "20231020T154900", "authors": ["IBD STAFF", "Investor's Business Daily"], "summary": "Stock Market Struggles As Treasury Yields Soar. Tesla, Nvidia ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/02/Stock-UpDownArrows-04-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": -0.154552, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ENPH", "relevance_score": "0.044469", "ticker_sentiment_score": "-0.304019", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UAL", "relevance_score": "0.044469", "ticker_sentiment_score": "-0.263305", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VMW", "relevance_score": "0.088799", "ticker_sentiment_score": "-0.101013", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.044469", "ticker_sentiment_score": "-0.09585", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEX", "relevance_score": "0.11087", "ticker_sentiment_score": "-0.277675", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JNJ", "relevance_score": "0.044469", "ticker_sentiment_score": "-0.064247", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLB", "relevance_score": "0.044469", "ticker_sentiment_score": "0.163964", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SKXJF", "relevance_score": "0.022243", "ticker_sentiment_score": "-0.342954", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DSKYF", "relevance_score": "0.022243", "ticker_sentiment_score": "-0.342954", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "STT", "relevance_score": "0.044469", "ticker_sentiment_score": "-0.079928", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.044469", "ticker_sentiment_score": "-0.064247", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.132855", "ticker_sentiment_score": "-0.15922", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UNP", "relevance_score": "0.06666", "ticker_sentiment_score": "-0.28162", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LRCX", "relevance_score": "0.044469", "ticker_sentiment_score": "-0.048687", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.088799", "ticker_sentiment_score": "0.032981", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.044469", "ticker_sentiment_score": "0.069336", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBKR", "relevance_score": "0.044469", "ticker_sentiment_score": "-0.068991", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.088799", "ticker_sentiment_score": "-0.160615", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TSM", "relevance_score": "0.044469", "ticker_sentiment_score": "-0.048687", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLR", "relevance_score": "0.044469", "ticker_sentiment_score": "-0.304019", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LMT", "relevance_score": "0.06666", "ticker_sentiment_score": "-0.106722", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEDG", "relevance_score": "0.06666", "ticker_sentiment_score": "-0.310714", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AZN", "relevance_score": "0.044469", "ticker_sentiment_score": "-0.359384", "ticker_sentiment_label": "Bearish"}, {"ticker": "CAT", "relevance_score": "0.044469", "ticker_sentiment_score": "-0.219468", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PG", "relevance_score": "0.06666", "ticker_sentiment_score": "0.117914", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.044469", "ticker_sentiment_score": "0.347311", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SCHW", "relevance_score": "0.06666", "ticker_sentiment_score": "-0.070334", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.044469", "ticker_sentiment_score": "-0.263305", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Dow Jones Falls As Gold Heads Higher; Student Loans Repayment Misfires", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-as-gold-rises-trump-ally-makes-speaker-bid-as-student-loans-repayment-misfires/", "time_published": "20231020T145500", "authors": ["VIDYA RAMAKRISHNAN", "Investor's Business Daily"], "summary": "Dow Jones Falls As Gold Rises. Trump Ally Makes Speaker Bid Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/02/stock-capital-hill-redSky-01-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.999606"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.972476"}], "overall_sentiment_score": -0.054056, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.15347", "ticker_sentiment_score": "-0.275633", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AAPL", "relevance_score": "0.15347", "ticker_sentiment_score": "-0.275633", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SEDG", "relevance_score": "0.15347", "ticker_sentiment_score": "-0.386135", "ticker_sentiment_label": "Bearish"}, {"ticker": "INTC", "relevance_score": "0.15347", "ticker_sentiment_score": "-0.275633", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DDOG", "relevance_score": "0.228431", "ticker_sentiment_score": "0.297147", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ADBE", "relevance_score": "0.228431", "ticker_sentiment_score": "0.145706", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKR", "relevance_score": "0.15347", "ticker_sentiment_score": "0.207114", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SLB", "relevance_score": "0.228431", "ticker_sentiment_score": "-0.003787", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.15347", "ticker_sentiment_score": "0.099422", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.228431", "ticker_sentiment_score": "-0.003787", "ticker_sentiment_label": "Neutral"}]}, {"title": "Medical device makers see limited hit from weight-loss drugs", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/medical-device-makers-see-limited-hit-weight-loss-drugs-2023-10-20/", "time_published": "20231020T141800", "authors": ["Reuters"], "summary": "[1/2] Boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo Acquire Licensing Rights", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/V6WKJ3BLKRML3BRCVWOIWT5H3M.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.011811, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.078611", "ticker_sentiment_score": "0.005137", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.078611", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.156461", "ticker_sentiment_score": "-0.029172", "ticker_sentiment_label": "Neutral"}]}, {"title": "The top 10 things to watch in the stock market Friday", "url": "https://www.cnbc.com/2023/10/20/the-top-10-things-to-watch-in-the-stock-market-friday.html", "time_published": "20231020T131905", "authors": ["Jeff Marks"], "summary": "Will the yield on the 10-year Treasury breach 5% Friday, and how will markets react?", "banner_image": "https://image.cnbcfm.com/api/v1/image/107123736-1663957784492-gettyimages-482832746-000070312695_Unapproved.jpeg?v=1697807945&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.997405"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.995015"}], "overall_sentiment_score": 0.173123, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "F", "relevance_score": "0.13459", "ticker_sentiment_score": "0.176393", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GM", "relevance_score": "0.13459", "ticker_sentiment_score": "0.176393", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JPM", "relevance_score": "0.067536", "ticker_sentiment_score": "0.145206", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.13459", "ticker_sentiment_score": "-0.06791", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNP", "relevance_score": "0.13459", "ticker_sentiment_score": "0.174759", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LLY", "relevance_score": "0.200688", "ticker_sentiment_score": "0.159599", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SLB", "relevance_score": "0.067536", "ticker_sentiment_score": "0.07438", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.13459", "ticker_sentiment_score": "0.123096", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.067536", "ticker_sentiment_score": "-0.114966", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.13459", "ticker_sentiment_score": "0.012275", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.200688", "ticker_sentiment_score": "0.229", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Wall St eyes lower open on elevated Treasury yields, Middle East worries", "url": "https://www.reuters.com/markets/us/futures-inch-lower-treasury-yields-surge-earnings-focus-2023-10-20/", "time_published": "20231020T125700", "authors": ["Shashwat Chauhan", "Shubham Batra"], "summary": "A street sign for Wall Street is seen in the financial district in New York, U.S., November 8, 2021. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights Oct 20 ( Reuters ) - Wall Street's main indexes were set for a lower open on Friday as U.S.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/V6WKJ3BLKRML3BRCVWOIWT5H3M.jpg", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.928139"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.495866"}], "overall_sentiment_score": -0.069394, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SLB", "relevance_score": "0.07423", "ticker_sentiment_score": "0.069259", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENPH", "relevance_score": "0.07423", "ticker_sentiment_score": "0.28064", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FSLR", "relevance_score": "0.07423", "ticker_sentiment_score": "0.28064", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SEDG", "relevance_score": "0.07423", "ticker_sentiment_score": "-0.405265", "ticker_sentiment_label": "Bearish"}, {"ticker": "ISRG", "relevance_score": "0.07423", "ticker_sentiment_score": "-0.306143", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CMA", "relevance_score": "0.07423", "ticker_sentiment_score": "0.054273", "ticker_sentiment_label": "Neutral"}]}, {"title": "Futures Extend Losses; This Solar Stock Crashes", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-extend-losses-from-market-sell-off-solaredge-crashes-on-warning/", "time_published": "20231020T121100", "authors": ["SCOTT LEHTONEN", "Investor's Business Daily"], "summary": "Dow Jones Futures Extend Losses From Market Sell-Off. SolarEdge ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2017/10/stock-eclipse-solar-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.857896"}], "overall_sentiment_score": -0.002432, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ENPH", "relevance_score": "0.067919", "ticker_sentiment_score": "0.077381", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.101725", "ticker_sentiment_score": "0.101858", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.067919", "ticker_sentiment_score": "-0.172678", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AAPL", "relevance_score": "0.168726", "ticker_sentiment_score": "0.001457", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANET", "relevance_score": "0.101725", "ticker_sentiment_score": "0.073962", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.168726", "ticker_sentiment_score": "0.016968", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLB", "relevance_score": "0.101725", "ticker_sentiment_score": "-0.044764", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.03399", "ticker_sentiment_score": "0.008803", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.101725", "ticker_sentiment_score": "0.001111", "ticker_sentiment_label": "Neutral"}, {"ticker": "LULU", "relevance_score": "0.101725", "ticker_sentiment_score": "0.042585", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEDG", "relevance_score": "0.168726", "ticker_sentiment_score": "-0.177213", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TSLA", "relevance_score": "0.101725", "ticker_sentiment_score": "0.001111", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.101725", "ticker_sentiment_score": "-0.044764", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.101725", "ticker_sentiment_score": "0.079746", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.135347", "ticker_sentiment_score": "0.034724", "ticker_sentiment_label": "Neutral"}]}, {"title": "US Regulatory Green-lights Mobile VR Devices, Cryptocurrency 'Mixers' Deemed 'National Security Risks' - Top Headlines Today While US Was Sleeping", "url": "https://www.benzinga.com/news/23/10/35347626/us-regulatory-green-lights-mobile-vr-devices-cryptocurrency-mixers-deemed-national-security-risks-to", "time_published": "20231020T115858", "authors": ["Akanksha Bakshi"], "summary": "Investor Fear Grows Following Powell's Comments SolarEdge Technologies, Intuitive Surgical And Other Big Stocks Moving Lower In Friday's Pre-Market Session US Treasury Unit Deems Cryptocurrency 'Mixers' As 'National Security Risks,' Proposes Crackdown Amid Israel-Hamas Conflict", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/20/news.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Blockchain", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.060919, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYPL", "relevance_score": "0.072435", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.072435", "ticker_sentiment_score": "0.194706", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LCID", "relevance_score": "0.072435", "ticker_sentiment_score": "0.168377", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVDA", "relevance_score": "0.072435", "ticker_sentiment_score": "0.188774", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SEDG", "relevance_score": "0.072435", "ticker_sentiment_score": "-0.168377", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TSLA", "relevance_score": "0.144275", "ticker_sentiment_score": "-0.155268", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NYT", "relevance_score": "0.072435", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.072435", "ticker_sentiment_score": "-0.168377", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.214937", "ticker_sentiment_score": "-0.239046", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.144275", "ticker_sentiment_score": "-0.212806", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRYPTO:DOGE", "relevance_score": "0.214937", "ticker_sentiment_score": "-0.177255", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRYPTO:XRP", "relevance_score": "0.072435", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Knight-Swift Transportation Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Aravive  ( NASDAQ:ARAV ) , American Well  ( NYSE:AMWL ) ", "url": "https://www.benzinga.com/news/23/10/35347610/why-knight-swift-transportation-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-pre", "time_published": "20231020T114219", "authors": ["Lisa Levin"], "summary": "XORTX Therapeutics Inc. XRTX shares surged 95.5% to $0.6226 in pre-market trading after jumping 34% on Thursday. Urgent.ly Inc. ULY shares rose 61.6% to $8.89 in pre-market trading after falling around 52% on Thursday. -Urgent.ly announced the closing of its acquisition of Otonomo Technologies Ltd.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/20/image21.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.865346"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.106029, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LAES", "relevance_score": "0.193723", "ticker_sentiment_score": "0.104058", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTMO", "relevance_score": "0.06515", "ticker_sentiment_score": "0.021115", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUEN", "relevance_score": "0.129866", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.129866", "ticker_sentiment_score": "-0.077973", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARQT", "relevance_score": "0.193723", "ticker_sentiment_score": "0.190418", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILAG", "relevance_score": "0.129866", "ticker_sentiment_score": "0.071833", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASST", "relevance_score": "0.193723", "ticker_sentiment_score": "-0.034526", "ticker_sentiment_label": "Neutral"}, {"ticker": "VICI", "relevance_score": "0.06515", "ticker_sentiment_score": "0.147255", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEDG", "relevance_score": "0.193723", "ticker_sentiment_score": "-0.197234", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KNX", "relevance_score": "0.129866", "ticker_sentiment_score": "0.434182", "ticker_sentiment_label": "Bullish"}, {"ticker": "UK", "relevance_score": "0.193723", "ticker_sentiment_score": "0.215562", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BCEL", "relevance_score": "0.129866", "ticker_sentiment_score": "-0.051417", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRTX", "relevance_score": "0.129866", "ticker_sentiment_score": "0.159934", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ARAV", "relevance_score": "0.129866", "ticker_sentiment_score": "0.215808", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ICU", "relevance_score": "0.129866", "ticker_sentiment_score": "0.189662", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDAI", "relevance_score": "0.193723", "ticker_sentiment_score": "-0.121484", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOWL", "relevance_score": "0.193723", "ticker_sentiment_score": "0.221545", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.129866", "ticker_sentiment_score": "-0.185973", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AMWL", "relevance_score": "0.129866", "ticker_sentiment_score": "0.14219", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDOS", "relevance_score": "0.06515", "ticker_sentiment_score": "0.121175", "ticker_sentiment_label": "Neutral"}, {"ticker": "WHLR", "relevance_score": "0.129866", "ticker_sentiment_score": "0.044566", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical  ( ISRG )  Q3 Earnings Beat, Procedures Robust", "url": "https://www.zacks.com/stock/news/2169451/intuitive-surgical-isrg-q3-earnings-beat-procedures-robust", "time_published": "20231020T113900", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical's (ISRG) third-quarter results reflect healthy demand for procedures, partially offset by lower system sales. Higher pricing boosted procedure sales.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/53200.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.999162"}], "overall_sentiment_score": 0.10305, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALC", "relevance_score": "0.188928", "ticker_sentiment_score": "0.130336", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.188928", "ticker_sentiment_score": "0.123554", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCK", "relevance_score": "0.142284", "ticker_sentiment_score": "0.043738", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.4499", "ticker_sentiment_score": "0.03923", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Nasdaq, S&P 500 Futures Are Sagging Today - Netflix  ( NASDAQ:NFLX ) , WD-40  ( NASDAQ:WDFC ) , SLB  ( NYSE:SLB ) , CSX  ( NASDAQ:CSX ) ", "url": "https://www.benzinga.com/news/earnings/23/10/35347388/nasdaq-s-p-500-futures-sag-on-rate-worries-mixed-earnings-analyst-touts-2-data-points-for-possible-", "time_published": "20231020T112605", "authors": ["Shanthi Rexaline"], "summary": "The negative sentiment that has blanketed the market for much of the week will likely extend into the final session of the trading week. The index futures were modestly lower early Friday. Earnings continue to be mixed, likely creating uncertainty concerning the corporate profit growth outlook.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/nyse_shutter_2.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.997405"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.451494"}], "overall_sentiment_score": -0.021857, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.09495", "ticker_sentiment_score": "0.217188", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WDFC", "relevance_score": "0.09495", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPQ", "relevance_score": "0.047559", "ticker_sentiment_score": "-0.488747", "ticker_sentiment_label": "Bearish"}, {"ticker": "SLB", "relevance_score": "0.047559", "ticker_sentiment_score": "-0.072046", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSX", "relevance_score": "0.09495", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RUN", "relevance_score": "0.09495", "ticker_sentiment_score": "-0.07674", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALV", "relevance_score": "0.09495", "ticker_sentiment_score": "-0.076457", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.047559", "ticker_sentiment_score": "0.062972", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLR", "relevance_score": "0.09495", "ticker_sentiment_score": "-0.07674", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEDG", "relevance_score": "0.09495", "ticker_sentiment_score": "-0.07674", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNX", "relevance_score": "0.09495", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RF", "relevance_score": "0.09495", "ticker_sentiment_score": "-0.076457", "ticker_sentiment_label": "Neutral"}, {"ticker": "BACHY", "relevance_score": "0.047559", "ticker_sentiment_score": "0.113943", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMA", "relevance_score": "0.09495", "ticker_sentiment_score": "-0.076457", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.09495", "ticker_sentiment_score": "-0.076457", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPE", "relevance_score": "0.09495", "ticker_sentiment_score": "-0.516962", "ticker_sentiment_label": "Bearish"}, {"ticker": "ISRG", "relevance_score": "0.09495", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Schlumberger, American Express And 3 Stocks To Watch Heading Into Friday - American Express  ( NYSE:AXP ) , Autoliv  ( NYSE:ALV ) ", "url": "https://www.benzinga.com/news/earnings/23/10/35344679/schlumberger-american-express-and-3-stocks-to-watch-heading-into-friday", "time_published": "20231020T111458", "authors": ["Lisa Levin"], "summary": "With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: Wall Street expects American Express Company AXP to report quarterly earnings at $2.94 per share on revenue of $15.37 billion before the opening bell.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/20/schlumberger_slb_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.990786"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.038734, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SLB", "relevance_score": "0.353059", "ticker_sentiment_score": "-0.028317", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.507932", "ticker_sentiment_score": "0.395297", "ticker_sentiment_label": "Bullish"}, {"ticker": "WDFC", "relevance_score": "0.507932", "ticker_sentiment_score": "-0.30459", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALV", "relevance_score": "0.507932", "ticker_sentiment_score": "0.406053", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.507932", "ticker_sentiment_score": "0.104568", "ticker_sentiment_label": "Neutral"}]}, {"title": "SolarEdge Technologies, Intuitive Surgical And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Enphase Energy  ( NASDAQ:ENPH ) , Canadian Solar  ( NASDAQ:CSIQ ) ", "url": "https://www.benzinga.com/news/23/10/35345728/solaredge-technologies-intuitive-surgical-and-other-big-stocks-moving-lower-in-fridays-pre-market-se", "time_published": "20231020T100021", "authors": ["Lisa Levin"], "summary": "U.S. stock futures traded lower this morning on Friday. Here are some big stocks recording losses in today's pre-market trading session. SolarEdge Technologies, Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/20/solaredge_technologies_-_ogo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.839681"}], "overall_sentiment_score": -0.158768, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ENPH", "relevance_score": "0.213048", "ticker_sentiment_score": "0.020075", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLR", "relevance_score": "0.213048", "ticker_sentiment_score": "-0.109148", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDFC", "relevance_score": "0.31482", "ticker_sentiment_score": "-0.233101", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SEDG", "relevance_score": "0.411176", "ticker_sentiment_score": "-0.203922", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JPM", "relevance_score": "0.107495", "ticker_sentiment_score": "-0.08425", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSIQ", "relevance_score": "0.31482", "ticker_sentiment_score": "-0.077464", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOVA", "relevance_score": "0.31482", "ticker_sentiment_score": "-0.168611", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RUN", "relevance_score": "0.31482", "ticker_sentiment_score": "-0.173413", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ISRG", "relevance_score": "0.213048", "ticker_sentiment_score": "-0.06618", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTC", "relevance_score": "0.31482", "ticker_sentiment_score": "-0.055523", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Intuitive Surgical Is a Screaming Buy on the Pullback", "url": "https://www.fool.com/investing/2023/10/20/why-intuitive-surgical-is-a-screaming-buy-on-the-p/", "time_published": "20231020T095100", "authors": ["Keith Speights"], "summary": "Don't sweat Intuitive Surgical's mixed Q3 results. There are plenty of reasons to like this beaten-down stock.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999612"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.113315, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.422493", "ticker_sentiment_score": "-0.106292", "ticker_sentiment_label": "Neutral"}]}, {"title": "Solar shares plunge after SolarEdge warning, as Urgent.ly stock soars on deal news and more moving shares", "url": "https://www.marketwatch.com/story/solar-shares-plunge-after-solaredge-warning-as-urgent-ly-stock-soars-on-deal-news-and-more-moving-shares-b126df83", "time_published": "20231020T094900", "authors": ["MarketWatch"], "summary": "Shares in SolarEdge Technologies, Urgent.ly, Intuitive Surgical, Enphase Energy, SunRun, SunPower and First Solar were all active in pre-market trading ...", "banner_image": "https://images.mktw.net/im-872389/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": -0.246725, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ENPH", "relevance_score": "0.436009", "ticker_sentiment_score": "-0.38191", "ticker_sentiment_label": "Bearish"}, {"ticker": "FSLR", "relevance_score": "0.436009", "ticker_sentiment_score": "-0.38191", "ticker_sentiment_label": "Bearish"}, {"ticker": "SEDG", "relevance_score": "0.436009", "ticker_sentiment_score": "-0.522986", "ticker_sentiment_label": "Bearish"}, {"ticker": "HPQ", "relevance_score": "0.227007", "ticker_sentiment_score": "-0.322831", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RUN", "relevance_score": "0.436009", "ticker_sentiment_score": "-0.38191", "ticker_sentiment_label": "Bearish"}, {"ticker": "SRGRF", "relevance_score": "0.227007", "ticker_sentiment_score": "-0.244017", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HPE", "relevance_score": "0.436009", "ticker_sentiment_score": "-0.495112", "ticker_sentiment_label": "Bearish"}, {"ticker": "ISRG", "relevance_score": "0.436009", "ticker_sentiment_score": "-0.406164", "ticker_sentiment_label": "Bearish"}, {"ticker": "SPWR", "relevance_score": "0.436009", "ticker_sentiment_score": "-0.38191", "ticker_sentiment_label": "Bearish"}]}, {"title": "Intuitive Surgical  ( ISRG )  Q3 2023 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2023/10/19/intuitive-surgical-isrg-q3-2023-earnings-call-tran/", "time_published": "20231020T023019", "authors": ["Motley Fool Transcribing"], "summary": "ISRG earnings call for the period ending September 30, 2023.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.241624, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BCS", "relevance_score": "0.005191", "ticker_sentiment_score": "0.168636", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BAC", "relevance_score": "0.005191", "ticker_sentiment_score": "0.140875", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.010382", "ticker_sentiment_score": "0.114241", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.005191", "ticker_sentiment_score": "0.130318", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.020762", "ticker_sentiment_score": "0.1143", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Q3 Earnings Surpass Estimates", "url": "https://www.zacks.com/stock/news/2169184/intuitive-surgical-inc-isrg-q3-earnings-surpass-estimates", "time_published": "20231019T212504", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 3.55% and 1.37%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default226.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.135007, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.401331", "ticker_sentiment_score": "0.114434", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGR", "relevance_score": "0.139265", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pressure Mounts As Yields Flirt With 5%; Fear Gauge Offers Hope", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-pressure-mounts-as-yields-flirt-with-5-tesla-dives-this-market-gauge-offers-hope/", "time_published": "20231019T203200", "authors": ["Investor's Business Daily", "ED CARSON"], "summary": "Pressure Mounts As Yields Flirt With 5%. Fear Gauge Offers Hope Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2018/01/FAB-fear-020518-shutterstock.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": -0.053454, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.236588", "ticker_sentiment_score": "0.089875", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.079921", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANET", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.05506", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.210961", "ticker_sentiment_score": "0.005183", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.05333", "ticker_sentiment_score": "-0.271887", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UNP", "relevance_score": "0.05333", "ticker_sentiment_score": "-0.159029", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ADBE", "relevance_score": "0.185103", "ticker_sentiment_score": "0.021017", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.05333", "ticker_sentiment_score": "-0.271887", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SLB", "relevance_score": "0.106423", "ticker_sentiment_score": "0.112494", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.106423", "ticker_sentiment_score": "-0.230299", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PLTR", "relevance_score": "0.106423", "ticker_sentiment_score": "0.010019", "ticker_sentiment_label": "Neutral"}]}, {"title": "Robotic Surgery Giant Tumbles On Light Third-Quarter Sales", "url": "https://www.investors.com/news/technology/isrg-stock-intuitive-surgical-earnings-q3-2023/", "time_published": "20231019T201400", "authors": ["ALLISON GATLIN", "Investor's Business Daily"], "summary": "ISRG Stock Dives As Robotic Surgery Behemoth Lags Sales ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/11/stock-Intuitive-Surgical-06-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}], "overall_sentiment_score": 0.078616, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.932163", "ticker_sentiment_score": "-0.086299", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.205807", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Announces Third Quarter Earnings", "url": "https://www.globenewswire.com/news-release/2023/10/19/2763661/7637/en/Intuitive-Announces-Third-Quarter-Earnings.html", "time_published": "20231019T200500", "authors": ["Inc.", "Intuitive Surgical"], "summary": "SUNNYVALE, Calif., Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- Intuitive ( the \"Company\" ) ( Nasdaq: ISRG ) , a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2023.", "banner_image": "https://ml.globenewswire.com/Resource/Download/db89f2a9-76ed-4743-84d3-a7ac75605b6c", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.218908, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "FOSUF", "relevance_score": "0.030661", "ticker_sentiment_score": "0.033755", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.285001", "ticker_sentiment_score": "0.295674", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SFOSF", "relevance_score": "0.015333", "ticker_sentiment_score": "-0.014248", "ticker_sentiment_label": "Neutral"}]}, {"title": "Robot Market worth $231.48 Billion by 2030 - Exclusive Report by The Insight Partners", "url": "https://www.benzinga.com/pressreleases/23/10/g35326594/robot-market-worth-231-48-billion-by-2030-exclusive-report-by-the-insight-partners", "time_published": "20231019T114424", "authors": ["Globe Newswire"], "summary": "Pune, India, Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- A robot is a programmable, autonomous, or semi-autonomous machine designed to perform tasks or manipulate objects, primarily in industrial scenarios.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.278392, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DFKCY", "relevance_score": "0.062679", "ticker_sentiment_score": "0.164185", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "YASKF", "relevance_score": "0.062679", "ticker_sentiment_score": "0.101037", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOC", "relevance_score": "0.031364", "ticker_sentiment_score": "0.096676", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABLZF", "relevance_score": "0.031364", "ticker_sentiment_score": "0.177895", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DNZOF", "relevance_score": "0.062679", "ticker_sentiment_score": "0.164185", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SYK", "relevance_score": "0.031364", "ticker_sentiment_score": "0.096676", "ticker_sentiment_label": "Neutral"}, {"ticker": "KR", "relevance_score": "0.062679", "ticker_sentiment_score": "0.174277", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OCDGF", "relevance_score": "0.062679", "ticker_sentiment_score": "0.155173", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FANUF", "relevance_score": "0.093897", "ticker_sentiment_score": "0.172461", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.031364", "ticker_sentiment_score": "0.096676", "ticker_sentiment_label": "Neutral"}, {"ticker": "KUKAF", "relevance_score": "0.062679", "ticker_sentiment_score": "0.164185", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Corporate America weighs risks of the Ozempic effect", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/corporate-america-weighs-risks-ozempic-effect-2023-10-19/", "time_published": "20231019T112800", "authors": ["Reuters"], "summary": "Boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo Acquire Licensing Rights", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/QBKENUA4NBKF7OENKFKMX6MUYM.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.117802, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.07913", "ticker_sentiment_score": "0.182216", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FSNUF", "relevance_score": "0.07913", "ticker_sentiment_score": "0.085254", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.07913", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "COR", "relevance_score": "0.07913", "ticker_sentiment_score": "0.034637", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEP", "relevance_score": "0.07913", "ticker_sentiment_score": "0.131114", "ticker_sentiment_label": "Neutral"}, {"ticker": "PODD", "relevance_score": "0.07913", "ticker_sentiment_score": "-0.049676", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAH", "relevance_score": "0.07913", "ticker_sentiment_score": "0.034637", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.07913", "ticker_sentiment_score": "-0.024285", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.07913", "ticker_sentiment_score": "0.037046", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.07913", "ticker_sentiment_score": "0.270432", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "S&P 500, Nasdaq Set For Mixed Open After Tesla, Netflix Earnings: What's Moving Stock Futures? - Alaska Air Gr  ( NYSE:ALK ) , Netflix  ( NASDAQ:NFLX ) , VMware  ( NYSE:VMW ) , Broadcom  ( NASDAQ:AVGO ) ", "url": "https://www.benzinga.com/news/earnings/23/10/35325705/wall-street-set-for-mixed-open-as-teslas-q3-blow-blunts-netflix-earnings-cheer-analyst-sees-sustain", "time_published": "20231019T110324", "authors": ["Shanthi Rexaline"], "summary": "U.S. stocks face a mixed opening on Thursday as traders grapple with a blend of earnings reports and increasing economic uncertainty. Tesla, Inc.'s TSLA underwhelming quarterly results are putting pressure on sentiment, but this could be offset by positive performances from companies like ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/NYSE.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "Financial Markets", "relevance_score": "0.992549"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.11506, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALK", "relevance_score": "0.085173", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.127456", "ticker_sentiment_score": "-0.090507", "ticker_sentiment_label": "Neutral"}, {"ticker": "VMW", "relevance_score": "0.085173", "ticker_sentiment_score": "-0.142777", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.085173", "ticker_sentiment_score": "-0.142777", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVS", "relevance_score": "0.085173", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSX", "relevance_score": "0.085173", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOK", "relevance_score": "0.085173", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.042647", "ticker_sentiment_score": "0.211069", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FITB", "relevance_score": "0.085173", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWBC", "relevance_score": "0.085173", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.127456", "ticker_sentiment_score": "-0.090507", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNX", "relevance_score": "0.085173", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "T", "relevance_score": "0.042647", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.085173", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNP", "relevance_score": "0.085173", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.085173", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PM", "relevance_score": "0.042647", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KEY", "relevance_score": "0.085173", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.042647", "ticker_sentiment_score": "-0.066198", "ticker_sentiment_label": "Neutral"}]}, {"title": "Morning Bid: To 5% and beyond, bond yields soar", "url": "https://www.reuters.com/markets/us/global-markets-view-usa-2023-10-19/", "time_published": "20231019T100100", "authors": ["Reuters"], "summary": "Traders work on the floor of the New York Stock Exchange ( NYSE ) in New York City, U.S., September 26, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights A look at the day ahead in U.S. and global markets from Mike Dolan", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/HZN3YBA4MVJTBDNQAKJGCL2BN4.jpg", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.999174"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.576289"}], "overall_sentiment_score": -0.109715, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALK", "relevance_score": "0.047559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.047559", "ticker_sentiment_score": "-0.149639", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNA", "relevance_score": "0.047559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAL", "relevance_score": "0.047559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFC", "relevance_score": "0.047559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FITB", "relevance_score": "0.047559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.047559", "ticker_sentiment_score": "-0.149639", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.047559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNP", "relevance_score": "0.047559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRYF", "relevance_score": "0.047559", "ticker_sentiment_score": "-0.04292", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCX", "relevance_score": "0.047559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPC", "relevance_score": "0.047559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.047559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PM", "relevance_score": "0.047559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KEY", "relevance_score": "0.047559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:JPY", "relevance_score": "0.047559", "ticker_sentiment_score": "-0.069021", "ticker_sentiment_label": "Neutral"}]}, {"title": "Tesla, Netflix, AT&T, Taiwan Semi, Las Vegas Sands, Equifax, and More Stock Market Movers", "url": "https://www.barrons.com/amp/articles/stock-market-movers-80ee4602", "time_published": "20231019T084600", "authors": ["Joe Woelfel"], "summary": "Tesla, Netflix, Taiwan Semi, SAP, Las Vegas Sands, AT&T, and More Market Movers ...", "banner_image": "https://images.barrons.com/im-459897/social", "source": "Barrons", "category_within_source": "n/a", "source_domain": "www.barrons.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.839681"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.99992"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.007247, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALK", "relevance_score": "0.135729", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.202366", "ticker_sentiment_score": "0.106003", "ticker_sentiment_label": "Neutral"}, {"ticker": "FL", "relevance_score": "0.202366", "ticker_sentiment_score": "-0.187033", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LVS", "relevance_score": "0.135729", "ticker_sentiment_score": "0.106739", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOK", "relevance_score": "0.135729", "ticker_sentiment_score": "-0.100238", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAL", "relevance_score": "0.135729", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.068112", "ticker_sentiment_score": "-0.120391", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSM", "relevance_score": "0.135729", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFC", "relevance_score": "0.135729", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.202366", "ticker_sentiment_score": "0.101992", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.135729", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFX", "relevance_score": "0.330876", "ticker_sentiment_score": "-0.451257", "ticker_sentiment_label": "Bearish"}, {"ticker": "UNP", "relevance_score": "0.135729", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCX", "relevance_score": "0.135729", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.135729", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PM", "relevance_score": "0.135729", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KEY", "relevance_score": "0.135729", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "S&P 500 futures extend losses as Treasury yield nears 5%, Powell speech looms", "url": "https://www.marketwatch.com/story/s-p-500-futures-extend-losses-as-treasury-yield-nears-5-powell-speech-looms-7574cd86", "time_published": "20231019T083500", "authors": ["Jamie Chisholm"], "summary": "U.S. stock futures were struggling to rebound from the previous session's dive as the sell-off in bond markets continued and tensions in the Middle East weighed ...", "banner_image": "https://images.mktw.net/im-871185/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.682689"}, {"topic": "Financial Markets", "relevance_score": "0.94762"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.114151, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.16171", "ticker_sentiment_score": "-0.033854", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.16171", "ticker_sentiment_score": "-0.033854", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAL", "relevance_score": "0.16171", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.16171", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCX", "relevance_score": "0.16171", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRGLF", "relevance_score": "0.081276", "ticker_sentiment_score": "-0.004168", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.16171", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Procedure Volume Growth To Drive Intuitive Surgical's Q3", "url": "https://www.forbes.com/sites/greatspeculations/2023/10/18/procedure-volume-growth-to-drive-intuitive-surgicals-q3/", "time_published": "20231018T143015", "authors": ["Trefis Team"], "summary": "Earnings are likely to come in at about $1.42 on a per-share and adjusted basis, in line with the consensus estimate of $1.41.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/63fec3826af3169855ec682c/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds", "source": "Forbes", "category_within_source": "Money", "source_domain": "www.forbes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.714479"}], "overall_sentiment_score": 0.202946, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.712594", "ticker_sentiment_score": "0.36657", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bariatric Surgeries Market Worth $27.64 Billion by 2030 - Exclusive Report by The Insight Partners", "url": "https://www.benzinga.com/pressreleases/23/10/g35287685/bariatric-surgeries-market-worth-27-64-billion-by-2030-exclusive-report-by-the-insight-partners", "time_published": "20231017T132022", "authors": ["Globe Newswire"], "summary": "Pune, India, Oct. 17, 2023 ( GLOBE NEWSWIRE ) -- The basic principle of bariatric surgery is restricting food intake and reducing food absorption in the intestines and stomach. Bariatric surgery is done when exercise and diet fail to reduce weight or when a patient has serious health problems ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.200911, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ALUR", "relevance_score": "0.032338", "ticker_sentiment_score": "0.077639", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.032338", "ticker_sentiment_score": "-0.001927", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFX", "relevance_score": "0.032338", "ticker_sentiment_score": "0.089424", "ticker_sentiment_label": "Neutral"}, {"ticker": "IART", "relevance_score": "0.032338", "ticker_sentiment_score": "0.096139", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.032338", "ticker_sentiment_score": "0.096139", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCPNF", "relevance_score": "0.032338", "ticker_sentiment_score": "0.096139", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNMD", "relevance_score": "0.032338", "ticker_sentiment_score": "0.096139", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.032338", "ticker_sentiment_score": "0.045714", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSLS", "relevance_score": "0.032338", "ticker_sentiment_score": "0.096139", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical  ( ISRG )  to Post Q3 Earnings: What's in Store?", "url": "https://www.zacks.com/stock/news/2167270/intuitive-surgical-isrg-to-post-q3-earnings-whats-in-store", "time_published": "20231017T130700", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical's (ISRG) third-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c2/53795.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999937"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.185389, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.09495", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.142005", "ticker_sentiment_score": "-0.00628", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.366736", "ticker_sentiment_score": "0.109696", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQV", "relevance_score": "0.142005", "ticker_sentiment_score": "-0.006276", "ticker_sentiment_label": "Neutral"}]}, {"title": "A Bull Market Is Coming: 2 Stocks That Could Be Worth $1 Trillion in 20 Years", "url": "https://www.fool.com/investing/2023/10/17/a-bull-market-is-coming-2-stocks-that-could-be-wor/", "time_published": "20231017T114500", "authors": ["Prosper Junior Bakiny"], "summary": "Don't wait for a bull run to buy these companies' shares.", "banner_image": "https://media.ycharts.com/charts/c1cbcd72df46d356817f10a52e8d7661.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.214378"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.267562, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SHOP", "relevance_score": "0.320676", "ticker_sentiment_score": "0.341553", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.232217", "ticker_sentiment_score": "0.265304", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Intuitive Surgical, Inc.  ( ISRG )  Could Beat Earnings Estimates Again", "url": "https://www.zacks.com/stock/news/2166642/why-intuitive-surgical-inc-isrg-could-beat-earnings-estimates-again", "time_published": "20231016T161009", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default166.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99989"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.32237, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.411848", "ticker_sentiment_score": "0.452477", "ticker_sentiment_label": "Bullish"}]}, {"title": "Argus Research Initiates Equity Report Coverage on SS Innovations International, Inc.  ( OTC: SSII ) ", "url": "https://www.prnewswire.com/news-releases/argus-research-initiates-equity-report-coverage-on-ss-innovations-international-inc-otc-ssii-301956953.html", "time_published": "20231016T114500", "authors": ["Argus Research"], "summary": "NEW YORK, Oct. 16, 2023 /PRNewswire/ -- Argus Research, an independent investment research firm, has launched Equity Report coverage on SS Innovations International, Inc. ( OTC: SSII ) Excerpts & Highlights from the Report as conveyed by Argus Analyst Steve Silver, follow:", "banner_image": "https://mma.prnewswire.com/media/1492597/Argus_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.990893"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.839681"}], "overall_sentiment_score": 0.249975, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SPGI", "relevance_score": "0.020404", "ticker_sentiment_score": "0.073868", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRI", "relevance_score": "0.020404", "ticker_sentiment_score": "0.073868", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.020404", "ticker_sentiment_score": "0.164706", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SSII", "relevance_score": "0.33628", "ticker_sentiment_score": "0.318824", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RSSS", "relevance_score": "0.020404", "ticker_sentiment_score": "0.073868", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Sees Relative Strength Rating Improve To 71", "url": "https://www.investors.com/ibd-data-stories/intuitive-surgical-sees-relative-strength-rating-improve-to-71/", "time_published": "20231016T070000", "authors": ["Investor's Business Daily", "INVESTOR'S BUSINESS DAILY"], "summary": "The Relative Strength ( RS ) Rating for Intuitive Surgical ( ISRG ) moved up into a higher percentile Monday, as it got a lift from 62 to 71. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.333751, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.27432", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.70749", "ticker_sentiment_score": "0.346911", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.139265", "ticker_sentiment_score": "0.162068", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical Stock Rating Climbs As Sales, Profits Rise", "url": "https://www.investors.com/news/technology/intuitive-surgical-sees-relative-strength-rating-improve-to-71/", "time_published": "20231016T070000", "authors": ["INVESTOR'S BUSINESS DAILY", "JAMES DETAR", "Investor's Business Daily"], "summary": "Intuitive Surgical Stock Rating Climbs As Sales Growth Rises Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/11/stock-Intuitive-Surgical-06-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972756"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.267008, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.156461", "ticker_sentiment_score": "0.058396", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.625544", "ticker_sentiment_score": "0.306394", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.078611", "ticker_sentiment_score": "0.135087", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why You Should Invest In Healthcare Stocks", "url": "https://www.kiplinger.com/investing/healthcare-stocks/why-you-should-invest-in-healthcare-stocks", "time_published": "20231015T140059", "authors": ["James K. Glassman"], "summary": "Healthcare stocks have had a rough few years. So why invest in them? First, I'm a contrarian. I like what's down. Second, healthcare is a booming industry, accounting for 18% of gross domestic product ( GDP ) in 2021, up from 12% in 1991. Third, the sector adds stability to any portfolio.", "banner_image": "https://cdn.mos.cms.futurecdn.net/KKJr2NN3xukR5Kxuhz2vrY-415-80.jpg", "source": "Kiplinger", "category_within_source": "n/a", "source_domain": "www.kiplinger.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.99737"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.183015, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SYK", "relevance_score": "0.099752", "ticker_sentiment_score": "0.18093", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.066598", "ticker_sentiment_score": "0.119713", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCA", "relevance_score": "0.099752", "ticker_sentiment_score": "0.087475", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.066598", "ticker_sentiment_score": "0.0641", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.066598", "ticker_sentiment_score": "-0.162455", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IVZ", "relevance_score": "0.033328", "ticker_sentiment_score": "0.12656", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.099752", "ticker_sentiment_score": "-0.01214", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.099752", "ticker_sentiment_score": "0.276915", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DHR", "relevance_score": "0.066598", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KVUE", "relevance_score": "0.132733", "ticker_sentiment_score": "0.109596", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPGI", "relevance_score": "0.033328", "ticker_sentiment_score": "-0.068677", "ticker_sentiment_label": "Neutral"}, {"ticker": "WST", "relevance_score": "0.066598", "ticker_sentiment_score": "0.068343", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUGX", "relevance_score": "0.099752", "ticker_sentiment_score": "-0.041137", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.066598", "ticker_sentiment_score": "0.068343", "ticker_sentiment_label": "Neutral"}]}, {"title": "Investing Action Plan: A Change Of Season As Netflix, Tesla Face Tests", "url": "https://www.investors.com/research/investing-action-plan/investing-action-plan-a-change-of-season-as-netflix-tesla-face-tests/", "time_published": "20231013T214500", "authors": ["Investor's Business Daily", "IBD STAFF"], "summary": "Investing Action Plan: A Change Of Season As Netflix, Tesla Face ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2020/09/Stock-fallleaves-02-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.999701"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.08389, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.091597", "ticker_sentiment_score": "0.091347", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.045874", "ticker_sentiment_score": "0.089595", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANET", "relevance_score": "0.045874", "ticker_sentiment_score": "0.032889", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.068764", "ticker_sentiment_score": "0.033399", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.045874", "ticker_sentiment_score": "0.17754", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GM", "relevance_score": "0.045874", "ticker_sentiment_score": "0.080844", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.022947", "ticker_sentiment_score": "0.01108", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.022947", "ticker_sentiment_score": "-0.008963", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.045874", "ticker_sentiment_score": "0.016984", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVS", "relevance_score": "0.045874", "ticker_sentiment_score": "0.067379", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.045874", "ticker_sentiment_score": "0.016984", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTES", "relevance_score": "0.068764", "ticker_sentiment_score": "0.033399", "ticker_sentiment_label": "Neutral"}, {"ticker": "FITB", "relevance_score": "0.045874", "ticker_sentiment_score": "-0.009969", "ticker_sentiment_label": "Neutral"}, {"ticker": "COST", "relevance_score": "0.068764", "ticker_sentiment_score": "0.033399", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMT", "relevance_score": "0.045874", "ticker_sentiment_score": "0.020974", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.137018", "ticker_sentiment_score": "-0.034349", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNP", "relevance_score": "0.091597", "ticker_sentiment_score": "0.012766", "ticker_sentiment_label": "Neutral"}, {"ticker": "PG", "relevance_score": "0.045874", "ticker_sentiment_score": "0.016984", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRCX", "relevance_score": "0.045874", "ticker_sentiment_score": "0.123449", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCHW", "relevance_score": "0.045874", "ticker_sentiment_score": "0.067704", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCX", "relevance_score": "0.045874", "ticker_sentiment_score": "-0.092", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.045874", "ticker_sentiment_score": "0.032889", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.045874", "ticker_sentiment_score": "0.101496", "ticker_sentiment_label": "Neutral"}, {"ticker": "STLD", "relevance_score": "0.045874", "ticker_sentiment_score": "-0.122362", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Top Healthcare Stocks to Buy for October", "url": "https://www.fool.com/investing/2023/10/12/3-top-healthcare-stocks-to-buy-for-october/", "time_published": "20231012T133648", "authors": ["Rachel Warren"], "summary": "These stocks have oodles of room left to run.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.918141"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.269776, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.089797", "ticker_sentiment_score": "0.185757", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.134339", "ticker_sentiment_score": "0.046252", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Unusual Options Activity For October 11 - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/10/35204173/intuitive-surgical-unusual-options-activity-for-october-11", "time_published": "20231011T201638", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bearish stance on Intuitive Surgical ISRG. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.190362, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.701476", "ticker_sentiment_score": "0.164621", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical  ( NASDAQ:ISRG )  Downgraded to \"Hold\" at StockNews.com", "url": "https://www.defenseworld.net/2023/10/11/intuitive-surgical-nasdaqisrg-downgraded-to-hold-at-stocknews-com.html", "time_published": "20231011T071444", "authors": ["Defense World Staff"], "summary": "Intuitive Surgical ( NASDAQ:ISRG ) Downgraded to \"Hold\" at ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&Symbol=ISRG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999998"}, {"topic": "Earnings", "relevance_score": "0.947132"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.292638, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.085936", "ticker_sentiment_score": "0.203206", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AB", "relevance_score": "0.085936", "ticker_sentiment_score": "0.203206", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STT", "relevance_score": "0.085936", "ticker_sentiment_score": "0.203206", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WFC", "relevance_score": "0.04303", "ticker_sentiment_score": "0.049999", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.04303", "ticker_sentiment_score": "0.065888", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBARF", "relevance_score": "0.085936", "ticker_sentiment_score": "0.203206", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.719473", "ticker_sentiment_score": "0.411321", "ticker_sentiment_label": "Bullish"}]}, {"title": "Want Growth? These 3 Numbers Show Why You Could Find It With Intuitive Surgical Stock", "url": "https://www.fool.com/investing/2023/10/08/want-growth-these-3-numbers-intuitive-surgical/", "time_published": "20231008T120000", "authors": ["Alex Carchidi"], "summary": "There's little to suggest it'll have problems continuing to expand in the future.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.271165, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.18967", "ticker_sentiment_score": "0.251964", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Rises Higher Than Market: Key Facts", "url": "https://www.zacks.com/stock/news/2161874/intuitive-surgical-inc-isrg-rises-higher-than-market-key-facts", "time_published": "20231006T215019", "authors": ["Zacks Equity Research"], "summary": "In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $295.68, denoting a +1.93% change from the preceding trading day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default344.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.192852, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.576289", "ticker_sentiment_score": "0.368011", "ticker_sentiment_label": "Bullish"}]}, {"title": "SS Innovations Appoints Colin Eke to Lead Global Business Development - SS INNOVATIONS INTL INC by SS Innovations International Inc  ( OTC:SSII ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35126031/ss-innovations-appoints-colin-eke-to-lead-global-business-development", "time_published": "20231006T132255", "authors": ["Globe Newswire"], "summary": "Mr. Eke brings more than 20 years' industry experience to the role, including time spent at Intuitive Surgical and CMR Surgical", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.334183, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.163539", "ticker_sentiment_score": "0.031988", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSII", "relevance_score": "0.464259", "ticker_sentiment_score": "0.448834", "ticker_sentiment_label": "Bullish"}]}, {"title": "SS Innovations Appoints Colin Eke to Lead Global Business Development", "url": "https://www.globenewswire.com/news-release/2023/10/06/2756134/0/en/SS-Innovations-Appoints-Colin-Eke-to-Lead-Global-Business-Development.html", "time_published": "20231006T132200", "authors": ["SS Innovations International", "Inc."], "summary": "Mr. Eke brings more than 20 years' industry experience to the role, including time spent at Intuitive Surgical and CMR Surgical ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d8c18bbf-e8e4-4d8a-909c-498abfdaa4d0", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.297035, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.140621", "ticker_sentiment_score": "0.029187", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSII", "relevance_score": "0.484053", "ticker_sentiment_score": "0.348746", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "What Are The Best Stocks To Invest In? 2 Healthcare Stocks To Know", "url": "https://stockmarket.com/featured/what-are-the-best-stocks-to-invest-in-2-healthcare-stocks-to-know-2023-10-05", "time_published": "20231005T143817", "authors": ["Brandon Michael"], "summary": "The healthcare sector is an expansive domain that entails a wide range of companies. These companies are involved in the provision of medical services, the manufacture of medical equipment, and the development of pharmaceuticals. This sector plays a pivotal role in the well-being of society.", "banner_image": "https://u3j7m9h7.rocketcdn.me/wp-content/uploads/2023/10/LLY-stock.jpg", "source": "StockMarket.com", "category_within_source": "n/a", "source_domain": "stockmarket.com", "topics": [{"topic": "Earnings", "relevance_score": "0.858979"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999921"}], "overall_sentiment_score": 0.215872, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.259727", "ticker_sentiment_score": "-0.021809", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.321393", "ticker_sentiment_score": "0.230452", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HCSG", "relevance_score": "0.066047", "ticker_sentiment_score": "0.16363", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Check Out What Whales Are Doing With ISRG - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/10/35097925/check-out-what-whales-are-doing-with-isrg", "time_published": "20231004T204825", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bearish stance on Intuitive Surgical ISRG. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.134279, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.781591", "ticker_sentiment_score": "0.28462", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Promaxo Receives Direct Investment from Surgical Robotics Industry Pioneer Fred Moll and Announces Appointment as Strategic Advisor", "url": "https://www.benzinga.com/pressreleases/23/10/g35092941/promaxo-receives-direct-investment-from-surgical-robotics-industry-pioneer-fred-moll-and-announces", "time_published": "20231004T160000", "authors": ["Globe Newswire"], "summary": "OAKLAND, Calif., Oct. 04, 2023 ( GLOBE NEWSWIRE ) -- Promaxo, Inc. ( \"Promaxo\" or the \"Company\" ) , a medical imaging, robotics, and AI technology company, announced today that it has received a direct investment from Fred Moll, M.D., industry pioneer and leader in surgical robotics and ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Economy - Fiscal", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.229312, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.172713", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCT", "relevance_score": "0.172713", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWAV", "relevance_score": "0.172713", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.172713", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation", "url": "https://www.globenewswire.com/news-release/2023/10/04/2754606/21634/en/Stereotaxis-Robotic-Technology-to-be-Featured-during-7th-Annual-Meeting-of-the-Society-for-Cardiac-Robotic-Navigation.html", "time_published": "20231004T124900", "authors": ["Stereotaxis", "Inc."], "summary": "ST. LOUIS, Oct. 04, 2023 ( GLOBE NEWSWIRE ) -- Stereotaxis ( NYSE: STXS ) , a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will participate in the Society for Cardiac Robotic Navigation's 7th Annual Meeting, which will ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/95a5b8ca-b7c0-4c80-8ca7-063ef10706c3", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.229484, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.066598", "ticker_sentiment_score": "0.119265", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation - Stereotaxis  ( AMEX:STXS ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35087502/stereotaxis-robotic-technology-to-be-featured-during-7th-annual-meeting-of-the-society-for-cardiac", "time_published": "20231004T124900", "authors": ["Globe Newswire"], "summary": "ST. LOUIS, Oct. 04, 2023 ( GLOBE NEWSWIRE ) -- Stereotaxis STXS, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will participate in the Society for Cardiac Robotic Navigation's 7th Annual Meeting, which will take place ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.243051, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.060541", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Esteemed Leader, Robert Pemberton, Joins Forces with Co-Founders Anthony Uzzo and Jim Gregory to Accelerate ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/esteemed-leader-robert-pemberton-joins-forces-with-co-founders-anthony-uzzo-and-jim-gregory-to-accelerate-service-insights-path-to-enable-digital-transformation-across-diverse-industries-301946103.html", "time_published": "20231004T120000", "authors": [], "summary": "Esteemed Leader, Robert Pemberton, Joins Forces with Co-Founders Anthony Uzzo and Jim Gregory to Accelerate ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.564212, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.045396", "ticker_sentiment_score": "0.256005", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AGTEF", "relevance_score": "0.045396", "ticker_sentiment_score": "0.172068", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.045396", "ticker_sentiment_score": "0.256005", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical  ( NASDAQ:ISRG )  Upgraded by StockNews.com to \"Buy\"", "url": "https://www.defenseworld.net/2023/10/04/intuitive-surgical-nasdaqisrg-upgraded-by-stocknews-com-to-buy.html", "time_published": "20231004T082854", "authors": ["Defense World Staff"], "summary": "Intuitive Surgical ( NASDAQ:ISRG ) Upgraded by StockNews.com to ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&Symbol=ISRG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.320995, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RL", "relevance_score": "0.044386", "ticker_sentiment_score": "0.015996", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.044386", "ticker_sentiment_score": "0.086181", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.757528", "ticker_sentiment_score": "0.501488", "ticker_sentiment_label": "Bullish"}, {"ticker": "WFC", "relevance_score": "0.044386", "ticker_sentiment_score": "0.086181", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.044386", "ticker_sentiment_score": "0.086181", "ticker_sentiment_label": "Neutral"}]}, {"title": "$100 Invested In Intuitive Surgical 15 Years Ago Would Be Worth This Much Today - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/23/10/35075339/100-invested-in-intuitive-surgical-15-years-ago-would-be-worth-this-much-today", "time_published": "20231003T213034", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 15 years by 8.75% on an annualized basis producing an average annual return of 19.01%. Currently, Intuitive Surgical has a market capitalization of $101.16 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Outpaces Stock Market Gains: What You Should Know", "url": "https://www.zacks.com/stock/news/2158880/intuitive-surgical-inc-isrg-outpaces-stock-market-gains-what-you-should-know", "time_published": "20231002T220021", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed at $294.98 in the latest trading session, marking a +0.92% move from the prior day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default166.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.162267, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.601928", "ticker_sentiment_score": "0.309704", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "This fund shows that industry expertise can help you make a lot of money in the stock market", "url": "https://www.marketwatch.com/story/this-fund-shows-that-industry-expertise-can-help-you-make-a-lot-of-money-in-the-stock-market-5d104b1d", "time_published": "20231002T162800", "authors": ["Philip van Doorn"], "summary": "The managers of the Janus Henderson Global Life Sciences Fund have direct experience to help them separate promising innovators from flashes in the pan.", "banner_image": "https://images.mktw.net/im-861100?width=700&height=593", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.986564"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.174392, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ETNB", "relevance_score": "0.083107", "ticker_sentiment_score": "-0.074703", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.04161", "ticker_sentiment_score": "0.084583", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHG", "relevance_score": "0.205807", "ticker_sentiment_score": "0.11181", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.083107", "ticker_sentiment_score": "0.089042", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDGL", "relevance_score": "0.083107", "ticker_sentiment_score": "-0.03668", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.083107", "ticker_sentiment_score": "-0.074703", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.083107", "ticker_sentiment_score": "0.238236", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Investors Heavily Search Intuitive Surgical, Inc.  ( ISRG ) : Here is What You Need to Know", "url": "https://www.zacks.com/stock/news/2157679/investors-heavily-search-intuitive-surgical-inc-isrg-here-is-what-you-need-to-know", "time_published": "20230929T130007", "authors": ["Zacks Equity Research"], "summary": "Zacks.com users have recently been watching Intuitive Surgical, Inc. (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default347.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.240024, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.507331", "ticker_sentiment_score": "0.141452", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Retain CVS Health  ( CVS )  Stock for Now", "url": "https://www.zacks.com/stock/news/2157644/heres-why-you-should-retain-cvs-health-cvs-stock-for-now", "time_published": "20230929T124900", "authors": ["Zacks Equity Research"], "summary": "Investors continue to remain optimistic about CVS Health (CVS) due to the new acquisitions and the strong execution of the pharmacy business.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5a/926.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.99237"}], "overall_sentiment_score": 0.26883, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CURN", "relevance_score": "0.042122", "ticker_sentiment_score": "-0.134618", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVS", "relevance_score": "0.47379", "ticker_sentiment_score": "0.322406", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HAE", "relevance_score": "0.167322", "ticker_sentiment_score": "0.09623", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.125898", "ticker_sentiment_score": "0.117993", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.167322", "ticker_sentiment_score": "0.033407", "ticker_sentiment_label": "Neutral"}]}, {"title": "Zimmer Biomet  ( ZBH )  Gains From ROSA Sales Growth Amid FX Woes", "url": "https://www.zacks.com/stock/news/2157617/zimmer-biomet-zbh-gains-from-rosa-sales-growth-amid-fx-woes", "time_published": "20230929T123200", "authors": ["Zacks Equity Research"], "summary": "Zimmer Biomet (ZBH) plans to work on the overall shift of the company's legacy knee systems to a fully rounded-out Persona portfolio.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.972193"}], "overall_sentiment_score": 0.19659, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ZBH", "relevance_score": "0.313674", "ticker_sentiment_score": "0.105851", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAE", "relevance_score": "0.182506", "ticker_sentiment_score": "0.102278", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.137409", "ticker_sentiment_score": "0.12322", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.182506", "ticker_sentiment_score": "0.035528", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:CHF", "relevance_score": "0.046006", "ticker_sentiment_score": "0.027857", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:JPY", "relevance_score": "0.046006", "ticker_sentiment_score": "0.027857", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.046006", "ticker_sentiment_score": "0.027857", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.046006", "ticker_sentiment_score": "0.027857", "ticker_sentiment_label": "Neutral"}]}, {"title": "MedBot Seeks Commercial Edge With Dual-Use Surgical Robot - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/23/09/34983170/medbot-seeks-commercial-edge-with-dual-use-surgical-robot", "time_published": "20230928T171106", "authors": ["The Bamboo Works"], "summary": "Even with its latest product, MicroPort MedBot faces intensifying competition in the field of medical automation from dominant imports and rival Chinese devices", "banner_image": "https://cdn.benzinga.com/files/medbot.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.858979"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.203012, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.072108", "ticker_sentiment_score": "0.20983", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SZIHF", "relevance_score": "0.036091", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Abbott  ( ABT )  Rides on Nutrition Recovery Amid Low Testing Sales", "url": "https://www.zacks.com/stock/news/2157147/abbott-abt-rides-on-nutrition-recovery-amid-low-testing-sales", "time_published": "20230928T143700", "authors": ["Zacks Equity Research"], "summary": "Abbott's (ABT) Nutrition business has started showing signs of recovery since the beginning of 2023.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/1479.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.995869"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.219573, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.219809", "ticker_sentiment_score": "0.11783", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.165788", "ticker_sentiment_score": "0.137897", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.219809", "ticker_sentiment_score": "0.040975", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is Intuitive Surgical  ( ISRG )  Stock Outpacing Its Medical Peers This Year?", "url": "https://www.zacks.com/stock/news/2157063/is-intuitive-surgical-isrg-stock-outpacing-its-medical-peers-this-year", "time_published": "20230928T134007", "authors": ["Zacks Equity Research"], "summary": "Here is how Intuitive Surgical, Inc. (ISRG) and Artivion (AORT) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default337.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.203868, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.765728", "ticker_sentiment_score": "0.253797", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AORT", "relevance_score": "0.402941", "ticker_sentiment_score": "0.104515", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Best Stocks to Buy With $300 Right Now", "url": "https://www.fool.com/investing/2023/09/28/3-best-stocks-to-buy-with-300-right-now/", "time_published": "20230928T133700", "authors": ["Josh Kohn-Lindquist"], "summary": "Whether driven by unstoppable megatrends or wide moats, these three stocks are poised to continue growing.", "banner_image": "https://media.ycharts.com/charts/c73994a426e0cc28f9c69673951186df.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.993856"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.289567, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MEDP", "relevance_score": "0.412093", "ticker_sentiment_score": "0.497234", "ticker_sentiment_label": "Bullish"}, {"ticker": "TMDX", "relevance_score": "0.306484", "ticker_sentiment_score": "0.352865", "ticker_sentiment_label": "Bullish"}, {"ticker": "MDT", "relevance_score": "0.039289", "ticker_sentiment_score": "0.20108", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.194554", "ticker_sentiment_score": "0.282899", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's Why You Should Retain Hologic  ( HOLX )  Stock for Now", "url": "https://www.zacks.com/stock/news/2157011/heres-why-you-should-retain-hologic-holx-stock-for-now", "time_published": "20230928T131600", "authors": ["Zacks Equity Research"], "summary": "Investors continue to remain optimistic about Hologic (HOLX), backed by the Breast Health business' performance and international execution.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/2563.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.155028, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HOLX", "relevance_score": "0.342093", "ticker_sentiment_score": "0.355507", "ticker_sentiment_label": "Bullish"}, {"ticker": "HAE", "relevance_score": "0.175221", "ticker_sentiment_score": "0.099346", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.131884", "ticker_sentiment_score": "0.120648", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.175221", "ticker_sentiment_score": "0.0345", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why Investors Should Retain Labcorp  ( LH )  Stock for Now", "url": "https://www.zacks.com/stock/news/2157001/heres-why-investors-should-retain-labcorp-lh-stock-for-now", "time_published": "20230928T130600", "authors": ["Zacks Equity Research"], "summary": "Investors are increasingly optimistic about Labcorp (LH) due to its progress in hospital partnerships.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/2563.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.236895, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DGX", "relevance_score": "0.043818", "ticker_sentiment_score": "0.1238", "ticker_sentiment_label": "Neutral"}, {"ticker": "LH", "relevance_score": "0.173958", "ticker_sentiment_score": "0.169093", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HAE", "relevance_score": "0.173958", "ticker_sentiment_score": "0.098843", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.130926", "ticker_sentiment_score": "0.120213", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.173958", "ticker_sentiment_score": "0.034324", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Top Growth Stocks Up 50% and 10% to Buy Whether a 2023 Bull Market Happens or Not", "url": "https://www.fool.com/investing/2023/09/28/top-growth-stocks-buy-whether-bull-market/", "time_published": "20230928T105700", "authors": ["Rachel Warren"], "summary": "You don't have to wait for the next bull market to put your cash to work.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}, {"topic": "Earnings", "relevance_score": "0.87644"}], "overall_sentiment_score": 0.205677, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.249106", "ticker_sentiment_score": "0.17055", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMZN", "relevance_score": "0.366061", "ticker_sentiment_score": "0.229977", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "3 Growth Stocks to Buy That Could Be Massive Long-Term Winners", "url": "https://www.fool.com/investing/2023/09/27/3-growth-stocks-to-buy-that-could-be-massive-long/", "time_published": "20230927T141600", "authors": ["Bradley Guichard"], "summary": "These stocks are worth a look.", "banner_image": "https://media.ycharts.com/charts/ccf8bfee0f190f33094bf1e1d225e96a.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.266143"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.246998, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.224903", "ticker_sentiment_score": "0.11903", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.224903", "ticker_sentiment_score": "0.167094", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PGNY", "relevance_score": "0.310843", "ticker_sentiment_score": "0.332907", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Neogen  ( NEOG )  Gains From Strong Segmental Sales, Innovation", "url": "https://www.zacks.com/stock/news/2156107/neogen-neog-gains-from-strong-segmental-sales-innovation", "time_published": "20230927T131200", "authors": ["Zacks Equity Research"], "summary": "Within the biosecurity portfolio, Neogen (NEOG) continues to record solid growth in cleaners, disinfectants and rodenticides.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/15/2078.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.976671"}], "overall_sentiment_score": 0.276001, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NEOG", "relevance_score": "0.459624", "ticker_sentiment_score": "0.381243", "ticker_sentiment_label": "Bullish"}, {"ticker": "HAE", "relevance_score": "0.214462", "ticker_sentiment_score": "0.089664", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.16171", "ticker_sentiment_score": "0.071433", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.108222", "ticker_sentiment_score": "0.056455", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.054236", "ticker_sentiment_score": "-0.002999", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why Investors Should Retain STERIS  ( STE )  Stock for Now", "url": "https://www.zacks.com/stock/news/2155994/heres-why-investors-should-retain-steris-ste-stock-for-now", "time_published": "20230927T115100", "authors": ["Zacks Equity Research"], "summary": "STERIS' (STE) healthcare segment benefits from procedure recovery, boosting investors' optimism.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/2387.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99489"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.217011, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.192694", "ticker_sentiment_score": "0.104923", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.145145", "ticker_sentiment_score": "0.126997", "ticker_sentiment_label": "Neutral"}, {"ticker": "STE", "relevance_score": "0.457977", "ticker_sentiment_score": "0.149115", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.048621", "ticker_sentiment_score": "0.279176", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "QTRX", "relevance_score": "0.192694", "ticker_sentiment_score": "0.036992", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Buy Align Technology  ( ALGN )  Stock Now", "url": "https://www.zacks.com/stock/news/2155986/heres-why-you-should-buy-align-technology-algn-stock-now", "time_published": "20230927T114700", "authors": ["Zacks Equity Research"], "summary": "The rapid expansion of Align Technology's (ALGN) business in international markets remains a key growth driver.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/2563.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.242976, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ALGN", "relevance_score": "0.224487", "ticker_sentiment_score": "0.296154", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HAE", "relevance_score": "0.18046", "ticker_sentiment_score": "0.101469", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.135857", "ticker_sentiment_score": "0.121278", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.18046", "ticker_sentiment_score": "0.035221", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Recession-Resistant Stocks to Buy Now", "url": "https://www.fool.com/investing/2023/09/27/3-recession-resistant-dividend-stocks-to-buy-now/", "time_published": "20230927T100000", "authors": ["Scott Levine", "Daniel Foelber", "and Lee Samaha"], "summary": "The utility sector and healthcare sector offer opportunities for risk-averse income-orientated investors.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F747904%2Fgettyimages-1350848039.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}, {"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Energy & Transportation", "relevance_score": "0.5"}], "overall_sentiment_score": 0.267286, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "WTRG", "relevance_score": "0.35278", "ticker_sentiment_score": "0.075977", "ticker_sentiment_label": "Neutral"}, {"ticker": "NGS", "relevance_score": "0.040553", "ticker_sentiment_score": "0.049266", "ticker_sentiment_label": "Neutral"}, {"ticker": "SO", "relevance_score": "0.388879", "ticker_sentiment_score": "0.336952", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.200688", "ticker_sentiment_score": "0.072567", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Stock Moves -0.86%: What You Should Know", "url": "https://www.zacks.com/stock/news/2155717/intuitive-surgical-inc-isrg-stock-moves--086-what-you-should-know", "time_published": "20230926T215018", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed at $290.74 in the latest trading session, marking a -0.86% move from the prior day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default212.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.122869, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.648164", "ticker_sentiment_score": "0.202912", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical Stock Nearly Doubles; Gets Rating Upgrade", "url": "https://www.investors.com/news/technology/intuitive-surgical-scores-relative-strength-rating-upgrade-hits-key-benchmark/", "time_published": "20230926T205400", "authors": ["INVESTOR'S BUSINESS DAILY", "JAMES DETAR", "Investor's Business Daily"], "summary": "Intuitive Surgical Stock Nearly Doubled In A Year. Gets Rating ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/01/stock-Intuitive-Surgical-04-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.796627"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.214234, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.164468", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.700759", "ticker_sentiment_score": "0.230971", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STE", "relevance_score": "0.164468", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Henry Schein  ( HSIC )  Gains From Strong Global Network Amid FX Woes", "url": "https://www.zacks.com/stock/news/2155547/henry-schein-hsic-gains-from-strong-global-network-amid-fx-woes", "time_published": "20230926T151000", "authors": ["Zacks Equity Research"], "summary": "Henry Schein's (HSIC) dental software business is progressing well despite a challenging business environment.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/87/2133.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.988787"}], "overall_sentiment_score": 0.290511, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HSIC", "relevance_score": "0.458708", "ticker_sentiment_score": "0.313002", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HAE", "relevance_score": "0.161349", "ticker_sentiment_score": "0.11527", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.161349", "ticker_sentiment_score": "0.11527", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.107978", "ticker_sentiment_score": "0.093815", "ticker_sentiment_label": "Neutral"}]}, {"title": "Terumo's  ( TRUMY )  MicroVention Enters Transradial Access Space", "url": "https://www.zacks.com/stock/news/2155552/terumos-trumy-microvention-enters-transradial-access-space", "time_published": "20230926T150600", "authors": ["Zacks Equity Research"], "summary": "The SOFIA EX 5F Catheter by Terumo's (TRUMY) MicroVention boasts a new design to enhance trackability.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.281839, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.256989", "ticker_sentiment_score": "0.064099", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.130217", "ticker_sentiment_score": "0.059736", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRUMF", "relevance_score": "0.194242", "ticker_sentiment_score": "0.110259", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.130217", "ticker_sentiment_score": "0.059736", "ticker_sentiment_label": "Neutral"}]}, {"title": "Charles River  ( CRL )  Opens a RightSource Lab in Stevenage", "url": "https://www.zacks.com/stock/news/2155278/charles-river-crl-opens-a-rightsource-lab-in-stevenage", "time_published": "20230926T120200", "authors": ["Zacks Equity Research"], "summary": "Charles River's (CRL) new RightSource facility is likely to provide services to the Stevenage advanced therapy biocluster.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/2584.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.294482, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRL", "relevance_score": "0.151222", "ticker_sentiment_score": "0.264384", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HAE", "relevance_score": "0.200688", "ticker_sentiment_score": "0.054117", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.151222", "ticker_sentiment_score": "0.069751", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.101154", "ticker_sentiment_score": "0.056362", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Monster Stocks to Buy Without Any Hesitation", "url": "https://www.fool.com/investing/2023/09/26/2-monster-stocks-to-buy-without-any-hesitation/", "time_published": "20230926T114100", "authors": ["Prosper Junior Bakiny"], "summary": "Recent bumps in the road won't deter these companies.", "banner_image": "https://media.ycharts.com/charts/bf3239a52945726203afde3d89eccd2d.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.251048, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.056808", "ticker_sentiment_score": "0.071998", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.224383", "ticker_sentiment_score": "0.281205", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.478692", "ticker_sentiment_score": "0.313658", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Wearable Robots Market expected to hit USD 9205.5 Mn by 2029 at a CAGR of 41.6 percent - says Maximize Market Research", "url": "https://www.benzinga.com/pressreleases/23/09/g34898853/wearable-robots-market-expected-to-hit-usd-9205-5-mn-by-2029-at-a-cagr-of-41-6-percent-says-maximi", "time_published": "20230926T103939", "authors": ["Globe Newswire"], "summary": "Dublin, Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- A global Automation & Process Control research and business consulting firm, Maximize Market Research, has published a market intelligence report on the \"Wearable Robots Market\".", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.342772, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MFCSF", "relevance_score": "0.023372", "ticker_sentiment_score": "0.263049", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EKSO", "relevance_score": "0.023372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RWLK", "relevance_score": "0.023372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "YASKF", "relevance_score": "0.023372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLDS", "relevance_score": "0.070036", "ticker_sentiment_score": "0.139789", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNKL", "relevance_score": "0.023372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMT", "relevance_score": "0.023372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFTBF", "relevance_score": "0.023372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSBHF", "relevance_score": "0.023372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIELF", "relevance_score": "0.023372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.023372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHX", "relevance_score": "0.023372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMC", "relevance_score": "0.023372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Scores Relative Strength Rating Upgrade; Hits Key Benchmark", "url": "https://www.investors.com/ibd-data-stories/intuitive-surgical-scores-relative-strength-rating-upgrade-hits-key-benchmark/", "time_published": "20230926T070000", "authors": ["INVESTOR'S BUSINESS DAILY", "Investor's Business Daily", "JAMES DETAR"], "summary": "Intuitive Surgical Scores Relative Strength Rating Upgrade. Hits Key ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2017/05/IRU1.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.333094, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.325208", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.598621", "ticker_sentiment_score": "0.566137", "ticker_sentiment_label": "Bullish"}, {"ticker": "STE", "relevance_score": "0.325208", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical  ( NASDAQ:ISRG )  Downgraded by StockNews.com to \"Hold\"", "url": "https://www.defenseworld.net/2023/09/26/intuitive-surgical-nasdaqisrg-downgraded-by-stocknews-com-to-hold.html", "time_published": "20230926T065248", "authors": ["Defense World Staff"], "summary": "Intuitive Surgical ( NASDAQ:ISRG ) Downgraded by StockNews.com ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&Symbol=ISRG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.752319"}, {"topic": "Earnings", "relevance_score": "0.905476"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Blockchain", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.2743, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BOM", "relevance_score": "0.045396", "ticker_sentiment_score": "0.181739", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BCS", "relevance_score": "0.135602", "ticker_sentiment_score": "0.159574", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "C", "relevance_score": "0.045396", "ticker_sentiment_score": "0.073215", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.090645", "ticker_sentiment_score": "0.191876", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RBCPF", "relevance_score": "0.045396", "ticker_sentiment_score": "0.073215", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBARF", "relevance_score": "0.090645", "ticker_sentiment_score": "0.191876", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.745097", "ticker_sentiment_score": "0.378846", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Outpaces Stock Market Gains: What You Should Know", "url": "https://www.zacks.com/stock/news/2155129/intuitive-surgical-inc-isrg-outpaces-stock-market-gains-what-you-should-know", "time_published": "20230925T220019", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $293.25, moving +1.75% from the previous trading session.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default240.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.180316, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.600271", "ticker_sentiment_score": "0.367774", "ticker_sentiment_label": "Bullish"}]}, {"title": " ( ISRG )  - Analyzing Intuitive Surgical's Short Interest - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/short-sellers/23/09/34870467/isrg-analyzing-intuitive-surgicals-short-interest", "time_published": "20230925T153018", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical's ISRG short percent of float has risen 17.81% since its last report. The company recently reported that it has 2.99 million shares sold short, which is 0.86% of all regular shares that are available for trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.287384, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.221819", "ticker_sentiment_score": "0.184023", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ResMed  ( RMD )  Gains From Mask Sales Amid Macro Headwinds", "url": "https://www.zacks.com/stock/news/2154875/resmed-rmd-gains-from-mask-sales-amid-macro-headwinds", "time_published": "20230925T134500", "authors": ["Zacks Equity Research"], "summary": "ResMed's (RMD) respiratory care business continues to drive growth, courtesy of the adoption of bilevel and other non-invasive ventilator solutions worldwide.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}, {"topic": "Earnings", "relevance_score": "0.928139"}], "overall_sentiment_score": 0.120444, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RMD", "relevance_score": "0.308246", "ticker_sentiment_score": "0.115557", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURN", "relevance_score": "0.052685", "ticker_sentiment_score": "-0.126024", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAE", "relevance_score": "0.208464", "ticker_sentiment_score": "0.089288", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.157141", "ticker_sentiment_score": "0.071452", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.105141", "ticker_sentiment_score": "0.057011", "ticker_sentiment_label": "Neutral"}]}, {"title": "Boston Scientific  ( BSX )  Set to Acquire Relievant Medsystems", "url": "https://www.zacks.com/stock/news/2154695/boston-scientific-bsx-set-to-acquire-relievant-medsystems", "time_published": "20230925T123100", "authors": ["Zacks Equity Research"], "summary": "Boston Scientific's (BSX) new M&A deal is likely to broaden the Neuromodulation business portfolio.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/2563.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99237"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.204576, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.255641", "ticker_sentiment_score": "0.105161", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.193207", "ticker_sentiment_score": "0.082588", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.316439", "ticker_sentiment_score": "0.237923", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "QTRX", "relevance_score": "0.129516", "ticker_sentiment_score": "0.061926", "ticker_sentiment_label": "Neutral"}]}, {"title": "Laparoscopic Devices Market to grow by USD 4.39 billion from 2022-2027, North America to account for 36% of market ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/laparoscopic-devices-market-to-grow-by-usd-4-39-billion-from-2022-2027--north-america-to-account-for-36-of-market-growth---technavio-301935797.html", "time_published": "20230924T103500", "authors": [], "summary": "Laparoscopic Devices Market to grow by USD 4.39 billion from 2022-2027, North America to account for 36% of market ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.254084, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "COO", "relevance_score": "0.054359", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.054359", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.108466", "ticker_sentiment_score": "0.110819", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.108466", "ticker_sentiment_score": "0.132623", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFX", "relevance_score": "0.054359", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOCPF", "relevance_score": "0.054359", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMDIF", "relevance_score": "0.054359", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCPNF", "relevance_score": "0.054359", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNN", "relevance_score": "0.054359", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.054359", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.054359", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.108466", "ticker_sentiment_score": "0.132623", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNMD", "relevance_score": "0.054359", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.054359", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Align  ( ALGN )  Gains From Growing Invisalign Volume, Innovation", "url": "https://www.zacks.com/stock/news/2154173/align-algn-gains-from-growing-invisalign-volume-innovation", "time_published": "20230922T133700", "authors": ["Zacks Equity Research"], "summary": "Align Technology (ALGN) is expanding its sales and marketing by reaching new countries and regions, including new areas within Africa and Latin America.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e0/1180.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.928139"}], "overall_sentiment_score": 0.226732, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ALGN", "relevance_score": "0.524949", "ticker_sentiment_score": "0.274817", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HAE", "relevance_score": "0.224903", "ticker_sentiment_score": "0.096508", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.169676", "ticker_sentiment_score": "0.075193", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.113597", "ticker_sentiment_score": "0.060759", "ticker_sentiment_label": "Neutral"}]}, {"title": "Medtronic  ( MDT )  Gets CE Mark Approval for the New Simplera CGM", "url": "https://www.zacks.com/stock/news/2154102/medtronic-mdt-gets-ce-mark-approval-for-the-new-simplera-cgm", "time_published": "20230922T125900", "authors": ["Zacks Equity Research"], "summary": "Medtronic's (MDT) next-generation sensor Simplera receives CE Mark approval.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.313061, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.364529", "ticker_sentiment_score": "0.378736", "ticker_sentiment_label": "Bullish"}, {"ticker": "HAE", "relevance_score": "0.213517", "ticker_sentiment_score": "0.09098", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.16099", "ticker_sentiment_score": "0.072582", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.107736", "ticker_sentiment_score": "0.057459", "ticker_sentiment_label": "Neutral"}]}, {"title": "Did a Data-Driven Fed Get it Right?", "url": "https://www.zacks.com/commentary/2153881/did-a-data-driven-fed-get-it-right", "time_published": "20230921T195100", "authors": ["John Blank"], "summary": "The FOMC meeting is done. Let's discuss the latest macro facts.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e0/1446.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.063358, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IR", "relevance_score": "0.294093", "ticker_sentiment_score": "0.174183", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.294093", "ticker_sentiment_score": "0.174183", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WY", "relevance_score": "0.294093", "ticker_sentiment_score": "0.174183", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Looking At Intuitive Surgical's Recent Unusual Options Activity - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/09/34800785/looking-at-intuitive-surgicals-recent-unusual-options-activity", "time_published": "20230921T170236", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bullish stance on Intuitive Surgical ISRG. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.173088, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.77688", "ticker_sentiment_score": "0.43302", "ticker_sentiment_label": "Bullish"}]}, {"title": "Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio", "url": "https://www.zacks.com/stock/news/2153686/why-this-1-momentum-stock-could-be-a-great-addition-to-your-portfolio", "time_published": "20230921T135007", "authors": ["Zacks Equity Research"], "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default348.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}], "overall_sentiment_score": 0.32914, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.428632", "ticker_sentiment_score": "0.201973", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's Why Investors Should Buy Alcon  ( ALC )  Stock Right Now", "url": "https://www.zacks.com/stock/news/2153663/heres-why-investors-should-buy-alcon-alc-stock-right-now", "time_published": "20230921T134200", "authors": ["Zacks Equity Research"], "summary": "Investors continue to be optimistic about Alcon (ALC) on the impressive performance of its portfolio.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9973"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.336764, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ALC", "relevance_score": "0.585898", "ticker_sentiment_score": "0.530255", "ticker_sentiment_label": "Bullish"}, {"ticker": "HAE", "relevance_score": "0.214557", "ticker_sentiment_score": "0.115835", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.129749", "ticker_sentiment_score": "0.118504", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.172404", "ticker_sentiment_score": "0.090081", "ticker_sentiment_label": "Neutral"}]}, {"title": "Abbott  ( ABT )  to Commercialize Biosimilars in Emerging Markets", "url": "https://www.zacks.com/stock/news/2153624/abbott-abt-to-commercialize-biosimilars-in-emerging-markets", "time_published": "20230921T133000", "authors": ["Zacks Equity Research"], "summary": "Abbott (ABT) is set to commercialize several biosimilar molecules in key emerging markets via an expanded collaboration with mAbxience.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/1479.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.249251, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "FSNUF", "relevance_score": "0.09439", "ticker_sentiment_score": "0.11105", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAE", "relevance_score": "0.187463", "ticker_sentiment_score": "0.083835", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.141171", "ticker_sentiment_score": "0.069488", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.09439", "ticker_sentiment_score": "0.057471", "ticker_sentiment_label": "Neutral"}]}, {"title": "Orthofix  ( OFIX )  Unveils Gemini System, Advances in Trauma Wing", "url": "https://www.zacks.com/stock/news/2153591/orthofix-ofix-unveils-gemini-system-advances-in-trauma-wing", "time_published": "20230921T132200", "authors": ["Zacks Equity Research"], "summary": "According to Orthofix (OFIX), with the launch of the Galaxy Fixation Gemini system surgeons now have efficient solutions for lower extremity trauma scenarios where time is an important factor.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.196728, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "OFIX", "relevance_score": "0.104228", "ticker_sentiment_score": "0.069616", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAE", "relevance_score": "0.206685", "ticker_sentiment_score": "0.088694", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.155786", "ticker_sentiment_score": "0.069714", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.104228", "ticker_sentiment_score": "0.056858", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Reasons to Add Intuitive Surgical  ( ISRG )  to Your Portfolio", "url": "https://www.zacks.com/stock/news/2153102/3-reasons-to-add-intuitive-surgical-isrg-to-your-portfolio", "time_published": "20230920T124300", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/2297.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": 0.310883, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HQY", "relevance_score": "0.155451", "ticker_sentiment_score": "0.04748", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGN", "relevance_score": "0.155451", "ticker_sentiment_score": "0.110161", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCK", "relevance_score": "0.155451", "ticker_sentiment_score": "0.04748", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.398939", "ticker_sentiment_score": "0.444662", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Gains As Market Dips: What You Should Know", "url": "https://www.zacks.com/stock/news/2152765/intuitive-surgical-inc-isrg-gains-as-market-dips-what-you-should-know", "time_published": "20230919T215020", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $299.65, moving +0.5% from the previous trading session.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default24.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.127245, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.479683", "ticker_sentiment_score": "0.105157", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Zacks Analyst Blog Highlights Intuitive Surgical, Ingersoll Rand and Weyerhaeuser", "url": "https://www.zacks.com/stock/news/2152436/the-zacks-analyst-blog-highlights-intuitive-surgical-ingersoll-rand-and-weyerhaeuser", "time_published": "20230919T122800", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Ingersoll Rand and Weyerhaeuser are part of the Zacks top Analyst Blog.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/61/11728.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.999937"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.997405"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.068917, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GIC", "relevance_score": "0.02074", "ticker_sentiment_score": "0.078452", "ticker_sentiment_label": "Neutral"}, {"ticker": "IR", "relevance_score": "0.184991", "ticker_sentiment_score": "0.033981", "ticker_sentiment_label": "Neutral"}, {"ticker": "WY", "relevance_score": "0.08282", "ticker_sentiment_score": "-0.004086", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.062164", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:JPY", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.111455", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.032952", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.02074", "ticker_sentiment_score": "0.056001", "ticker_sentiment_label": "Neutral"}]}, {"title": "Billionaire Ray Dalio Just Recommended 4 Things for Investors to Do in Today's Volatile Market -- and 1 Thing to Absolutely Avoid", "url": "https://www.fool.com/investing/2023/09/19/billionaire-ray-dalio-things-investors-do/", "time_published": "20230919T095000", "authors": ["Keith Speights"], "summary": "Ray Dalio, who is worth more than $15 billion, provided some straightforward investing advice last week.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F747862%2Fcharts-on-screenperson-looking.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.976913"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.150087, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.104002", "ticker_sentiment_score": "-0.015484", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.155451", "ticker_sentiment_score": "0.001338", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.104002", "ticker_sentiment_score": "-0.015484", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Stocks That Could Be Kicked Out of the Dow -- and the Companies That May Replace Them", "url": "https://www.fool.com/investing/2023/09/19/3-stocks-that-could-be-kicked-out-of-the-dow/", "time_published": "20230919T090600", "authors": ["Sean Williams"], "summary": "Three time-tested yet poor-performing Dow components are at risk of being removed from the index.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F747918%2Fnyse-wall-street-trading-new-york-financial-stock-market-getty.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.158609, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CVS", "relevance_score": "0.064797", "ticker_sentiment_score": "-0.050033", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.129168", "ticker_sentiment_score": "0.006204", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.161062", "ticker_sentiment_score": "0.127854", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.129168", "ticker_sentiment_score": "0.204767", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VZ", "relevance_score": "0.192694", "ticker_sentiment_score": "0.112182", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.032425", "ticker_sentiment_score": "0.185748", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HCSG", "relevance_score": "0.032425", "ticker_sentiment_score": "0.019421", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.032425", "ticker_sentiment_score": "-0.046667", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSM", "relevance_score": "0.032425", "ticker_sentiment_score": "0.118551", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.224013", "ticker_sentiment_score": "0.257241", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WBA", "relevance_score": "0.097062", "ticker_sentiment_score": "0.112527", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.129168", "ticker_sentiment_score": "0.208321", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SPGI", "relevance_score": "0.032425", "ticker_sentiment_score": "0.039135", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRV", "relevance_score": "0.032425", "ticker_sentiment_score": "0.02127", "ticker_sentiment_label": "Neutral"}, {"ticker": "CME", "relevance_score": "0.032425", "ticker_sentiment_score": "0.039135", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.097062", "ticker_sentiment_score": "0.134101", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.032425", "ticker_sentiment_score": "0.039135", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Outpaces Stock Market Gains: What You Should Know", "url": "https://www.zacks.com/stock/news/2152171/intuitive-surgical-inc-isrg-outpaces-stock-market-gains-what-you-should-know", "time_published": "20230918T220019", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $298.17, moving +0.89% from the previous trading session.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default77.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.226026, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.479683", "ticker_sentiment_score": "0.28171", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here is What to Know Beyond Why Intuitive Surgical, Inc.  ( ISRG )  is a Trending Stock", "url": "https://www.zacks.com/stock/news/2151778/here-is-what-to-know-beyond-why-intuitive-surgical-inc-isrg-is-a-trending-stock", "time_published": "20230918T130006", "authors": ["Zacks Equity Research"], "summary": "Recently, Zacks.com users have been paying close attention to Intuitive Surgical, Inc. (ISRG). This makes it worthwhile to examine what the stock has in store.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default90.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.219959, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.505538", "ticker_sentiment_score": "0.162844", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "You Don't Have to Pick a Winner in Artificial Intelligence  ( AI ) . Here's Why.", "url": "https://www.fool.com/investing/2023/09/17/you-dont-have-to-pick-a-winner-in-artificial-intel/", "time_published": "20230917T131000", "authors": ["Jeremy Bowman"], "summary": "You have plenty of options when it comes to investing in AI stocks.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.980716"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.256388, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.062761", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.062761", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.186738", "ticker_sentiment_score": "0.134838", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMNF", "relevance_score": "0.062761", "ticker_sentiment_score": "0.031098", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYCCF", "relevance_score": "0.062761", "ticker_sentiment_score": "0.104042", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.062761", "ticker_sentiment_score": "0.113052", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.062761", "ticker_sentiment_score": "0.113052", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.062761", "ticker_sentiment_score": "0.104042", "ticker_sentiment_label": "Neutral"}]}, {"title": "$1000 Invested In This Stock 10 Years Ago Would Be Worth $7,200 Today - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/23/09/34617585/1000-invested-in-this-stock-10-years-ago-would-be-worth-7-200-today", "time_published": "20230915T143031", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 10 years by 12.02% on an annualized basis producing an average annual return of 21.96%. Currently, Intuitive Surgical has a market capitalization of $105.17 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "Philips  ( PHG )  Expands Mobile C-arm Portfolio With Zenition 30", "url": "https://www.zacks.com/stock/news/2149592/philips-phg-expands-mobile-c-arm-portfolio-with-zenition-30", "time_published": "20230915T134600", "authors": ["Zacks Equity Research"], "summary": "Philips (PHG) expands its mobile C-arm lineup with Zenition 30, which provides surgeons with more control and customization.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/b3/30471.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.399615, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "BABA", "relevance_score": "0.05339", "ticker_sentiment_score": "0.166724", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MASI", "relevance_score": "0.159218", "ticker_sentiment_score": "0.214883", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OPCH", "relevance_score": "0.211191", "ticker_sentiment_score": "0.245682", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.211191", "ticker_sentiment_score": "0.245682", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PHG", "relevance_score": "0.211191", "ticker_sentiment_score": "0.388745", "ticker_sentiment_label": "Bullish"}]}, {"title": "UnitedHealth Group  ( UNH )  Wins Medicaid Deal to Help Serve Texas", "url": "https://www.zacks.com/stock/news/2149114/unitedhealth-group-unh-wins-medicaid-deal-to-help-serve-texas", "time_published": "20230914T162000", "authors": ["Zacks Equity Research"], "summary": "UnitedHealth Group (UNH) unit has been awarded a contract by the Texas Health and Human Services Commission to better cater to the statewide Medicaid members.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/16/2258.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.349859, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MEDP", "relevance_score": "0.217346", "ticker_sentiment_score": "0.133504", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIP", "relevance_score": "0.269776", "ticker_sentiment_score": "0.162594", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.217346", "ticker_sentiment_score": "0.133504", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.370733", "ticker_sentiment_score": "0.44944", "ticker_sentiment_label": "Bullish"}]}, {"title": "Strength Seen in Pacific Biosciences  ( PACB ) : Can Its 8.9% Jump Turn into More Strength?", "url": "https://www.zacks.com/stock/news/2148734/strength-seen-in-pacific-biosciences-pacb-can-its-89-jump-turn-into-more-strength", "time_published": "20230914T113000", "authors": ["Zacks Equity Research"], "summary": "Pacific Biosciences (PACB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default233.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.289897, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.53784", "ticker_sentiment_score": "0.110138", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACB", "relevance_score": "0.340915", "ticker_sentiment_score": "0.36407", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Stock Moves -0.24%: What You Should Know", "url": "https://www.zacks.com/stock/news/2148032/intuitive-surgical-inc-isrg-stock-moves--024-what-you-should-know", "time_published": "20230912T215018", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed at $301.62 in the latest trading session, marking a -0.24% move from the prior day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default76.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.144022, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.654859", "ticker_sentiment_score": "0.239231", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Are Medical Stocks Lagging Augmedix  ( AUGX )  This Year?", "url": "https://www.zacks.com/stock/news/2147730/are-medical-stocks-lagging-augmedix-augx-this-year", "time_published": "20230912T134008", "authors": ["Zacks Equity Research"], "summary": "Here is how Augmedix, Inc. (AUGX) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default119.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": 0.289343, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.493128", "ticker_sentiment_score": "0.369219", "ticker_sentiment_label": "Bullish"}, {"ticker": "AUGX", "relevance_score": "0.767792", "ticker_sentiment_score": "0.452198", "ticker_sentiment_label": "Bullish"}]}, {"title": "Have $1,500 to Invest? 2 Growth Stocks to Buy Now", "url": "https://www.fool.com/investing/2023/09/11/have-1500-invest-2-growth-stocks-buy-now/", "time_published": "20230911T091000", "authors": ["Rachel Warren"], "summary": "These companies are roaring back to life.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.972756"}, {"topic": "Earnings", "relevance_score": "0.94762"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.214615, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SHOP", "relevance_score": "0.516971", "ticker_sentiment_score": "0.352326", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.253866", "ticker_sentiment_score": "0.059316", "ticker_sentiment_label": "Neutral"}]}, {"title": "Looking Into Intuitive Surgical's Recent Short Interest - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/short-sellers/23/09/34363281/looking-into-intuitive-surgicals-recent-short-interest", "time_published": "20230908T143030", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical's ISRG short percent of float has fallen 16.09% since its last report. The company recently reported that it has 2.57 million shares sold short, which is 0.73% of all regular shares that are available for trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.259737, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.221819", "ticker_sentiment_score": "0.110774", "ticker_sentiment_label": "Neutral"}]}, {"title": "With 2x Potential Returns Is DexCom A Better Pick Over Intuitive Surgical?", "url": "https://www.forbes.com/sites/greatspeculations/2023/09/08/with-2x-potential-returns-is-dexcom-a-better-pick-over-intuitive-surgical/", "time_published": "20230908T100041", "authors": ["Trefis Team"], "summary": "We believe DexCom stock (NASDAQ: DXCM) is a better healthcare pick than Intuitive Surgical stock (NASDAQ: ISRG).", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/649a8cfb03be94c29c09d90c/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Markets", "source_domain": "www.forbes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.205194, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.755843", "ticker_sentiment_score": "0.330948", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DXCM", "relevance_score": "0.703596", "ticker_sentiment_score": "0.361349", "ticker_sentiment_label": "Bullish"}]}, {"title": "2 Nasdaq 100 Stocks That Are Surefire Buys in September and 1 to Avoid Like the Plague", "url": "https://www.fool.com/investing/2023/09/08/2-nasdaq-100-stocks-buy-and-1-to-avoid-like-plague/", "time_published": "20230908T092100", "authors": ["Sean Williams"], "summary": "Two high-growth Nasdaq 100 stocks are phenomenal businesses hiding in plain sight, while another Nasdaq 100 component comes with outsize risk.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F746450%2Fstock-chart-crash-correction-plunge-bounce-bear-market-bar-trend-invest-crypto-getty.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}, {"topic": "Earnings", "relevance_score": "0.650727"}], "overall_sentiment_score": 0.102765, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NVAX", "relevance_score": "0.030064", "ticker_sentiment_score": "0.11464", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.321545", "ticker_sentiment_score": "0.133089", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.208081", "ticker_sentiment_score": "0.121112", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.236972", "ticker_sentiment_score": "0.13131", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Unusual Options Activity For September 07 - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/09/34333153/intuitive-surgical-unusual-options-activity-for-september-07", "time_published": "20230907T191912", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ISRG we detected 10 strange trades.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.19775, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.685386", "ticker_sentiment_score": "0.056407", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Gains As Market Dips: What You Should Know", "url": "https://www.zacks.com/stock/news/2145688/intuitive-surgical-inc-isrg-gains-as-market-dips-what-you-should-know", "time_published": "20230906T215020", "authors": ["Zacks Equity Research"], "summary": "In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $307.84, marking a +0.05% move from the previous day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default182.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.177857, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.610329", "ticker_sentiment_score": "0.186458", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Is Trending Stock Intuitive Surgical, Inc.  ( ISRG )  a Buy Now?", "url": "https://www.zacks.com/stock/news/2144739/is-trending-stock-intuitive-surgical-inc-isrg-a-buy-now", "time_published": "20230905T130005", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default55.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.232944, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.509136", "ticker_sentiment_score": "0.132117", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's How Much $1000 Invested In Intuitive Surgical 15 Years Ago Would Be Worth Today - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/23/09/34175530/heres-how-much-1000-invested-in-intuitive-surgical-15-years-ago-would-be-worth-today", "time_published": "20230901T153025", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 15 years by 8.0% on an annualized basis producing an average annual return of 16.81%. Currently, Intuitive Surgical has a market capitalization of $109.00 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Dips More Than Broader Markets: What You Should Know", "url": "https://www.zacks.com/stock/news/2143297/intuitive-surgical-inc-isrg-dips-more-than-broader-markets-what-you-should-know", "time_published": "20230831T215010", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $312.68, moving -1.85% from the previous trading session.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default90.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.173523, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.700759", "ticker_sentiment_score": "0.270817", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical Unusual Options Activity For August 31 - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/08/34155377/intuitive-surgical-unusual-options-activity-for-august-31", "time_published": "20230831T191822", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bearish stance on Intuitive Surgical ISRG. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.145842, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.765213", "ticker_sentiment_score": "0.282329", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Idexx  ( IDXX )  Down 1.6% Since Last Earnings Report: Can It Rebound?", "url": "https://www.zacks.com/stock/news/2143127/idexx-idxx-down-16-since-last-earnings-report-can-it-rebound", "time_published": "20230831T153124", "authors": ["Zacks Equity Research"], "summary": "Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default147.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999162"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}], "overall_sentiment_score": 0.15217, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IDXX", "relevance_score": "0.098255", "ticker_sentiment_score": "0.041829", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.195025", "ticker_sentiment_score": "0.05598", "ticker_sentiment_label": "Neutral"}]}, {"title": "Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF  ( RSPH ) ?", "url": "https://www.zacks.com/stock/news/2141148/should-you-invest-in-the-invesco-sp-500-equal-weight-health-care-etf-rsph", "time_published": "20230828T102007", "authors": ["Zacks Equity Research"], "summary": "Sector ETF report for ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default207.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.306901, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.131643", "ticker_sentiment_score": "0.063605", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.259727", "ticker_sentiment_score": "0.235608", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.131643", "ticker_sentiment_score": "0.063605", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.131643", "ticker_sentiment_score": "0.063605", "ticker_sentiment_label": "Neutral"}]}, {"title": "Industrials over tech? Gauging productivity play among AI ETFs", "url": "https://www.cnbc.com/2023/08/26/industrials-over-tech-gauging-productivity-play-among-ai-etfs-.html", "time_published": "20230826T140002", "authors": ["Kevin Schmidt"], "summary": "Exchange-traded funds tied to the AI boom might be outperforming this year, but momentum is shifting as investors weigh the tech-fueled hype and higher rates.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107289701-1692652698ETF-SEG1-082123.jpg?v=1692653211&w=750&h=422&vtcrop=y", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.96136"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.233665, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DT", "relevance_score": "0.066784", "ticker_sentiment_score": "0.070121", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.066784", "ticker_sentiment_score": "0.144386", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.066784", "ticker_sentiment_score": "0.070121", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYCCF", "relevance_score": "0.066784", "ticker_sentiment_score": "0.070121", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.066784", "ticker_sentiment_score": "0.070121", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Is Considered a Good Investment by Brokers: Is That True?", "url": "https://www.zacks.com/stock/news/2140737/intuitive-surgical-inc-isrg-is-considered-a-good-investment-by-brokers-is-that-true", "time_published": "20230825T133005", "authors": ["Zacks Equity Research"], "summary": "Based on the average brokerage recommendation (ABR), Intuitive Surgical, Inc. (ISRG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default43.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}], "overall_sentiment_score": 0.273558, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.350564", "ticker_sentiment_score": "0.163386", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Is Medtronic Stock a Buy Now?", "url": "https://www.fool.com/investing/2023/08/25/is-medtronic-stock-a-buy-now/", "time_published": "20230825T131500", "authors": ["Sushree Mohanty"], "summary": "This healthcare stock had a strong start to its fiscal 2024.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.996718"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.31898, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.622414", "ticker_sentiment_score": "0.483075", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.063933", "ticker_sentiment_score": "0.031089", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is Most-Watched Stock Intuitive Surgical, Inc.  ( ISRG )  Worth Betting on Now?", "url": "https://www.zacks.com/stock/news/2140697/is-most-watched-stock-intuitive-surgical-inc-isrg-worth-betting-on-now", "time_published": "20230825T130007", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default168.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.214967, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.504646", "ticker_sentiment_score": "0.131405", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Unusual Options Activity For August 24 - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/08/34031718/intuitive-surgical-unusual-options-activity-for-august-24", "time_published": "20230824T191911", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bullish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ISRG we detected 10 strange trades.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.233528, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.699089", "ticker_sentiment_score": "0.303198", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Outpaces Stock Market Gains: What You Should Know", "url": "https://www.zacks.com/stock/news/2139940/intuitive-surgical-inc-isrg-outpaces-stock-market-gains-what-you-should-know", "time_published": "20230823T215004", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $290.39, moving +1.12% from the previous trading session.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default39.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.976913"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.168177, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.598621", "ticker_sentiment_score": "0.333301", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": " ( ISRG )  - Analyzing Intuitive Surgical's Short Interest - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/short-sellers/23/08/33994419/isrg-analyzing-intuitive-surgicals-short-interest", "time_published": "20230822T204516", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical's ISRG short percent of float has fallen 3.33% since its last report. The company recently reported that it has 3.04 million shares sold short, which is 0.87% of all regular shares that are available for trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.259737, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.221819", "ticker_sentiment_score": "0.110774", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Reasons to Retain Intuitive Surgical  ( ISRG )  in Your Portfolio", "url": "https://www.zacks.com/stock/news/2138564/3-reasons-to-retain-intuitive-surgical-isrg-in-your-portfolio", "time_published": "20230821T115500", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/2297.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.309853, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ALC", "relevance_score": "0.145437", "ticker_sentiment_score": "0.100844", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.145437", "ticker_sentiment_score": "0.107102", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.458799", "ticker_sentiment_score": "0.429151", "ticker_sentiment_label": "Bullish"}]}, {"title": "2 Healthcare Stocks You Can Buy and Hold for the Next Decade", "url": "https://www.fool.com/investing/2023/08/19/2-healthcare-stocks-you-can-buy-and-hold-for-the/", "time_published": "20230819T122300", "authors": ["Prosper Junior Bakiny"], "summary": "Investors can expect steady returns from these two longtime market-beaters.", "banner_image": "https://media.ycharts.com/charts/b7ff43267b66c42848f8cade20566d5e.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.938793"}], "overall_sentiment_score": 0.286128, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.302553", "ticker_sentiment_score": "0.308318", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.254042", "ticker_sentiment_score": "0.209765", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Check Out What Whales Are Doing With ISRG - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/08/33921222/check-out-what-whales-are-doing-with-isrg", "time_published": "20230818T180052", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bullish stance on Intuitive Surgical ISRG. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.115586, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BCS", "relevance_score": "0.09439", "ticker_sentiment_score": "-0.12791", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.876805", "ticker_sentiment_score": "0.219743", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WFC", "relevance_score": "0.09439", "ticker_sentiment_score": "-0.12791", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.09439", "ticker_sentiment_score": "-0.12791", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.09439", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Robotics Market to grow by USD 22.2697 billion from 2022 to 2027; Stringent health and safety regulations to drive ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/robotics-market-to-grow-by-usd-22-2697-billion-from-2022-to-2027-stringent-health-and-safety-regulations-to-drive-market-growth---technavio-301903874.html", "time_published": "20230818T140100", "authors": [], "summary": "Robotics Market to grow by USD 22.2697 billion from 2022 to 2027. Stringent health and safety regulations to drive ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.235524, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TER", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABLZF", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNZOF", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "HON", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEAGF", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "KWHIF", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMRNF", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIGRY", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYBQF", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "FANUF", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHX", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBRA", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.050894", "ticker_sentiment_score": "0.018953", "ticker_sentiment_label": "Neutral"}]}, {"title": "Obesity Crisis Costs US $200B Annually, But Arrival Of Treatments Signal Declining Surgery Demands - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ", "url": "https://www.benzinga.com/general/biotech/23/08/33912796/obesity-crisis-costs-us-200b-annually-but-arrival-of-treatments-signal-declining-surgery-demands", "time_published": "20230818T120414", "authors": ["Vandana Singh"], "summary": "With an annual toll of $200 billion due to health complications like diabetes and heart disease, the surging obesity crisis has adversely impacted Americans regarding health and the economy.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/18/weight-loss-photo_by_vidmir_rais_via_pixabay.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.03167, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.167322", "ticker_sentiment_score": "0.20416", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.167322", "ticker_sentiment_score": "0.057442", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.167322", "ticker_sentiment_score": "0.20416", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.167322", "ticker_sentiment_score": "0.246186", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "3 Reasons to Buy Medtronic Stock", "url": "https://www.fool.com/investing/2023/08/17/3-reasons-to-buy-medtronic-stock/", "time_published": "20230817T141500", "authors": ["Prosper Junior Bakiny"], "summary": "Despite serious headwinds, this healthcare giant is worth serious consideration.", "banner_image": "https://media.ycharts.com/charts/78f0d831e3a6b7bbaf27b76769e3fb96.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.276954, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.632839", "ticker_sentiment_score": "0.497143", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.04794", "ticker_sentiment_score": "0.179769", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Alcon  ( ALC )  Q2 Earnings Surpass Estimates, Margins Increase", "url": "https://www.zacks.com/stock/news/2137512/alcon-alc-q2-earnings-surpass-estimates-margins-increase", "time_published": "20230817T134100", "authors": ["Zacks Equity Research"], "summary": "Alcon (ALC) delivers better-than-expected earnings and revenues in the second quarter of 2023.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/98/37130.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Earnings", "relevance_score": "0.998663"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.240451, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ALC", "relevance_score": "0.339874", "ticker_sentiment_score": "0.316228", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.077845", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.154951", "ticker_sentiment_score": "-0.00662", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.154951", "ticker_sentiment_score": "0.022325", "ticker_sentiment_label": "Neutral"}]}, {"title": "Abbott  ( ABT )  EPD Arm Grows, Low Testing Sales Play Spoilsport", "url": "https://www.zacks.com/stock/news/2136258/abbott-abt-epd-arm-grows-low-testing-sales-play-spoilsport", "time_published": "20230814T154400", "authors": ["Zacks Equity Research"], "summary": "Banking on the successful execution of Abbott's (ABT) branded generic operating model, EPD is well positioned for sustained growth in many of the growing pharmaceutical markets.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/1479.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.995869"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.232948, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.162073", "ticker_sentiment_score": "0.123826", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAE", "relevance_score": "0.214937", "ticker_sentiment_score": "0.083275", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.214937", "ticker_sentiment_score": "0.079526", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.214937", "ticker_sentiment_score": "0.119267", "ticker_sentiment_label": "Neutral"}]}, {"title": "Myriad Genetics  ( MYGN )  Unveils GeneSight Test Enhancement", "url": "https://www.zacks.com/stock/news/2135804/myriad-genetics-mygn-unveils-genesight-test-enhancement", "time_published": "20230811T143400", "authors": ["Zacks Equity Research"], "summary": "Myriad Genetics' (MYGN) GeneSight report will contain details on how a patient's smoking history may affect their metabolism of certain medications.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.839681"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.028733, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.199859", "ticker_sentiment_score": "0.067611", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.199859", "ticker_sentiment_score": "0.029935", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.199859", "ticker_sentiment_score": "-0.007955", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.342262", "ticker_sentiment_score": "0.097539", "ticker_sentiment_label": "Neutral"}]}, {"title": "Asensus Surgical  ( ASXC )  Q2 Loss Widens, Revenues In Line", "url": "https://www.zacks.com/stock/news/2135749/asensus-surgical-asxc-q2-loss-widens-revenues-in-line", "time_published": "20230811T142000", "authors": ["Zacks Equity Research"], "summary": "Asensus Surgical (ASXC) reports a significant increase in total surgical procedures completed utilizing the Senhance System.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/70/35723.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.995015"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.061625, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.222327", "ticker_sentiment_score": "-0.008628", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.222327", "ticker_sentiment_score": "0.030792", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.112269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's How Much You Would Have Made Owning Intuitive Surgical Stock In The Last 15 Years - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/23/08/33750217/heres-how-much-you-would-have-made-owning-intuitive-surgical-stock-in-the-last-15-years", "time_published": "20230811T140022", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 15 years by 7.43% on an annualized basis producing an average annual return of 16.05%. Currently, Intuitive Surgical has a market capitalization of $106.71 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "National Vision  ( EYE )  Q2 Earnings Top Estimates, Margins Down", "url": "https://www.zacks.com/stock/news/2135553/national-vision-eye-q2-earnings-top-estimates-margins-down", "time_published": "20230811T124800", "authors": ["Zacks Equity Research"], "summary": "National Vision's (EYE) second-quarter 2023 performance highlights positive comparable store sales growth, retention and recruitment trends.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Earnings", "relevance_score": "0.99992"}], "overall_sentiment_score": 0.164131, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EYE", "relevance_score": "0.45738", "ticker_sentiment_score": "0.397032", "ticker_sentiment_label": "Bullish"}, {"ticker": "ABT", "relevance_score": "0.088147", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.175221", "ticker_sentiment_score": "-0.007196", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.175221", "ticker_sentiment_score": "0.025684", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.044141", "ticker_sentiment_score": "0.167677", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Greenwave Appoints Henry Sicignano III and Jason Adelman to Board of Directors", "url": "https://www.prnewswire.com/news-releases/greenwave-appoints-henry-sicignano-iii-and-jason-adelman-to-board-of-directors-301898197.html", "time_published": "20230810T200100", "authors": ["Greenwave Technology Solutions"], "summary": "Former CEO of 22nd Century Group and current President of Charlie's Holdings, Henry Sicignano III is a seasoned public company executive with substantial expertise in competitive strategy and regulatory affairs.", "banner_image": "https://mma.prnewswire.com/media/2048410/Greenwave_Technology_Solutions__Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.961735"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.126943, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "XXII", "relevance_score": "0.096671", "ticker_sentiment_score": "0.048698", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBLG", "relevance_score": "0.048425", "ticker_sentiment_score": "0.033531", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.048425", "ticker_sentiment_score": "0.033531", "ticker_sentiment_label": "Neutral"}, {"ticker": "GWAV", "relevance_score": "0.144563", "ticker_sentiment_score": "0.123483", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.048425", "ticker_sentiment_score": "0.033531", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Invest in Alcon  ( ALC )  Stock Now", "url": "https://www.zacks.com/stock/news/2135283/heres-why-you-should-invest-in-alcon-alc-stock-now", "time_published": "20230810T154800", "authors": ["Zacks Equity Research"], "summary": "Investors are optimistic about Alcon (ALC) owing to its strength in Surgical and Vision Care franchises and upbeat 2023 guidance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.997335"}], "overall_sentiment_score": 0.213021, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ALC", "relevance_score": "0.377855", "ticker_sentiment_score": "0.453894", "ticker_sentiment_label": "Bullish"}, {"ticker": "PEN", "relevance_score": "0.194632", "ticker_sentiment_score": "0.066236", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.194632", "ticker_sentiment_score": "0.027783", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.194632", "ticker_sentiment_score": "-0.007793", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  Q2 Earnings Beat Estimates, Margins Contract", "url": "https://www.zacks.com/stock/news/2135276/illumina-ilmn-q2-earnings-beat-estimates-margins-contract", "time_published": "20230810T153700", "authors": ["Zacks Equity Research"], "summary": "Illumina (ILMN) shipped 109 NovaSeq X instruments in the second quarter, boosting its supply capacity to more than 390 instruments for fiscal 2023.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/35363.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.094845, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.14131", "ticker_sentiment_score": "0.050902", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.14131", "ticker_sentiment_score": "0.02237", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.14131", "ticker_sentiment_score": "-0.006266", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.602278", "ticker_sentiment_score": "0.346094", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Medtronic  ( MDT )  Rides on Strong Global Growth, New Launches", "url": "https://www.zacks.com/stock/news/2135176/medtronic-mdt-rides-on-strong-global-growth-new-launches", "time_published": "20230810T152700", "authors": ["Zacks Equity Research"], "summary": "Medtronic (MDT) is gaining from positive sales momentum with the rollout of its differentiated Hugo robotic system in many international markets.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.99489"}], "overall_sentiment_score": 0.227757, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.536645", "ticker_sentiment_score": "0.283489", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HAE", "relevance_score": "0.261117", "ticker_sentiment_score": "0.09744", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.158519", "ticker_sentiment_score": "0.060196", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.210274", "ticker_sentiment_score": "0.120453", "ticker_sentiment_label": "Neutral"}]}, {"title": "Accuray  ( ARAY )  Q4 Earnings and Revenues Lag Estimates", "url": "https://www.zacks.com/stock/news/2135175/accuray-aray-q4-earnings-and-revenues-lag-estimates", "time_published": "20230810T152600", "authors": ["Zacks Equity Research"], "summary": "Accuray (ARAY) reports a solid fiscal fourth quarter top line on the back of robust segmental performances.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/df/34747.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.996718"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.043492, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ITGR", "relevance_score": "0.17879", "ticker_sentiment_score": "0.026061", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.17879", "ticker_sentiment_score": "-0.007307", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.17879", "ticker_sentiment_score": "0.057806", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.465709", "ticker_sentiment_score": "0.164194", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Avanos  ( AVNS )  Q2 Earnings and Revenues Fall Shy of Estimates", "url": "https://www.zacks.com/stock/news/2135169/avanos-avns-q2-earnings-and-revenues-fall-shy-of-estimates", "time_published": "20230810T152200", "authors": ["Zacks Equity Research"], "summary": "Despite strength in Avanos' (AVNS) Digestive Health segment, its overall second-quarter results reflect soft performances.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.99992"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.004847, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AVNS", "relevance_score": "0.166455", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.166455", "ticker_sentiment_score": "0.024788", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.166455", "ticker_sentiment_score": "-0.006949", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.166455", "ticker_sentiment_score": "0.054988", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Retain National Vision  ( EYE )  Stock Now", "url": "https://www.zacks.com/stock/news/2134925/heres-why-you-should-retain-national-vision-eye-stock-now", "time_published": "20230810T130800", "authors": ["Zacks Equity Research"], "summary": "Investors are optimistic about National Vision's (EYE) stock, banking on comparable store sales growth and technological investments.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/b2/19786.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Earnings", "relevance_score": "0.998917"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.302517, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EYE", "relevance_score": "0.512453", "ticker_sentiment_score": "0.508479", "ticker_sentiment_label": "Bullish"}, {"ticker": "WRBY", "relevance_score": "0.039548", "ticker_sentiment_score": "-0.023785", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOPCF", "relevance_score": "0.039548", "ticker_sentiment_score": "0.229663", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HAE", "relevance_score": "0.195814", "ticker_sentiment_score": "0.063501", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.157227", "ticker_sentiment_score": "0.05304", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.118257", "ticker_sentiment_score": "0.028624", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Zacks Analyst Blog Highlights PepsiCo, Johnson & Johnson, Intuitive Surgical, Kimberly-Clark and Atmos Energy", "url": "https://www.zacks.com/stock/news/2134764/the-zacks-analyst-blog-highlights-pepsico-johnson-johnson-intuitive-surgical-kimberly-clark-and-atmos-energy", "time_published": "20230810T092100", "authors": ["Zacks Investment Research"], "summary": "PepsiCo, Johnson & Johnson, Intuitive Surgical, Kimberly-Clark and Atmos Energy are included in this Analyst Blog.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/40/102.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Economy - Monetary", "relevance_score": "0.990678"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.178447, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KMB", "relevance_score": "0.139872", "ticker_sentiment_score": "0.144251", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.174335", "ticker_sentiment_score": "0.110153", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCO", "relevance_score": "0.105141", "ticker_sentiment_score": "-0.05067", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEP", "relevance_score": "0.208464", "ticker_sentiment_score": "0.141853", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATO", "relevance_score": "0.208464", "ticker_sentiment_score": "0.233876", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AEXAF", "relevance_score": "0.035138", "ticker_sentiment_score": "0.261632", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.208464", "ticker_sentiment_score": "0.084247", "ticker_sentiment_label": "Neutral"}]}, {"title": "QuidelOrtho  ( QDEL )  Q2 Earnings Top Estimates, FY23 View Revised", "url": "https://www.zacks.com/stock/news/2134452/quidelortho-qdel-q2-earnings-top-estimates-fy23-view-revised", "time_published": "20230809T165300", "authors": ["Zacks Equity Research"], "summary": "Despite solid performances by the Labs segment and Other region, QuidelOrtho (QDEL) reports soft overall top-line results in second-quarter 2023.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/df/34747.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.999955"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.004769, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ITGR", "relevance_score": "0.140076", "ticker_sentiment_score": "0.021018", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.140076", "ticker_sentiment_score": "-0.006233", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.140076", "ticker_sentiment_score": "0.050651", "ticker_sentiment_label": "Neutral"}, {"ticker": "QDEL", "relevance_score": "0.40348", "ticker_sentiment_score": "0.084533", "ticker_sentiment_label": "Neutral"}]}, {"title": "Masimo  ( MASI )  Q2 Earnings Lag Estimates, Margins Rise", "url": "https://www.zacks.com/stock/news/2134451/masimo-masi-q2-earnings-lag-estimates-margins-rise", "time_published": "20230809T165100", "authors": ["Zacks Equity Research"], "summary": "Despite strength in Hearables category, Masimo's (MASI) overall second-quarter results reflect soft performances.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.999975"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.028439, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MASI", "relevance_score": "0.415802", "ticker_sentiment_score": "0.100787", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.157741", "ticker_sentiment_score": "0.023919", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.157741", "ticker_sentiment_score": "-0.006705", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.157741", "ticker_sentiment_score": "0.053067", "ticker_sentiment_label": "Neutral"}]}, {"title": "Charles River  ( CRL )  Q2 Earnings Top, 2023 View Narrowed", "url": "https://www.zacks.com/stock/news/2134393/charles-river-crl-q2-earnings-top-2023-view-narrowed", "time_published": "20230809T151200", "authors": ["Zacks Equity Research"], "summary": "Charles River (CRL) registers robust growth in small research models, research model services and the Safety Assessment business.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/70/35723.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.187651, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.09186", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRL", "relevance_score": "0.182506", "ticker_sentiment_score": "-0.026802", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.182506", "ticker_sentiment_score": "-0.007413", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.182506", "ticker_sentiment_score": "0.026453", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.046006", "ticker_sentiment_score": "0.157968", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Insulet  ( PODD )  Q2 Earnings Beat, Sales Growth View Raised", "url": "https://www.zacks.com/stock/news/2134385/insulet-podd-q2-earnings-beat-sales-growth-view-raised", "time_published": "20230809T150300", "authors": ["Zacks Equity Research"], "summary": "Insulet's (PODD) Omnipod 5 gains market share in the second quarter within the diabetes technology market as the only FDA-approved fully disposable, pod-based automated insulin delivery system.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.139824, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.417611", "ticker_sentiment_score": "0.467144", "ticker_sentiment_label": "Bullish"}, {"ticker": "ABT", "relevance_score": "0.097259", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.193078", "ticker_sentiment_score": "-0.00773", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.193078", "ticker_sentiment_score": "0.027584", "ticker_sentiment_label": "Neutral"}]}, {"title": "Haemonetics  ( HAE )  Q1 Earnings Top Estimates, 2024 View Up", "url": "https://www.zacks.com/stock/news/2134403/haemonetics-hae-q1-earnings-top-estimates-2024-view-up", "time_published": "20230809T143100", "authors": ["Zacks Equity Research"], "summary": "The robust volume growth and price benefits in the Plasma business drive Haemonetics' (HAE) fiscal first-quarter performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/35363.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.124267, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.175539", "ticker_sentiment_score": "0.058497", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.175539", "ticker_sentiment_score": "0.025717", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAE", "relevance_score": "0.458126", "ticker_sentiment_score": "0.30774", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.175539", "ticker_sentiment_score": "-0.00721", "ticker_sentiment_label": "Neutral"}]}, {"title": "QIAGEN  ( QGEN )  Q2 Earnings and Revenues Top, '23 View Slashed", "url": "https://www.zacks.com/stock/news/2134203/qiagen-qgen-q2-earnings-and-revenues-top-23-view-slashed", "time_published": "20230809T122100", "authors": ["Zacks Equity Research"], "summary": "QIAGEN (QGEN) surpasses the earnings and revenue outlook in the second quarter of 2023 amid a challenging macro environment.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/22/35722.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Earnings", "relevance_score": "0.999996"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.052362, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "QGEN", "relevance_score": "0.379531", "ticker_sentiment_score": "0.055178", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.065775", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.131105", "ticker_sentiment_score": "-0.006012", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.131105", "ticker_sentiment_score": "0.021486", "ticker_sentiment_label": "Neutral"}]}, {"title": "SmileDirectClub  ( SDC )  Q2 Earnings Miss Estimates, '23 View Up", "url": "https://www.zacks.com/stock/news/2134193/smiledirectclub-sdc-q2-earnings-miss-estimates-23-view-up", "time_published": "20230809T121700", "authors": ["Zacks Equity Research"], "summary": "SmileDirectClub (SDC) reports a higher-than-expected loss in the second quarter of 2023.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/70/35723.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.98396"}], "overall_sentiment_score": -0.068668, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.100941", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDC", "relevance_score": "0.431881", "ticker_sentiment_score": "-0.161945", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ISRG", "relevance_score": "0.200273", "ticker_sentiment_score": "-0.007944", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.200273", "ticker_sentiment_score": "0.026779", "ticker_sentiment_label": "Neutral"}]}, {"title": "5 Defensive Stocks for Stable Returns Amid Recent Volatility", "url": "https://www.zacks.com/stock/news/2134256/5-defensive-stocks-for-stable-returns-amid-recent-volatility", "time_published": "20230809T120400", "authors": ["Nalak Das"], "summary": "We have narrowed our search to five stocks from defensive sectors. These are: JNJ, PEP, ISRG, KMB, ATO.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f6/47493.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Economy - Monetary", "relevance_score": "0.990678"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.183341, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KMB", "relevance_score": "0.109956", "ticker_sentiment_score": "0.215087", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.146247", "ticker_sentiment_score": "0.15633", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MCO", "relevance_score": "0.109956", "ticker_sentiment_score": "-0.051574", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEP", "relevance_score": "0.18223", "ticker_sentiment_score": "0.202318", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ATO", "relevance_score": "0.18223", "ticker_sentiment_score": "0.334923", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AEXAF", "relevance_score": "0.036756", "ticker_sentiment_score": "0.246139", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.18223", "ticker_sentiment_score": "0.116814", "ticker_sentiment_label": "Neutral"}]}, {"title": "A Bull Market Is Coming: 2 Warren Buffett Stocks to Buy and Hold Forever", "url": "https://www.fool.com/investing/2023/08/09/a-bull-market-is-coming-2-warren-buffet-stocks-to/", "time_published": "20230809T120000", "authors": ["Prosper Junior Bakiny"], "summary": "These two stocks have delivered outsize returns over the long run.", "banner_image": "https://media.ycharts.com/charts/5e5b710cdc779f878d67112431c20e69.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.32542, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AAPL", "relevance_score": "0.344987", "ticker_sentiment_score": "0.289903", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.050894", "ticker_sentiment_score": "0.142352", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRK-A", "relevance_score": "0.101582", "ticker_sentiment_score": "0.154424", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.47672", "ticker_sentiment_score": "0.444243", "ticker_sentiment_label": "Bullish"}]}, {"title": "Shockwave Medical  ( SWAV )  Q2 Earnings Miss, Revenues Surge Y/Y", "url": "https://www.zacks.com/stock/news/2133843/shockwave-medical-swav-q2-earnings-miss-revenues-surge-yy", "time_published": "20230808T172600", "authors": ["Zacks Equity Research"], "summary": "Shockwave Medical's (SWAV) second-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/70/35723.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999819"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.210832, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SYK", "relevance_score": "0.212115", "ticker_sentiment_score": "0.039293", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.212115", "ticker_sentiment_score": "0.039309", "ticker_sentiment_label": "Neutral"}, {"ticker": "NARI", "relevance_score": "0.212115", "ticker_sentiment_score": "0.113182", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWAV", "relevance_score": "0.455074", "ticker_sentiment_score": "0.2081", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "QIAGEN  ( QGEN )  Receives FDA Approval for AYVAKIT CDX Test", "url": "https://www.zacks.com/stock/news/2133808/qiagen-qgen-receives-fda-approval-for-ayvakit-cdx-test", "time_published": "20230808T164800", "authors": ["Zacks Equity Research"], "summary": "QIAGEN's (QGEN) latest approval adds to its leading portfolio in precision medicine, including 12 FDA-approved companion diagnostics.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.839681"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.071335, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.204503", "ticker_sentiment_score": "0.07208", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.254042", "ticker_sentiment_score": "0.026536", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPMC", "relevance_score": "0.103109", "ticker_sentiment_score": "-0.012955", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.204503", "ticker_sentiment_score": "0.07208", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.204503", "ticker_sentiment_score": "0.037268", "ticker_sentiment_label": "Neutral"}]}, {"title": "Inogen  ( INGN )  Q2 Earnings Beat Estimates, Revenues Down Y/Y", "url": "https://www.zacks.com/stock/news/2133763/inogen-ingn-q2-earnings-beat-estimates-revenues-down-yy", "time_published": "20230808T154000", "authors": ["Zacks Equity Research"], "summary": "Despite higher domestic business-to-business sales and rental revenues, Inogen's (INGN) overall second-quarter results reflect soft performances.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.998663"}], "overall_sentiment_score": 0.035864, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ITGR", "relevance_score": "0.173645", "ticker_sentiment_score": "0.025524", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.173645", "ticker_sentiment_score": "-0.007157", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.173645", "ticker_sentiment_score": "0.056618", "ticker_sentiment_label": "Neutral"}, {"ticker": "INGN", "relevance_score": "0.524142", "ticker_sentiment_score": "0.043467", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Invest in Medtronic  ( MDT )  Stock Now", "url": "https://www.zacks.com/stock/news/2133796/heres-why-you-should-invest-in-medtronic-mdt-stock-now", "time_published": "20230808T152100", "authors": ["Zacks Equity Research"], "summary": "Investors are optimistic about Medtronic (MDT) on strong growth prospects within the Neurosurgery portfolio and upbeat 2024 guidance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.999994"}], "overall_sentiment_score": 0.278264, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ITGR", "relevance_score": "0.162802", "ticker_sentiment_score": "0.024447", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.040969", "ticker_sentiment_score": "0.096299", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.040969", "ticker_sentiment_score": "0.096299", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVA", "relevance_score": "0.040969", "ticker_sentiment_score": "0.096299", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.040969", "ticker_sentiment_score": "0.096299", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEN", "relevance_score": "0.162802", "ticker_sentiment_score": "0.058316", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.392537", "ticker_sentiment_score": "0.301894", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.006855", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Retain Insulet  ( PODD )  Stock for Now", "url": "https://www.zacks.com/stock/news/2133521/heres-why-you-should-retain-insulet-podd-stock-for-now", "time_published": "20230808T122000", "authors": ["Zacks Equity Research"], "summary": "Investors continue to be optimistic about Insulet (PODD) on the strength of the Omnipod 5 AID system.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/2563.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.999997"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.197681, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.535653", "ticker_sentiment_score": "0.270795", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDT", "relevance_score": "0.038906", "ticker_sentiment_score": "0.182485", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TNDM", "relevance_score": "0.038906", "ticker_sentiment_score": "0.182485", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HAE", "relevance_score": "0.192694", "ticker_sentiment_score": "0.062734", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.154703", "ticker_sentiment_score": "0.131912", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.116348", "ticker_sentiment_score": "0.028426", "ticker_sentiment_label": "Neutral"}]}, {"title": "OPKO Health  ( OPK )  Q2 Earnings and Revenues Top Estimates", "url": "https://www.zacks.com/stock/news/2133267/opko-health-opk-q2-earnings-and-revenues-top-estimates", "time_published": "20230807T172100", "authors": ["Zacks Equity Research"], "summary": "Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall second-quarter results reflect soft performances.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.938793"}], "overall_sentiment_score": 0.047882, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "OPK", "relevance_score": "0.532761", "ticker_sentiment_score": "0.006736", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.153715", "ticker_sentiment_score": "0.022213", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.153715", "ticker_sentiment_score": "-0.00659", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.153715", "ticker_sentiment_score": "0.053522", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.077218", "ticker_sentiment_score": "0.184518", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Myriad Genetics  ( MYGN )  Posts Narrower-Than-Estimate Q2 Loss", "url": "https://www.zacks.com/stock/news/2133255/myriad-genetics-mygn-posts-narrower-than-estimate-q2-loss", "time_published": "20230807T161200", "authors": ["Zacks Equity Research"], "summary": "Strong testing volume improvement across all businesses drives Myriad Genetics' (MYGN) Q2 performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/70/35723.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.999606"}], "overall_sentiment_score": -0.05752, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.195419", "ticker_sentiment_score": "0.064853", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.195419", "ticker_sentiment_score": "0.027837", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.195419", "ticker_sentiment_score": "-0.007806", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.379291", "ticker_sentiment_score": "0.029661", "ticker_sentiment_label": "Neutral"}]}, {"title": "National Vision  ( EYE )  Gains From Store Openings Amid Cost Woes", "url": "https://www.zacks.com/stock/news/2133163/national-vision-eye-gains-from-store-openings-amid-cost-woes", "time_published": "20230807T145100", "authors": ["Zacks Equity Research"], "summary": "National Vision (EYE) continues to roll out its remote care capabilities, which provide doctors with additional levels of flexibility and expand exam capacity in many areas.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}, {"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.244715, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EYE", "relevance_score": "0.51384", "ticker_sentiment_score": "0.432654", "ticker_sentiment_label": "Bullish"}, {"ticker": "PEN", "relevance_score": "0.169676", "ticker_sentiment_score": "0.039515", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBH", "relevance_score": "0.169676", "ticker_sentiment_score": "0.052444", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRBY", "relevance_score": "0.042723", "ticker_sentiment_score": "0.062398", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.169676", "ticker_sentiment_score": "0.142811", "ticker_sentiment_label": "Neutral"}]}, {"title": "Henry Schein  ( HSIC )  Q2 Earnings Top, Operating Margin Dips", "url": "https://www.zacks.com/stock/news/2133149/henry-schein-hsic-q2-earnings-top-operating-margin-dips", "time_published": "20230807T142500", "authors": ["Zacks Equity Research"], "summary": "Henry Schein's (HSIC) second quarter 2023 performance demonstrates strength in the North American dental business.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/22/35722.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.905476"}, {"topic": "Earnings", "relevance_score": "0.999606"}], "overall_sentiment_score": 0.097128, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CURN", "relevance_score": "0.150592", "ticker_sentiment_score": "0.048453", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.075635", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSIC", "relevance_score": "0.431065", "ticker_sentiment_score": "0.180841", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.150592", "ticker_sentiment_score": "-0.006504", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.150592", "ticker_sentiment_score": "0.023227", "ticker_sentiment_label": "Neutral"}]}, {"title": "Motley Fool Rule Breaker Investing Fundamentals", "url": "https://www.fool.com/retirement/2023/08/05/motley-fool-rule-breaker-investing-fundamentals/", "time_published": "20230805T123000", "authors": ["Motley Fool Staff"], "summary": "Investing has plenty of rules. But who made those rules anyway?", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F741594%2Fnest-with-golden-eggs-and-social-security-card.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.185299, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.02361", "ticker_sentiment_score": "0.083218", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.015742", "ticker_sentiment_score": "0.070194", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Rad  ( BIO )  Beats on Q2 Earnings Estimates, Cuts 2023 View", "url": "https://www.zacks.com/stock/news/2132866/bio-rad-bio-beats-on-q2-earnings-estimates-cuts-2023-view", "time_published": "20230804T163000", "authors": ["Zacks Equity Research"], "summary": "Growth across the Life Science portfolio and strong double-digit growth for ddPCR drive Bio-Rad (BIO) Q2 performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/70/35723.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.999996"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.040688, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.170576", "ticker_sentiment_score": "0.058742", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.170576", "ticker_sentiment_score": "-0.119613", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.170576", "ticker_sentiment_score": "0.025208", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.170576", "ticker_sentiment_score": "-0.007068", "ticker_sentiment_label": "Neutral"}]}, {"title": "Globus Medical  ( GMED )  Q2 Earnings Beat Estimates, Margins Dip", "url": "https://www.zacks.com/stock/news/2132825/globus-medical-gmed-q2-earnings-beat-estimates-margins-dip", "time_published": "20230804T162600", "authors": ["Zacks Equity Research"], "summary": "According to Globus Medical (GMED), the increase in R&D expenses is largely focused on Spine and Enabling Technologies.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.999955"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.232752, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.082111", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMED", "relevance_score": "0.357293", "ticker_sentiment_score": "0.394698", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.163354", "ticker_sentiment_score": "-0.006855", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.163354", "ticker_sentiment_score": "0.024472", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVA", "relevance_score": "0.04111", "ticker_sentiment_score": "0.185472", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ResMed's  ( RMD )  Q4 Earnings Miss, Revenues Beat Estimates", "url": "https://www.zacks.com/stock/news/2132820/resmeds-rmd-q4-earnings-miss-revenues-beat-estimates", "time_published": "20230804T162000", "authors": ["Zacks Equity Research"], "summary": "ResMed (RMD) records a robust sales performance in fiscal Q4 backed by the ongoing combined availability of cloud-connected AirSense 10 and AirSense 11 sleep devices.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/70/35723.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}, {"topic": "Earnings", "relevance_score": "0.999981"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.110318, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RMD", "relevance_score": "0.2827", "ticker_sentiment_score": "0.135512", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.082393", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.163909", "ticker_sentiment_score": "-0.006868", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.163909", "ticker_sentiment_score": "0.023159", "ticker_sentiment_label": "Neutral"}]}, {"title": "AMN Healthcare  ( AMN )  Q2 Earnings and Revenues Beat Estimates", "url": "https://www.zacks.com/stock/news/2132795/amn-healthcare-amn-q2-earnings-and-revenues-beat-estimates", "time_published": "20230804T153100", "authors": ["Zacks Equity Research"], "summary": "AMN Healthcare's (AMN) dismal results in all its segments led to a soft overall Q2 performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/df/34747.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.999696"}], "overall_sentiment_score": 0.007216, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AMN", "relevance_score": "0.512453", "ticker_sentiment_score": "0.036093", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.157227", "ticker_sentiment_score": "0.058417", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.157227", "ticker_sentiment_score": "0.02819", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.118257", "ticker_sentiment_score": "-0.019514", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.079", "ticker_sentiment_score": "0.071", "ticker_sentiment_label": "Neutral"}]}, {"title": "DaVita  ( DVA )  Tops Q2 Earnings Estimates, Ups FY23 EPS View", "url": "https://www.zacks.com/stock/news/2132781/davita-dva-tops-q2-earnings-estimates-ups-fy23-eps-view", "time_published": "20230804T152900", "authors": ["Zacks Equity Research"], "summary": "DaVita's (DVA) robust dialysis patient service drives its second-quarter performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.999896"}], "overall_sentiment_score": 0.099295, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ITGR", "relevance_score": "0.195814", "ticker_sentiment_score": "0.068211", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.195814", "ticker_sentiment_score": "0.032942", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.464633", "ticker_sentiment_score": "0.307045", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BDX", "relevance_score": "0.098659", "ticker_sentiment_score": "0.074008", "ticker_sentiment_label": "Neutral"}]}, {"title": "Teleflex  ( TFX )  Q2 Earnings Top Estimates, 2023 Sales View Up", "url": "https://www.zacks.com/stock/news/2132770/teleflex-tfx-q2-earnings-top-estimates-2023-sales-view-up", "time_published": "20230804T140700", "authors": ["Zacks Equity Research"], "summary": "Strong performances in its Vascular, Interventional and Surgical businesses drives Teleflex (TFX) Q2 revenues.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/df/34747.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.130909, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.160901", "ticker_sentiment_score": "0.056471", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.160901", "ticker_sentiment_score": "0.024231", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.160901", "ticker_sentiment_score": "-0.006792", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFX", "relevance_score": "0.315325", "ticker_sentiment_score": "0.283579", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Tandem Diabetes  ( TNDM )  Reports Narrower Q2 Loss, Trims '23 View", "url": "https://www.zacks.com/stock/news/2132706/tandem-diabetes-tndm-reports-narrower-q2-loss-trims-23-view", "time_published": "20230804T134900", "authors": ["Zacks Equity Research"], "summary": "Tandem Diabetes' (TNDM) second-quarter 2023 performance reflects new technology innovations and operational improvements throughout its business.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/95/42646.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.033331, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.086556", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNDM", "relevance_score": "0.214177", "ticker_sentiment_score": "0.120522", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.172097", "ticker_sentiment_score": "-0.007105", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.172097", "ticker_sentiment_score": "0.025361", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bruker  ( BRKR )  Q2 Earnings and Revenues Top, '23 Sales View Up", "url": "https://www.zacks.com/stock/news/2132699/bruker-brkr-q2-earnings-and-revenues-top-23-sales-view-up", "time_published": "20230804T134500", "authors": ["Zacks Equity Research"], "summary": "Bruker (BRKR) delivers better-than-expected earnings and revenues in the second quarter of 2023.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f6/47493.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.177428, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BRKR", "relevance_score": "0.441059", "ticker_sentiment_score": "0.309351", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EW", "relevance_score": "0.154455", "ticker_sentiment_score": "-0.025114", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.154455", "ticker_sentiment_score": "0.005204", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.154455", "ticker_sentiment_score": "0.052515", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.077593", "ticker_sentiment_score": "0.106397", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stryker  ( SYK )  Q2 Earnings Beat Estimates, Volume Improves", "url": "https://www.zacks.com/stock/news/2132719/stryker-syk-q2-earnings-beat-estimates-volume-improves", "time_published": "20230804T130100", "authors": ["Zacks Equity Research"], "summary": "Stryker's (SYK) second-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/46/45482.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99994"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.212074, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.102888", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.395012", "ticker_sentiment_score": "0.429673", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.204072", "ticker_sentiment_score": "0.038138", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.204072", "ticker_sentiment_score": "0.075247", "ticker_sentiment_label": "Neutral"}]}, {"title": "Inari Medical  ( NARI )  Q2 Earnings Top, Revenues Rise Y/Y", "url": "https://www.zacks.com/stock/news/2132712/inari-medical-nari-q2-earnings-top-revenues-rise-yy", "time_published": "20230804T125900", "authors": ["Zacks Equity Research"], "summary": "Inari Medical's (NARI) second-quarter results benefit from significant progress made across all its growth drivers.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/60/43413.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.988915"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.138392, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.113597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.224903", "ticker_sentiment_score": "0.041184", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.224903", "ticker_sentiment_score": "0.081247", "ticker_sentiment_label": "Neutral"}, {"ticker": "NARI", "relevance_score": "0.432291", "ticker_sentiment_score": "0.393307", "ticker_sentiment_label": "Bullish"}]}, {"title": "Cigna  ( CI )  Q2 Earnings Beat on Strong U.S. Commercial Unit", "url": "https://www.zacks.com/stock/news/2132224/cigna-ci-q2-earnings-beat-on-strong-us-commercial-unit", "time_published": "20230803T180200", "authors": ["Zacks Equity Research"], "summary": "Cigna's (CI) Q2 results reflect solid premium rate hikes and a growing membership base across its U.S. Commercial and Medicare Advantage businesses.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/af/2600.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.213148, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.138066", "ticker_sentiment_score": "0.090502", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.138066", "ticker_sentiment_score": "0.139374", "ticker_sentiment_label": "Neutral"}, {"ticker": "CI", "relevance_score": "0.272029", "ticker_sentiment_score": "0.177363", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ELV", "relevance_score": "0.138066", "ticker_sentiment_score": "0.118661", "ticker_sentiment_label": "Neutral"}]}, {"title": "PacBio  ( PACB )  Tops on Q2 Earnings, Raises FY23 Revenue View", "url": "https://www.zacks.com/stock/news/2132189/pacbio-pacb-tops-on-q2-earnings-raises-fy23-revenue-view", "time_published": "20230803T171600", "authors": ["Zacks Equity Research"], "summary": "PacBio (PACB) witnesses strong revenue growth in the second quarter, partly aided by customers' product transition to the Revio system.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/35363.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.998663"}], "overall_sentiment_score": 0.03357, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.088472", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.175859", "ticker_sentiment_score": "0.025754", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.175859", "ticker_sentiment_score": "-0.007221", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACB", "relevance_score": "0.218817", "ticker_sentiment_score": "0.352451", "ticker_sentiment_label": "Bullish"}]}, {"title": "Surmodics  ( SRDX )  Q3 Earnings Top Estimates, FY23 View Up", "url": "https://www.zacks.com/stock/news/2132180/surmodics-srdx-q3-earnings-top-estimates-fy23-view-up", "time_published": "20230803T170300", "authors": ["Zacks Equity Research"], "summary": "Surmodics (SRDX) reports a solid fiscal third quarter top line on the back of robust Medical Device revenues.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/df/34747.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.999996"}], "overall_sentiment_score": 0.125649, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.077218", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.153715", "ticker_sentiment_score": "0.022213", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.153715", "ticker_sentiment_score": "-0.00659", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRDX", "relevance_score": "0.590009", "ticker_sentiment_score": "0.354893", "ticker_sentiment_label": "Bullish"}]}, {"title": "BD  ( BDX )  Q3 Earnings Surpass Estimates, Margins Contract", "url": "https://www.zacks.com/stock/news/2132172/bd-bdx-q3-earnings-surpass-estimates-margins-contract", "time_published": "20230803T165700", "authors": ["Zacks Equity Research"], "summary": "BD's (BDX) overall top line benefits from revenue growth in the majority of its segments and both geographic regions in the fiscal third quarter.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.119982, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.063425", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.12645", "ticker_sentiment_score": "0.019929", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.005906", "ticker_sentiment_label": "Neutral"}, {"ticker": "STE", "relevance_score": "0.031738", "ticker_sentiment_score": "0.25468", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BDX", "relevance_score": "0.12645", "ticker_sentiment_score": "0.115899", "ticker_sentiment_label": "Neutral"}]}, {"title": "Envista  ( NVST )  Q2 Earnings Top Estimates, Margins Expands", "url": "https://www.zacks.com/stock/news/2132147/envista-nvst-q2-earnings-top-estimates-margins-expands", "time_published": "20230803T152200", "authors": ["Zacks Equity Research"], "summary": "Consistent growth in the Specialty Products & Technologies segment and a return to growth in the Equipment & Consumables segment drive Envista's (NVST) Q2 revenues.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/95/42646.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.996718"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.129942, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.105141", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.208464", "ticker_sentiment_score": "-0.008206", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVST", "relevance_score": "0.402941", "ticker_sentiment_score": "0.186536", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ELV", "relevance_score": "0.208464", "ticker_sentiment_score": "0.029262", "ticker_sentiment_label": "Neutral"}]}, {"title": "Glaukos  ( GKOS )  Q2 Earnings Beat Estimates, Revenues Rise Y/Y", "url": "https://www.zacks.com/stock/news/2132137/glaukos-gkos-q2-earnings-beat-estimates-revenues-rise-yy", "time_published": "20230803T151600", "authors": ["Zacks Equity Research"], "summary": "Glaukos' (GKOS) second-quarter revenues beat estimates but fall year over year. Sales and gross margin improve, while higher operating expenses lead to a wider operating loss.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/85/44157.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.995015"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.043111, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GKOS", "relevance_score": "0.570165", "ticker_sentiment_score": "0.086853", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.114137", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.22595", "ticker_sentiment_score": "0.041337", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.22595", "ticker_sentiment_score": "0.08155", "ticker_sentiment_label": "Neutral"}]}, {"title": "STERIS  ( STE )  Q1 Earnings Beat Estimates, Gross Margin Falls", "url": "https://www.zacks.com/stock/news/2132049/steris-ste-q1-earnings-beat-estimates-gross-margin-falls", "time_published": "20230803T151200", "authors": ["Zacks Equity Research"], "summary": "Barring Life Sciences and Dental, rest of STERIS (STE) operating segments report organic revenue growth in fiscal Q1.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/70/35723.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.147401, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.085629", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.170275", "ticker_sentiment_score": "-0.007054", "ticker_sentiment_label": "Neutral"}, {"ticker": "STE", "relevance_score": "0.445746", "ticker_sentiment_score": "0.313723", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ELV", "relevance_score": "0.170275", "ticker_sentiment_score": "0.025177", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.085629", "ticker_sentiment_score": "0.137813", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Buy SmileDirectClub  ( SDC )  Stock Now", "url": "https://www.zacks.com/stock/news/2132123/heres-why-you-should-buy-smiledirectclub-sdc-stock-now", "time_published": "20230803T150300", "authors": ["Zacks Equity Research"], "summary": "Investors are likely to benefit from the SmileDirectClub (SDC) stock, backed by strategic alliances and targeted long-term growth.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/dc/1715.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.996675"}], "overall_sentiment_score": 0.239533, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CVS", "relevance_score": "0.047844", "ticker_sentiment_score": "0.298062", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ZBH", "relevance_score": "0.18967", "ticker_sentiment_score": "0.09224", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDC", "relevance_score": "0.410803", "ticker_sentiment_score": "0.447211", "ticker_sentiment_label": "Bullish"}, {"ticker": "PEN", "relevance_score": "0.18967", "ticker_sentiment_score": "0.041279", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGN", "relevance_score": "0.047844", "ticker_sentiment_score": "0.116431", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.18967", "ticker_sentiment_score": "0.151535", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WMT", "relevance_score": "0.047844", "ticker_sentiment_score": "0.298062", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "McKesson  ( MCK )  Q1 Earnings Beat Estimates, U.S. Sales Strong", "url": "https://www.zacks.com/stock/news/2132121/mckesson-mck-q1-earnings-beat-estimates-us-sales-strong", "time_published": "20230803T150000", "authors": ["Zacks Equity Research"], "summary": "McKesson's (MCK) fiscal first-quarter 2024 results benefit from growth in the United States. Divestment hurts the International segment.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/60/43413.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999986"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": 0.213464, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.091335", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCK", "relevance_score": "0.31197", "ticker_sentiment_score": "0.301259", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.181477", "ticker_sentiment_score": "0.034912", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.181477", "ticker_sentiment_score": "0.068904", "ticker_sentiment_label": "Neutral"}]}, {"title": "Fresenius Medical  ( FMS )  Q2 Earnings and Revenues Beat Estimates", "url": "https://www.zacks.com/stock/news/2132095/fresenius-medical-fms-q2-earnings-and-revenues-beat-estimates", "time_published": "20230803T145500", "authors": ["Zacks Equity Research"], "summary": "Fresenius Medical's (FMS) second-quarter revenues benefit from strong performance across all segments. Inflationary pressure continues to improve, benefiting operating income.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f2/33314.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999691"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.320645, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.105836", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSNUF", "relevance_score": "0.358521", "ticker_sentiment_score": "0.239539", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FMS", "relevance_score": "0.31019", "ticker_sentiment_score": "0.240964", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.209819", "ticker_sentiment_score": "0.040601", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.209819", "ticker_sentiment_score": "0.076893", "ticker_sentiment_label": "Neutral"}]}, {"title": "DENTSPLY SIRONA  ( XRAY )  Beats on Q2 Earnings, Ups '23 EPS View", "url": "https://www.zacks.com/stock/news/2132093/dentsply-sirona-xray-beats-on-q2-earnings-ups-23-eps-view", "time_published": "20230803T145300", "authors": ["Zacks Equity Research"], "summary": "DENTSPLY SIRONA's (XRAY) Q2 revenues are driven by a rise in demand across key markets, especially in China. Improved pricing and restructuring initiatives boost earnings.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/88/34457.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.237595, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.032251", "ticker_sentiment_score": "0.071621", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.064449", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRAY", "relevance_score": "0.253646", "ticker_sentiment_score": "0.084857", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.128478", "ticker_sentiment_score": "0.029398", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.128478", "ticker_sentiment_score": "0.055846", "ticker_sentiment_label": "Neutral"}]}, {"title": "NuVasive  ( NUVA )  Q2 Earnings Meet Estimates, Margins Down", "url": "https://www.zacks.com/stock/news/2132002/nuvasive-nuva-q2-earnings-meet-estimates-margins-down", "time_published": "20230803T141400", "authors": ["Zacks Equity Research"], "summary": "NuVasive's (NUVA) second-quarter 2023 results reflect the robust performance of the U.S. Cervical business.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/88/34457.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}, {"topic": "Earnings", "relevance_score": "0.999491"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.157828, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.082963", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMED", "relevance_score": "0.041538", "ticker_sentiment_score": "0.11103", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.165031", "ticker_sentiment_score": "-0.006902", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.165031", "ticker_sentiment_score": "0.02464", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVA", "relevance_score": "0.433299", "ticker_sentiment_score": "0.029371", "ticker_sentiment_label": "Neutral"}]}, {"title": "Price Over Earnings Overview: Intuitive Surgical - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/23/08/33529397/price-over-earnings-overview-intuitive-surgical", "time_published": "20230802T184516", "authors": ["Benzinga Insights"], "summary": "Looking into the current session, Intuitive Surgical Inc. ISRG shares are trading at $314.13, after a 3.03% decrease. Over the past month, the stock fell by 5.92%, but over the past year, it actually went up by 29.56%.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": -0.023912, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.414559", "ticker_sentiment_score": "0.108081", "ticker_sentiment_label": "Neutral"}]}, {"title": "CVS Health  ( CVS )  Q2 Earnings Surpass Estimates, Margins Up", "url": "https://www.zacks.com/stock/news/2131295/cvs-health-cvs-q2-earnings-surpass-estimates-margins-up", "time_published": "20230802T162800", "authors": ["Zacks Equity Research"], "summary": "Pharmacy drug mix, growth in specialty pharmacy, brand inflation and the acquisitions of Oak Street Health and Signify Health drive CVS Health's (CVS) Q2 revenues.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/84/38219.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}, {"topic": "Earnings", "relevance_score": "0.99992"}], "overall_sentiment_score": 0.158524, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CVS", "relevance_score": "0.354952", "ticker_sentiment_score": "0.323085", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.091684", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.182162", "ticker_sentiment_score": "-0.007407", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.182162", "ticker_sentiment_score": "0.026417", "ticker_sentiment_label": "Neutral"}]}, {"title": "Penumbra  ( PEN )  Q2 Earnings Top Estimates, Sales View Raised", "url": "https://www.zacks.com/stock/news/2131234/penumbra-pen-q2-earnings-top-estimates-sales-view-raised", "time_published": "20230802T155100", "authors": ["Zacks Equity Research"], "summary": "Penumbra's (PEN) U.S. thrombectomy records 50% year-over-year growth, while the international Vascular business sees relatively flat sales in the second quarter.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.999819"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.178329, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.520209", "ticker_sentiment_score": "0.336027", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.102231", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.20279", "ticker_sentiment_score": "-0.008023", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.20279", "ticker_sentiment_score": "0.02864", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nevro  ( NVRO )  Q2 Earnings Lag Estimates, FY23 View Cut", "url": "https://www.zacks.com/stock/news/2131208/nevro-nvro-q2-earnings-lag-estimates-fy23-view-cut", "time_published": "20230802T152800", "authors": ["Zacks Equity Research"], "summary": "Nevro's (NVRO) worldwide revenues improve on a year-over-year basis in the second quarter owing to robust domestic and international performances.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/df/34747.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.995921"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.069306, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NVRO", "relevance_score": "0.513895", "ticker_sentiment_score": "0.114647", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.079261", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.157741", "ticker_sentiment_score": "0.023919", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.157741", "ticker_sentiment_score": "-0.006705", "ticker_sentiment_label": "Neutral"}]}, {"title": "Inspire Medical  ( INSP )  Q2 Earnings & Revenues Top Estimates", "url": "https://www.zacks.com/stock/news/2131206/inspire-medical-insp-q2-earnings-revenues-top-estimates", "time_published": "20230802T152500", "authors": ["Zacks Equity Research"], "summary": "Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the second quarter.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.988915"}], "overall_sentiment_score": 0.239599, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "INSP", "relevance_score": "0.245752", "ticker_sentiment_score": "-0.090686", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.083107", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.165314", "ticker_sentiment_score": "0.024672", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.165314", "ticker_sentiment_score": "-0.006917", "ticker_sentiment_label": "Neutral"}]}, {"title": "Exact Sciences  ( EXAS )  Beats on Q2 Earnings, Ups '23 Sales View", "url": "https://www.zacks.com/stock/news/2131232/exact-sciences-exas-beats-on-q2-earnings-ups-23-sales-view", "time_published": "20230802T144400", "authors": ["Zacks Equity Research"], "summary": "Strength in Screening revenues and Precision Oncology drive Exact Sciences (EXAS) Q2 performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/95/42646.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.988915"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.007203, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.105604", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAS", "relevance_score": "0.404563", "ticker_sentiment_score": "0.047903", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.008231", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.209365", "ticker_sentiment_score": "0.029357", "ticker_sentiment_label": "Neutral"}]}, {"title": "AmerisourceBergen  ( ABC )  Beats on Q3 Earnings, Ups '23 EPS View", "url": "https://www.zacks.com/stock/news/2131183/amerisourcebergen-abc-beats-on-q3-earnings-ups-23-eps-view", "time_published": "20230802T135300", "authors": ["Zacks Equity Research"], "summary": "AmerisourceBergen's (ABC) fiscal third-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/95/42646.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999981"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.245828, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.16144", "ticker_sentiment_score": "0.032188", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.16144", "ticker_sentiment_score": "0.063568", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.081138", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Revvity  ( RVTY )  Beats on Q2 Earnings, Lowers '23 EPS View", "url": "https://www.zacks.com/stock/news/2131116/revvity-rvty-beats-on-q2-earnings-lowers-23-eps-view", "time_published": "20230802T130000", "authors": ["Zacks Equity Research"], "summary": "Revvity's (RVTY) second-quarter results reflect the impact of lower COVID-related sales. Both earnings and sales outpace their respective consensus estimate.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f2/33314.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.100378, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.100518", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.199447", "ticker_sentiment_score": "0.039033", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.199447", "ticker_sentiment_score": "0.073929", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVTY", "relevance_score": "0.51278", "ticker_sentiment_score": "0.18048", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Omnicell  ( OMCL )  Q2 Earnings and Revenues Top, '23 View Raised", "url": "https://www.zacks.com/stock/news/2130995/omnicell-omcl-q2-earnings-and-revenues-top-23-view-raised", "time_published": "20230802T124800", "authors": ["Zacks Equity Research"], "summary": "Omnicell's (OMCL) second-quarter 2023 performance reflects strength in advanced services and technical services as well as continued strong execution.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/29/44156.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.999981"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.072865, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "OMCL", "relevance_score": "0.46341", "ticker_sentiment_score": "0.364715", "ticker_sentiment_label": "Bullish"}, {"ticker": "ABT", "relevance_score": "0.089462", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.177802", "ticker_sentiment_score": "-0.007271", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.177802", "ticker_sentiment_score": "0.025954", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cathie Wood Buys $3.4M Worth Of Shares In This Payments Software Firm - Also Increases Exposure To Iridium Stock - Iridium Comms  ( NASDAQ:IRDM ) , ARK Fintech Innovation ETF  ( ARCA:ARKF ) , ARK Genomic Revolution ETF  ( BATS:ARKG ) , Iovance Biotherapeutics  ( NASDAQ:IOVA ) , AvidXchange Holdings  ( NASDAQ:AVDX ) , ARK Autonomous Technology & Robotics ETF  ( BATS:ARKQ ) , Pinterest  ( NYSE:PINS ) , Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/equities/23/08/33510903/cathie-wood-buys-3-4m-worth-of-shares-in-this-payments-software-firm-also-increases-exposure-to-", "time_published": "20230802T021746", "authors": ["Benzinga Neuro"], "summary": "On Tuesday, Cathie Wood-led Ark Invest made several trades, the most prominent of which was a significant purchase of shares in AvidXchange Holdings Inc AVDX. This move comes amidst a series of upcoming investor conferences that the payments processing software firm is set to participate in.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Photo_courtesy_Benzinga_YouTube_and_Unsplash_22.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.714479"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.397174, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "IRDM", "relevance_score": "0.305058", "ticker_sentiment_score": "0.496237", "ticker_sentiment_label": "Bullish"}, {"ticker": "IOVA", "relevance_score": "0.305058", "ticker_sentiment_score": "0.378163", "ticker_sentiment_label": "Bullish"}, {"ticker": "PINS", "relevance_score": "0.305058", "ticker_sentiment_score": "0.594411", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.305058", "ticker_sentiment_score": "0.408854", "ticker_sentiment_label": "Bullish"}, {"ticker": "AVDX", "relevance_score": "0.567144", "ticker_sentiment_score": "0.558878", "ticker_sentiment_label": "Bullish"}]}, {"title": "Tenet Healthcare  ( THC )  Q2 Earnings Beat on Solid Hospital Unit", "url": "https://www.zacks.com/stock/news/2130616/tenet-healthcare-thc-q2-earnings-beat-on-solid-hospital-unit", "time_published": "20230801T161500", "authors": ["Zacks Equity Research"], "summary": "Tenet Healthcare's (THC) Q2 results gain on improved adjusted admissions and higher pricing yield. Management expects adjusted EPS of $5.18-$6.03 for this year.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fb/35964.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999816"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.227105, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.119532", "ticker_sentiment_score": "0.064923", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.119532", "ticker_sentiment_score": "0.093738", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.119532", "ticker_sentiment_score": "0.090332", "ticker_sentiment_label": "Neutral"}, {"ticker": "THC", "relevance_score": "0.320784", "ticker_sentiment_score": "0.386498", "ticker_sentiment_label": "Bullish"}]}, {"title": "Ecolab  ( ECL )  Q2 Earnings Surpass Estimates, Margins Rise", "url": "https://www.zacks.com/stock/news/2130585/ecolab-ecl-q2-earnings-surpass-estimates-margins-rise", "time_published": "20230801T161200", "authors": ["Zacks Equity Research"], "summary": "Ecolab's (ECL) robust performance across all segments drives its Q2 sales, despite business challenges.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.999981"}], "overall_sentiment_score": 0.202683, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GIC", "relevance_score": "0.042876", "ticker_sentiment_score": "0.14237", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.085629", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.170275", "ticker_sentiment_score": "0.023769", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.170275", "ticker_sentiment_score": "-0.007054", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECL", "relevance_score": "0.409171", "ticker_sentiment_score": "0.473525", "ticker_sentiment_label": "Bullish"}]}, {"title": "Hologic's  ( HOLX )  Q3 Earnings Beat Estimates, 2023 View Up", "url": "https://www.zacks.com/stock/news/2130597/hologics-holx-q3-earnings-beat-estimates-2023-view-up", "time_published": "20230801T152700", "authors": ["Zacks Equity Research"], "summary": "Strength in Breast Health and GYN Surgical drives Hologic's (HOLX) Q3 performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/29/44156.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.040534, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HOLX", "relevance_score": "0.302708", "ticker_sentiment_score": "0.302844", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.077468", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.154207", "ticker_sentiment_score": "-0.006608", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.154207", "ticker_sentiment_score": "0.023576", "ticker_sentiment_label": "Neutral"}]}, {"title": "IDEXX  ( IDXX )  Q2 Earnings and Revenues Beat Estimates, View Up", "url": "https://www.zacks.com/stock/news/2130520/idexx-idxx-q2-earnings-and-revenues-beat-estimates-view-up", "time_published": "20230801T150200", "authors": ["Zacks Equity Research"], "summary": "IDEXX (IDXX) delivers better-than-expected earnings and revenues in the second quarter of 2023, backed by CAG Diagnostics' recurring revenue growth.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/35363.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999955"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.170419, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IDXX", "relevance_score": "0.210457", "ticker_sentiment_score": "0.075467", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.085022", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.169081", "ticker_sentiment_score": "-0.007018", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.169081", "ticker_sentiment_score": "0.025051", "ticker_sentiment_label": "Neutral"}]}, {"title": "Zimmer Biomet  ( ZBH )  Q2 Earnings Match Estimates, View Raised", "url": "https://www.zacks.com/stock/news/2130501/zimmer-biomet-zbh-q2-earnings-match-estimates-view-raised", "time_published": "20230801T144400", "authors": ["Zacks Equity Research"], "summary": "Barring S.E.T., Zimmer Biomet (ZBH) records strong growth across each of its business segments in the second quarter.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.172896, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ZBH", "relevance_score": "0.423843", "ticker_sentiment_score": "0.471834", "ticker_sentiment_label": "Bullish"}, {"ticker": "ABT", "relevance_score": "0.098862", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.196212", "ticker_sentiment_score": "-0.007823", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.196212", "ticker_sentiment_score": "0.026362", "ticker_sentiment_label": "Neutral"}]}, {"title": "Avantor  ( AVTR )  Q2 Earnings Lag Estimates, FY23 View Revised", "url": "https://www.zacks.com/stock/news/2130026/avantor-avtr-q2-earnings-lag-estimates-fy23-view-revised", "time_published": "20230731T165000", "authors": ["Zacks Equity Research"], "summary": "Despite Avantor's (AVTR) strength in end markets, it reports an overall soft second-quarter performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": -0.095892, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AMAT", "relevance_score": "0.073209", "ticker_sentiment_score": "-0.115101", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.073209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTR", "relevance_score": "0.386694", "ticker_sentiment_score": "-0.078889", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.145804", "ticker_sentiment_score": "-0.006384", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.145804", "ticker_sentiment_score": "0.022783", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Top Healthcare Stocks to Buy With $100", "url": "https://www.fool.com/investing/2023/07/30/the-top-healthcare-stocks-to-buy-with-100/", "time_published": "20230730T114500", "authors": ["Prosper Junior Bakiny"], "summary": "There's no need to have a fortune to invest in stocks.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Earnings", "relevance_score": "0.961735"}], "overall_sentiment_score": 0.269565, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CURN", "relevance_score": "0.052685", "ticker_sentiment_score": "-0.014013", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.447965", "ticker_sentiment_score": "0.284741", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.052685", "ticker_sentiment_score": "0.210996", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SNY", "relevance_score": "0.447965", "ticker_sentiment_score": "0.358919", "ticker_sentiment_label": "Bullish"}]}, {"title": "Integer Holdings  ( ITGR )  Q2 Earnings Top Estimates, FY23 View Up", "url": "https://www.zacks.com/stock/news/2129651/integer-holdings-itgr-q2-earnings-top-estimates-fy23-view-up", "time_published": "20230728T173900", "authors": ["Zacks Equity Research"], "summary": "Integer Holdings' (ITGR) second-quarter results reflect robust Medical and Non-Medical Sales, besides strength in all the product lines.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.999174"}], "overall_sentiment_score": 0.136594, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.074115", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.454589", "ticker_sentiment_score": "0.181751", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.147592", "ticker_sentiment_score": "-0.006427", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.147592", "ticker_sentiment_score": "0.021665", "ticker_sentiment_label": "Neutral"}]}, {"title": "Amedisys  ( AMED )  Q2 Earnings Beat Estimates, Margins Dip", "url": "https://www.zacks.com/stock/news/2129610/amedisys-amed-q2-earnings-beat-estimates-margins-dip", "time_published": "20230728T154700", "authors": ["Zacks Equity Research"], "summary": "Strength in Hugh Acuity Care segment and Hospice division drive Amedisys (AMED) Q2 performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/70/35723.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Earnings", "relevance_score": "0.99992"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.09886, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.096866", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPCH", "relevance_score": "0.048523", "ticker_sentiment_score": "0.158627", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMED", "relevance_score": "0.496741", "ticker_sentiment_score": "0.168586", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.19231", "ticker_sentiment_score": "-0.007712", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.19231", "ticker_sentiment_score": "0.027501", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.096866", "ticker_sentiment_score": "0.125798", "ticker_sentiment_label": "Neutral"}]}, {"title": " ( ISRG )  - Analyzing Intuitive Surgical's Short Interest - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/short-sellers/23/07/33444939/isrg-analyzing-intuitive-surgicals-short-interest", "time_published": "20230728T151516", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical's ISRG short percent of float has risen 7.14% since its last report. The company recently reported that it has 3.15 million shares sold short, which is 0.9% of all regular shares that are available for trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.287384, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.221819", "ticker_sentiment_score": "0.184023", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Integra's  ( IART )  Q2 Earnings Top Estimates, 2023 View Cut", "url": "https://www.zacks.com/stock/news/2129597/integras-iart-q2-earnings-top-estimates-2023-view-cut", "time_published": "20230728T151200", "authors": ["Zacks Equity Research"], "summary": "In CSS, Integra (IART) registers strong growth owing to high single-digit growth in Advanced Energy and mid-single-digit growth in CSF management during Q2.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/8d/31682.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999981"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.120212, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IART", "relevance_score": "0.24289", "ticker_sentiment_score": "0.280218", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.082111", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.163354", "ticker_sentiment_score": "-0.006861", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.163354", "ticker_sentiment_score": "0.024475", "ticker_sentiment_label": "Neutral"}]}, {"title": "DexCom  ( DXCM )  Q2 Earnings Beat Estimates, Volumes Remain Strong", "url": "https://www.zacks.com/stock/news/2129448/dexcom-dxcm-q2-earnings-beat-estimates-volumes-remain-strong", "time_published": "20230728T125200", "authors": ["Zacks Equity Research"], "summary": "DexCom's (DXCM) second-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.226145, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.092748", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.184246", "ticker_sentiment_score": "0.0353", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.515466", "ticker_sentiment_score": "0.394568", "ticker_sentiment_label": "Bullish"}, {"ticker": "ELV", "relevance_score": "0.184246", "ticker_sentiment_score": "0.069667", "ticker_sentiment_label": "Neutral"}]}, {"title": "Neogen  ( NEOG )  Q4 Earnings Beat Estimates, Gross Margin Up", "url": "https://www.zacks.com/stock/news/2129319/neogen-neog-q4-earnings-beat-estimates-gross-margin-up", "time_published": "20230728T121400", "authors": ["Zacks Equity Research"], "summary": "Neogen (NEOG) Q4 fiscal 2023 results reflect core growth in both operating segments despite softening market conditions.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.213725, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.081276", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.459624", "ticker_sentiment_score": "0.384183", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.16171", "ticker_sentiment_score": "-0.006806", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.16171", "ticker_sentiment_score": "0.022952", "ticker_sentiment_label": "Neutral"}]}, {"title": "LabCorp  ( LH )  Q2 Earnings Miss Estimates, Margins Decline", "url": "https://www.zacks.com/stock/news/2128991/labcorp-lh-q2-earnings-miss-estimates-margins-decline", "time_published": "20230727T170000", "authors": ["Zacks Equity Research"], "summary": "A rise in organic revenues, acquisitions, net of divestitures and foreign currency translation drive LabCorp's (LH) Q2 revenues.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/70/35723.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999819"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.040307, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.083541", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LH", "relevance_score": "0.166169", "ticker_sentiment_score": "0.080689", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.166169", "ticker_sentiment_score": "-0.006941", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.166169", "ticker_sentiment_score": "0.024759", "ticker_sentiment_label": "Neutral"}]}, {"title": "Edwards Lifesciences  ( EW )  Q2 Earnings Top Estimates, View Up", "url": "https://www.zacks.com/stock/news/2128980/edwards-lifesciences-ew-q2-earnings-top-estimates-view-up", "time_published": "20230727T163300", "authors": ["Zacks Equity Research"], "summary": "The growing adoption of the PASCAL Precision system in Europe and the United States and Edwards' premium products across all regions have driven Edwards Lifesciences' (EW) Q2 revenues.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/df/34747.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999975"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.714479"}], "overall_sentiment_score": 0.208191, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.303644", "ticker_sentiment_score": "0.378844", "ticker_sentiment_label": "Bullish"}, {"ticker": "ABT", "relevance_score": "0.077719", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.154703", "ticker_sentiment_score": "-0.006619", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.154703", "ticker_sentiment_score": "0.02362", "ticker_sentiment_label": "Neutral"}]}, {"title": "Boston Scientific  ( BSX )  Q2 Earnings Beat, Margins Improve", "url": "https://www.zacks.com/stock/news/2128921/boston-scientific-bsx-q2-earnings-beat-margins-improve", "time_published": "20230727T155300", "authors": ["Zacks Equity Research"], "summary": "Boston Scientific's (BSX) organic and operational revenues at its respective core business segments and geographies rise in the second quarter.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.234013, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.07423", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.147818", "ticker_sentiment_score": "-0.006435", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.290607", "ticker_sentiment_score": "0.348556", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ELV", "relevance_score": "0.147818", "ticker_sentiment_score": "0.022966", "ticker_sentiment_label": "Neutral"}]}, {"title": "CONMED  ( CNMD )  Beats on Q2 Earnings, Ups '23 EPS View", "url": "https://www.zacks.com/stock/news/2128899/conmed-cnmd-beats-on-q2-earnings-ups-23-eps-view", "time_published": "20230727T143300", "authors": ["Zacks Equity Research"], "summary": "CONMED's (CNMD) adjusted second-quarter earnings and sales recover from the disruption in the last two quarters due to implementation of a new warehouse management system.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f2/33314.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.576289"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.173394, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.090134", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNMD", "relevance_score": "0.389552", "ticker_sentiment_score": "0.239205", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.179121", "ticker_sentiment_score": "0.036027", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.179121", "ticker_sentiment_score": "0.06826", "ticker_sentiment_label": "Neutral"}]}, {"title": "Baxter  ( BAX )  Beats on Q2 Earnings, Revises 2023 EPS Guidance", "url": "https://www.zacks.com/stock/news/2128871/baxter-bax-beats-on-q2-earnings-revises-2023-eps-guidance", "time_published": "20230727T141300", "authors": ["Zacks Equity Research"], "summary": "Baxter's (BAX) second-quarter 2023 results reflect sustained demand for its medically essential products amid a stabilizing macroeconomic climate and healthcare marketplace.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/22/35722.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999995"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.122388, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BAX", "relevance_score": "0.440331", "ticker_sentiment_score": "0.177913", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.066414", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.132368", "ticker_sentiment_score": "0.029839", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.132368", "ticker_sentiment_score": "0.056666", "ticker_sentiment_label": "Neutral"}]}, {"title": "West Pharmaceutical  ( WST )  Q2 Earnings Beat, HVP Drives Sales", "url": "https://www.zacks.com/stock/news/2128868/west-pharmaceutical-wst-q2-earnings-beat-hvp-drives-sales", "time_published": "20230727T140800", "authors": ["Zacks Equity Research"], "summary": "West Pharmaceutical's (WST) second-quarter results reflect a sustained recovery in non-COVID-19 demand amid dismal overall performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/70/35723.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.999955"}], "overall_sentiment_score": 0.167448, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "WST", "relevance_score": "0.238133", "ticker_sentiment_score": "0.171714", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.080458", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.160099", "ticker_sentiment_score": "0.032013", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.160099", "ticker_sentiment_score": "0.063225", "ticker_sentiment_label": "Neutral"}]}, {"title": "AI Stocks Are Overpriced. The Next Big Growth Opportunity Could Instead Be in This Industry", "url": "https://www.fool.com/investing/2023/07/27/ai-stocks-overpriced-next-big-growth-opportunity/", "time_published": "20230727T134014", "authors": ["David Jagielski"], "summary": "Healthcare stocks are underrated buys right now.", "banner_image": "https://media.ycharts.com/charts/8eb22aee501e7938c446cacbe0b5dbb6.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.967321"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.337135, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TSLA", "relevance_score": "0.059785", "ticker_sentiment_score": "-0.002001", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.059785", "ticker_sentiment_score": "0.113109", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.059785", "ticker_sentiment_score": "0.113109", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.059785", "ticker_sentiment_score": "0.113109", "ticker_sentiment_label": "Neutral"}]}, {"title": "Fed's July Rate Hike and Comments Match Expectations: 5 Picks", "url": "https://www.zacks.com/stock/news/2128716/feds-july-rate-hike-and-comments-match-expectations-5-picks", "time_published": "20230727T122900", "authors": ["Nalak Das"], "summary": "We have narrowed our search to five U.S. corporate behemoths. These are: META, GOOGL, ISRG, JNJ, PEP.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f1/39131.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.972193"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.253092, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.079261", "ticker_sentiment_score": "0.02353", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.234684", "ticker_sentiment_score": "0.206769", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PEP", "relevance_score": "0.196451", "ticker_sentiment_score": "0.213588", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.196451", "ticker_sentiment_score": "0.123485", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.157741", "ticker_sentiment_score": "0.163709", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chemed  ( CHE )  Q2 Earnings Miss Estimates, '23 EPS View Down", "url": "https://www.zacks.com/stock/news/2128627/chemed-che-q2-earnings-miss-estimates-23-eps-view-down", "time_published": "20230727T122300", "authors": ["Zacks Equity Research"], "summary": "Chemed's (CHE) second-quarter 2023 performance reflects strength in the VITAS segment, while expenses weigh on margins.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d6/3739.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999996"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.11144, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CHE", "relevance_score": "0.398781", "ticker_sentiment_score": "0.027627", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.083251", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.165598", "ticker_sentiment_score": "-0.006918", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.165598", "ticker_sentiment_score": "0.024697", "ticker_sentiment_label": "Neutral"}]}, {"title": "Align Technology  ( ALGN )  Q2 Earnings Beat, Gross Margin Up", "url": "https://www.zacks.com/stock/news/2128589/align-technology-algn-q2-earnings-beat-gross-margin-up", "time_published": "20230727T115800", "authors": ["Zacks Equity Research"], "summary": "Align Technology (ALGN) delivers impressive earnings in the second quarter of 2023.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.967645"}, {"topic": "Earnings", "relevance_score": "0.999975"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.147553, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGN", "relevance_score": "0.434142", "ticker_sentiment_score": "0.414787", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.151778", "ticker_sentiment_score": "-0.006536", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.151778", "ticker_sentiment_score": "0.02334", "ticker_sentiment_label": "Neutral"}]}, {"title": "Merit Medical  ( MMSI )  Q2 Earnings & Revenues Beat Estimates", "url": "https://www.zacks.com/stock/news/2128089/merit-medical-mmsi-q2-earnings-revenues-beat-estimates", "time_published": "20230726T160700", "authors": ["Zacks Equity Research"], "summary": "Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the second quarter.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Earnings", "relevance_score": "0.999862"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.177197, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MMSI", "relevance_score": "0.134027", "ticker_sentiment_score": "0.05941", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.067252", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.134027", "ticker_sentiment_score": "-0.006084", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.134027", "ticker_sentiment_score": "0.02052", "ticker_sentiment_label": "Neutral"}]}, {"title": "Universal Health  ( UHS )  Q2 Earnings Beat, Boosts '23 EPS View", "url": "https://www.zacks.com/stock/news/2128140/universal-health-uhs-q2-earnings-beat-boosts-23-eps-view", "time_published": "20230726T153200", "authors": ["Zacks Equity Research"], "summary": "Universal Health's (UHS) Q2 results indicate improved patient admissions and solid segmental performance. Management currently expects adjusted EPS within $9.85-$10.50 for 2023.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fb/35964.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.995921"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.288174, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "UHID", "relevance_score": "0.115048", "ticker_sentiment_score": "0.062167", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.152983", "ticker_sentiment_score": "0.096074", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.152983", "ticker_sentiment_score": "0.127138", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.152983", "ticker_sentiment_score": "0.125848", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.038468", "ticker_sentiment_score": "0.126909", "ticker_sentiment_label": "Neutral"}]}, {"title": "Thermo Fisher  ( TMO )  Q2 Earnings Miss Estimates, Margins Down", "url": "https://www.zacks.com/stock/news/2128091/thermo-fisher-tmo-q2-earnings-miss-estimates-margins-down", "time_published": "20230726T150500", "authors": ["Zacks Equity Research"], "summary": "Challenging macroeconomic conditions and slowdown in activities in China impede Thermo Fisher's (TMO) Q2 revenues.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/70/35723.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.126446, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.100518", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.199447", "ticker_sentiment_score": "-0.007929", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.199447", "ticker_sentiment_score": "0.028275", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.199447", "ticker_sentiment_score": "-0.113509", "ticker_sentiment_label": "Neutral"}]}, {"title": "Quest Diagnostics  ( DGX )  Q2 Earnings Beat Estimates, FY View Up", "url": "https://www.zacks.com/stock/news/2127978/quest-diagnostics-dgx-q2-earnings-beat-estimates-fy-view-up", "time_published": "20230726T141000", "authors": ["Zacks Equity Research"], "summary": "Quest Diagnostics (DGX) delivers better-than-expected earnings and revenues in the second quarter of 2023.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/1450.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.087952, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "III", "relevance_score": "0.049526", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.098862", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGX", "relevance_score": "0.380736", "ticker_sentiment_score": "0.2391", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.196212", "ticker_sentiment_score": "-0.007828", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.196212", "ticker_sentiment_score": "0.027919", "ticker_sentiment_label": "Neutral"}]}, {"title": "Should First Trust NASDAQ-100 Equal Weighted ETF  ( QQEW )  Be on Your Investing Radar?", "url": "https://www.zacks.com/stock/news/2127493/should-first-trust-nasdaq-100-equal-weighted-etf-qqew-be-on-your-investing-radar", "time_published": "20230726T102008", "authors": ["Zacks Equity Research"], "summary": "Style Box ETF report for ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default217.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.266396, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LCID", "relevance_score": "0.116914", "ticker_sentiment_score": "0.060317", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.116914", "ticker_sentiment_score": "0.101724", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.116914", "ticker_sentiment_score": "0.060317", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.116914", "ticker_sentiment_score": "0.060317", "ticker_sentiment_label": "Neutral"}]}, {"title": "NextGen  ( NXGN )  Q1 Earnings Top Estimates, Revenues Surge Y/Y", "url": "https://www.zacks.com/stock/news/2127174/nextgen-nxgn-q1-earnings-top-estimates-revenues-surge-yy", "time_published": "20230725T160200", "authors": ["Zacks Equity Research"], "summary": "NextGen's (NXGN) first-quarter fiscal 2024 results reflect strength in its revenue sources.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.999696"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.105842, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.090989", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.180798", "ticker_sentiment_score": "-0.007362", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXGN", "relevance_score": "0.180798", "ticker_sentiment_score": "0.073028", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.180798", "ticker_sentiment_score": "0.024803", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Is a Trending Stock: Facts to Know Before Betting on It", "url": "https://www.zacks.com/stock/news/2126796/intuitive-surgical-inc-isrg-is-a-trending-stock-facts-to-know-before-betting-on-it", "time_published": "20230725T130006", "authors": ["Zacks Equity Research"], "summary": "Recently, Zacks.com users have been paying close attention to Intuitive Surgical, Inc. (ISRG). This makes it worthwhile to examine what the stock has in store.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default165.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.226383, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.507331", "ticker_sentiment_score": "0.172023", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical Unusual Options Activity - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/07/33351455/intuitive-surgical-unusual-options-activity", "time_published": "20230724T174537", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bearish stance on Intuitive Surgical ISRG. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.103864, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.872351", "ticker_sentiment_score": "0.187722", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.093289", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.093289", "ticker_sentiment_score": "-0.127563", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks making the biggest moves midday: AMC Entertainment, Mattel, Chevron, Spotify and more", "url": "https://www.cnbc.com/2023/07/24/stocks-making-the-biggest-moves-midday-amc-mat-cvx-spot.html", "time_published": "20230724T170023", "authors": ["Tanaya Macheel"], "summary": "These are the stocks posting the largest moves in midday trading.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107270624-16891860642023-07-12t181656z_1498558957_rc2t12aywftd_rtrmadp_0_netflix-results.jpeg?v=1690194348", "source": "CNBC", "category_within_source": "Market Insider", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.999981"}], "overall_sentiment_score": 0.200788, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DMPZF", "relevance_score": "0.117486", "ticker_sentiment_score": "0.090542", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAT", "relevance_score": "0.058903", "ticker_sentiment_score": "0.242049", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KNX", "relevance_score": "0.058903", "ticker_sentiment_score": "0.161001", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "APE", "relevance_score": "0.058903", "ticker_sentiment_score": "-0.041162", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAX", "relevance_score": "0.175433", "ticker_sentiment_score": "0.130766", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.058903", "ticker_sentiment_score": "-0.081065", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIRI", "relevance_score": "0.058903", "ticker_sentiment_score": "0.22203", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.117486", "ticker_sentiment_score": "0.029906", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.117486", "ticker_sentiment_score": "0.090542", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks This Week: Buy Intuit And Sell Short Intuitive Surgical", "url": "https://www.forbes.com/sites/greatspeculations/2023/07/23/stocks-this-week-buy-intuit-and-sell-short-intuitive-surgical/", "time_published": "20230723T160000", "authors": ["Bill Sarubbi"], "summary": "Over the near term, the indices are likely to move higher, but an autumn correction looms. Here are a pair of stock recommendations, one long and one short.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/64bc8dc16fb16295e7d3e1a4/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Money", "source_domain": "www.forbes.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.026133, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.224903", "ticker_sentiment_score": "-0.101594", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Revolutionary Stocks to Buy and Hold for 10 Years", "url": "https://www.fool.com/investing/2023/07/22/2-revolutionary-stocks-to-buy-and-hold-for-10-year/", "time_published": "20230722T124500", "authors": ["Prosper Junior Bakiny"], "summary": "Breaking new ground can be highly lucrative.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F740368%2Fstack-of-one-hundred-dollar-bills-cash-money-stimulus-invest-retire-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.839681"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.135207, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.05833", "ticker_sentiment_score": "0.023", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAS", "relevance_score": "0.391486", "ticker_sentiment_score": "-0.041578", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.339356", "ticker_sentiment_score": "0.103757", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.05833", "ticker_sentiment_score": "0.023", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks making the biggest moves midday: Scholastic, AutoNation, Herc, American Express and more", "url": "https://www.cnbc.com/2023/07/21/stocks-making-the-biggest-moves-midday-scholastic-autonation-herc-american-express-and-more.html", "time_published": "20230721T152944", "authors": ["Sarah Min"], "summary": "These are the stocks posting the largest moves in midday trading.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107274471-TESLA_FINAL.png?v=1689886521", "source": "CNBC", "category_within_source": "Market Insider", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.10797, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BAC", "relevance_score": "0.07913", "ticker_sentiment_score": "-0.07096", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNX", "relevance_score": "0.157483", "ticker_sentiment_score": "-0.011324", "ticker_sentiment_label": "Neutral"}, {"ticker": "PPG", "relevance_score": "0.157483", "ticker_sentiment_score": "0.216043", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NOVA", "relevance_score": "0.07913", "ticker_sentiment_score": "0.041999", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.157483", "ticker_sentiment_score": "0.104965", "ticker_sentiment_label": "Neutral"}, {"ticker": "COF", "relevance_score": "0.157483", "ticker_sentiment_score": "0.054873", "ticker_sentiment_label": "Neutral"}, {"ticker": "AN", "relevance_score": "0.234307", "ticker_sentiment_score": "0.136357", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.157483", "ticker_sentiment_score": "-0.065841", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRI", "relevance_score": "0.157483", "ticker_sentiment_score": "-0.093558", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Jones Fades; Trump-Backed DWAC Surges As Cathie Wood Swoops On Battered Chip Leader", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-trump-backed-dwac-surges-as-cathie-wood-swoops-down-on-battered-chip-leader/", "time_published": "20230721T145700", "authors": ["Investor's Business Daily", "VIDYA RAMAKRISHNAN"], "summary": "Dow Jones Fades. Trump-Backed DWAC Surges As Cathie Wood Swoops On Battered Chip Leader Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2022/01/Stock-nasdaq-0122-shutt.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.999355"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.857896"}], "overall_sentiment_score": -0.113814, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MDLZ", "relevance_score": "0.145583", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.21686", "ticker_sentiment_score": "-0.054212", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADI", "relevance_score": "0.145583", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLB", "relevance_score": "0.145583", "ticker_sentiment_score": "-0.258745", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MDB", "relevance_score": "0.145583", "ticker_sentiment_score": "0.143522", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALV", "relevance_score": "0.145583", "ticker_sentiment_score": "-0.103407", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADP", "relevance_score": "0.145583", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AN", "relevance_score": "0.073098", "ticker_sentiment_score": "-0.083585", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.21686", "ticker_sentiment_score": "-0.054212", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.145583", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.145583", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.145583", "ticker_sentiment_score": "-0.098649", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.145583", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUBS", "relevance_score": "0.145583", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKNG", "relevance_score": "0.145583", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.145583", "ticker_sentiment_score": "-0.258745", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HRI", "relevance_score": "0.145583", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Leads As Tesla, Netflix, Taiwan Semi Hit Growth: Weekly Review", "url": "https://www.investors.com/news/dow-jones-leads-market-advance-as-tesla-netflix-taiwan-semiconductor-hit-growth-weekly-review/", "time_published": "20230721T140300", "authors": ["IBD STAFF", "Investor's Business Daily"], "summary": "The stock market rally saw the Dow Jones join the S&P 500 and Nasdaq composite in hitting 52-week highs, but then the Nasdaq sold off hard Thursday, wiping out weekly gains, amid earnings-related sell-offs from Tesla ( TSLA ) , Netflix ( NFLX ) and Taiwan Semiconductor ( TSM ) .", "banner_image": "https://www.investors.com/wp-content/uploads/2023/05/Stock-wallstreet-financial-01-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": -0.02936, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.116442", "ticker_sentiment_score": "-0.022392", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.058377", "ticker_sentiment_score": "0.098167", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBKR", "relevance_score": "0.058377", "ticker_sentiment_score": "-0.098367", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAL", "relevance_score": "0.038937", "ticker_sentiment_score": "0.061923", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.038937", "ticker_sentiment_score": "0.061923", "ticker_sentiment_label": "Neutral"}, {"ticker": "F", "relevance_score": "0.077782", "ticker_sentiment_score": "-0.01142", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.038937", "ticker_sentiment_score": "0.061923", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.077782", "ticker_sentiment_score": "0.066829", "ticker_sentiment_label": "Neutral"}, {"ticker": "APLS", "relevance_score": "0.038937", "ticker_sentiment_score": "0.012933", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAL", "relevance_score": "0.058377", "ticker_sentiment_score": "0.098167", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.038937", "ticker_sentiment_score": "0.061923", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSM", "relevance_score": "0.058377", "ticker_sentiment_score": "-0.073177", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.077782", "ticker_sentiment_score": "0.122701", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMT", "relevance_score": "0.038937", "ticker_sentiment_score": "0.013771", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.038937", "ticker_sentiment_score": "0.064974", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.116442", "ticker_sentiment_score": "-0.015326", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBIO", "relevance_score": "0.038937", "ticker_sentiment_score": "0.012933", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVNA", "relevance_score": "0.038937", "ticker_sentiment_score": "0.021957", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCHW", "relevance_score": "0.038937", "ticker_sentiment_score": "-0.097167", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCX", "relevance_score": "0.058377", "ticker_sentiment_score": "-0.067377", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOST", "relevance_score": "0.058377", "ticker_sentiment_score": "-0.043002", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARGX", "relevance_score": "0.058377", "ticker_sentiment_score": "0.013084", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.038937", "ticker_sentiment_score": "0.062257", "ticker_sentiment_label": "Neutral"}]}, {"title": "Baxter  ( BAX )  to Post Q2 Earnings: What's in the Offing?", "url": "https://www.zacks.com/stock/news/2125454/baxter-bax-to-post-q2-earnings-whats-in-the-offing", "time_published": "20230721T135700", "authors": ["Zacks Equity Research"], "summary": "Baxter's (BAX) second-quarter results are likely to reflect growth in elective surgical procedures, offset by currency movement. Hillrom's products might have boosted sales.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/09/2677.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": 0.173006, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BAX", "relevance_score": "0.305058", "ticker_sentiment_score": "0.303456", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AVNS", "relevance_score": "0.116914", "ticker_sentiment_score": "-0.004651", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCK", "relevance_score": "0.116914", "ticker_sentiment_score": "0.07603", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.039096", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACB", "relevance_score": "0.078099", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical  ( ISRG )  Q2 Earnings Beat, Procedures Robust", "url": "https://www.zacks.com/stock/news/2125444/intuitive-surgical-isrg-q2-earnings-beat-procedures-robust", "time_published": "20230721T134700", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical's (ISRG) second-quarter results reflect healthy demand for procedures, partially offset by unfavorable currency. COVID-19 impacts procedure volume in China.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/85/44157.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.997874"}], "overall_sentiment_score": 0.176037, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MCK", "relevance_score": "0.148121", "ticker_sentiment_score": "0.03956", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.466325", "ticker_sentiment_score": "0.18596", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OPK", "relevance_score": "0.19661", "ticker_sentiment_score": "-0.018865", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive says bariatric surgeries shrink as obesity drugs lift off", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/intuitive-says-bariatric-surgeries-shrink-obesity-drugs-lift-off-2023-07-21/", "time_published": "20230721T132013", "authors": ["Manas Mishra"], "summary": "July 21 ( Reuters ) - The rising popularity of highly-effective obesity drugs is weighing on demand for robot-assisted bariatric surgeries, top surgical robots maker Intuitive Surgical ( ISRG.O ) said late on Thursday.", "banner_image": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.webp?d=149", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.240657, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVR", "relevance_score": "0.116348", "ticker_sentiment_score": "0.184373", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.116348", "ticker_sentiment_score": "0.123933", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks making the biggest moves premarket: American Express, AutoNation, CSX and more", "url": "https://www.cnbc.com/2023/07/21/stocks-making-the-biggest-moves-premarket-american-express-autonation-csx-and-more.html", "time_published": "20230721T122113", "authors": ["Sarah Min"], "summary": "These are the stocks posting the largest moves in early trading.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107179500-1673970513093-230113-credit-cards-CNBC-aw-3.jpg?v=1689942073&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.09827, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KNX", "relevance_score": "0.073546", "ticker_sentiment_score": "0.007184", "ticker_sentiment_label": "Neutral"}, {"ticker": "PPG", "relevance_score": "0.146469", "ticker_sentiment_score": "0.09813", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOVA", "relevance_score": "0.073546", "ticker_sentiment_score": "0.055027", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.146469", "ticker_sentiment_score": "0.108798", "ticker_sentiment_label": "Neutral"}, {"ticker": "COF", "relevance_score": "0.073546", "ticker_sentiment_score": "0.05537", "ticker_sentiment_label": "Neutral"}, {"ticker": "AN", "relevance_score": "0.146469", "ticker_sentiment_score": "0.161647", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.146469", "ticker_sentiment_score": "0.075766", "ticker_sentiment_label": "Neutral"}]}, {"title": "Futures: Growth Leads Bounce; Nasdaq 100 Rebalance On Tap", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-growth-stocks-try-to-rebound-nasdaq-100-special-rebalance-on-tap/", "time_published": "20230721T120200", "authors": ["ED CARSON", "Investor's Business Daily"], "summary": "Dow Jones Futures: Growth Stocks Try To Rebound. Nasdaq 100 Special Rebalance On Tap Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/08/stock-bounce-back-01-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.972756"}], "overall_sentiment_score": -0.004844, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.238133", "ticker_sentiment_score": "0.227405", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NFLX", "relevance_score": "0.120431", "ticker_sentiment_score": "-0.382885", "ticker_sentiment_label": "Bearish"}, {"ticker": "GOOG", "relevance_score": "0.199365", "ticker_sentiment_score": "0.241164", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "META", "relevance_score": "0.080458", "ticker_sentiment_score": "0.167236", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVDA", "relevance_score": "0.160099", "ticker_sentiment_score": "0.04721", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.120431", "ticker_sentiment_score": "0.050982", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.313817", "ticker_sentiment_score": "-0.129302", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLB", "relevance_score": "0.199365", "ticker_sentiment_score": "-0.073755", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.276313", "ticker_sentiment_score": "-0.092014", "ticker_sentiment_label": "Neutral"}, {"ticker": "COF", "relevance_score": "0.120431", "ticker_sentiment_score": "-0.108588", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.160099", "ticker_sentiment_score": "-0.012451", "ticker_sentiment_label": "Neutral"}]}, {"title": "Metaverse in Healthcare Market to grow at a CAGR of 34.92% by 2027 | Advantages of Metaverse in Healthcare Market ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/metaverse-in-healthcare-market-to-grow-at-a-cagr-of-34-92-by-2027--advantages-of-metaverse-in-healthcare-market-to-boost-growth---technavio-301882306.html", "time_published": "20230721T110000", "authors": [], "summary": "Metaverse in Healthcare Market to grow at a CAGR of 34.92% by 2027 | Advantages of Metaverse in Healthcare Market ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Blockchain", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.251884, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.073321", "ticker_sentiment_score": "0.140198", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.073321", "ticker_sentiment_score": "0.140198", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDD", "relevance_score": "0.073321", "ticker_sentiment_score": "0.140198", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAE", "relevance_score": "0.073321", "ticker_sentiment_score": "0.140198", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMHF", "relevance_score": "0.073321", "ticker_sentiment_score": "0.140198", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.073321", "ticker_sentiment_score": "0.140198", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.073321", "ticker_sentiment_score": "0.140198", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Gets A Composite Rating Upgrade", "url": "https://www.investors.com/ibd-data-stories/intuitive-surgical-gets-a-composite-rating-upgrade-2/", "time_published": "20230721T070000", "authors": ["Investor's Business Daily", "INVESTOR'S BUSINESS DAILY"], "summary": "The IBD SmartSelect Composite Rating for Intuitive Surgical ( ISRG ) increased from 91 to 97 Friday. X The new score indicates the company is now outperforming 97% of all stocks in terms of the most important fundamental and technical stock-picking criteria.", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.986564"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.432663, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.598621", "ticker_sentiment_score": "0.130592", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.325208", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Futures: Tesla Dives, But This Was The Key Market Loser", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-tesla-tumbles-in-divided-market-but-this-was-the-key-loser/", "time_published": "20230720T224600", "authors": ["Investor's Business Daily", "ED CARSON"], "summary": "Dow Jones futures were little changed after hours, along with S&P 500 futures and Nasdaq futures. The stock market rally was decidedly mixed Thursday. The Dow Jones rose for a ninth straight session while the Nasdaq suffered its worst loss in more than four months.", "banner_image": "https://www.investors.com/wp-content/uploads/2017/04/Chips-IC-4.25.17.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.999691"}], "overall_sentiment_score": 0.009752, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.129237", "ticker_sentiment_score": "0.008855", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.025957", "ticker_sentiment_score": "0.032287", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.051886", "ticker_sentiment_score": "0.127507", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.051886", "ticker_sentiment_score": "0.127507", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRWD", "relevance_score": "0.077761", "ticker_sentiment_score": "0.001015", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.129237", "ticker_sentiment_score": "0.080662", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.051886", "ticker_sentiment_score": "-0.056982", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLB", "relevance_score": "0.051886", "ticker_sentiment_score": "-0.057863", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBS", "relevance_score": "0.051886", "ticker_sentiment_score": "-0.177543", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TSLA", "relevance_score": "0.255106", "ticker_sentiment_score": "0.030625", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.051886", "ticker_sentiment_score": "-0.177543", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "COF", "relevance_score": "0.077761", "ticker_sentiment_score": "-0.092277", "ticker_sentiment_label": "Neutral"}, {"ticker": "NET", "relevance_score": "0.051886", "ticker_sentiment_score": "0.03574", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.129237", "ticker_sentiment_score": "-0.054639", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why 2 Key Stocks Dropped After Hours Thursday", "url": "https://www.fool.com/investing/2023/07/20/why-2-key-stocks-dropped-after-hours-thursday/", "time_published": "20230720T221548", "authors": ["Dan Caplinger"], "summary": "Financial reports raised some issues in investors' minds. Learn more about what they were.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F740414%2Ftsla_sankey_q22023.png&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.891286"}], "overall_sentiment_score": 0.137759, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.38588", "ticker_sentiment_score": "0.239295", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Tops Q2 Earnings and Revenue Estimates", "url": "https://www.zacks.com/stock/news/2124988/intuitive-surgical-inc-isrg-tops-q2-earnings-and-revenue-estimates", "time_published": "20230720T213508", "authors": ["Zacks Equity Research"], "summary": "Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 7.58% and 1.35%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default180.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.196065, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DCTH", "relevance_score": "0.206392", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.399204", "ticker_sentiment_score": "0.276951", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Stocks making the biggest moves after hours: CSX, PPG Industries, Knight-Swift Transportation and more", "url": "https://www.cnbc.com/2023/07/20/stocks-making-the-biggest-moves-after-hours-csx-ppg-knx-and-more.html", "time_published": "20230720T212231", "authors": ["Alex Harring"], "summary": "These are the stocks posting the largest moves in extended trading.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107273871-goldman_sachs.png?v=1689798636", "source": "CNBC", "category_within_source": "Market Insider", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Energy & Transportation", "relevance_score": "0.5"}], "overall_sentiment_score": 0.1241, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "WERN", "relevance_score": "0.090474", "ticker_sentiment_score": "-0.040335", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNX", "relevance_score": "0.090474", "ticker_sentiment_score": "-0.040335", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.090474", "ticker_sentiment_score": "0.069231", "ticker_sentiment_label": "Neutral"}, {"ticker": "PPG", "relevance_score": "0.090474", "ticker_sentiment_score": "0.177979", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical beats profit, revenue estimates", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/intuitive-surgical-beats-profit-revenue-estimates-2023-07-20/", "time_published": "20230720T210023", "authors": ["Reuters"], "summary": "July 20 ( Reuters ) - Intuitive Surgical Inc ( ISRG.O ) beat Wall Street estimates for quarterly sales and profit on Thursday, boosted by a rise in total procedures volume of its surgical robot da Vinci. Shares of the company, however, fell about 6% to $328, after the bell, due to higher ...", "banner_image": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.webp?d=149", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.243937, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.258351", "ticker_sentiment_score": "0.158919", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UNH", "relevance_score": "0.130926", "ticker_sentiment_score": "0.255573", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.130926", "ticker_sentiment_score": "0.099404", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Stock Is Sliding After Hours: What's Going On? - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/23/07/33311746/intuitive-surgical-stock-is-sliding-after-hours-whats-going-on", "time_published": "20230720T202155", "authors": ["Adam Eckert"], "summary": "Intuitive Surgical Inc ISRG shares are trading lower in Tuesday's after-hours session on the heels of the company's second-quarter results. Q2 Revenue: $1.756 billion beat estimates of $1.74 billion Worldwide da Vinci procedures increased approximately 22% year-over-year.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/07/20/intuitive-da-vinci-or-staff-with-vision-cart-hi-res.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.157864, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.82082", "ticker_sentiment_score": "0.134924", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Crumbles Despite Beating Quarterly Calls", "url": "https://www.investors.com/news/technology/isrg-stock-intuitive-surgical-earnings-q2-2023/", "time_published": "20230720T201500", "authors": ["ALLISON GATLIN", "Investor's Business Daily"], "summary": "ISRG Stock Crumbles Despite Beating Second-Quarter Expectations Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/07/stock-Intuitive-Surgical-05-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}], "overall_sentiment_score": 0.240539, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.947069", "ticker_sentiment_score": "0.348885", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "The Retail Army Is VERY Bullish - Abbott Laboratories  ( NYSE:ABT ) ", "url": "https://www.benzinga.com/economics/macro-economic-events/23/07/33304748/the-retail-army-is-very-bullish", "time_published": "20230720T140247", "authors": ["GRIT Capital"], "summary": "Do with this information as you see fit: Jim Cramer said this week he doesn't see a recession in the cards for the US\u2026 The end of Fed hikes may be on the horizon but what about their effects on the economy? According to TD, the peak impact from a rate hike occurs ~4 quarters later for GDP and ~6 ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/07/20/nicholas-cappello-wb63zqj5gne-unsplash_8.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.918141"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.033623, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.08183", "ticker_sentiment_score": "0.108134", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.08183", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.040969", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.08183", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.040969", "ticker_sentiment_score": "0.131799", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTLT", "relevance_score": "0.040969", "ticker_sentiment_score": "0.118955", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.08183", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATVI", "relevance_score": "0.040969", "ticker_sentiment_score": "0.237359", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TRV", "relevance_score": "0.08183", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCX", "relevance_score": "0.08183", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.08183", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSM", "relevance_score": "0.08183", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.122477", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.040969", "ticker_sentiment_score": "0.163523", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "This Growth Stock Has Market-Beating Potential", "url": "https://www.fool.com/investing/2023/07/20/this-growth-stock-has-market-beating-potential/", "time_published": "20230720T123000", "authors": ["Sushree Mohanty"], "summary": "This exceptional growth stock has made investors rich before -- can it do it again?", "banner_image": "https://media.ycharts.com/charts/92b3de70f47dca99f17bdc389d54d4b2.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.98396"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99793"}], "overall_sentiment_score": 0.303485, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.053153", "ticker_sentiment_score": "0.190731", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.10607", "ticker_sentiment_score": "0.283114", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.053153", "ticker_sentiment_score": "0.190731", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Morning Bid: Tesla, Netflix underwhelm", "url": "https://www.reuters.com/markets/us/global-markets-view-usa-2023-07-20/", "time_published": "20230720T100200", "authors": ["Reuters"], "summary": "Morning Bid: Tesla, ...", "banner_image": "https://graphics.reuters.com/EARNINGS-AUTOMATED/TSLA-OQ-20230719/gkplxmemxpb/chart.png", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.795202"}], "overall_sentiment_score": 0.036149, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.067347", "ticker_sentiment_score": "0.037172", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFG", "relevance_score": "0.067347", "ticker_sentiment_score": "0.199781", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MKTX", "relevance_score": "0.067347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.067347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNA", "relevance_score": "0.067347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAL", "relevance_score": "0.067347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFC", "relevance_score": "0.067347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.067347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.200134", "ticker_sentiment_score": "0.112188", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.067347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEM", "relevance_score": "0.067347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCX", "relevance_score": "0.067347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.067347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PM", "relevance_score": "0.067347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KEY", "relevance_score": "0.067347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical  ( ISRG )  to Post Q2 Earnings: What's in Store?", "url": "https://www.zacks.com/stock/news/2123858/intuitive-surgical-isrg-to-post-q2-earnings-whats-in-store", "time_published": "20230719T140200", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical's (ISRG) second-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs may have hurt margins.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/15/2078.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.999937"}], "overall_sentiment_score": 0.199577, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MASI", "relevance_score": "0.047465", "ticker_sentiment_score": "-0.077905", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVNS", "relevance_score": "0.141726", "ticker_sentiment_score": "-0.06291", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.047465", "ticker_sentiment_score": "0.031001", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCK", "relevance_score": "0.141726", "ticker_sentiment_score": "0.094448", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.323078", "ticker_sentiment_score": "0.021006", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACB", "relevance_score": "0.094762", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "These 3 AI Stocks Report This Week... What to Know", "url": "https://moneymorning.com/2023/07/19/these-3-ai-stocks-report-this-week-what-to-know/", "time_published": "20230719T111543", "authors": ["kottenheimer", "Chris Johnson", "Tom Gentile"], "summary": "Two words can sum up the reason for 2023's monster returns: artificial intelligence ( AI ) . Of course, corporations are taking note..., and every company is trying to figure out a way to thread AI into its business plan ( or at the very least, an investor presentation ) .", "banner_image": "https://moneymorning.com/wp-content/blogs.dir/1/files/2023/07/AI-Man.jpg", "source": "Money Morning", "category_within_source": "RSS", "source_domain": "moneymorning.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.993856"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.186523, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.042647", "ticker_sentiment_score": "0.105408", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.085173", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTST", "relevance_score": "0.042647", "ticker_sentiment_score": "0.07215", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.042647", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.169378", "ticker_sentiment_score": "0.047377", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.085173", "ticker_sentiment_score": "0.079971", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.085173", "ticker_sentiment_score": "0.079971", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.085173", "ticker_sentiment_score": "0.079971", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.042647", "ticker_sentiment_score": "0.105408", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADBE", "relevance_score": "0.085173", "ticker_sentiment_score": "0.13046", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.210823", "ticker_sentiment_score": "0.228573", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSM", "relevance_score": "0.085173", "ticker_sentiment_score": "-0.039236", "ticker_sentiment_label": "Neutral"}]}, {"title": "Telix Reports Continued Double-Digit Revenue Growth and Positive Operating Cash Flow", "url": "https://www.prnewswire.com/apac/news-releases/telix-reports-continued-double-digit-revenue-growth-and-positive-operating-cash-flow-301880668.html", "time_published": "20230719T081400", "authors": ["Telix Pharmaceuticals Limited"], "summary": "MELBOURNE, Australia, July 19, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited ( ASX: TLX, Telix, the Company ) today issues its Appendix 4C quarterly cash flow report and accompanying Activities Report for the quarter ended 30 June 2023 ( Q2 2023 ) .", "banner_image": "https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.972756"}, {"topic": "Economy - Macro", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.173651, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.026357", "ticker_sentiment_score": "0.018003", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLPPF", "relevance_score": "0.06583", "ticker_sentiment_score": "-0.020089", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Medical Stocks to Buy as Earnings Approach", "url": "https://www.zacks.com/commentary/2123222/2-medical-stocks-to-buy-as-earnings-approach", "time_published": "20230718T215400", "authors": ["Zacks Investment Research"], "summary": "Among the broader healthcare space, Abbott Laboratories (ABT) and Intuitive Surgical (ISRG) are two medical stocks that will highlight this week's earnings lineup.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/charts/9d/47320.jpg?v=480008754", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.347705, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.417995", "ticker_sentiment_score": "0.411716", "ticker_sentiment_label": "Bullish"}, {"ticker": "ABT", "relevance_score": "0.591019", "ticker_sentiment_score": "0.397412", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Surgical Unusual Options Activity - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/07/33268959/intuitive-surgical-unusual-options-activity", "time_published": "20230718T150100", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ISRG we detected 13 strange trades.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.174304, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.791081", "ticker_sentiment_score": "0.122928", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.124809", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical  ( ISRG )  Hits 52-Week High: What's Aiding It?", "url": "https://www.zacks.com/stock/news/2122309/intuitive-surgical-isrg-hits-52-week-high-whats-aiding-it", "time_published": "20230717T164200", "authors": ["Zacks Investment Research"], "summary": "Investors are optimistic about Intuitive Surgical's (ISRG) strength in robotics.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.305974, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HQY", "relevance_score": "0.21686", "ticker_sentiment_score": "0.090639", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.320279", "ticker_sentiment_score": "0.210744", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BSX", "relevance_score": "0.21686", "ticker_sentiment_score": "0.087112", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.109455", "ticker_sentiment_score": "0.08296", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Unusual Options Activity For July 17 - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/07/33252443/intuitive-surgical-unusual-options-activity-for-july-17", "time_published": "20230717T154654", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ISRG we detected 11 strange trades.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.174329, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.793468", "ticker_sentiment_score": "0.123071", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.12546", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's How Much You'd Have If You Invested $1000 in Intuitive Surgical, Inc. a Decade Ago", "url": "https://www.zacks.com/stock/news/2121943/heres-how-much-youd-have-if-you-invested-1000-in-intuitive-surgical-inc-a-decade-ago", "time_published": "20230717T123005", "authors": ["Zacks Investment Research"], "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default134.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.25638, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.528121", "ticker_sentiment_score": "0.33698", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FOREX:USD", "relevance_score": "0.057352", "ticker_sentiment_score": "0.112334", "ticker_sentiment_label": "Neutral"}]}, {"title": "Investing Action Plan: Tesla, Netflix And Airlines Fly Into The Q2 Season", "url": "https://www.investors.com/research/investing-action-plan/stock-market-action-plan-tesla-netflix-and-airlines-fly-into-the-q2-earnings-season/", "time_published": "20230714T215400", "authors": ["Investor's Business Daily", "IBD STAFF"], "summary": "After a rousing week of stock market gains, earnings season is upon us. Analysts and companies have lowered their expectations for second-quarter earnings. Early rounds of reports, however, have shown investors briskly rewarding performances that top those low targets.", "banner_image": "https://www.investors.com/wp-content/uploads/2018/01/Stock-AmericanAirlines-04-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.161248, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PACW", "relevance_score": "0.036615", "ticker_sentiment_score": "0.003958", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.073154", "ticker_sentiment_score": "0.094271", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANET", "relevance_score": "0.036615", "ticker_sentiment_score": "0.036231", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.018312", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.073154", "ticker_sentiment_score": "0.046641", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLB", "relevance_score": "0.054899", "ticker_sentiment_score": "0.105821", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOVE", "relevance_score": "0.036615", "ticker_sentiment_score": "0.183304", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.036615", "ticker_sentiment_score": "-0.073412", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.109538", "ticker_sentiment_score": "0.019185", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMA", "relevance_score": "0.054899", "ticker_sentiment_score": "0.022109", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.036615", "ticker_sentiment_score": "0.112444", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.09137", "ticker_sentiment_score": "0.021123", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYF", "relevance_score": "0.036615", "ticker_sentiment_score": "-0.070342", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBKR", "relevance_score": "0.054899", "ticker_sentiment_score": "0.012012", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.036615", "ticker_sentiment_score": "0.151014", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.054899", "ticker_sentiment_score": "-0.010018", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKR", "relevance_score": "0.054899", "ticker_sentiment_score": "0.220931", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AAL", "relevance_score": "0.036615", "ticker_sentiment_score": "0.124313", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.073154", "ticker_sentiment_score": "0.046641", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAL", "relevance_score": "0.073154", "ticker_sentiment_score": "0.070143", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSM", "relevance_score": "0.036615", "ticker_sentiment_score": "0.085035", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAL", "relevance_score": "0.054899", "ticker_sentiment_score": "0.158859", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LMT", "relevance_score": "0.036615", "ticker_sentiment_score": "0.142827", "ticker_sentiment_label": "Neutral"}, {"ticker": "RH", "relevance_score": "0.036615", "ticker_sentiment_score": "0.183304", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AXP", "relevance_score": "0.073154", "ticker_sentiment_score": "0.024554", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCHW", "relevance_score": "0.036615", "ticker_sentiment_score": "0.011796", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCX", "relevance_score": "0.054899", "ticker_sentiment_score": "0.079958", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAS", "relevance_score": "0.018312", "ticker_sentiment_score": "0.002671", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.036615", "ticker_sentiment_score": "0.067776", "ticker_sentiment_label": "Neutral"}, {"ticker": "PM", "relevance_score": "0.054899", "ticker_sentiment_score": "0.199907", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "The Zacks Analyst Blog Highlights Broadcom, Intuit, Intuitive Surgical, Shopify and Intercontinental Exchange", "url": "https://www.zacks.com/stock/news/2121215/the-zacks-analyst-blog-highlights-broadcom-intuit-intuitive-surgical-shopify-and-intercontinental-exchange", "time_published": "20230714T121400", "authors": ["Zacks Investment Research"], "summary": "Broadcom, Intuit, Intuitive Surgical, Shopify and Intercontinental Exchange are part of the Zacks top Analyst Blog.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/61/11728.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SHOP", "relevance_score": "0.724687", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICE", "relevance_score": "0.724687", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.724687", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTU", "relevance_score": "0.724687", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.724687", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks Run With Big Earnings, Nasdaq Rebalance Due", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-stocks-run-with-big-earnings-nasdaq-100-rebalance-due/", "time_published": "20230713T204000", "authors": ["Investor's Business Daily", "ED CARSON"], "summary": "Dow Jones futures tilted lower after hours, along with S&P 500 futures and Nasdaq futures. JPMorgan Chase headlines big earnings Friday. Tech growth plays led another solid session for the stock market rally, with Treasury yields and the dollar continuing to slide.", "banner_image": "https://www.investors.com/wp-content/uploads/2018/07/stock-bull-charge-02-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.714479"}], "overall_sentiment_score": 0.163032, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.099168", "ticker_sentiment_score": "-0.032745", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.148273", "ticker_sentiment_score": "0.040072", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDLZ", "relevance_score": "0.04968", "ticker_sentiment_score": "0.278397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "META", "relevance_score": "0.07446", "ticker_sentiment_score": "0.102565", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.172624", "ticker_sentiment_score": "0.027269", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.12378", "ticker_sentiment_score": "0.082327", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANET", "relevance_score": "0.12378", "ticker_sentiment_score": "0.052377", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.07446", "ticker_sentiment_score": "-0.031226", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.099168", "ticker_sentiment_score": "0.054809", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADI", "relevance_score": "0.04968", "ticker_sentiment_score": "0.278397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JPM", "relevance_score": "0.12378", "ticker_sentiment_score": "-0.056044", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.024852", "ticker_sentiment_score": "0.263562", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ADP", "relevance_score": "0.04968", "ticker_sentiment_score": "0.278397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UNH", "relevance_score": "0.12378", "ticker_sentiment_score": "0.027071", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEHR", "relevance_score": "0.099168", "ticker_sentiment_score": "0.005472", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.148273", "ticker_sentiment_score": "0.028787", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.19681", "ticker_sentiment_score": "0.095225", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.04968", "ticker_sentiment_score": "0.278397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WFC", "relevance_score": "0.099168", "ticker_sentiment_score": "0.048015", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.04968", "ticker_sentiment_score": "0.278397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BKNG", "relevance_score": "0.04968", "ticker_sentiment_score": "0.278397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.04968", "ticker_sentiment_score": "0.278397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMZN", "relevance_score": "0.07446", "ticker_sentiment_score": "0.040683", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.04968", "ticker_sentiment_score": "0.080084", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.024852", "ticker_sentiment_score": "-0.071168", "ticker_sentiment_label": "Neutral"}]}, {"title": "A Look Into Intuitive Surgical Inc's Price Over Earnings - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/23/07/33222217/a-look-into-intuitive-surgical-incs-price-over-earnings", "time_published": "20230713T194612", "authors": ["Benzinga Insights"], "summary": "In the current session, the stock is trading at $347.62, after a 0.01% increase. Over the past month, Intuitive Surgical Inc. ISRG stock increased by 5.90%, and in the past year, by 64.81%.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}], "overall_sentiment_score": -0.019003, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.419153", "ticker_sentiment_score": "0.110053", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Hidden Winner Of Nasdaq's \"Great Rebalancing\"", "url": "https://moneymorning.com/investing/the-hidden-winner-of-nasdaqs-great-rebalancing/", "time_published": "20230713T191302", "authors": ["Chris Johnson", "alexkagin", "Shah Gilani", "Alex Kagin"], "summary": "One of the most notable trends in the stock market this year has been the meteoric rise of mega-cap tech. These companies have outperformed all other sectors of the equity market, and their dominance has become increasingly concentrated. Currently, the seven largest companies account for over 54% ...", "banner_image": "https://moneymorning.com/wp-content/blogs.dir/1/files/2023/06/bp-report-01.png", "source": "Money Morning", "category_within_source": "GoogleRSS", "source_domain": "moneymorning.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.905476"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.217229, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ENPH", "relevance_score": "0.16117", "ticker_sentiment_score": "0.181986", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDLZ", "relevance_score": "0.16117", "ticker_sentiment_score": "0.425203", "ticker_sentiment_label": "Bullish"}, {"ticker": "AAPL", "relevance_score": "0.239698", "ticker_sentiment_score": "0.031604", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADI", "relevance_score": "0.16117", "ticker_sentiment_score": "0.425203", "ticker_sentiment_label": "Bullish"}, {"ticker": "SIRI", "relevance_score": "0.16117", "ticker_sentiment_score": "0.181986", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ADP", "relevance_score": "0.16117", "ticker_sentiment_score": "0.425203", "ticker_sentiment_label": "Bullish"}, {"ticker": "MSFT", "relevance_score": "0.16117", "ticker_sentiment_score": "0.054892", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZM", "relevance_score": "0.16117", "ticker_sentiment_score": "0.181986", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SBUX", "relevance_score": "0.16117", "ticker_sentiment_score": "0.425203", "ticker_sentiment_label": "Bullish"}, {"ticker": "WFC", "relevance_score": "0.081001", "ticker_sentiment_score": "0.332231", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GILD", "relevance_score": "0.16117", "ticker_sentiment_score": "0.425203", "ticker_sentiment_label": "Bullish"}, {"ticker": "BKNG", "relevance_score": "0.16117", "ticker_sentiment_score": "0.425203", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.16117", "ticker_sentiment_score": "0.425203", "ticker_sentiment_label": "Bullish"}]}, {"title": "Top Research Reports for Broadcom, Intuit & Intuitive Surgical", "url": "https://www.zacks.com/research-daily/2120695/top-research-reports-for-broadcom-intuit-intuitive-surgical", "time_published": "20230713T165800", "authors": ["Zacks Investment Research"], "summary": "Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Intuit Inc. (INTU) and Intuitive Surgical, Inc. (ISRG).", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default10.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.255345, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SHOP", "relevance_score": "0.123526", "ticker_sentiment_score": "0.128578", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICE", "relevance_score": "0.123526", "ticker_sentiment_score": "0.128578", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.302429", "ticker_sentiment_score": "0.239502", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "INTU", "relevance_score": "0.244109", "ticker_sentiment_score": "0.202807", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "T", "relevance_score": "0.061949", "ticker_sentiment_score": "0.110214", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.359014", "ticker_sentiment_score": "0.271773", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FOREX:USD", "relevance_score": "0.061949", "ticker_sentiment_score": "0.110214", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Buoyant As Cooling Inflation Raises Hopes Of Second Rate Pause; Meta Gains On Analyst Upgrade", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-as-cooling-inflation-raises-hopes-of-second-rate-pause-meta-gains-on-analyst-upgrade/", "time_published": "20230713T150500", "authors": ["VIDYA RAMAKRISHNAN", "Investor's Business Daily"], "summary": "Dow Buoyant As Cooling Inflation Raises Hopes Of Second Rate Pause. Meta Gains On Analyst Upgrade Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2022/01/Stock-meta-facebook-01-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.999174"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.682689"}], "overall_sentiment_score": 0.088858, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MDLZ", "relevance_score": "0.122269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.122269", "ticker_sentiment_score": "0.301829", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AAPL", "relevance_score": "0.182506", "ticker_sentiment_score": "0.034526", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANET", "relevance_score": "0.182506", "ticker_sentiment_score": "0.290701", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "C", "relevance_score": "0.122269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.122269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CROX", "relevance_score": "0.122269", "ticker_sentiment_score": "0.231633", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.061315", "ticker_sentiment_score": "0.299412", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DAL", "relevance_score": "0.122269", "ticker_sentiment_score": "-0.00248", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.122269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.241684", "ticker_sentiment_score": "0.043006", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.122269", "ticker_sentiment_score": "0.043191", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.122269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.182506", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.122269", "ticker_sentiment_score": "0.108696", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEP", "relevance_score": "0.122269", "ticker_sentiment_score": "0.364735", "ticker_sentiment_label": "Bullish"}, {"ticker": "FAST", "relevance_score": "0.182506", "ticker_sentiment_score": "-0.003195", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKNG", "relevance_score": "0.122269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.122269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Reasons to Add Intuitive Surgical  ( ISRG )  to Your Portfolio", "url": "https://www.zacks.com/stock/news/2120724/3-reasons-to-add-intuitive-surgical-isrg-to-your-portfolio", "time_published": "20230713T140100", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/2387.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.384259, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ALC", "relevance_score": "0.159218", "ticker_sentiment_score": "0.117127", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.159218", "ticker_sentiment_score": "0.113162", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.453277", "ticker_sentiment_score": "0.457739", "ticker_sentiment_label": "Bullish"}, {"ticker": "DXCM", "relevance_score": "0.159218", "ticker_sentiment_score": "0.110518", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's What To Expect From Intuitive Surgical's Q2", "url": "https://www.forbes.com/sites/greatspeculations/2023/07/13/heres-what-to-expect-from-intuitive-surgicals-q2/", "time_published": "20230713T120000", "authors": ["Trefis Team"], "summary": "We expect the company's revenues to come in at $1.7 billion, aligning with the consensus estimate.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/649a8cfb03be94c29c09d90c/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Markets", "source_domain": "www.forbes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.988787"}], "overall_sentiment_score": 0.260613, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.68471", "ticker_sentiment_score": "0.373782", "ticker_sentiment_label": "Bullish"}]}, {"title": "Brookdale  ( BKD )  Reports Occupancy Growth for 20 Straight Months", "url": "https://www.zacks.com/stock/news/2120159/brookdale-bkd-reports-occupancy-growth-for-20-straight-months", "time_published": "20230712T161700", "authors": ["Zacks Investment Research"], "summary": "The continuous uptick observed in Brookdale's (BKD) weighted average occupancy level is expected to inflict a favorable impact on its resident fee revenues in the days ahead.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6e/37920.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.904684"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.23598, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BKD", "relevance_score": "0.412861", "ticker_sentiment_score": "0.154636", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ENSG", "relevance_score": "0.316168", "ticker_sentiment_score": "0.187908", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.213988", "ticker_sentiment_score": "0.131884", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.213988", "ticker_sentiment_score": "0.131884", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.107978", "ticker_sentiment_score": "0.153428", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ETFs in Focus as Nasdaq 100 Undergoes Rejiggering", "url": "https://www.zacks.com/stock/news/2119996/etfs-in-focus-as-nasdaq-100-undergoes-rejiggering", "time_published": "20230712T144200", "authors": ["Zacks Investment Research"], "summary": "The Nasdaq 100 is set to undergo a special rebalance on Jul 24 to address overconcentration issues posed by a handful of technology stocks on the index by redistributing the weights.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/0c/833.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.999894"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.234634, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.100308", "ticker_sentiment_score": "0.103204", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDLZ", "relevance_score": "0.050254", "ticker_sentiment_score": "0.047906", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.100308", "ticker_sentiment_score": "0.172861", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVDA", "relevance_score": "0.149966", "ticker_sentiment_score": "0.123868", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.149966", "ticker_sentiment_score": "0.123868", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADI", "relevance_score": "0.050254", "ticker_sentiment_score": "0.047906", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.050254", "ticker_sentiment_score": "0.161254", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IVZ", "relevance_score": "0.340915", "ticker_sentiment_score": "0.24557", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ADP", "relevance_score": "0.050254", "ticker_sentiment_score": "0.047906", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.149966", "ticker_sentiment_score": "0.123868", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.149966", "ticker_sentiment_score": "0.123868", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.050254", "ticker_sentiment_score": "0.047906", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.050254", "ticker_sentiment_score": "0.047906", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKNG", "relevance_score": "0.050254", "ticker_sentiment_score": "0.047906", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.050254", "ticker_sentiment_score": "0.047906", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.149966", "ticker_sentiment_score": "0.123868", "ticker_sentiment_label": "Neutral"}]}, {"title": "Investors Heavily Search Intuitive Surgical, Inc.  ( ISRG ) : Here is What You Need to Know", "url": "https://www.zacks.com/stock/news/2119774/investors-heavily-search-intuitive-surgical-inc-isrg-here-is-what-you-need-to-know", "time_published": "20230712T130006", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default72.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.253067, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.510952", "ticker_sentiment_score": "0.185107", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Stock Sinks As Market Gains: What You Should Know", "url": "https://www.zacks.com/stock/news/2119545/intuitive-surgical-inc-isrg-stock-sinks-as-market-gains-what-you-should-know", "time_published": "20230711T220018", "authors": ["Zacks Investment Research"], "summary": "In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $339.11, marking a -0.34% move from the previous day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default270.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.174262, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.556576", "ticker_sentiment_score": "0.234631", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical Unusual Options Activity For July 11 - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/07/33190171/intuitive-surgical-unusual-options-activity-for-july-11", "time_published": "20230711T190235", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bullish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ISRG we detected 10 strange trades.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.161817, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.832201", "ticker_sentiment_score": "0.373575", "ticker_sentiment_label": "Bullish"}, {"ticker": "C", "relevance_score": "0.136888", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Explainer: What is Nasdaq's special rebalancing and its impact?", "url": "https://www.reuters.com/markets/us/what-is-nasdaqs-special-rebalancing-its-impact-2023-07-11/", "time_published": "20230711T172100", "authors": ["Sruthi Shankar", "Medha Singh"], "summary": "July 11 ( Reuters ) - A \"special rebalance\" of the Nasdaq 100 index ( .NDX ) will take place later this month as exchange operator Nasdaq ( NDAQ.O ) looks to reduce the concentration of heavyweight companies that account for nearly half of the index's weight.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/RQOQAIWD5JIR7OD2Z7OHFMW33E.jpg", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.928769"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.147234, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MDLZ", "relevance_score": "0.063425", "ticker_sentiment_score": "0.099056", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.063425", "ticker_sentiment_score": "0.086041", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.249744", "ticker_sentiment_score": "0.139977", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADI", "relevance_score": "0.063425", "ticker_sentiment_score": "0.099056", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.063425", "ticker_sentiment_score": "0.091047", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADP", "relevance_score": "0.063425", "ticker_sentiment_score": "0.099056", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.30928", "ticker_sentiment_score": "0.073968", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.249744", "ticker_sentiment_score": "0.139977", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.063425", "ticker_sentiment_score": "0.099056", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.12645", "ticker_sentiment_score": "0.112402", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.063425", "ticker_sentiment_score": "0.099056", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKNG", "relevance_score": "0.063425", "ticker_sentiment_score": "0.099056", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.063425", "ticker_sentiment_score": "0.099056", "ticker_sentiment_label": "Neutral"}]}, {"title": "Mega-cap tech stocks have gotten so big that the Nasdaq 100 is about to undergo a 'special rebalance' to address overconcentration", "url": "https://markets.businessinsider.com/news/stocks/mega-cap-tech-stocks-nasdaq-100-forcing-special-rebalance-winners-2023-7", "time_published": "20230711T143100", "authors": ["Matthew Fox"], "summary": "Mega-cap tech stocks are so big that the Nasdaq 100 is forcing a shake-up - Markets Insider ...", "banner_image": "https://i.insider.com/64620f7711971c00188f4844?width=1200&format=jpeg", "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.164702, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.340915", "ticker_sentiment_score": "0.042236", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDLZ", "relevance_score": "0.087824", "ticker_sentiment_score": "0.17276", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "META", "relevance_score": "0.087824", "ticker_sentiment_score": "0.065924", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.087824", "ticker_sentiment_score": "0.065924", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.087824", "ticker_sentiment_score": "0.065924", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.087824", "ticker_sentiment_score": "0.17276", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WFC", "relevance_score": "0.174587", "ticker_sentiment_score": "0.103482", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADI", "relevance_score": "0.087824", "ticker_sentiment_score": "0.17276", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GILD", "relevance_score": "0.087824", "ticker_sentiment_score": "0.17276", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ADP", "relevance_score": "0.087824", "ticker_sentiment_score": "0.17276", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BKNG", "relevance_score": "0.087824", "ticker_sentiment_score": "0.17276", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.087824", "ticker_sentiment_score": "0.17276", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "2 Top Healthcare Stocks Defying the Bear Market", "url": "https://www.fool.com/investing/2023/07/11/2-top-healthcare-stocks-defying-the-bear-market/", "time_published": "20230711T100000", "authors": ["Adria Cimino"], "summary": "These stocks are rising in the double digits -- and outperforming the S&P 500.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F738884%2Fbuy-sell-stock-market-rolling-dice-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.266143"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}], "overall_sentiment_score": 0.320313, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.067919", "ticker_sentiment_score": "0.053115", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.135347", "ticker_sentiment_score": "0.139132", "ticker_sentiment_label": "Neutral"}]}, {"title": "$1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/23/07/33172734/1000-invested-in-this-stock-15-years-ago-would-be-worth-11-000-today", "time_published": "20230710T200030", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 15 years by 8.58% on an annualized basis producing an average annual return of 17.55%. Currently, Intuitive Surgical has a market capitalization of $119.07 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "Should You Buy the First Half's Worst-Performing Sector?", "url": "https://www.fool.com/investing/2023/07/10/should-you-buy-the-worst-performing-sector/", "time_published": "20230710T093000", "authors": ["Adria Cimino"], "summary": "Healthcare stocks may not lead gains in the next bull market.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F738898%2Frally-leaders_statista.jpeg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Blockchain", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.294361, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TRMNF", "relevance_score": "0.060694", "ticker_sentiment_score": "0.066106", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.060694", "ticker_sentiment_score": "0.157179", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.180685", "ticker_sentiment_score": "-0.135143", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.121037", "ticker_sentiment_score": "0.076734", "ticker_sentiment_label": "Neutral"}]}, {"title": "Wall Street Thinks Intuitive Surgical Stock Will Fall, But Investors Should Be Skeptical", "url": "https://www.fool.com/investing/2023/07/06/wall-street-thinks-intuitive-surgical-will-fall/", "time_published": "20230706T140700", "authors": ["Alex Carchidi"], "summary": "Its recent trend has been one of improving fortunes rather than rising challenges.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F738310%2Fstock-certificate-investment-retire-heirloom-donate-capital-gains-tax-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.067196, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.166935", "ticker_sentiment_score": "-0.050402", "ticker_sentiment_label": "Neutral"}]}, {"title": "Better Buy: Medtronic vs. Intuitive Surgical", "url": "https://www.fool.com/investing/2023/07/06/better-buy-medtronic-vs-intuitive-surgical/", "time_published": "20230706T123000", "authors": ["Sushree Mohanty"], "summary": "Both medical device companies are doing well, but one has a tremendous future.", "banner_image": "https://media.ycharts.com/charts/8a7fcc6e7515f70efe6e09b3101bf253.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999819"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.972756"}], "overall_sentiment_score": 0.267701, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.38489", "ticker_sentiment_score": "0.328994", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.1331", "ticker_sentiment_score": "0.323055", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Dips More Than Broader Markets: What You Should Know", "url": "https://www.zacks.com/stock/news/2117228/intuitive-surgical-inc-isrg-dips-more-than-broader-markets-what-you-should-know", "time_published": "20230705T220021", "authors": ["Zacks Investment Research"], "summary": "In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $333.89, marking a -0.64% move from the previous day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default359.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.983783"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.193434, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.592095", "ticker_sentiment_score": "0.157103", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "3 Top Stocks to Buy Now and Hold Forever", "url": "https://www.fool.com/investing/2023/07/05/3-top-stocks-to-buy-now-and-hold-forever/", "time_published": "20230705T085200", "authors": ["Joe Tenebruso"], "summary": "These exceptional enterprises could form the foundation of your diversified investment portfolio.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F735393%2Fliquefied-natural-gas-lng-storage-tanks-energy.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.310953, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AAPL", "relevance_score": "0.443626", "ticker_sentiment_score": "0.460969", "ticker_sentiment_label": "Bullish"}, {"ticker": "CRBO", "relevance_score": "0.052112", "ticker_sentiment_score": "0.210999", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WLDS", "relevance_score": "0.052112", "ticker_sentiment_score": "0.157552", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.104002", "ticker_sentiment_score": "0.265043", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "XOM", "relevance_score": "0.104002", "ticker_sentiment_score": "0.184469", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Stocks This Week: Buy D.H Horton And Intuitive Surgical", "url": "https://www.forbes.com/sites/greatspeculations/2023/07/03/stocks-this-week-buy-dh-horton-and-intuitive-surgical/", "time_published": "20230703T100000", "authors": ["Bill Sarubbi"], "summary": "The S&P is in both the bullish end-of-month and the holiday periods of bullish bias.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/64a1d456565c8af1f5e45c7b/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Markets", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.375933, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.194242", "ticker_sentiment_score": "0.278502", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "You Don't Have to Pick a Winner in Artificial Intelligence: Here's Why", "url": "https://www.fool.com/investing/2023/07/01/you-dont-have-to-pick-a-winner-in-ai/", "time_published": "20230701T120000", "authors": ["Justin Pope"], "summary": "Here's how to gain the upside from AI without all the risk.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F735395%2Fcomplex-confusing-confused-perplexed-intimidated-difficult-impossible.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.988787"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.117559, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.049939", "ticker_sentiment_score": "0.17921", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PATH", "relevance_score": "0.049939", "ticker_sentiment_score": "0.042975", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.099683", "ticker_sentiment_score": "0.080817", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROKU", "relevance_score": "0.049939", "ticker_sentiment_score": "0.042975", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYCCF", "relevance_score": "0.049939", "ticker_sentiment_score": "0.006992", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.099683", "ticker_sentiment_score": "0.109402", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.049939", "ticker_sentiment_score": "0.17921", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.049939", "ticker_sentiment_score": "0.006992", "ticker_sentiment_label": "Neutral"}]}, {"title": "Check Out What Whales Are Doing With ISRG - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/06/33082953/check-out-what-whales-are-doing-with-isrg", "time_published": "20230630T174728", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bearish stance on Intuitive Surgical ISRG. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.12712, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.812186", "ticker_sentiment_score": "0.258643", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": " ( ISRG )  - Analyzing Intuitive Surgical's Short Interest - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/short-sellers/23/06/33077842/isrg-analyzing-intuitive-surgicals-short-interest", "time_published": "20230630T131538", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical's ISRG short percent of float has risen 13.33% since its last report. The company recently reported that it has 2.96 million shares sold short, which is 0.85% of all regular shares that are available for trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.287384, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.221819", "ticker_sentiment_score": "0.184023", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical Unusual Options Activity - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/06/33063502/intuitive-surgical-unusual-options-activity", "time_published": "20230629T163910", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bullish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ISRG we detected 13 strange trades.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.163777, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.874135", "ticker_sentiment_score": "0.361363", "ticker_sentiment_label": "Bullish"}, {"ticker": "MS", "relevance_score": "0.12165", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is Invesco S&P 500 Equal Weight Health Care ETF  ( RSPH )  a Strong ETF Right Now?", "url": "https://www.zacks.com/stock/news/2114581/is-invesco-sp-500-equal-weight-health-care-etf-rsph-a-strong-etf-right-now", "time_published": "20230629T102010", "authors": ["Zacks Investment Research"], "summary": "Smart Beta ETF report for ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default145.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999759"}], "overall_sentiment_score": 0.353167, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.116631", "ticker_sentiment_score": "0.055779", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.174167", "ticker_sentiment_score": "0.322738", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.116631", "ticker_sentiment_score": "0.055779", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.116631", "ticker_sentiment_score": "0.055779", "ticker_sentiment_label": "Neutral"}]}, {"title": "Safety-first AI comes to health care", "url": "https://www.axios.com/2023/06/29/ai-health-care-safety", "time_published": "20230629T024029", "authors": ["Ryan Heath", "https://www.axios.com/authors/rheath"], "summary": "As companies rush AI-powered products and services to market, some non-profits and safety-focused companies are pushing to slow them down in higher-risk use cases such as health care.", "banner_image": "https://images.axios.com/JMcR8BSRdtvCczrGxDZxXZCjGnE=/0x0:1920x1080/1366x768/2023/06/29/1688032223324.jpg", "source": "Axios", "category_within_source": "Markets", "source_domain": "www.axios.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.230023, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.069697", "ticker_sentiment_score": "-0.086171", "ticker_sentiment_label": "Neutral"}]}, {"title": "Safety-first AI comes to health care", "url": "https://www.axios.com/2023/06/29/ai-health-care-safety", "time_published": "20230629T023700", "authors": ["Ryan Heath", "https://www.axios.com/authors/rheath"], "summary": "As companies rush AI-powered products and services to market, some non-profits and safety-focused companies are pushing to slow them down in higher-risk use cases such as health care.", "banner_image": "https://images.axios.com/JMcR8BSRdtvCczrGxDZxXZCjGnE=/0x0:1920x1080/1366x768/2023/06/29/1688032223324.jpg", "source": "Axios", "category_within_source": "Economy", "source_domain": "www.axios.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.230023, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.069697", "ticker_sentiment_score": "-0.086171", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Gains As Market Dips: What You Should Know", "url": "https://www.zacks.com/stock/news/2114484/intuitive-surgical-inc-isrg-gains-as-market-dips-what-you-should-know", "time_published": "20230628T220019", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed at $332.98 in the latest trading session, marking a +0.9% move from the prior day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default323.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.188511, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.648164", "ticker_sentiment_score": "0.249768", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF  ( RSPH ) ?", "url": "https://www.zacks.com/stock/news/2113978/should-you-invest-in-the-invesco-sp-500-equal-weight-health-care-etf-rsph", "time_published": "20230628T102009", "authors": ["Zacks Investment Research"], "summary": "Sector ETF report for ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default189.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}], "overall_sentiment_score": 0.290237, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.131284", "ticker_sentiment_score": "0.063519", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.195814", "ticker_sentiment_score": "0.188203", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.131284", "ticker_sentiment_score": "0.063519", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.131284", "ticker_sentiment_score": "0.063519", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Best Stocks to Invest $20,000 in Right Now", "url": "https://www.fool.com/investing/2023/06/28/the-best-stocks-to-invest-20000-in-right-now/", "time_published": "20230628T093000", "authors": ["Adria Cimino"], "summary": "You can invest in these companies with $20,000 -- or even a lot less.", "banner_image": "https://media.ycharts.com/charts/25a167c3d6c0112ea73bddb0bb3832a2.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.94762"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}], "overall_sentiment_score": 0.261963, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.0378", "ticker_sentiment_score": "0.168065", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDT", "relevance_score": "0.223866", "ticker_sentiment_score": "0.293472", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.075516", "ticker_sentiment_score": "0.086389", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXSM", "relevance_score": "0.075516", "ticker_sentiment_score": "0.073391", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.075516", "ticker_sentiment_score": "0.213808", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "GE HealthCare's Solid Demand And Sensible Margin Targets: Morgan Stanley Sees Potential Upside Despite Street's High Expectations - GE HealthCare Techs  ( NASDAQ:GEHC ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/06/33030575/ge-healthcares-solid-demand-and-sensible-margin-targets-morgan-stanley-sees-potenti", "time_published": "20230627T182515", "authors": ["Shivani Kumaresan"], "summary": "Morgan Stanley analyst Patrick Wood initiated coverage on GE HealthCare Technologies Inc GEHC with an Equal-Weight rating and a price target of $76.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/27/gehc.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": 0.268, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GEHC", "relevance_score": "0.7887", "ticker_sentiment_score": "0.439552", "ticker_sentiment_label": "Bullish"}, {"ticker": "ABT", "relevance_score": "0.245339", "ticker_sentiment_score": "0.113125", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMHF", "relevance_score": "0.124164", "ticker_sentiment_score": "0.070895", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.245339", "ticker_sentiment_score": "0.113125", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.124164", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Should You Buy Intuitive Surgical Stock Over MDT?", "url": "https://www.forbes.com/sites/greatspeculations/2023/06/27/should-you-buy-intuitive-surgical-stock-over-mdt/", "time_published": "20230627T140033", "authors": ["Trefis Team"], "summary": "There is more to the comparison, and in the sections below, we discuss why we believe ISRG stock will offer better returns than MDT stock in the next three years.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/649a8cfb03be94c29c09d90c/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds", "source": "Forbes", "category_within_source": "Markets", "source_domain": "www.forbes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.723405"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.230589, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.722793", "ticker_sentiment_score": "0.40789", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.743146", "ticker_sentiment_score": "0.360036", "ticker_sentiment_label": "Bullish"}]}, {"title": "Missed Out On Nvidia? This AI ETF Will Give You More Growth Opportunities", "url": "https://www.fool.com/investing/2023/06/27/missed-out-on-nvidia-this-ai-etf-will-give-you-mor/", "time_published": "20230627T092700", "authors": ["David Jagielski"], "summary": "The fund has been soundly beating the market this year.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F737406%2Fwoman-hijabi-eating-apple-on-phone-online-banking.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999981"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.311825, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.192694", "ticker_sentiment_score": "0.139914", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.129168", "ticker_sentiment_score": "0.073716", "ticker_sentiment_label": "Neutral"}]}, {"title": "Looking for Blue Chip Growth Stocks? These 2 Healthcare Stocks Have Crushed the Market", "url": "https://www.fool.com/investing/2023/06/23/looking-for-blue-chip-growth-stocks-these-2-health/", "time_published": "20230623T140700", "authors": ["Kody Kester"], "summary": "A surgical robotics company and a health insurer have each trounced the market in the past 10 years.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F736977%2Fa-businessperson-works-in-a-spreadsheet.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}], "overall_sentiment_score": 0.260549, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.201244", "ticker_sentiment_score": "0.159934", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Got $1,000? 3 Unstoppable Growth Stocks to Buy", "url": "https://www.fool.com/investing/2023/06/23/got-1000-3-unstoppable-growth-stocks-to-buy/", "time_published": "20230623T100000", "authors": ["Adria Cimino"], "summary": "With $1,000 you can invest in all three of these top long-term stocks.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F736790%2Fbuffett11-tmf.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.340098, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SHOP", "relevance_score": "0.499789", "ticker_sentiment_score": "0.336282", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.107255", "ticker_sentiment_score": "0.102001", "ticker_sentiment_label": "Neutral"}, {"ticker": "LULU", "relevance_score": "0.107255", "ticker_sentiment_score": "0.102001", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Outpaces Stock Market Gains: What You Should Know", "url": "https://www.zacks.com/stock/news/2112082/intuitive-surgical-inc-isrg-outpaces-stock-market-gains-what-you-should-know", "time_published": "20230622T220018", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $327.62, moving +1.2% from the previous trading session.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default266.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.983783"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.210008, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.593715", "ticker_sentiment_score": "0.242509", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's How Much $100 Invested In Intuitive Surgical 10 Years Ago Would Be Worth Today - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/23/06/32970487/heres-how-much-100-invested-in-intuitive-surgical-10-years-ago-would-be-worth-today", "time_published": "20230622T160033", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 10 years by 8.73% on an annualized basis producing an average annual return of 19.26%. Currently, Intuitive Surgical has a market capitalization of $114.27 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "The co-leader of an AI-driven quant fund beating the market this year shares 2 stocks his model is betting most on right now - and a simple way individual investors can use AI technology to pick stocks", "url": "https://www.businessinsider.com/how-to-use-ai-to-invest-artificial-intelligence-stock-picks-2023-6", "time_published": "20230622T145900", "authors": ["William Edwards"], "summary": "How to Use AI to Invest in the Stock Market: Quant Fund CEO - Business Insider ...", "banner_image": null, "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "www.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.999896"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.219122, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ENPH", "relevance_score": "0.116631", "ticker_sentiment_score": "-0.002266", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.058472", "ticker_sentiment_score": "0.022031", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.174167", "ticker_sentiment_score": "0.099815", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.174167", "ticker_sentiment_score": "0.099815", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEDG", "relevance_score": "0.116631", "ticker_sentiment_score": "-0.002266", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.116631", "ticker_sentiment_score": "-0.002266", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOW", "relevance_score": "0.116631", "ticker_sentiment_score": "-0.002266", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.116631", "ticker_sentiment_score": "-0.002266", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFRM", "relevance_score": "0.116631", "ticker_sentiment_score": "-0.002266", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.286193", "ticker_sentiment_score": "0.269027", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GME", "relevance_score": "0.116631", "ticker_sentiment_score": "-0.002266", "ticker_sentiment_label": "Neutral"}]}, {"title": "Elective Surgeries Are On the Rise: 3 Stocks That Can Benefit From This Trend", "url": "https://www.fool.com/investing/2023/06/22/elective-surgeries-are-on-the-rise-3-stocks-that/", "time_published": "20230622T140700", "authors": ["David Jagielski"], "summary": "These have been some of the hottest healthcare stocks on the markets this year.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F737029%2Finvesting-screen-analysis-investor-growth-stocks-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}, {"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.218752, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HUM", "relevance_score": "0.063594", "ticker_sentiment_score": "-0.113081", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.31006", "ticker_sentiment_score": "0.129782", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.250386", "ticker_sentiment_score": "0.229193", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.189175", "ticker_sentiment_score": "0.20664", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UNH", "relevance_score": "0.063594", "ticker_sentiment_score": "-0.113081", "ticker_sentiment_label": "Neutral"}]}, {"title": "If You Invested $25,000 in Intuitive Surgical In 2020, This Is How Much You Would Have Today", "url": "https://www.fool.com/investing/2023/06/22/if-you-invested-25000-in-intuitive-surgical-in-202/", "time_published": "20230622T134000", "authors": ["David Jagielski"], "summary": "Although the pandemic has weighed down Intuitive's business, this has proven to be a resilient investment in recent years.", "banner_image": "https://media.ycharts.com/charts/cf61555dc9d3e3ed6536be2919758d38.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}, {"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.303447, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HUM", "relevance_score": "0.07031", "ticker_sentiment_score": "0.119211", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.40348", "ticker_sentiment_score": "0.402716", "ticker_sentiment_label": "Bullish"}, {"ticker": "UNH", "relevance_score": "0.07031", "ticker_sentiment_score": "0.119211", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here is What to Know Beyond Why Intuitive Surgical, Inc.  ( ISRG )  is a Trending Stock", "url": "https://www.zacks.com/stock/news/2111715/here-is-what-to-know-beyond-why-intuitive-surgical-inc-isrg-is-a-trending-stock", "time_published": "20230622T130007", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default128.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.237299, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.508232", "ticker_sentiment_score": "0.168737", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "These 3 Tech Stocks Are Building the Future", "url": "https://www.fool.com/investing/2023/06/22/these-3-tech-stocks-are-building-the-future/", "time_published": "20230622T130000", "authors": ["Bradley Guichard"], "summary": "The rapid advancement of technology spells opportunity for investors.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F736674%2Fretired-woman-investing-laptop-401k-ira.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.989041"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.316726"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.188513, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.041181", "ticker_sentiment_score": "0.110145", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.041181", "ticker_sentiment_score": "-0.017869", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXN", "relevance_score": "0.203729", "ticker_sentiment_score": "0.12119", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.203729", "ticker_sentiment_score": "0.02905", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.123104", "ticker_sentiment_score": "0.19879", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "2 AI Stocks to Buy Before They Skyrocket", "url": "https://www.fool.com/investing/2023/06/21/2-ai-stocks-to-buy-before-they-skyrocket/", "time_published": "20230621T111500", "authors": ["Manali Bhade"], "summary": "Intuitive Surgical and Lemonade stand to benefit dramatically from breakthroughs in AI technologies.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F736580%2Ffarmer-in-tractor-spraying-pesticides.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Earnings", "relevance_score": "0.839681"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.179989, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.044469", "ticker_sentiment_score": "0.046696", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMND", "relevance_score": "0.344473", "ticker_sentiment_score": "0.139102", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.044469", "ticker_sentiment_score": "0.046696", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.132855", "ticker_sentiment_score": "0.112138", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.044469", "ticker_sentiment_score": "0.048623", "ticker_sentiment_label": "Neutral"}]}, {"title": "Telix to Expand Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical", "url": "https://www.prnewswire.com/apac/news-releases/telix-to-expand-late-stage-urologic-pipeline-with-acquisition-of-lightpoint-medical-301856510.html", "time_published": "20230621T093200", "authors": ["Telix Pharmaceuticals Limited"], "summary": "MELBOURNE, Australia, June 21, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited ( ASX: TLX, Telix, the Company ) today announces it has entered into an agreement to acquire Lightpoint Medical and its SENSEI\u00ae radio-guided surgery business.", "banner_image": "https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.130684, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.028388", "ticker_sentiment_score": "0.031882", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLPPF", "relevance_score": "0.141227", "ticker_sentiment_score": "-0.021546", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Gains As Market Dips: What You Should Know", "url": "https://www.zacks.com/stock/news/2109679/intuitive-surgical-inc-isrg-gains-as-market-dips-what-you-should-know", "time_published": "20230616T215019", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed at $329.36 in the latest trading session, marking a +0.33% move from the prior day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default8.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.151833, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.656549", "ticker_sentiment_score": "0.185218", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "After Another Surge, Stocks Approach Weekend On Six-Day Win Streak On Rate Hopes - Cava Group  ( NYSE:CAVA ) , Adobe  ( NASDAQ:ADBE ) ", "url": "https://www.benzinga.com/markets/23/06/32896561/after-another-surge-stocks-approach-weekend-on-six-day-win-streak-on-rate-hopes", "time_published": "20230616T162726", "authors": ["Alex Coffey"], "summary": "( Friday market open ) The S&P 500\u00ae Index ( SPX ) is on a six-day winning streak following another surge yesterday amid growing investor optimism that interest rates might be close to peaking.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/16/shutterstock_1714097677_1.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.9545"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.99999"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.99489"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.050384, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.039944", "ticker_sentiment_score": "0.094241", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.039944", "ticker_sentiment_score": "0.141304", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.039944", "ticker_sentiment_score": "0.056762", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYT", "relevance_score": "0.019978", "ticker_sentiment_score": "-0.021961", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.059885", "ticker_sentiment_score": "0.057432", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBH", "relevance_score": "0.039944", "ticker_sentiment_score": "0.069514", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.039944", "ticker_sentiment_score": "0.141304", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.039944", "ticker_sentiment_score": "0.094241", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEN", "relevance_score": "0.039944", "ticker_sentiment_score": "0.07349", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.079788", "ticker_sentiment_score": "0.065449", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADBE", "relevance_score": "0.059885", "ticker_sentiment_score": "0.071049", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRI", "relevance_score": "0.079788", "ticker_sentiment_score": "0.080766", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDX", "relevance_score": "0.099642", "ticker_sentiment_score": "0.154313", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.039944", "ticker_sentiment_score": "0.056762", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:JPY", "relevance_score": "0.019978", "ticker_sentiment_score": "-0.040863", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.039944", "ticker_sentiment_score": "-0.002974", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.039944", "ticker_sentiment_score": "-0.002974", "ticker_sentiment_label": "Neutral"}]}, {"title": "2-Step Strategy to Spotting Early Profit Opportunities", "url": "https://moneymorning.com/investing/2-step-strategy-to-spotting-early-profit-opportunities/", "time_published": "20230616T152308", "authors": ["Alex Kagin", "Tom-Gentile", "Matthew Carr", "Tom Gentile"], "summary": "The last few months of financial news have felt like a constant onslaught... But when you keep jumping from one major story to the next, you never have any time to prepare. You're always on your back foot... and that's the worst possible place for any trader to be. Are these events tradable?", "banner_image": "https://powerprofittrades.com/wp-content/uploads/2023/06/23-06-16-isrg-1024x557.png", "source": "Money Morning", "category_within_source": "GoogleRSS", "source_domain": "moneymorning.com", "topics": [{"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.133046, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.245339", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Growth Stocks to Buy and Hold for 10 Years", "url": "https://www.fool.com/investing/2023/06/16/2-growth-stocks-to-buy-and-hold-for-10-years/", "time_published": "20230616T135300", "authors": ["Prosper Junior Bakiny"], "summary": "Both companies are benefiting from industries with a bright future.", "banner_image": "https://media.ycharts.com/charts/a72b7e5f9cca1552dc01c79039ad3db9.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.905476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.3477, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TDOC", "relevance_score": "0.10607", "ticker_sentiment_score": "0.257917", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDT", "relevance_score": "0.053153", "ticker_sentiment_score": "0.211952", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.310843", "ticker_sentiment_score": "0.324856", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.053153", "ticker_sentiment_score": "0.211952", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "If You Invested $1000 in Intuitive Surgical, Inc. a Decade Ago, This is How Much It'd Be Worth Now", "url": "https://www.zacks.com/stock/news/2109275/if-you-invested-1000-in-intuitive-surgical-inc-a-decade-ago-this-is-how-much-itd-be-worth-now", "time_published": "20230616T123003", "authors": ["Zacks Investment Research"], "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default177.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.263267, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.533481", "ticker_sentiment_score": "0.359571", "ticker_sentiment_label": "Bullish"}, {"ticker": "FOREX:USD", "relevance_score": "0.058047", "ticker_sentiment_score": "0.112393", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Outpaces Stock Market Gains: What You Should Know", "url": "https://www.zacks.com/stock/news/2109112/intuitive-surgical-inc-isrg-outpaces-stock-market-gains-what-you-should-know", "time_published": "20230615T220022", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed at $328.27 in the latest trading session, marking a +1.61% move from the prior day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default161.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.223027, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.605266", "ticker_sentiment_score": "0.336946", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "2 Unstoppable Stocks to Buy and Hold for Decades", "url": "https://www.fool.com/investing/2023/06/14/2-unstoppable-stocks-to-buy-and-hold-for-decades/", "time_published": "20230614T131500", "authors": ["David Jagielski"], "summary": "These are some of the best growth stocks you can buy for the long term.", "banner_image": "https://media.ycharts.com/charts/0851cf72ab1bc5c7215ebf289be497e0.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.928769"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.340534, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.064973", "ticker_sentiment_score": "0.245699", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOOG", "relevance_score": "0.672055", "ticker_sentiment_score": "0.383167", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.316439", "ticker_sentiment_score": "0.278389", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "3 Industry-Leading AI Stocks Outside the Tech Sector That Are on the Cutting Edge of Innovation", "url": "https://www.fool.com/investing/2023/06/14/3-leading-ai-stocks-on-cutting-edge-of-innovation/", "time_published": "20230614T090600", "authors": ["Sean Williams"], "summary": "The rise of artificial intelligence (AI) is a marketwide phenomenon that'll impact far more than the tech sector.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F735991%2Fai-artificial-intelligence-robots-office-working-conference-room-laptop-getty.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999365"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.24755, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.032294", "ticker_sentiment_score": "0.181037", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.28442", "ticker_sentiment_score": "0.119696", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.28442", "ticker_sentiment_score": "0.276585", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.22313", "ticker_sentiment_score": "0.149834", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Growing Healthcare Stocks to Own for the Long Term", "url": "https://www.fool.com/investing/2023/06/13/2-growing-healthcare-stocks-to-own-long-term/", "time_published": "20230613T113000", "authors": ["Nicholas Rossolillo"], "summary": "Healthcare is often viewed as a defensive investment, but these two stocks offer lots of growth potential.", "banner_image": "https://media.ycharts.com/charts/ef43a8d53ab393c5f0dcaee73767e600.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.972756"}, {"topic": "Earnings", "relevance_score": "0.999981"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.288892, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.148426", "ticker_sentiment_score": "0.195872", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DOCS", "relevance_score": "0.337592", "ticker_sentiment_score": "0.336803", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "InMode Stock Performs Beautifully. Big Money Still Wary Though.", "url": "https://www.investors.com/news/technology/inmode-earns-relative-strength-rating-upgrade-hits-key-threshold-2/", "time_published": "20230612T205900", "authors": ["JAMES DETAR", "INVESTOR'S BUSINESS DAILY", "Investor's Business Daily"], "summary": "InMode Stock Performs Beautifully | Investor's Business Daily Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/07/Stock-Beauty-09-shutt.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.839681"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}], "overall_sentiment_score": 0.425872, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.154455", "ticker_sentiment_score": "0.090941", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.619309", "ticker_sentiment_score": "0.583084", "ticker_sentiment_label": "Bullish"}, {"ticker": "SWAV", "relevance_score": "0.154455", "ticker_sentiment_score": "0.090941", "ticker_sentiment_label": "Neutral"}]}, {"title": "Where Will Intuitive Surgical Be in 10 Years?", "url": "https://www.fool.com/investing/2023/06/12/where-will-intuitive-surgical-be-in-10-years/", "time_published": "20230612T140000", "authors": ["Alex Carchidi"], "summary": "It'll be even bigger, but it probably won't be the only player in its space anymore.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F734974%2Ftwo-people-looking-at-laptop.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.858979"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.257177, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.046095", "ticker_sentiment_score": "0.141338", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.182851", "ticker_sentiment_score": "0.097407", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.046095", "ticker_sentiment_score": "0.141338", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical: Buy, Sell, or Hold?", "url": "https://www.fool.com/investing/2023/06/11/intuitive-surgical-buy-sell-or-hold/", "time_published": "20230611T093000", "authors": ["Adria Cimino"], "summary": "Intuitive's shares have started to pick up momentum this year.", "banner_image": "https://media.ycharts.com/charts/074057d5f924fd6de4738dad6a825391.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Earnings", "relevance_score": "0.990999"}], "overall_sentiment_score": 0.198355, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.102668", "ticker_sentiment_score": "-0.148721", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Outpaces Stock Market Gains: What You Should Know", "url": "https://www.zacks.com/stock/news/2106652/intuitive-surgical-inc-isrg-outpaces-stock-market-gains-what-you-should-know", "time_published": "20230609T215022", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed at $312.81 in the latest trading session, marking a +0.64% move from the prior day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default56.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.219581, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.649828", "ticker_sentiment_score": "0.374879", "ticker_sentiment_label": "Bullish"}]}, {"title": "Is Intuitive Surgical Stock a Buy Now?", "url": "https://www.fool.com/investing/2023/06/09/is-intuitive-surgical-stock-a-buy-now/", "time_published": "20230609T114500", "authors": ["Alex Carchidi"], "summary": "There's reason to believe that things will keep getting better from here.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F735380%2Fa-person-staring-at-graphs-and-charts-on-a-computer-monitor.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.115715, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.1568", "ticker_sentiment_score": "0.222855", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Outpaces Stock Market Gains: What You Should Know", "url": "https://www.zacks.com/stock/news/2106112/intuitive-surgical-inc-isrg-outpaces-stock-market-gains-what-you-should-know", "time_published": "20230608T220018", "authors": ["Zacks Investment Research"], "summary": "In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $310.82, marking a +1.17% move from the previous day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default272.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.266038, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.665097", "ticker_sentiment_score": "0.446943", "ticker_sentiment_label": "Bullish"}]}, {"title": "Medical Stock With 164% Growth On Track To 'Crack' Breakout Code", "url": "https://www.investors.com/research/ibd-stock-analysis/shockwave-medical-in-demand-among-top-funds-as-swav-stock-aims-to-crack-breakout-code/", "time_published": "20230608T180000", "authors": ["Investor's Business Daily", "MATTHEW GALGANI"], "summary": "Shockwave Medical On Track To Crack Breakout Code | Investor's ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2023/06/Stock-heartbody-01-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Earnings", "relevance_score": "0.795202"}], "overall_sentiment_score": 0.232592, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BRKR", "relevance_score": "0.142565", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRMD", "relevance_score": "0.142565", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.142565", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.142565", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWAV", "relevance_score": "0.873226", "ticker_sentiment_score": "0.351585", "ticker_sentiment_label": "Bullish"}]}, {"title": "Is Trending Stock Intuitive Surgical, Inc.  ( ISRG )  a Buy Now?", "url": "https://www.zacks.com/stock/news/2105650/is-trending-stock-intuitive-surgical-inc-isrg-a-buy-now", "time_published": "20230608T130007", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default149.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.246494, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.506433", "ticker_sentiment_score": "0.116366", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Reasons to Retain Intuitive Surgical  ( ISRG )  Stock for Now", "url": "https://www.zacks.com/stock/news/2105355/3-reasons-to-retain-intuitive-surgical-isrg-stock-for-now", "time_published": "20230607T184400", "authors": ["Zacks Investment Research"], "summary": "Investors continue to be optimistic about Intuitive Surgical (ISRG) owing to its strength in robotics.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.356204, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "HOLX", "relevance_score": "0.212115", "ticker_sentiment_score": "0.134216", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMSI", "relevance_score": "0.107016", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.313484", "ticker_sentiment_score": "0.308062", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BSX", "relevance_score": "0.212115", "ticker_sentiment_score": "0.04036", "ticker_sentiment_label": "Neutral"}]}, {"title": "Looking At Intuitive Surgical's Recent Unusual Options Activity - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/06/32762181/looking-at-intuitive-surgicals-recent-unusual-options-activity", "time_published": "20230607T154641", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ISRG we detected 10 strange trades.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.180772, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.835133", "ticker_sentiment_score": "0.149041", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.110462", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Building Better Breakouts: These Growth Stocks Are Getting Pumped", "url": "https://www.investors.com/research/breakout-stocks-technical-analysis/growth-stocks-to-watch-asml-tsm-stock-among-top-names-pumping-up-breakouts/", "time_published": "20230607T120000", "authors": ["Investor's Business Daily", "MATTHEW GALGANI"], "summary": "The latest IBD/TIPP survey shows the U.S. economy remains stuck in a rut, and President Joe Biden's job approval rating just slid to its worst level of 2023.", "banner_image": "https://www.investors.com/wp-content/uploads/2023/06/Stock-muscles-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.990893"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.192588, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KLAC", "relevance_score": "0.15697", "ticker_sentiment_score": "0.027894", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELH", "relevance_score": "0.233556", "ticker_sentiment_score": "0.118798", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANET", "relevance_score": "0.233556", "ticker_sentiment_score": "0.092758", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSCO", "relevance_score": "0.233556", "ticker_sentiment_score": "-0.106464", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.15697", "ticker_sentiment_score": "0.16064", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JPM", "relevance_score": "0.15697", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBS", "relevance_score": "0.233556", "ticker_sentiment_score": "0.106679", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEHR", "relevance_score": "0.307924", "ticker_sentiment_score": "0.115111", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHOP", "relevance_score": "0.307924", "ticker_sentiment_score": "0.284106", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EXTR", "relevance_score": "0.15697", "ticker_sentiment_score": "-0.137046", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADBE", "relevance_score": "0.15697", "ticker_sentiment_score": "0.16064", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LRCX", "relevance_score": "0.15697", "ticker_sentiment_score": "0.027894", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCL", "relevance_score": "0.15697", "ticker_sentiment_score": "0.206463", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DBX", "relevance_score": "0.15697", "ticker_sentiment_score": "-0.137046", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.15697", "ticker_sentiment_score": "0.206463", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DXCM", "relevance_score": "0.15697", "ticker_sentiment_score": "0.16064", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRVL", "relevance_score": "0.15697", "ticker_sentiment_score": "0.027894", "ticker_sentiment_label": "Neutral"}, {"ticker": "ON", "relevance_score": "0.07887", "ticker_sentiment_score": "0.020823", "ticker_sentiment_label": "Neutral"}]}, {"title": "This Secret Options Pattern Is More Reliable than Price Movement", "url": "https://moneymorning.com/investing/this-secret-options-pattern-is-more-reliable-than-price-movement/", "time_published": "20230606T175432", "authors": ["Garrett Baldwin", "Shah Gilani", "Tom-Gentile", "Tom Gentile"], "summary": "We can finally stop talking about the debt ceiling! ( For now... ) But while everyone else goes from processing the exciting conclusion of the debt ceiling standoff... ...to dissecting whether or not the Fed will raise rates again in 11 days... I want to move on to the actual next big profit ...", "banner_image": "https://moneymappress.com/wp-content/uploads/2023/06/image001-3.png", "source": "Money Morning", "category_within_source": "GoogleRSS", "source_domain": "moneymorning.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.890401"}], "overall_sentiment_score": 0.217156, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.242084", "ticker_sentiment_score": "0.111388", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.162802", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Healthcare Stocks That Would Have Doubled Your Investment in 5 Years", "url": "https://www.fool.com/investing/2023/06/06/healthcare-stocks-would-double-investment-5-years/", "time_published": "20230606T135904", "authors": ["David Jagielski"], "summary": "Are these growth stocks still good buys today?", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F734958%2Fbuffett6-tmf.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}, {"topic": "Earnings", "relevance_score": "0.988915"}], "overall_sentiment_score": 0.262377, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MCK", "relevance_score": "0.31282", "ticker_sentiment_score": "0.216299", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.211652", "ticker_sentiment_score": "0.234457", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TMO", "relevance_score": "0.159569", "ticker_sentiment_score": "0.13583", "ticker_sentiment_label": "Neutral"}]}, {"title": "1 AI ETF Poised to Outperform the Market Over the Next 5 Years", "url": "https://www.fool.com/investing/2023/06/06/1-ai-etf-that-may-outperform-the-market-in-5-years/", "time_published": "20230606T134700", "authors": ["Anders Bylund"], "summary": "Looking for a smart way to invest in AI? Find out why this exchange-traded fund is hard to beat.", "banner_image": "https://media.ycharts.com/charts/5a046df6a3284722fd8b5de11b89ecb4.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999994"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.295755, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.148426", "ticker_sentiment_score": "0.238871", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVDA", "relevance_score": "0.197011", "ticker_sentiment_score": "0.221832", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KYCCF", "relevance_score": "0.099271", "ticker_sentiment_score": "0.03998", "ticker_sentiment_label": "Neutral"}]}, {"title": "Missed Out On Intuitive Surgical's Boom? This Stock May Be a Better Buy Now", "url": "https://www.fool.com/investing/2023/06/06/missed-out-on-intuitive-surgicals-boom-this-stock/", "time_published": "20230606T110000", "authors": ["Jim Halley"], "summary": "Alphatec's strong revenue growth makes it worth watching.", "banner_image": "https://media.ycharts.com/charts/034362fd3d6fe2fb12707f0a89d1738b.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.998333"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.202295, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ATCN", "relevance_score": "0.110209", "ticker_sentiment_score": "0.003375", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBH", "relevance_score": "0.055236", "ticker_sentiment_score": "0.054864", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.055236", "ticker_sentiment_score": "0.054864", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.110209", "ticker_sentiment_score": "0.070574", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATEC", "relevance_score": "0.467081", "ticker_sentiment_score": "0.179965", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.055236", "ticker_sentiment_score": "0.054864", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Top Healthcare Stocks to Buy for June", "url": "https://www.fool.com/investing/2023/06/06/3-top-healthcare-stocks-to-buy-for-june/", "time_published": "20230606T093000", "authors": ["Adria Cimino"], "summary": "These stocks have what it takes to deliver long-term growth.", "banner_image": "https://media.ycharts.com/charts/7676a54c5b7402a9aa48961c8417352b.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.999966"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.313549, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.047654", "ticker_sentiment_score": "0.108827", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCS", "relevance_score": "0.4499", "ticker_sentiment_score": "0.311091", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TMDIF", "relevance_score": "0.047654", "ticker_sentiment_score": "0.142886", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.095138", "ticker_sentiment_score": "0.230909", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical Unusual Options Activity - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/06/32725695/intuitive-surgical-unusual-options-activity", "time_published": "20230605T203205", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bullish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ISRG we detected 12 strange trades.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.216679, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.831224", "ticker_sentiment_score": "0.293803", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.109455", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Best Growth Stocks to Buy Hand Over Fist in June", "url": "https://www.fool.com/investing/2023/06/05/2-best-growth-stocks-to-buy-hand-over-fist-in-june/", "time_published": "20230605T160826", "authors": ["Rachel Warren"], "summary": "These businesses succeed even in a challenging operating environment.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F734829%2Fstock-certificate-investment-retire-heirloom-donate-capital-gains-tax-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Earnings", "relevance_score": "0.961735"}], "overall_sentiment_score": 0.191199, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "FVRR", "relevance_score": "0.261584", "ticker_sentiment_score": "0.254583", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.343875", "ticker_sentiment_score": "0.175796", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "2 Incredible Growth Stocks to Buy Without Hesitation in June", "url": "https://www.fool.com/investing/2023/06/05/2-incredible-stocks-to-buy-without-hesitation/", "time_published": "20230605T133000", "authors": ["Rachel Warren"], "summary": "E-commerce and healthcare are growth sectors that should remain resilient no matter what the economy brings.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F734829%2Fstock-certificate-investment-retire-heirloom-donate-capital-gains-tax-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.999499"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.128103, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SHOP", "relevance_score": "0.320453", "ticker_sentiment_score": "0.158165", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.320453", "ticker_sentiment_score": "0.122235", "ticker_sentiment_label": "Neutral"}]}, {"title": "Meta Platforms To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday - Apple  ( NASDAQ:AAPL ) , Broadcom  ( NASDAQ:AVGO ) ", "url": "https://www.benzinga.com/news/23/06/32712849/meta-platforms-to-rally-around-30-here-are-10-other-analyst-forecasts-for-monday", "time_published": "20230605T115951", "authors": ["Lisa Levin"], "summary": "BMO Capital boosted the price target for Equity Residential EQR from $60 to $64. BMO Capital analyst John Kim upgraded the stock from Underperform to Market Perform. Equity Residential shares rose 0.7% to $63.56 in pre-market trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/05/meta_platforms_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.999997"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.140355, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.191929", "ticker_sentiment_score": "0.108698", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.28442", "ticker_sentiment_score": "0.38906", "ticker_sentiment_label": "Bullish"}, {"ticker": "AVGO", "relevance_score": "0.28442", "ticker_sentiment_score": "0.089204", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.28442", "ticker_sentiment_score": "-0.094237", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPN", "relevance_score": "0.191929", "ticker_sentiment_score": "0.170487", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SPOT", "relevance_score": "0.28442", "ticker_sentiment_score": "0.289742", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WFC", "relevance_score": "0.191929", "ticker_sentiment_score": "0.065583", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.191929", "ticker_sentiment_score": "-0.114587", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDB", "relevance_score": "0.28442", "ticker_sentiment_score": "0.147471", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPMC", "relevance_score": "0.28442", "ticker_sentiment_score": "-0.156749", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ISRG", "relevance_score": "0.28442", "ticker_sentiment_score": "0.089204", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.191929", "ticker_sentiment_score": "-0.114587", "ticker_sentiment_label": "Neutral"}]}, {"title": "Futures: Character Change For Market; Here's What To Do", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-shows-character-change-tesla-apple-in-focus/", "time_published": "20230604T185800", "authors": ["ED CARSON", "Investor's Business Daily"], "summary": "Dow Jones Futures: Market Rally Shows Character Change. Tesla ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2018/07/stock-bull-charge-02-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.155959, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.080796", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.20019", "ticker_sentiment_score": "-0.014138", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.239109", "ticker_sentiment_score": "0.120195", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEN", "relevance_score": "0.180535", "ticker_sentiment_score": "0.054716", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.140896", "ticker_sentiment_score": "0.10828", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCL", "relevance_score": "0.04045", "ticker_sentiment_score": "0.011726", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.020232", "ticker_sentiment_score": "0.096166", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.04045", "ticker_sentiment_score": "0.087318", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.140896", "ticker_sentiment_score": "0.11029", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWAV", "relevance_score": "0.04045", "ticker_sentiment_score": "0.087318", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAR", "relevance_score": "0.120936", "ticker_sentiment_score": "0.011597", "ticker_sentiment_label": "Neutral"}, {"ticker": "PANW", "relevance_score": "0.120936", "ticker_sentiment_score": "0.003485", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rule Breaker Investor Habit No. 6: Aim for 60% Accuracy", "url": "https://www.fool.com/retirement/2023/06/03/rule-breaker-investor-habit-no-6-aim-for-60-accura/", "time_published": "20230603T133000", "authors": ["Motley Fool Staff"], "summary": "\"Rule Breaker Investing\" Old, New, Borrowed & Blue, Vol. 7.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F734385%2Fretiree-6.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.221278, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HLFFF", "relevance_score": "0.021967", "ticker_sentiment_score": "0.045997", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.005493", "ticker_sentiment_score": "0.108996", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLUMY", "relevance_score": "0.005493", "ticker_sentiment_score": "0.070351", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRN", "relevance_score": "0.120376", "ticker_sentiment_score": "0.088147", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.005493", "ticker_sentiment_score": "0.108996", "ticker_sentiment_label": "Neutral"}, {"ticker": "KR", "relevance_score": "0.005493", "ticker_sentiment_score": "0.020413", "ticker_sentiment_label": "Neutral"}]}, {"title": "Market Rally Shows Strength, Breadth; Here's What To Do", "url": "https://www.investors.com/market-trend/stock-market-today/stock-market-rally-shows-strength-breadth-tesla-apple-in-focus-what-to-do-now/", "time_published": "20230602T211400", "authors": ["ED CARSON", "Investor's Business Daily"], "summary": "Market Rally Shows Strength, Breadth. Here's What To Do Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2018/07/stock-bull-charge-02-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.181031, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.092569", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.206392", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.206392", "ticker_sentiment_score": "0.137986", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEN", "relevance_score": "0.206392", "ticker_sentiment_score": "0.065575", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.161247", "ticker_sentiment_score": "0.117567", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCL", "relevance_score": "0.046363", "ticker_sentiment_score": "0.011892", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.023191", "ticker_sentiment_score": "0.097665", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.046363", "ticker_sentiment_score": "0.0887", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.161247", "ticker_sentiment_score": "0.11971", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWAV", "relevance_score": "0.046363", "ticker_sentiment_score": "0.0887", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAR", "relevance_score": "0.138464", "ticker_sentiment_score": "0.012421", "ticker_sentiment_label": "Neutral"}]}, {"title": "Double Your Returns: Seize The AI And Tech Boom With This Unique 2X Leverage Fund - Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 2X Shares  ( ARCA:UBOT ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/23/06/32693545/double-your-returns-seize-the-ai-and-tech-boom-with-this-unique-2x-leverage-fund", "time_published": "20230602T165534", "authors": ["Melanie Schaffer"], "summary": "Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 2X Shares UBOT was trading over 3% higher on Friday after closing Thursday's session up 3.92%. AI and tech stocks have experienced a strong rally recently as automation becomes more advanced and integrated into people's ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/02/robot_chart_shutter.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999499"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.255977, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.22595", "ticker_sentiment_score": "0.127475", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.22595", "ticker_sentiment_score": "0.127475", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Gains But Lags Market: What You Should Know", "url": "https://www.zacks.com/stock/news/2102859/intuitive-surgical-inc-isrg-gains-but-lags-market-what-you-should-know", "time_published": "20230601T215010", "authors": ["Zacks Investment Research"], "summary": "In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $310.54, marking a +0.88% move from the previous day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default166.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.226955, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.686288", "ticker_sentiment_score": "0.335459", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Idexx  ( IDXX )  Down 2.9% Since Last Earnings Report: Can It Rebound?", "url": "https://www.zacks.com/stock/news/2102682/idexx-idxx-down-29-since-last-earnings-report-can-it-rebound", "time_published": "20230601T153115", "authors": ["Zacks Investment Research"], "summary": "Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default113.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999813"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}], "overall_sentiment_score": 0.124367, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IDXX", "relevance_score": "0.103109", "ticker_sentiment_score": "0.042474", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.204503", "ticker_sentiment_score": "0.058057", "ticker_sentiment_label": "Neutral"}]}, {"title": "How Will AI Affect Investing?", "url": "https://investingnews.com/impact-ai-on-investing/", "time_published": "20230601T054947", "authors": [], "summary": "With the rise of platforms like OpenAI's ChatGPT and other generative AI technologies, the possibilities seem endless. Investors are particularly curious about how AI can be leveraged to make better investment decisions and generate higher returns.", "banner_image": "https://investingnews.com/media-library/ai-robot-standing-in-front-of-a-stock-ticker-chart-and-analyzing-stocks.jpg?id=33782372&width=2500&height=1667&quality=85&coordinates=0%2C0%2C0%2C0", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.288303, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.055686", "ticker_sentiment_score": "0.186167", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "META", "relevance_score": "0.02786", "ticker_sentiment_score": "0.124515", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.02786", "ticker_sentiment_score": "0.124515", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASML", "relevance_score": "0.02786", "ticker_sentiment_score": "0.124515", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOW", "relevance_score": "0.02786", "ticker_sentiment_score": "0.124515", "ticker_sentiment_label": "Neutral"}]}, {"title": "These ETFs Ride AI Rally, Including A Cathie Wood Fund", "url": "https://www.investors.com/research/these-etfs-bank-on-ai-stocks-including-a-cathie-wood-fund/", "time_published": "20230531T120000", "authors": ["KIMBERLEY KOENIG", "Investor's Business Daily"], "summary": "It's no surprise that artificial intelligence ( AI ) is on investors' minds, as the AI industry takes off. Leading chip developer and AI leader Nvidia ( NVDA ) reported a spectacular first quarter earnings report late Wednesday, lifting AI stocks.", "banner_image": "https://www.investors.com/wp-content/uploads/2021/11/Stock-CathieWoods-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.875462"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.274107, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.16117", "ticker_sentiment_score": "0.062171", "ticker_sentiment_label": "Neutral"}, {"ticker": "PATH", "relevance_score": "0.16117", "ticker_sentiment_score": "-0.039873", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.31583", "ticker_sentiment_score": "0.104703", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.584103", "ticker_sentiment_score": "0.321423", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AAPL", "relevance_score": "0.16117", "ticker_sentiment_score": "0.062171", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.31583", "ticker_sentiment_score": "0.31893", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.239698", "ticker_sentiment_score": "0.083749", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Zacks Analyst Blog Highlights Tesla, TotalEnergies, Intuitive Surgical, Charles Schwab and Monster Beverage", "url": "https://www.zacks.com/stock/news/2101708/the-zacks-analyst-blog-highlights-tesla-totalenergies-intuitive-surgical-charles-schwab-and-monster-beverage", "time_published": "20230531T085100", "authors": ["Zacks Investment Research"], "summary": "Tesla, TotalEnergies, Intuitive Surgical, Charles Schwab and Monster Beverage are included in this Analyst Blog.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3e/106.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SCHW", "relevance_score": "0.716023", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.716023", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTE", "relevance_score": "0.716023", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.716023", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNST", "relevance_score": "0.716023", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Top Research Reports for Tesla, TotalEnergies & Intuitive Surgical", "url": "https://www.zacks.com/research-daily/2101321/top-research-reports-for-tesla-totalenergies-intuitive-surgical", "time_published": "20230530T202900", "authors": ["Zacks Investment Research"], "summary": "Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), TotalEnergies SE (TTE) and Intuitive Surgical, Inc. (ISRG).", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7c/572.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.22583, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SCHW", "relevance_score": "0.128822", "ticker_sentiment_score": "0.115574", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.254307", "ticker_sentiment_score": "0.18508", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TTE", "relevance_score": "0.429671", "ticker_sentiment_score": "0.271661", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.373378", "ticker_sentiment_score": "0.247198", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ELV", "relevance_score": "0.128822", "ticker_sentiment_score": "0.115574", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNST", "relevance_score": "0.128822", "ticker_sentiment_score": "0.115574", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.064623", "ticker_sentiment_score": "0.096528", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Zacks Analyst Blog Highlights InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare", "url": "https://www.zacks.com/stock/news/2101176/the-zacks-analyst-blog-highlights-inmode-johnson-johnson-intuitive-surgical-and-ge-healthcare", "time_published": "20230530T101500", "authors": ["Zacks Investment Research"], "summary": "InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare are included in this Analyst Blog.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e3/1178.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.905476"}], "overall_sentiment_score": 0.29684, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GEHC", "relevance_score": "0.157483", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.40375", "ticker_sentiment_score": "0.423087", "ticker_sentiment_label": "Bullish"}, {"ticker": "INMD", "relevance_score": "0.40375", "ticker_sentiment_score": "0.256965", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.40375", "ticker_sentiment_score": "0.274014", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Got $1,500? 2 Top Growth Stocks to Buy Right Now", "url": "https://www.fool.com/investing/2023/05/28/got-1500-2-top-growth-stocks-to-buy-right-now/", "time_published": "20230528T140000", "authors": ["Rachel Warren"], "summary": "Short-term macro challenges have not stopped these two companies from continuing to expand their businesses.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F733638%2Fbuffett17-tmf.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Earnings", "relevance_score": "0.967645"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.22281, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.220809", "ticker_sentiment_score": "0.258965", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UPST", "relevance_score": "0.220809", "ticker_sentiment_score": "0.291538", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "2 Revolutionary Stocks I'd Buy Right Now Without Hesitation", "url": "https://www.fool.com/investing/2023/05/27/2-revolutionary-stocks-id-buy-right-now-without-he/", "time_published": "20230527T110500", "authors": ["Sushree Mohanty"], "summary": "These high-growth stocks could be a good long-term investment.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F733568%2Fdoctor-in-an-online-appointment.jpeg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.98396"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.311568, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.175859", "ticker_sentiment_score": "0.118142", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDOC", "relevance_score": "0.117774", "ticker_sentiment_score": "0.205338", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Gains But Lags Market: What You Should Know", "url": "https://www.zacks.com/stock/news/2100565/intuitive-surgical-inc-isrg-gains-but-lags-market-what-you-should-know", "time_published": "20230526T215003", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $306.90, moving +1.03% from the previous trading session.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default297.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.983783"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.226838, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.641573", "ticker_sentiment_score": "0.313159", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Titan Medical Signs License Agreement with Intuitive Surgical", "url": "https://www.globenewswire.com/news-release/2023/05/26/2677345/0/en/Titan-Medical-Signs-License-Agreement-with-Intuitive-Surgical.html", "time_published": "20230526T183000", "authors": ["Titan Medical Inc."], "summary": "TORONTO, Ontario, May 26, 2023 ( GLOBE NEWSWIRE ) -- Titan Medical Inc. ( \"Titan\" or the \"Company\" ) ( TSX: TMD. OTC: TMDIF ) announced today that the Company has entered into a license agreement ( \"Agreement\" ) with Intuitive Surgical, Inc. ( \"Intuitive\" ) ( Nasdaq: ISRG ) , a global technology ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/e9df9371-cb74-4840-8337-d9d5faea1dce", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.282177, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.094762", "ticker_sentiment_score": "0.209461", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TMDIF", "relevance_score": "0.188193", "ticker_sentiment_score": "0.219211", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Thermo Fisher  ( TMO )  Down 4.1% Since Last Earnings Report: Can It Rebound?", "url": "https://www.zacks.com/stock/news/2100421/thermo-fisher-tmo-down-41-since-last-earnings-report-can-it-rebound", "time_published": "20230526T153128", "authors": ["Zacks Investment Research"], "summary": "Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default113.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9996"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}], "overall_sentiment_score": 0.047612, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.237551", "ticker_sentiment_score": "0.063654", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.060236", "ticker_sentiment_score": "-0.004013", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Incredible Growth Stocks That Could Make a Comeback in 2023", "url": "https://www.fool.com/investing/2023/05/26/2-incredible-growth-stocks-that-could-make-a-comeb/", "time_published": "20230526T141500", "authors": ["Rachel Warren"], "summary": "These companies are changing the future of their respective industries.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F733304%2Fbuffett13-tmf.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.891286"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.225237, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "FVRR", "relevance_score": "0.237204", "ticker_sentiment_score": "0.087227", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.190793", "ticker_sentiment_score": "0.190084", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Solid Earnings Fuel Potential Bull Market in Medical Devices", "url": "https://www.zacks.com/stock/news/2100240/solid-earnings-fuel-potential-bull-market-in-medical-devices", "time_published": "20230526T135100", "authors": ["Zacks Investment Research"], "summary": "CNBC's Jim Cramer predicts a booming bull market for medical devices, with positive earnings reports across the space. INMD, JNJ, ISRG and GEHC can emerge as potential winners.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/09/2677.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.839681"}], "overall_sentiment_score": 0.317122, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GEHC", "relevance_score": "0.170475", "ticker_sentiment_score": "0.15112", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.384608", "ticker_sentiment_score": "0.494259", "ticker_sentiment_label": "Bullish"}, {"ticker": "INMD", "relevance_score": "0.384608", "ticker_sentiment_score": "0.291234", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.384608", "ticker_sentiment_score": "0.31924", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "3 No-Brainer Stocks to Buy in a Correction", "url": "https://www.fool.com/investing/2023/05/26/3-no-brainer-stocks-to-buy-in-a-correction/", "time_published": "20230526T103200", "authors": ["Selena Maranjian"], "summary": "Stock market downturns present great opportunities to go shopping for wonderful stocks.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F733741%2Fgettyimages-1056449108.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Earnings", "relevance_score": "0.858979"}, {"topic": "Energy & Transportation", "relevance_score": "0.5"}], "overall_sentiment_score": 0.167166, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DGX", "relevance_score": "0.054983", "ticker_sentiment_score": "0.07883", "ticker_sentiment_label": "Neutral"}, {"ticker": "LH", "relevance_score": "0.109705", "ticker_sentiment_score": "0.086319", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.109705", "ticker_sentiment_score": "0.094703", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEE", "relevance_score": "0.163909", "ticker_sentiment_score": "0.18666", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  is Attracting Investor Attention: Here is What You Should Know", "url": "https://www.zacks.com/stock/news/2099564/intuitive-surgical-inc-isrg-is-attracting-investor-attention-here-is-what-you-should-know", "time_published": "20230525T130006", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default360.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.210596, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.507331", "ticker_sentiment_score": "0.131804", "ticker_sentiment_label": "Neutral"}]}, {"title": "NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales", "url": "https://www.globenewswire.com/news-release/2023/05/24/2675668/0/en/NeuroPace-Announces-Addition-of-Kelley-Nicholas-as-Vice-President-Sales.html", "time_published": "20230524T200500", "authors": ["NeuroPace", "Inc."], "summary": "To focus on commercial growth, including expanding adoption and driving higher utilization of NeuroPace's RNS System To focus on commercial growth, including expanding adoption and driving higher utilization of NeuroPace's RNS System ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.218101, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NPCE", "relevance_score": "0.389636", "ticker_sentiment_score": "0.259586", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HOLX", "relevance_score": "0.151539", "ticker_sentiment_score": "0.07775", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.050786", "ticker_sentiment_score": "0.10138", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.050786", "ticker_sentiment_score": "0.10138", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.050786", "ticker_sentiment_score": "0.05895", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical  ( ISRG )  Hits 52-Week High: What's Driving It?", "url": "https://www.zacks.com/stock/news/2098625/intuitive-surgical-isrg-hits-52-week-high-whats-driving-it", "time_published": "20230523T155600", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical (ISRG) outperforms the industry and the S&P 500 Index due to its strength in robotics.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/61/11728.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.890401"}], "overall_sentiment_score": 0.319352, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "WST", "relevance_score": "0.167322", "ticker_sentiment_score": "0.081396", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMSI", "relevance_score": "0.167322", "ticker_sentiment_score": "0.119636", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.426824", "ticker_sentiment_score": "0.29055", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRGO", "relevance_score": "0.112008", "ticker_sentiment_score": "0.056033", "ticker_sentiment_label": "Neutral"}]}, {"title": "Should First Trust NASDAQ-100 Equal Weighted ETF  ( QQEW )  Be on Your Investing Radar?", "url": "https://www.zacks.com/stock/news/2098304/should-first-trust-nasdaq-100-equal-weighted-etf-qqew-be-on-your-investing-radar", "time_published": "20230523T102005", "authors": ["Zacks Investment Research"], "summary": "Style Box ETF report for ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default25.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999994"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.233315, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LCID", "relevance_score": "0.116914", "ticker_sentiment_score": "0.060317", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.116914", "ticker_sentiment_score": "0.101724", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.116914", "ticker_sentiment_score": "0.060317", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.116914", "ticker_sentiment_score": "0.060317", "ticker_sentiment_label": "Neutral"}]}, {"title": "Medical device companies are in an 'emerging bull market,' Jim Cramer says", "url": "https://www.cnbc.com/2023/05/22/medical-device-companies-are-in-an-emerging-bull-market-jim-cramer-says.html", "time_published": "20230522T231340", "authors": ["Julie Coleman"], "summary": "CNBC's Jim Cramer touted the burgeoning bull market of medical devices, which is taking off post Covid.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107243731-1684454364693-gettyimages-1254161031-AFP_33EX9LE.jpeg?v=1684769394", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.891286"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.109019, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.073546", "ticker_sentiment_score": "-0.090564", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.073546", "ticker_sentiment_score": "0.164543", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "INMD", "relevance_score": "0.218161", "ticker_sentiment_score": "-0.075638", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.146469", "ticker_sentiment_score": "0.389319", "ticker_sentiment_label": "Bullish"}]}, {"title": "3 Healthcare Trends to Ride for Longevity", "url": "https://www.zacks.com/commentary/2098205/3-healthcare-trends-to-ride-for-longevity", "time_published": "20230522T201500", "authors": ["Zacks Investment Research"], "summary": "Because of their longevity, predictability, and stability, healthcare trends can persist for years. The companies covered today are fundamentally and technically robust stocks currently taking advantage of these trends.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/82/41137.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}], "overall_sentiment_score": 0.313339, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SYK", "relevance_score": "0.141726", "ticker_sentiment_score": "-0.026767", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.094762", "ticker_sentiment_score": "0.222956", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVO", "relevance_score": "0.141726", "ticker_sentiment_score": "0.0142", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWAV", "relevance_score": "0.141726", "ticker_sentiment_score": "0.055742", "ticker_sentiment_label": "Neutral"}]}, {"title": "Luna in the Spotlight: Analyst Initiates Coverage with High Hopes for Revenue and EPS Growth - Luna Innovations  ( NASDAQ:LUNA ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/05/32514217/luna-in-the-spotlight-analyst-initiates-coverage-with-high-hopes-for-revenue-and-ep", "time_published": "20230522T190943", "authors": ["Lekha Gupta"], "summary": "Needham analyst Alex Henderson initiated coverage on Luna Innovations Inc LUNA at a Buy rating with a price target of $10. The analyst believes in LUNA's strategy of building a robust diagnostics business around fiber technologies.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/22/luna.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.317466, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EADSF", "relevance_score": "0.329551", "ticker_sentiment_score": "0.628365", "ticker_sentiment_label": "Bullish"}, {"ticker": "LMT", "relevance_score": "0.329551", "ticker_sentiment_score": "0.628365", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.329551", "ticker_sentiment_score": "0.190126", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LUNA", "relevance_score": "0.47672", "ticker_sentiment_score": "0.182447", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's How Much You Would Have Made Owning Intuitive Surgical Stock In The Last 20 Years - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/23/05/32511997/heres-how-much-you-would-have-made-owning-intuitive-surgical-stock-in-the-last-20-years", "time_published": "20230522T160027", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 20 years by 21.37% on an annualized basis producing an average annual return of 29.05%. Currently, Intuitive Surgical has a market capitalization of $111.00 billion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "Warren Buffett's Berkshire Hathaway And Two More Stocks Hit New Highs", "url": "https://www.investors.com/stock-lists/new-highs/new-highs-warren-buffetts-berkshire-hathaway-hits-fresh-peak/", "time_published": "20230519T183700", "authors": ["VIDYA RAMAKRISHNAN", "Investor's Business Daily"], "summary": "New Highs: Warren Buffett's Berkshire Hathaway Hits Fresh Peak ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2023/05/SMT-warrenbuffett-0519-news.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.955357"}, {"topic": "Earnings", "relevance_score": "0.917436"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.287052, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.235823", "ticker_sentiment_score": "0.173942", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LPG", "relevance_score": "0.34729", "ticker_sentiment_score": "0.292289", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BRK-A", "relevance_score": "0.119235", "ticker_sentiment_score": "-0.020989", "ticker_sentiment_label": "Neutral"}]}, {"title": "Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime", "url": "https://www.fool.com/investing/2023/05/18/got-2500-2-top-stocks-that-you-can-buy-and-hold-fo/", "time_published": "20230518T095200", "authors": ["Keith Speights"], "summary": "Buy these stocks, then...do nothing.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732462%2Fstock-chart-quote-bear-bull-trading-invest-short-options-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.972756"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.336785, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AAPL", "relevance_score": "0.720958", "ticker_sentiment_score": "0.533368", "ticker_sentiment_label": "Bullish"}, {"ticker": "MDT", "relevance_score": "0.061631", "ticker_sentiment_score": "0.149452", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.300946", "ticker_sentiment_score": "0.439977", "ticker_sentiment_label": "Bullish"}, {"ticker": "BRK-A", "relevance_score": "0.061631", "ticker_sentiment_score": "0.1811", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.061631", "ticker_sentiment_score": "0.149452", "ticker_sentiment_label": "Neutral"}]}, {"title": "What Is Artificial Intelligence?", "url": "https://www.fool.com/terms/a/artificial-intelligence/", "time_published": "20230517T203943", "authors": ["Motley Fool Staff"], "summary": "Artificial intelligence uses machines -- generally, computers -- to mimic human intelligence. Although there are debates about its utility, AI has become common in applications that range from the creation of generative chatbots to the selections displayed in your Netflix queue.", "banner_image": "https://m.foolcdn.com/media/dubs/images/nvidia-nvda-stock-ai-artificial-intelligence-2.width-880.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.188463, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.1331", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.066784", "ticker_sentiment_score": "0.152425", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOOG", "relevance_score": "0.1331", "ticker_sentiment_score": "0.187035", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PINS", "relevance_score": "0.1331", "ticker_sentiment_score": "0.004853", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.1331", "ticker_sentiment_score": "0.055635", "ticker_sentiment_label": "Neutral"}]}, {"title": "20 AI stocks expected to post the highest compound annual sales growth through 2025", "url": "https://www.marketwatch.com/story/20-ai-stocks-expected-to-post-the-highest-compound-annual-sales-growth-through-2025-17f4f293", "time_published": "20230517T165800", "authors": ["Philip van Doorn"], "summary": "AI is \"the next new thing\" in tech, but unlike other investment fads, this one seems likely to have staying power as it transforms many industries.", "banner_image": "https://images.mktw.net/im-783595/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.980509"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.980716"}], "overall_sentiment_score": 0.212631, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.09402", "ticker_sentiment_score": "0.126739", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTAI", "relevance_score": "0.09402", "ticker_sentiment_score": "0.125523", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.09402", "ticker_sentiment_score": "0.126739", "ticker_sentiment_label": "Neutral"}, {"ticker": "WT", "relevance_score": "0.047092", "ticker_sentiment_score": "0.119661", "ticker_sentiment_label": "Neutral"}]}, {"title": "Which Healthcare Stock Is A Better Pick: Abbott Or This Robotic Products Company?", "url": "https://www.forbes.com/sites/greatspeculations/2023/05/15/which-healthcare-stock-is-a-better-pick-abbott-or-this-robotic-products-company/", "time_published": "20230515T123045", "authors": ["Trefis Team"], "summary": "There is more to the comparison, and in the sections below, we discuss why we believe ISRG stock will offer higher returns than ABT stock in the next three years.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/61efad4cf236864124c99299/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Money", "source_domain": "www.forbes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.723405"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.202687, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.744916", "ticker_sentiment_score": "0.381758", "ticker_sentiment_label": "Bullish"}, {"ticker": "XYL", "relevance_score": "0.03631", "ticker_sentiment_score": "0.137152", "ticker_sentiment_label": "Neutral"}]}, {"title": " ( ISRG )  - Analyzing Intuitive Surgical's Short Interest - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/short-sellers/23/05/32370486/isrg-analyzing-intuitive-surgicals-short-interest", "time_published": "20230512T181603", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical's ISRG short percent of float has risen 16.95% since its last report. The company recently reported that it has 2.42 million shares sold short, which is 0.69% of all regular shares that are available for trading.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.287384, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.221819", "ticker_sentiment_score": "0.184023", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "STERIS  ( STE )  Q4 Earnings Beat Estimates, Gross Margin Falls", "url": "https://www.zacks.com/stock/news/2094734/steris-ste-q4-earnings-beat-estimates-gross-margin-falls", "time_published": "20230512T134700", "authors": ["Zacks Investment Research"], "summary": "Heading into fiscal 2024, STERIS (STE) expects many of its fiscal 2023 challenges to abate, including procedure volumes and supply chain constraints.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/94/1507.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.091675, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.187463", "ticker_sentiment_score": "0.00452", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.187463", "ticker_sentiment_score": "0.005948", "ticker_sentiment_label": "Neutral"}, {"ticker": "STE", "relevance_score": "0.40638", "ticker_sentiment_score": "0.110426", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.187463", "ticker_sentiment_score": "0.060027", "ticker_sentiment_label": "Neutral"}]}, {"title": "Haemonetics  ( HAE )  Q4 Earnings and Revenues Top Estimates", "url": "https://www.zacks.com/stock/news/2094599/haemonetics-hae-q4-earnings-and-revenues-top-estimates", "time_published": "20230512T123200", "authors": ["Zacks Investment Research"], "summary": "Amid a challenging economic environment, Haemonetics (HAE) delivers impressive fiscal fourth-quarter organic revenues, led by the stellar performance across the Plasma and Hospital business.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/eb/4111.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.148115, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.157483", "ticker_sentiment_score": "-0.025429", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAE", "relevance_score": "0.41518", "ticker_sentiment_score": "0.335595", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.157483", "ticker_sentiment_score": "0.005269", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.157483", "ticker_sentiment_score": "0.05317", "ticker_sentiment_label": "Neutral"}]}, {"title": "Can You Still Buy the Nasdaq's Best-Performing April Stocks?", "url": "https://www.fool.com/investing/2023/05/12/can-you-still-buy-the-nasdaqs-best-performing-apri/", "time_published": "20230512T112100", "authors": ["Jeremy Bowman"], "summary": "Last month's winners could have more room to run.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F731390%2Fbuffett8-tmf.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}, {"topic": "Earnings", "relevance_score": "0.999998"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.254377, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.34729", "ticker_sentiment_score": "0.336385", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "META", "relevance_score": "0.29234", "ticker_sentiment_score": "0.305362", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CSGP", "relevance_score": "0.119235", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Things You Shouldn't Do if the Stock Market Crashes", "url": "https://www.fool.com/investing/2023/05/12/3-things-you-shouldnt-do-if-the-stock-market-crash/", "time_published": "20230512T105500", "authors": ["Bradley Guichard"], "summary": "Avoiding these things could prevent financial ruin and keep long-term goals intact.", "banner_image": "https://media.ycharts.com/charts/efd82f4f135a088c8bd68f41977677e0.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.014898, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.059935", "ticker_sentiment_score": "0.053826", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.059935", "ticker_sentiment_score": "0.053826", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.059935", "ticker_sentiment_score": "0.053826", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.059935", "ticker_sentiment_score": "0.053826", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.059935", "ticker_sentiment_score": "0.016037", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Things About Intuitive Surgical That Smart Investors Know", "url": "https://www.fool.com/investing/2023/05/12/things-about-intuitive-surgical-smart-investors/", "time_published": "20230512T095000", "authors": ["Sushree Mohanty"], "summary": "Intuitive's business model makes it stand out in the medical device industry.", "banner_image": "https://media.ycharts.com/charts/6bc482b675f8befef407e3d7d2237236.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.955357"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.261717, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.060236", "ticker_sentiment_score": "0.173506", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.179343", "ticker_sentiment_score": "0.08143", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.060236", "ticker_sentiment_score": "0.173506", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Alcon  ( ALC )  Q1 Earnings Surpass Estimates, 23' EPS View Up", "url": "https://www.zacks.com/stock/news/2094384/alcon-alc-q1-earnings-surpass-estimates-23-eps-view-up", "time_published": "20230511T164000", "authors": ["Zacks Investment Research"], "summary": "Alcon (ALC) Q1 revenues were driven by strong consumables and equipment sales.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.999939"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.1155, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALC", "relevance_score": "0.262052", "ticker_sentiment_score": "0.238023", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EW", "relevance_score": "0.176502", "ticker_sentiment_score": "-0.002923", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.176502", "ticker_sentiment_score": "0.005698", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.176502", "ticker_sentiment_score": "0.058966", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Retain Walgreens Boots  ( WBA )  For Now", "url": "https://www.zacks.com/stock/news/2094383/heres-why-you-should-retain-walgreens-boots-wba-for-now", "time_published": "20230511T163700", "authors": ["Zacks Investment Research"], "summary": "Investors are optimistic about Walgreens Boots (WBA) on consistent partnership growth and a strong focus on strategic execution.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1108.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.997874"}], "overall_sentiment_score": 0.196114, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.199447", "ticker_sentiment_score": "-0.003201", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.100518", "ticker_sentiment_score": "0.182645", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.199447", "ticker_sentiment_score": "0.006239", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.199447", "ticker_sentiment_score": "0.064556", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBA", "relevance_score": "0.100518", "ticker_sentiment_score": "0.192701", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Charles River  ( CRL )  Q1 Earnings Top Estimates, View Narrowed", "url": "https://www.zacks.com/stock/news/2094318/charles-river-crl-q1-earnings-top-estimates-view-narrowed", "time_published": "20230511T154200", "authors": ["Zacks Investment Research"], "summary": "Charles River (CRL) registers robust growth in small research models, research model services and the Cell Solutions business.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/0c/2749.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.18929, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.17813", "ticker_sentiment_score": "0.004354", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRL", "relevance_score": "0.17813", "ticker_sentiment_score": "0.075098", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.17813", "ticker_sentiment_score": "0.00573", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.17813", "ticker_sentiment_score": "0.057831", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.044885", "ticker_sentiment_score": "0.157911", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "NuVasive  ( NUVA )  Q1 Earnings Beat Estimates, Margins Fall", "url": "https://www.zacks.com/stock/news/2094294/nuvasive-nuva-q1-earnings-beat-estimates-margins-fall", "time_published": "20230511T152600", "authors": ["Zacks Investment Research"], "summary": "NuVasive's (NUVA) strong sales across the U.S. Spinal Hardware and U.S. Surgical Support businesses instill optimism.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a0/644.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}, {"topic": "Earnings", "relevance_score": "0.999816"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.125217, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.185662", "ticker_sentiment_score": "0.004488", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMED", "relevance_score": "0.09347", "ticker_sentiment_score": "0.117104", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.185662", "ticker_sentiment_score": "0.005906", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVA", "relevance_score": "0.402761", "ticker_sentiment_score": "0.102956", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.185662", "ticker_sentiment_score": "0.0596", "ticker_sentiment_label": "Neutral"}]}, {"title": "Syneos Health  ( SYNH )  Tops Q1 Earnings, Announces Merger Plan", "url": "https://www.zacks.com/stock/news/2094120/syneos-health-synh-tops-q1-earnings-announces-merger-plan", "time_published": "20230511T131900", "authors": ["Zacks Investment Research"], "summary": "Syneos Health's (SYNH) first-quarter 2023 earnings and revenues beat estimates. The company enters into a definitive merger agreement to be acquired by a private investment consortium.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.992549"}, {"topic": "Earnings", "relevance_score": "0.999954"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.157316, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.09402", "ticker_sentiment_score": "0.219727", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EW", "relevance_score": "0.186738", "ticker_sentiment_score": "-0.02864", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.186738", "ticker_sentiment_score": "0.00593", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.186738", "ticker_sentiment_score": "0.059855", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYNH", "relevance_score": "0.624289", "ticker_sentiment_score": "0.309907", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  is Attracting Investor Attention: Here is What You Should Know", "url": "https://www.zacks.com/stock/news/2094095/intuitive-surgical-inc-isrg-is-attracting-investor-attention-here-is-what-you-should-know", "time_published": "20230511T130009", "authors": ["Zacks Investment Research"], "summary": "Zacks.com users have recently been watching Intuitive Surgical, Inc. (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default359.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.623304"}], "overall_sentiment_score": 0.239306, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.508232", "ticker_sentiment_score": "0.181043", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "BOTZ: 3 AI ETFs to Buy Now for Rapid Growth", "url": "https://stocknews.com/news/botz-robo-irbo-3-ai-etfs-to-buy-now-for-rapid-growth/", "time_published": "20230511T113355", "authors": [], "summary": "AI is a trending technology that intelligently renovates businesses' operational flows across various industries. Given the enormous potential of AI applications, companies and consumers are significantly boosting their AI adoption and investment.", "banner_image": "https://stocknews.com/wp-content/uploads/2022/06/AI_1200x630.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "stocknews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999174"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.273604, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABB", "relevance_score": "0.035345", "ticker_sentiment_score": "0.144176", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.070621", "ticker_sentiment_score": "0.130721", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.070621", "ticker_sentiment_score": "0.150892", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KYCCF", "relevance_score": "0.070621", "ticker_sentiment_score": "0.119634", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.070621", "ticker_sentiment_score": "0.130721", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZTA", "relevance_score": "0.035345", "ticker_sentiment_score": "0.078012", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQ", "relevance_score": "0.070621", "ticker_sentiment_score": "0.130721", "ticker_sentiment_label": "Neutral"}, {"ticker": "IT", "relevance_score": "0.035345", "ticker_sentiment_score": "0.148103", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRDXF", "relevance_score": "0.035345", "ticker_sentiment_score": "0.078012", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.14069", "ticker_sentiment_score": "0.145723", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEIUF", "relevance_score": "0.035345", "ticker_sentiment_score": "0.124598", "ticker_sentiment_label": "Neutral"}]}, {"title": "SmileDirectClub  ( SDC )  Q1 Earnings Miss, Gross Margin Up", "url": "https://www.zacks.com/stock/news/2093682/smiledirectclub-sdc-q1-earnings-miss-gross-margin-up", "time_published": "20230510T154200", "authors": ["Zacks Investment Research"], "summary": "SmileDirectClub (SDC) Q1 revenues are affected by persistent macroeconomic headwinds.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.990786"}], "overall_sentiment_score": -0.040299, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.21686", "ticker_sentiment_score": "-0.001706", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDC", "relevance_score": "0.508593", "ticker_sentiment_score": "-0.012984", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.21686", "ticker_sentiment_score": "0.006656", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.21686", "ticker_sentiment_score": "0.067141", "ticker_sentiment_label": "Neutral"}]}, {"title": "Exact Sciences  ( EXAS )  Q1 Earnings Top, Sales View Raised", "url": "https://www.zacks.com/stock/news/2093375/exact-sciences-exas-q1-earnings-top-sales-view-raised", "time_published": "20230510T133700", "authors": ["Zacks Investment Research"], "summary": "The upside in Exact Sciences' (EXAS) screening revenues is primarily coming from broad-based momentum in Cologuard adoption.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/27/21481.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.998311"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.016797, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.199447", "ticker_sentiment_score": "-0.028525", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.050359", "ticker_sentiment_score": "0.061474", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAS", "relevance_score": "0.386626", "ticker_sentiment_score": "0.049177", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.199447", "ticker_sentiment_score": "0.006234", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.199447", "ticker_sentiment_score": "0.0629", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why AI Stocks Could Be Your Key to Profits in 2023 and Beyond", "url": "https://www.fool.com/investing/2023/05/10/why-ai-stocks-could-be-your-key-to-profits-in-2023/", "time_published": "20230510T110300", "authors": ["Anders Bylund"], "summary": "Unleash your portfolio's long-term potential with the unstoppable force of AI stocks.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730945%2Fdrawing-growth-of-money-over-time.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.298594, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.037741", "ticker_sentiment_score": "0.103101", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDOC", "relevance_score": "0.037741", "ticker_sentiment_score": "0.162542", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.037741", "ticker_sentiment_score": "-0.016654", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBM", "relevance_score": "0.037741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "F", "relevance_score": "0.037741", "ticker_sentiment_score": "-0.016654", "ticker_sentiment_label": "Neutral"}, {"ticker": "GM", "relevance_score": "0.037741", "ticker_sentiment_score": "-0.016654", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.037741", "ticker_sentiment_score": "0.103101", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.075397", "ticker_sentiment_score": "0.188925", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HCSG", "relevance_score": "0.037741", "ticker_sentiment_score": "0.221441", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Henry Schein  ( HSIC )  Q1 Earnings Miss, Operating Margin Dips", "url": "https://www.zacks.com/stock/news/2092454/henry-schein-hsic-q1-earnings-miss-operating-margin-dips", "time_published": "20230509T150300", "authors": ["Zacks Investment Research"], "summary": "Henry Schein's (HSIC) first-quarter results largely reflect lower contributions from the sales of PPE products and COVID-19 test kits.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/79/961.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}, {"topic": "Earnings", "relevance_score": "0.99986"}], "overall_sentiment_score": 0.085303, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CURN", "relevance_score": "0.153961", "ticker_sentiment_score": "-0.070538", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.153961", "ticker_sentiment_score": "-0.025063", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSIC", "relevance_score": "0.439786", "ticker_sentiment_score": "0.095284", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.153961", "ticker_sentiment_score": "0.005194", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.153961", "ticker_sentiment_score": "0.052409", "ticker_sentiment_label": "Neutral"}]}, {"title": "Omnicell's  ( OMCL )  New Acquisitions Aid Growth, Cost Woes Stay", "url": "https://www.zacks.com/stock/news/2092444/omnicells-omcl-new-acquisitions-aid-growth-cost-woes-stay", "time_published": "20230509T145100", "authors": ["Zacks Investment Research"], "summary": "Omnicell (OMCL) remains well-positioned to meet pharmacy and hospital needs, backed by the recent acquisitions and expansion of its advanced services solutions.", "banner_image": "https://www.zacks.com/images/articles/main/e7/288.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.16346, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.194632", "ticker_sentiment_score": "-0.003142", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.333685", "ticker_sentiment_score": "0.274882", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.194632", "ticker_sentiment_score": "0.006124", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.194632", "ticker_sentiment_score": "0.063365", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bruker's  ( BRKR )  New Buyout to Advance Digital Transformation", "url": "https://www.zacks.com/stock/news/2092451/brukers-brkr-new-buyout-to-advance-digital-transformation", "time_published": "20230509T140200", "authors": ["Zacks Investment Research"], "summary": "Bruker's (BRKR) IDS division expands its unique vendor-agnostic software solutions portfolio by integrating ZONTAL with the Mestrelab Research and Arxspan scientific software solutions.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e7/288.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.967321"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.30606, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BRKR", "relevance_score": "0.442853", "ticker_sentiment_score": "0.438979", "ticker_sentiment_label": "Bullish"}, {"ticker": "DTST", "relevance_score": "0.046816", "ticker_sentiment_score": "0.156491", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EW", "relevance_score": "0.185662", "ticker_sentiment_score": "-0.003032", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.185662", "ticker_sentiment_score": "0.005911", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.185662", "ticker_sentiment_score": "0.061169", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Retain Abbott  ( ABT )  Stock For Now", "url": "https://www.zacks.com/stock/news/2092431/heres-why-you-should-retain-abbott-abt-stock-for-now", "time_published": "20230509T133700", "authors": ["Zacks Investment Research"], "summary": "Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/db/2802.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99915"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.242685, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.195419", "ticker_sentiment_score": "-0.003151", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.098456", "ticker_sentiment_score": "0.155885", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.195419", "ticker_sentiment_score": "-0.041668", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.195419", "ticker_sentiment_score": "0.063559", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.049322", "ticker_sentiment_score": "0.055924", "ticker_sentiment_label": "Neutral"}]}, {"title": "Teleflex  ( TFX )  Q1 Earnings Top Estimates, 2023 Sales View Up", "url": "https://www.zacks.com/stock/news/2091676/teleflex-tfx-q1-earnings-top-estimates-2023-sales-view-up", "time_published": "20230508T145000", "authors": ["Zacks Investment Research"], "summary": "Teleflex (TFX) registers growth across the majority of its businesses, including double-digit increases in interventional and surgical revenues in Q1.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e7/288.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.167929, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.178459", "ticker_sentiment_score": "-0.001471", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.178459", "ticker_sentiment_score": "0.005738", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.178459", "ticker_sentiment_score": "0.057908", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFX", "relevance_score": "0.348103", "ticker_sentiment_score": "0.30883", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AI Could Be a $14 Trillion Opportunity by 2030: Here Are 2 No-Brainer Stocks to Buy Now", "url": "https://www.fool.com/investing/2023/05/07/ai-could-be-a-14-trillion-opportunity-by-2030-here/", "time_published": "20230507T115200", "authors": ["Manali Bhade"], "summary": "The future looks bright for all of these AI-powered stocks.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F731141%2Fbear-market-stock-chart-quarter-report-financial-metrics-invest-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.24937, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.354319", "ticker_sentiment_score": "0.335447", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.269776", "ticker_sentiment_score": "0.040935", "ticker_sentiment_label": "Neutral"}]}, {"title": "Avanos  ( AVNS )  Q1 Earnings and Revenues Fall Shy of Estimates", "url": "https://www.zacks.com/stock/news/2091167/avanos-avns-q1-earnings-and-revenues-fall-shy-of-estimates", "time_published": "20230505T184900", "authors": ["Zacks Investment Research"], "summary": "Despite strength in Avanos' (AVNS) Chronic Care segment, its overall first-quarter results reflect soft performances.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/53/11339.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.012143, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AVNS", "relevance_score": "0.222022", "ticker_sentiment_score": "0.089819", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.178459", "ticker_sentiment_score": "0.005736", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAH", "relevance_score": "0.178459", "ticker_sentiment_score": "-0.007288", "ticker_sentiment_label": "Neutral"}]}, {"title": "Globus Medical  ( GMED )  Q1 Earnings Beat, Operating Margin Dips", "url": "https://www.zacks.com/stock/news/2091102/globus-medical-gmed-q1-earnings-beat-operating-margin-dips", "time_published": "20230505T172300", "authors": ["Zacks Investment Research"], "summary": "The significant year-over-year surge in Globus Medical's (GMED) Enabling Technologies sales is driven by ongoing demand for the company's robotics and imaging system technologies.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/0c/2749.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.999993"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.251328, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.174903", "ticker_sentiment_score": "0.004298", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMED", "relevance_score": "0.341503", "ticker_sentiment_score": "0.30126", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.174903", "ticker_sentiment_score": "0.005656", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVA", "relevance_score": "0.04406", "ticker_sentiment_score": "0.271768", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.174903", "ticker_sentiment_score": "0.057083", "ticker_sentiment_label": "Neutral"}]}, {"title": "Insulet  ( PODD )  Q1 Earnings Beat Estimates, Sales View Up", "url": "https://www.zacks.com/stock/news/2091100/insulet-podd-q1-earnings-beat-estimates-sales-view-up", "time_published": "20230505T172100", "authors": ["Zacks Investment Research"], "summary": "Omnipod 5 continues to be a driving force of Insulet's (PODD) strong U.S. growth, representing almost 95% of U.S. new customer starts in the first quarter.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/94/1507.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.073556, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.196212", "ticker_sentiment_score": "0.004681", "ticker_sentiment_label": "Neutral"}, {"ticker": "PODD", "relevance_score": "0.423843", "ticker_sentiment_score": "0.357646", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.196212", "ticker_sentiment_score": "0.006155", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.196212", "ticker_sentiment_score": "0.060554", "ticker_sentiment_label": "Neutral"}]}, {"title": "AMN Healthcare  ( AMN )  Q1 Earnings and Revenues Beat Estimates", "url": "https://www.zacks.com/stock/news/2091004/amn-healthcare-amn-q1-earnings-and-revenues-beat-estimates", "time_published": "20230505T153600", "authors": ["Zacks Investment Research"], "summary": "AMN Healthcare's (AMN) dismal results in all its segments led to a soft overall Q1 performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/79/359.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Earnings", "relevance_score": "0.999966"}], "overall_sentiment_score": -0.004808, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AMN", "relevance_score": "0.55971", "ticker_sentiment_score": "0.068982", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAH", "relevance_score": "0.152983", "ticker_sentiment_score": "-0.006566", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.152983", "ticker_sentiment_score": "0.005172", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.115048", "ticker_sentiment_score": "-0.019298", "ticker_sentiment_label": "Neutral"}]}, {"title": "Inogen  ( INGN )  Q1 Earnings Beat Estimates, Revenues Lag", "url": "https://www.zacks.com/stock/news/2090988/inogen-ingn-q1-earnings-beat-estimates-revenues-lag", "time_published": "20230505T152900", "authors": ["Zacks Investment Research"], "summary": "Despite higher domestic business-to-business sales and rental revenues, Inogen's (INGN) overall first-quarter results reflect soft performances.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.999816"}], "overall_sentiment_score": 0.00958, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.17813", "ticker_sentiment_score": "0.005728", "ticker_sentiment_label": "Neutral"}, {"ticker": "INGN", "relevance_score": "0.500592", "ticker_sentiment_score": "-0.029255", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAH", "relevance_score": "0.17813", "ticker_sentiment_score": "-0.007279", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Intuitive Surgical Stock Soared 18% Higher in April", "url": "https://www.fool.com/investing/2023/05/05/why-intuitive-surgical-stock-soared-18-in-april/", "time_published": "20230505T141754", "authors": ["Anders Bylund"], "summary": "Is Intuitive Surgical poised for even more growth? Find out here.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730305%2Fbuffett13-tmf.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.947132"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.372384, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.18602", "ticker_sentiment_score": "0.53548", "ticker_sentiment_label": "Bullish"}, {"ticker": "SPGI", "relevance_score": "0.093653", "ticker_sentiment_score": "0.401807", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bruker  ( BRKR )  Tops Q1 Earnings Estimates, Raises '23 Outlook", "url": "https://www.zacks.com/stock/news/2090714/bruker-brkr-tops-q1-earnings-estimates-raises-23-outlook", "time_published": "20230505T115900", "authors": ["Zacks Investment Research"], "summary": "Bruker (BRKR) delivers a year-over-year revenue increase across all its segments in the first quarter, led by the strong demand for differentiated, high-performance scientific instruments and life-science solutions.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/2563.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.149943, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BRKR", "relevance_score": "0.45283", "ticker_sentiment_score": "0.289671", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EW", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.025592", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.159043", "ticker_sentiment_score": "0.005302", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.159043", "ticker_sentiment_score": "0.05351", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.079921", "ticker_sentiment_score": "0.139658", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Rad  ( BIO )  Q1 Earnings Beat Estimates, Operating Margin Down", "url": "https://www.zacks.com/stock/news/2090697/bio-rad-bio-q1-earnings-beat-estimates-operating-margin-down", "time_published": "20230505T113500", "authors": ["Zacks Investment Research"], "summary": "Bio-Rad's (BIO) first-quarter results reflect core strength across the Life Science and Clinical Diagnostics segments amid ongoing supply-chain constraints.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c7/282.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.016706, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BIO", "relevance_score": "0.207216", "ticker_sentiment_score": "0.029101", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.166455", "ticker_sentiment_score": "-0.026384", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.166455", "ticker_sentiment_score": "0.005465", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.166455", "ticker_sentiment_score": "0.055156", "ticker_sentiment_label": "Neutral"}]}, {"title": "Business of law: best practice in legal work", "url": "https://www.ft.com/content/b164f6c2-3f75-44f8-b19e-be2b242e1c57", "time_published": "20230505T040008", "authors": [], "summary": "A showcase of how law firms are innovating as businesses - from working with clients to developing their people ...", "banner_image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F501689e2-7e0b-4e4f-818e-6ad351ab978c.jpg?fit=scale-down&source=next&width=700", "source": "Financial Times", "category_within_source": "Companies", "source_domain": "www.ft.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.392346, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.016749", "ticker_sentiment_score": "0.144467", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHHLF", "relevance_score": "0.016749", "ticker_sentiment_score": "0.019691", "ticker_sentiment_label": "Neutral"}]}, {"title": "If You Invested $1000 In This Stock 20 Years Ago, You Would Have $210 Thousand Today - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/23/05/32220979/if-you-invested-1000-in-this-stock-20-years-ago-you-would-have-210-thousand-today", "time_published": "20230504T173124", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 20 years by 23.32% on an annualized basis producing an average annual return of 30.87%. Currently, Intuitive Surgical has a market capitalization of $106.03 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1256.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "Amedisys  ( AMED )  Q1 Earnings Beat Estimates, Margins Dip", "url": "https://www.zacks.com/stock/news/2090275/amedisys-amed-q1-earnings-beat-estimates-margins-dip", "time_published": "20230504T164700", "authors": ["Zacks Investment Research"], "summary": "Amedisys (AMED) sees a year-over-year decline in the Hospice segment's revenues.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a0/644.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999894"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.131403, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.195419", "ticker_sentiment_score": "0.004664", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMED", "relevance_score": "0.379291", "ticker_sentiment_score": "0.121617", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.195419", "ticker_sentiment_score": "0.036889", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.195419", "ticker_sentiment_score": "0.061929", "ticker_sentiment_label": "Neutral"}]}, {"title": "Tandem Diabetes  ( TNDM )  Q1 Earnings Miss, Gross Margin Dips", "url": "https://www.zacks.com/stock/news/2090267/tandem-diabetes-tndm-q1-earnings-miss-gross-margin-dips", "time_published": "20230504T164300", "authors": ["Zacks Investment Research"], "summary": "According to Tandem Diabetes (TNDM), Q1 revenues are in line with the high end of its expectations.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/0c/2749.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999997"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.016694, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.213517", "ticker_sentiment_score": "0.004996", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNDM", "relevance_score": "0.213517", "ticker_sentiment_score": "-0.008692", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.213517", "ticker_sentiment_score": "0.039514", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.213517", "ticker_sentiment_score": "0.066323", "ticker_sentiment_label": "Neutral"}]}, {"title": "OPKO Health  ( OPK )  Q1 Earnings and Revenues Top Estimates", "url": "https://www.zacks.com/stock/news/2090255/opko-health-opk-q1-earnings-and-revenues-top-estimates", "time_published": "20230504T162300", "authors": ["Zacks Investment Research"], "summary": "Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall first-quarter results reflect soft performances.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/27/21481.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99246"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.019202, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.139467", "ticker_sentiment_score": "-0.001254", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMSI", "relevance_score": "0.070002", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WGS", "relevance_score": "0.035035", "ticker_sentiment_score": "-0.050107", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSNUF", "relevance_score": "0.035035", "ticker_sentiment_score": "0.110819", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.490013", "ticker_sentiment_score": "-0.104419", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.139467", "ticker_sentiment_score": "0.004899", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.070002", "ticker_sentiment_score": "0.214404", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "QuidelOrtho  ( QDEL )  Q1 Earnings Top Estimates, FY23 View Revised", "url": "https://www.zacks.com/stock/news/2090215/quidelortho-qdel-q1-earnings-top-estimates-fy23-view-revised", "time_published": "20230504T160600", "authors": ["Zacks Investment Research"], "summary": "Despite solid performances by the Labs segment and China region, QuidelOrtho (QDEL) reports soft overall top-line results in first-quarter 2023.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.009548, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.138066", "ticker_sentiment_score": "-0.02226", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMSI", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.138066", "ticker_sentiment_score": "0.004873", "ticker_sentiment_label": "Neutral"}, {"ticker": "QDEL", "relevance_score": "0.398148", "ticker_sentiment_score": "-0.106753", "ticker_sentiment_label": "Neutral"}]}, {"title": "Phibro  ( PAHC )  Q3 Earnings Miss Estimates, Gross Margin Up", "url": "https://www.zacks.com/stock/news/2090216/phibro-pahc-q3-earnings-miss-estimates-gross-margin-up", "time_published": "20230504T151200", "authors": ["Zacks Investment Research"], "summary": "Higher domestic demand and higher average selling prices for dairy products and growth in the companion animal product drive Phibro's (PAHC) Q3 revenues.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999998"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": -0.0144, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PAHC", "relevance_score": "0.182506", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.182506", "ticker_sentiment_score": "-0.001495", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.182506", "ticker_sentiment_score": "0.005832", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.182506", "ticker_sentiment_score": "0.058855", "ticker_sentiment_label": "Neutral"}]}, {"title": "Envista  ( NVST )  Q1 Earnings Miss Estimates, Margins Down", "url": "https://www.zacks.com/stock/news/2090207/envista-nvst-q1-earnings-miss-estimates-margins-down", "time_published": "20230504T145500", "authors": ["Zacks Investment Research"], "summary": "Weakness in China and Russia and lower demand for large capital equipment hurts Envista's (NVST) Q1 revenues.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.028878, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.199447", "ticker_sentiment_score": "-0.001598", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.199447", "ticker_sentiment_score": "0.006234", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVST", "relevance_score": "0.386626", "ticker_sentiment_score": "-0.247617", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JNJ", "relevance_score": "0.199447", "ticker_sentiment_score": "0.0629", "ticker_sentiment_label": "Neutral"}]}, {"title": "BD  ( BDX )  Q2 Earnings Surpass Estimates, FY23 View Revised", "url": "https://www.zacks.com/stock/news/2090159/bd-bdx-q2-earnings-surpass-estimates-fy23-view-revised", "time_published": "20230504T145300", "authors": ["Zacks Investment Research"], "summary": "BD's (BDX) overall top line benefits from revenue growth in the majority of its segments and both geographic regions in the fiscal second quarter.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/79/359.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.12458, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.120582", "ticker_sentiment_score": "-0.020796", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMSI", "relevance_score": "0.060464", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.120582", "ticker_sentiment_score": "0.00456", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.120582", "ticker_sentiment_score": "0.113477", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardinal Health  ( CAH )  Beats on Q3 Earnings, Ups '23 EPS View", "url": "https://www.zacks.com/stock/news/2090156/cardinal-health-cah-beats-on-q3-earnings-ups-23-eps-view", "time_published": "20230504T144700", "authors": ["Zacks Investment Research"], "summary": "Cardinal Health's (CAH) fiscal third-quarter results benefit from the Pharmaceutical segment's solid performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/28/29444.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.999992"}], "overall_sentiment_score": 0.13094, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.222838", "ticker_sentiment_score": "0.102049", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.222838", "ticker_sentiment_score": "0.110944", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAH", "relevance_score": "0.428632", "ticker_sentiment_score": "0.39044", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.222838", "ticker_sentiment_score": "0.076545", "ticker_sentiment_label": "Neutral"}]}, {"title": "Want to Get Richer? 2 Best Stocks to Buy Now and Hold Forever", "url": "https://www.fool.com/investing/2023/05/04/want-to-get-richer-2-best-stocks-to-buy-and-hold/", "time_published": "20230504T135300", "authors": ["Sushree Mohanty"], "summary": "These two high-growth stocks have the potential to deliver solid long-term returns.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730363%2Fbuffett22-tmf.png&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99393"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}], "overall_sentiment_score": 0.328509, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TDOC", "relevance_score": "0.107736", "ticker_sentiment_score": "-0.172627", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MDT", "relevance_score": "0.053992", "ticker_sentiment_score": "0.104986", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.107736", "ticker_sentiment_score": "0.083147", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.053992", "ticker_sentiment_score": "0.104986", "ticker_sentiment_label": "Neutral"}]}, {"title": "Qiagen  ( QGEN )  Q1 Earnings Top Estimates, Operating Margin Down", "url": "https://www.zacks.com/stock/news/2089830/qiagen-qgen-q1-earnings-top-estimates-operating-margin-down", "time_published": "20230504T122700", "authors": ["Zacks Investment Research"], "summary": "Amid an uncertain macroeconomic environment, Qiagen's (QGEN) first-quarter results reflect an impressive organic top line, led by strength in non-COVID-19 product groups.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.037873, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.145364", "ticker_sentiment_score": "-0.024195", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.417419", "ticker_sentiment_score": "0.117102", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.145364", "ticker_sentiment_score": "0.005016", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.145364", "ticker_sentiment_score": "0.050607", "ticker_sentiment_label": "Neutral"}]}, {"title": "Myriad Genetics  ( MYGN )  Lags Q1 Earnings, Updates '23 View", "url": "https://www.zacks.com/stock/news/2089774/myriad-genetics-mygn-lags-q1-earnings-updates-23-view", "time_published": "20230504T120000", "authors": ["Zacks Investment Research"], "summary": "Myriad Genetics (MYGN) delivers a year-over-year increase in first-quarter revenues, reflecting a positive volume improvement across the portfolio.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/8e/391.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99737"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": -0.023941, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.177802", "ticker_sentiment_score": "-0.027632", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.177802", "ticker_sentiment_score": "0.005722", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.177802", "ticker_sentiment_score": "0.057755", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.425746", "ticker_sentiment_score": "0.129613", "ticker_sentiment_label": "Neutral"}]}, {"title": "Inari Medical  ( NARI )  Q1 Earnings Top, Revenues Rise Y/Y", "url": "https://www.zacks.com/stock/news/2089832/inari-medical-nari-q1-earnings-top-revenues-rise-yy", "time_published": "20230504T113100", "authors": ["Zacks Investment Research"], "summary": "Inari Medical's (NARI) first-quarter results benefit from significant progress made across all its growth drivers.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5d/41051.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999483"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.127079, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.222838", "ticker_sentiment_score": "0.100334", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.222838", "ticker_sentiment_score": "0.109262", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.222838", "ticker_sentiment_score": "0.100316", "ticker_sentiment_label": "Neutral"}, {"ticker": "NARI", "relevance_score": "0.428632", "ticker_sentiment_score": "0.283204", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Glaukos'  ( GKOS )  Q1 Earnings Beat Estimates, Sales Rise Y/Y", "url": "https://www.zacks.com/stock/news/2089791/glaukos-gkos-q1-earnings-beat-estimates-sales-rise-yy", "time_published": "20230504T111300", "authors": ["Zacks Investment Research"], "summary": "Glaukos' (GKOS) Q1 revenues beat estimates but fall year over year. Sales and gross margin improve, while higher operating expenses lead to wider operating loss.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5d/41051.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999965"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.081333, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GKOS", "relevance_score": "0.58781", "ticker_sentiment_score": "0.081408", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.215415", "ticker_sentiment_score": "0.09768", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.215415", "ticker_sentiment_score": "0.106369", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.215415", "ticker_sentiment_score": "0.097663", "ticker_sentiment_label": "Neutral"}]}, {"title": "CVS Health  ( CVS )  Q1 Earnings Surpass Estimates, EPS View Cut", "url": "https://www.zacks.com/stock/news/2089344/cvs-health-cvs-q1-earnings-surpass-estimates-eps-view-cut", "time_published": "20230503T182200", "authors": ["Zacks Investment Research"], "summary": "CVS Health's (CVS) robust sales growth across all three operating segments drives top-line results.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5a/926.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.999994"}], "overall_sentiment_score": 0.185773, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CVS", "relevance_score": "0.372139", "ticker_sentiment_score": "0.370992", "ticker_sentiment_label": "Bullish"}, {"ticker": "EW", "relevance_score": "0.170576", "ticker_sentiment_score": "0.004223", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.170576", "ticker_sentiment_score": "0.005557", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSH", "relevance_score": "0.085782", "ticker_sentiment_score": "0.233275", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.170576", "ticker_sentiment_score": "0.05609", "ticker_sentiment_label": "Neutral"}]}, {"title": "PacBio  ( PACB )  Tops on Q1 Earnings, Raises FY23 Revenue View", "url": "https://www.zacks.com/stock/news/2089182/pacbio-pacb-tops-on-q1-earnings-raises-fy23-revenue-view", "time_published": "20230503T153500", "authors": ["Zacks Investment Research"], "summary": "PacBio (PACB) witnesses strong revenue growth in the first quarter. This is partly aided by customers' product transition to the Revio system.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999691"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.009651, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.161982", "ticker_sentiment_score": "-0.001376", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMSI", "relevance_score": "0.081414", "ticker_sentiment_score": "0.048832", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTVA", "relevance_score": "0.04076", "ticker_sentiment_score": "0.114939", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.161982", "ticker_sentiment_score": "0.038916", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACB", "relevance_score": "0.201691", "ticker_sentiment_score": "0.196327", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "DENTSPLY SIRONA  ( XRAY )  Q1 Earnings & Revenues Beat Estimates", "url": "https://www.zacks.com/stock/news/2089149/dentsply-sirona-xray-q1-earnings-revenues-beat-estimates", "time_published": "20230503T144900", "authors": ["Zacks Investment Research"], "summary": "DENTSPLY SIRONA's (XRAY) Q1 earnings and revenues decline year over year, driven by the unfavorable foreign currency movement and soft demand across all geographical segments.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/266.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999986"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.071398, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.194632", "ticker_sentiment_score": "0.09186", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRAY", "relevance_score": "0.377855", "ticker_sentiment_score": "0.049108", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.194632", "ticker_sentiment_score": "0.067342", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.194632", "ticker_sentiment_score": "0.098356", "ticker_sentiment_label": "Neutral"}]}, {"title": "BOTZ: The Future of Robotics: 3 ETFs Investing in Robotic Technology", "url": "https://stocknews.com/news/botz-robo-thnq-the-future-of-robotics-3-etfs-investing-in-robotic-technology/", "time_published": "20230503T143905", "authors": [], "summary": "Digitization and the industry 4.0 revolution have boosted the growth of automation and robotics across industries.", "banner_image": "https://stocknews.com/wp-content/uploads/2021/07/shutterstock_199193084-scaled.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "stocknews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.999996"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.217861, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GIC", "relevance_score": "0.046816", "ticker_sentiment_score": "0.308838", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MSFT", "relevance_score": "0.09347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABB", "relevance_score": "0.046816", "ticker_sentiment_score": "0.041291", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.046816", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.185662", "ticker_sentiment_score": "0.030583", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZTA", "relevance_score": "0.09347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRDXF", "relevance_score": "0.046816", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.185662", "ticker_sentiment_score": "0.029124", "ticker_sentiment_label": "Neutral"}]}, {"title": "Penumbra  ( PEN )  Q1 Earnings Top Estimates, Sales Remain Robust", "url": "https://www.zacks.com/stock/news/2089135/penumbra-pen-q1-earnings-top-estimates-sales-remain-robust", "time_published": "20230503T132800", "authors": ["Zacks Investment Research"], "summary": "Penumbra's (PEN) sales during the first quarter reflect continued demand for its products. The 2023 outlook is encouraging as earnings improve despite macro challenges.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/55/4324.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999763"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.182446, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.53764", "ticker_sentiment_score": "0.277843", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EW", "relevance_score": "0.210731", "ticker_sentiment_score": "0.09601", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.210731", "ticker_sentiment_score": "0.071586", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.210731", "ticker_sentiment_score": "0.10455", "ticker_sentiment_label": "Neutral"}]}, {"title": "Inspire Medical  ( INSP )  Q1 Earnings & Revenues Top Estimates", "url": "https://www.zacks.com/stock/news/2089006/inspire-medical-insp-q1-earnings-revenues-top-estimates", "time_published": "20230503T124100", "authors": ["Zacks Investment Research"], "summary": "Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the first quarter.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/79/359.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.976913"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.246542, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "INSP", "relevance_score": "0.314246", "ticker_sentiment_score": "0.224483", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EW", "relevance_score": "0.182851", "ticker_sentiment_score": "-0.002997", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMSI", "relevance_score": "0.092036", "ticker_sentiment_score": "0.050902", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.182851", "ticker_sentiment_score": "0.042352", "ticker_sentiment_label": "Neutral"}]}, {"title": "Omnicell  ( OMCL )  Q1 Earnings Top Estimates, Margins Down", "url": "https://www.zacks.com/stock/news/2088752/omnicell-omcl-q1-earnings-top-estimates-margins-down", "time_published": "20230503T112200", "authors": ["Zacks Investment Research"], "summary": "Despite a year-over-year decrease, Omnicell's (OMCL) first-quarter revenues and earnings exceed the top end of the previously announced outlook amid an uncertain macroeconomic environment.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/b2/19786.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.087158, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.162255", "ticker_sentiment_score": "-0.025933", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.42666", "ticker_sentiment_score": "0.365137", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.162255", "ticker_sentiment_score": "0.005372", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.162255", "ticker_sentiment_score": "0.054218", "ticker_sentiment_label": "Neutral"}]}, {"title": "Can You Still Buy the S&P 500's Best-Performing April Stocks?", "url": "https://www.fool.com/investing/2023/05/03/can-you-still-buy-the-sp-500s-best-performing-apri/", "time_published": "20230503T095000", "authors": ["Keith Speights"], "summary": "One of these stocks appears to be a solid pick to buy right now for long-term investors.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730463%2Fartificial-intelligence-ai-on-circuit-board.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.998932"}], "overall_sentiment_score": 0.371711, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "CMG", "relevance_score": "0.137671", "ticker_sentiment_score": "0.220732", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.205225", "ticker_sentiment_score": "0.325289", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UHID", "relevance_score": "0.069094", "ticker_sentiment_score": "0.087301", "ticker_sentiment_label": "Neutral"}]}, {"title": "AmerisourceBergen  ( ABC )  Beats on Q2 Earnings, Ups '23 EPS View", "url": "https://www.zacks.com/stock/news/2088476/amerisourcebergen-abc-beats-on-q2-earnings-ups-23-eps-view", "time_published": "20230502T191400", "authors": ["Zacks Investment Research"], "summary": "AmerisourceBergen's (ABC) fiscal second-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e7/4322.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.234079, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CHE", "relevance_score": "0.157483", "ticker_sentiment_score": "0.084826", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURN", "relevance_score": "0.039614", "ticker_sentiment_score": "0.073872", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.157483", "ticker_sentiment_score": "0.077841", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.157483", "ticker_sentiment_score": "0.058009", "ticker_sentiment_label": "Neutral"}]}, {"title": "Zimmer Biomet  ( ZBH )  Q1 Earnings Beat Estimates, View Raised", "url": "https://www.zacks.com/stock/news/2088455/zimmer-biomet-zbh-q1-earnings-beat-estimates-view-raised", "time_published": "20230502T180300", "authors": ["Zacks Investment Research"], "summary": "Each of Zimmer Biomet's (ZBH) geographic segments and product divisions records strong year-over-year sales growth at CER.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4f/17576.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.166489, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ZBH", "relevance_score": "0.409503", "ticker_sentiment_score": "0.42524", "ticker_sentiment_label": "Bullish"}, {"ticker": "EW", "relevance_score": "0.212115", "ticker_sentiment_score": "0.004973", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.212115", "ticker_sentiment_score": "0.039293", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.212115", "ticker_sentiment_score": "0.02799", "ticker_sentiment_label": "Neutral"}]}, {"title": "Hologic's  ( HOLX )  Q2 Earnings Beat Estimates, 2023 View Up", "url": "https://www.zacks.com/stock/news/2088415/hologics-holx-q2-earnings-beat-estimates-2023-view-up", "time_published": "20230502T162700", "authors": ["Zacks Investment Research"], "summary": "The year-over-year growth in Breast Health and GYN Surgical Businesses contributed to Hologic's (HOLX) Q2 revenues.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.021542, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.150357", "ticker_sentiment_score": "-0.023401", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.295421", "ticker_sentiment_score": "0.303319", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.150357", "ticker_sentiment_score": "0.005119", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.150357", "ticker_sentiment_score": "0.051644", "ticker_sentiment_label": "Neutral"}]}, {"title": "IDEXX  ( IDXX )  Q1 Earnings Beat Estimates, Margins Increase", "url": "https://www.zacks.com/stock/news/2088405/idexx-idxx-q1-earnings-beat-estimates-margins-increase", "time_published": "20230502T160200", "authors": ["Zacks Investment Research"], "summary": "Continued solid demand for veterinary services and record global premium instrument placements drive IDEXX's (IDXX) Q1 revenues.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999994"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.11575, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IDXX", "relevance_score": "0.185662", "ticker_sentiment_score": "0.089104", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.185662", "ticker_sentiment_score": "-0.001514", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.185662", "ticker_sentiment_score": "0.005906", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.185662", "ticker_sentiment_score": "0.0596", "ticker_sentiment_label": "Neutral"}]}, {"title": "Ecolab  ( ECL )  Q1 Earnings & Revenues Beat, Margins Up", "url": "https://www.zacks.com/stock/news/2088321/ecolab-ecl-q1-earnings-revenues-beat-margins-up", "time_published": "20230502T154600", "authors": ["Zacks Investment Research"], "summary": "Ecolab's (ECL) robust performance across all segments drives its Q1 sales despite business challenges.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/79/359.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.999966"}], "overall_sentiment_score": 0.242749, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GIC", "relevance_score": "0.082963", "ticker_sentiment_score": "0.114508", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.165031", "ticker_sentiment_score": "-0.024857", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMSI", "relevance_score": "0.082963", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.165031", "ticker_sentiment_score": "0.005434", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECL", "relevance_score": "0.397517", "ticker_sentiment_score": "0.410259", "ticker_sentiment_label": "Bullish"}]}, {"title": "Avantor  ( AVTR )  Q1 Earnings Surpass Estimates, Margins Down", "url": "https://www.zacks.com/stock/news/2088308/avantor-avtr-q1-earnings-surpass-estimates-margins-down", "time_published": "20230502T154000", "authors": ["Zacks Investment Research"], "summary": "Despite Avantor's (AVTR) strength in bioproduction and strength in Applied Technologies and Advanced Materials end markets, it reports an overall soft Q1 performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.019285, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AMAT", "relevance_score": "0.035502", "ticker_sentiment_score": "0.00394", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.14131", "ticker_sentiment_score": "-0.022553", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMSI", "relevance_score": "0.070935", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTR", "relevance_score": "0.375593", "ticker_sentiment_score": "0.145699", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.14131", "ticker_sentiment_score": "0.004936", "ticker_sentiment_label": "Neutral"}]}, {"title": "Better Growth Stock: Johnson & Johnson vs. Intuitive Surgical", "url": "https://www.fool.com/investing/2023/05/02/better-growth-stock-johnson-johnson-vs-intuitive-s/", "time_published": "20230502T112000", "authors": ["Sushree Mohanty"], "summary": "Both are great companies, but one might be a slightly better option.", "banner_image": "https://media.ycharts.com/charts/5a5eec70f5d76af05987d7a1d8397aa3.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.980716"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.336437, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.221616", "ticker_sentiment_score": "0.436559", "ticker_sentiment_label": "Bullish"}, {"ticker": "JNJ", "relevance_score": "0.13409", "ticker_sentiment_score": "0.01854", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stryker  ( SYK )  Q1 Earnings Beat Estimates, Volume Improves", "url": "https://www.zacks.com/stock/news/2087867/stryker-syk-q1-earnings-beat-estimates-volume-improves", "time_published": "20230502T103900", "authors": ["Zacks Investment Research"], "summary": "Stryker's (SYK) first-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/charts/11/5648.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999894"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.143198, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CHE", "relevance_score": "0.166455", "ticker_sentiment_score": "0.090668", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.166455", "ticker_sentiment_score": "0.083493", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.436691", "ticker_sentiment_score": "-0.006008", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.166455", "ticker_sentiment_score": "0.061557", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Unusual Options Activity - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/05/32131124/intuitive-surgical-unusual-options-activity", "time_published": "20230501T190128", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ISRG we detected 14 strange trades.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.11989, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.89979", "ticker_sentiment_score": "0.224959", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "C", "relevance_score": "0.108958", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "This Cathie Wood Growth Stock Is on a Bull Run -- but Is It a Buy?", "url": "https://moneymorning.com/investing/this-cathie-wood-growth-stock-is-on-a-bull-run-but-is-it-a-buy/", "time_published": "20230501T110000", "authors": ["Fool.com", "fool.com"], "summary": "Cathie Wood's ARK Autonomous Technology & Robotics ETF is known for investing in cutting-edge companies, whether their shares are up or down.", "banner_image": "https://moneymorning.com/wp-content/blogs.dir/1/files/2023/04/motley-fool-mark.png", "source": "Money Morning", "category_within_source": "RSS", "source_domain": "moneymorning.com", "topics": [{"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.18372, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.386477", "ticker_sentiment_score": "0.338026", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "This Cathie Wood Growth Stock Is on a Bull Run -- but Is It a Buy?", "url": "https://www.fool.com/investing/2023/05/01/this-cathie-wood-growth-stock-is-on-a-bull-run-but/", "time_published": "20230501T110000", "authors": ["Alex Carchidi"], "summary": "Intuitive Surgical has a razor-and-blade business model that helps keep sales flowing.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729969%2Fstock-market-crash-plunge-dollar-newspaper-invest-dow-sp-500-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}, {"topic": "Earnings", "relevance_score": "0.650727"}], "overall_sentiment_score": 0.150224, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.359014", "ticker_sentiment_score": "0.285515", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "The Fundamentals of Investing in Monopolies", "url": "https://www.fool.com/investing/2023/04/29/the-fundamentals-of-investing-in-monopolies/", "time_published": "20230429T110000", "authors": ["Chris Hill"], "summary": "A monopoly might sound like a bad thing, but it can be really good for investors.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726222%2Ftesla-cybertruck.png&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.999336"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.093502, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.009621", "ticker_sentiment_score": "-0.040589", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.009621", "ticker_sentiment_score": "-0.040589", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDFC", "relevance_score": "0.01924", "ticker_sentiment_score": "-0.009948", "ticker_sentiment_label": "Neutral"}, {"ticker": "WCN", "relevance_score": "0.009621", "ticker_sentiment_score": "-0.010966", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRK-A", "relevance_score": "0.009621", "ticker_sentiment_score": "0.047832", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSG", "relevance_score": "0.01924", "ticker_sentiment_score": "0.065952", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.009621", "ticker_sentiment_score": "0.011336", "ticker_sentiment_label": "Neutral"}, {"ticker": "T", "relevance_score": "0.009621", "ticker_sentiment_score": "-0.102211", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNP", "relevance_score": "0.067266", "ticker_sentiment_score": "0.085659", "ticker_sentiment_label": "Neutral"}, {"ticker": "WM", "relevance_score": "0.057674", "ticker_sentiment_score": "0.009011", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATVI", "relevance_score": "0.009621", "ticker_sentiment_score": "0.011336", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUK", "relevance_score": "0.067266", "ticker_sentiment_score": "0.07669", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.057674", "ticker_sentiment_score": "-0.001002", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSC", "relevance_score": "0.009621", "ticker_sentiment_score": "0.108552", "ticker_sentiment_label": "Neutral"}]}, {"title": "These 3 Large-Caps Roared in April", "url": "https://www.zacks.com/stock/news/2087137/these-3-large-caps-roared-in-april", "time_published": "20230428T201600", "authors": ["Zacks Investment Research"], "summary": "These stocks' performances raise a valid question: can they keep climbing, or has the move already ended?", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ad/30383.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.997874"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.424317, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.362858", "ticker_sentiment_score": "0.471388", "ticker_sentiment_label": "Bullish"}, {"ticker": "META", "relevance_score": "0.549581", "ticker_sentiment_score": "0.634154", "ticker_sentiment_label": "Bullish"}, {"ticker": "BCS", "relevance_score": "0.428632", "ticker_sentiment_score": "0.389833", "ticker_sentiment_label": "Bullish"}]}, {"title": "Merit Medical  ( MMSI )  Tops Q1 Earnings Estimates, Ups FY23 View", "url": "https://www.zacks.com/stock/news/2087122/merit-medical-mmsi-tops-q1-earnings-estimates-ups-fy23-view", "time_published": "20230428T172700", "authors": ["Zacks Investment Research"], "summary": "Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the first quarter.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.999955"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.224795, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.143629", "ticker_sentiment_score": "-0.024041", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMSI", "relevance_score": "0.143629", "ticker_sentiment_score": "0.064144", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.143629", "ticker_sentiment_score": "0.00498", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.143629", "ticker_sentiment_score": "0.02131", "ticker_sentiment_label": "Neutral"}]}, {"title": "Integer Holdings  ( ITGR )  Q1 Earnings, Revenues Beat Estimates", "url": "https://www.zacks.com/stock/news/2087031/integer-holdings-itgr-q1-earnings-revenues-beat-estimates", "time_published": "20230428T160100", "authors": ["Zacks Investment Research"], "summary": "Integer Holdings' (ITGR) first-quarter results reflect robust Medical and Non-Medical sales, besides strength in all the product lines.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/79/359.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.999896"}], "overall_sentiment_score": 0.139027, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.144275", "ticker_sentiment_score": "-0.022826", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.475461", "ticker_sentiment_score": "0.226256", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.144275", "ticker_sentiment_score": "0.004995", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.144275", "ticker_sentiment_score": "0.022642", "ticker_sentiment_label": "Neutral"}]}, {"title": "DexCom  ( DXCM )  Q1 Earnings Beat Estimates, Volumes Remain Strong", "url": "https://www.zacks.com/stock/news/2086982/dexcom-dxcm-q1-earnings-beat-estimates-volumes-remain-strong", "time_published": "20230428T152400", "authors": ["Zacks Investment Research"], "summary": "DexCom's (DXCM) first-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e7/4322.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999997"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.163347, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CHE", "relevance_score": "0.192694", "ticker_sentiment_score": "0.097619", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.192694", "ticker_sentiment_score": "0.089641", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.192694", "ticker_sentiment_score": "0.089641", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.457977", "ticker_sentiment_score": "0.26976", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "How AI Is Revolutionizing Tech, and Why You Should Invest in These Leading Companies", "url": "https://www.fool.com/investing/2023/04/28/how-ai-is-revolutionizing-tech-and-why-you-should/", "time_published": "20230428T141120", "authors": ["Bradley Guichard"], "summary": "Check out these compelling opportunities.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729205%2Fstatistic_id216573_global-desktop-market-share-of-search-engines-2015-2022-1.png&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.955357"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.962106"}], "overall_sentiment_score": 0.213147, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.19871", "ticker_sentiment_score": "0.150576", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOOG", "relevance_score": "0.040145", "ticker_sentiment_score": "0.06866", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.040145", "ticker_sentiment_score": "0.203984", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABCL", "relevance_score": "0.080188", "ticker_sentiment_score": "0.079531", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.19871", "ticker_sentiment_score": "0.057562", "ticker_sentiment_label": "Neutral"}, {"ticker": "NET", "relevance_score": "0.19871", "ticker_sentiment_score": "0.213332", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.080188", "ticker_sentiment_score": "0.255645", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMZN", "relevance_score": "0.275423", "ticker_sentiment_score": "0.051477", "ticker_sentiment_label": "Neutral"}]}, {"title": "How AI Is Revolutionizing Tech, and Why You Should Invest in These Leading Companies", "url": "https://moneymorning.com/investing/how-ai-is-revolutionizing-tech-and-why-you-should-invest-in-these-leading-companies/", "time_published": "20230428T141120", "authors": ["Fool.com", "fool.com"], "summary": "Artificial intelligence ( AI ) permeated industries for years, but the release of ChatGPT thrust it into the limelight. It's the talk of the investment community and around the water coolers across the country. But what exactly is it?", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729205%2Fstatistic_id216573_global-desktop-market-share-of-search-engines-2015-2022-1.png&w=700", "source": "Money Morning", "category_within_source": "RSS", "source_domain": "moneymorning.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.796627"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.215101, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.366061", "ticker_sentiment_score": "0.161885", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOOG", "relevance_score": "0.075874", "ticker_sentiment_score": "0.071709", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.366061", "ticker_sentiment_score": "0.092908", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCL", "relevance_score": "0.151064", "ticker_sentiment_score": "0.102139", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.151064", "ticker_sentiment_score": "0.32094", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ResMed  ( RMD )  Q3 Earnings and Revenues Surpass Estimates", "url": "https://www.zacks.com/stock/news/2086818/resmed-rmd-q3-earnings-and-revenues-surpass-estimates", "time_published": "20230428T131600", "authors": ["Zacks Investment Research"], "summary": "ResMed (RMD) reports a solid third-quarter top line, led by strong device sales growth through steady production and delivery of its cloud-connected flow generator devices to meet high market demand.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}, {"topic": "Earnings", "relevance_score": "0.999986"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.133968, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RMD", "relevance_score": "0.369685", "ticker_sentiment_score": "0.174758", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EW", "relevance_score": "0.169378", "ticker_sentiment_score": "-0.02672", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.169378", "ticker_sentiment_score": "0.005529", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.169378", "ticker_sentiment_score": "0.05441", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.042647", "ticker_sentiment_score": "-0.128404", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Is a Trending Stock: Facts to Know Before Betting on It", "url": "https://www.zacks.com/stock/news/2086796/intuitive-surgical-inc-isrg-is-a-trending-stock-facts-to-know-before-betting-on-it", "time_published": "20230428T130007", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default168.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}], "overall_sentiment_score": 0.241921, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.515543", "ticker_sentiment_score": "0.176799", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Baxter  ( BAX )  Beats on Q1 Earnings, Ups '23 EPS View", "url": "https://www.zacks.com/stock/news/2086331/baxter-bax-beats-on-q1-earnings-ups-23-eps-view", "time_published": "20230427T154700", "authors": ["Zacks Investment Research"], "summary": "Baxter's (BAX) first-quarter 2023 results reflect sustained demand for its medically essential products amid a stabilizing macroeconomic climate and healthcare marketplace.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/88/34457.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999975"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.118245, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BAX", "relevance_score": "0.462181", "ticker_sentiment_score": "0.124314", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHE", "relevance_score": "0.150357", "ticker_sentiment_score": "0.082434", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.150357", "ticker_sentiment_score": "0.046754", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.150357", "ticker_sentiment_score": "0.046789", "ticker_sentiment_label": "Neutral"}]}, {"title": "Accuray  ( ARAY )  Q3 Earnings and Revenues Surpass Estimates", "url": "https://www.zacks.com/stock/news/2086215/accuray-aray-q3-earnings-and-revenues-surpass-estimates", "time_published": "20230427T154200", "authors": ["Zacks Investment Research"], "summary": "Accuray (ARAY) reports a solid fiscal third-quarter top line on the back of robust segmental performances.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4b/23030.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.998311"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.007232, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.18856", "ticker_sentiment_score": "-0.027337", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.18856", "ticker_sentiment_score": "0.005974", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.449106", "ticker_sentiment_score": "0.368385", "ticker_sentiment_label": "Bullish"}, {"ticker": "JNJ", "relevance_score": "0.18856", "ticker_sentiment_score": "0.060288", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nevro  ( NVRO )  Q1 Earnings and Revenues Surpass Estimates", "url": "https://www.zacks.com/stock/news/2086189/nevro-nvro-q1-earnings-and-revenues-surpass-estimates", "time_published": "20230427T145700", "authors": ["Zacks Investment Research"], "summary": "Nevro's (NVRO) worldwide revenues improve on a year-over-year basis in Q1, partly owing to robust domestic performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Earnings", "relevance_score": "0.9996"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.067539, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NVRO", "relevance_score": "0.500902", "ticker_sentiment_score": "0.082006", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.164749", "ticker_sentiment_score": "-0.001391", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.164749", "ticker_sentiment_score": "0.005426", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.164749", "ticker_sentiment_score": "0.052012", "ticker_sentiment_label": "Neutral"}]}, {"title": "West Pharmaceutical  ( WST )  Q1 Earnings Beat, Order Book Strong", "url": "https://www.zacks.com/stock/news/2086243/west-pharmaceutical-wst-q1-earnings-beat-order-book-strong", "time_published": "20230427T144500", "authors": ["Zacks Investment Research"], "summary": "West Pharmaceutical's (WST) first-quarter results reflect a sustained recovery in non-COVID-19 demand amid dismal overall performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f2/33314.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.999975"}], "overall_sentiment_score": 0.121526, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CHE", "relevance_score": "0.159305", "ticker_sentiment_score": "0.085451", "ticker_sentiment_label": "Neutral"}, {"ticker": "WST", "relevance_score": "0.159305", "ticker_sentiment_score": "0.066978", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.159305", "ticker_sentiment_score": "0.048516", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.159305", "ticker_sentiment_score": "0.04854", "ticker_sentiment_label": "Neutral"}]}, {"title": "Surmodics  ( SRDX )  Q2 Earnings Top Estimates, FY23 View Revised", "url": "https://www.zacks.com/stock/news/2086168/surmodics-srdx-q2-earnings-top-estimates-fy23-view-revised", "time_published": "20230427T142900", "authors": ["Zacks Investment Research"], "summary": "Surmodics (SRDX) reports a solid fiscal second-quarter top line on the back of robust Medical Device revenues.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/79/359.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999998"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.060072, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.141517", "ticker_sentiment_score": "-0.001263", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.141517", "ticker_sentiment_score": "0.00494", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRDX", "relevance_score": "0.55143", "ticker_sentiment_score": "0.222102", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.141517", "ticker_sentiment_score": "0.049828", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chemed  ( CHE )  Lags Q1 Earnings Estimates, Reaffirms Guidance", "url": "https://www.zacks.com/stock/news/2085874/chemed-che-lags-q1-earnings-estimates-reaffirms-guidance", "time_published": "20230427T133300", "authors": ["Zacks Investment Research"], "summary": "Strength in the VITAS and Roto-Rooter branches contributes to Chemed's (CHE) first-quarter top line.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.15055, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CHE", "relevance_score": "0.440133", "ticker_sentiment_score": "0.14208", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.167904", "ticker_sentiment_score": "-0.026567", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.167904", "ticker_sentiment_score": "0.005496", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.167904", "ticker_sentiment_score": "0.054084", "ticker_sentiment_label": "Neutral"}]}, {"title": "CONMED  ( CNMD )  Beats on Q1 Earnings, Ups '23 EPS View", "url": "https://www.zacks.com/stock/news/2085636/conmed-cnmd-beats-on-q1-earnings-ups-23-eps-view", "time_published": "20230427T101100", "authors": ["Zacks Investment Research"], "summary": "CONMED's (CNMD) adjusted first-quarter sales and earnings recover from the disruption in the fourth quarter due to implementation of a new warehouse management system.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/37/40759.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.576289"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.174203, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CHE", "relevance_score": "0.164749", "ticker_sentiment_score": "0.087347", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.164749", "ticker_sentiment_score": "0.049599", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNMD", "relevance_score": "0.500902", "ticker_sentiment_score": "0.202077", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.164749", "ticker_sentiment_score": "0.049638", "ticker_sentiment_label": "Neutral"}]}, {"title": "Healthcare: An Essential Sector  ( 3 Stocks to Buy Ahead of Earnings ) ", "url": "https://www.zacks.com/commentary/2084719/healthcare-an-essential-sector-3-stocks-to-buy-ahead-of-earnings", "time_published": "20230426T115800", "authors": ["Zacks Investment Research"], "summary": "Healthcare stocks are an excellent place to park your money in the current market environment. Due to it's necessity, the sector tends to due well in any economy.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default313.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Financial Markets", "relevance_score": "0.818451"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.928769"}], "overall_sentiment_score": 0.060193, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.149966", "ticker_sentiment_score": "0.032", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.149966", "ticker_sentiment_score": "0.081033", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.149966", "ticker_sentiment_score": "0.032", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.100308", "ticker_sentiment_score": "0.138506", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRC", "relevance_score": "0.100308", "ticker_sentiment_score": "-0.111408", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.100308", "ticker_sentiment_score": "0.138506", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFC", "relevance_score": "0.050254", "ticker_sentiment_score": "-0.102848", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.199037", "ticker_sentiment_score": "0.190085", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HCSG", "relevance_score": "0.050254", "ticker_sentiment_score": "0.031059", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWAV", "relevance_score": "0.199037", "ticker_sentiment_score": "0.213786", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Buy This Top Growth Stock Before the Next Bull Market", "url": "https://www.fool.com/investing/2023/04/25/buy-this-top-growth-stock-before-next-bull-market/", "time_published": "20230425T140700", "authors": ["Prosper Junior Bakiny"], "summary": "The past three years have been difficult for the company, but the future still looks bright.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728810%2Finvestor-31.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.891286"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.132981, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.536744", "ticker_sentiment_score": "0.186567", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Is Anixa Biosciences  ( ANIX )  Outperforming Other Medical Stocks This Year?", "url": "https://www.zacks.com/stock/news/2084064/is-anixa-biosciences-anix-outperforming-other-medical-stocks-this-year", "time_published": "20230425T134009", "authors": ["Zacks Investment Research"], "summary": "Here is how ANIXA BIOSCIENCES INC (ANIX) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default249.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.242567, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.468029", "ticker_sentiment_score": "0.282881", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANIX", "relevance_score": "0.739411", "ticker_sentiment_score": "0.410427", "ticker_sentiment_label": "Bullish"}]}, {"title": "3 Winning Stocks to Buy No Matter What the Market Is Doing", "url": "https://www.fool.com/investing/2023/04/25/3-winning-stocks-to-buy-no-matter-what-the-market/", "time_published": "20230425T100000", "authors": ["Adria Cimino"], "summary": "The long-term picture for these stocks remains bright.", "banner_image": "https://media.ycharts.com/charts/25ff89004d527c47d182102b1b858a4f.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.998663"}], "overall_sentiment_score": 0.317035, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.30569", "ticker_sentiment_score": "0.24373", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HD", "relevance_score": "0.399734", "ticker_sentiment_score": "0.421716", "ticker_sentiment_label": "Bullish"}, {"ticker": "MDT", "relevance_score": "0.052226", "ticker_sentiment_score": "0.075909", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.104228", "ticker_sentiment_score": "-0.116239", "ticker_sentiment_label": "Neutral"}]}, {"title": "Zacks Investment Ideas feature highlights: Nasdaq 100 ETF, Dexcom, Merck, Intuitive Surgical and SPDR S&P Regional Bank ETF", "url": "https://www.zacks.com/stock/news/2083812/zacks-investment-ideas-feature-highlights-nasdaq-100-etf-dexcom-merck-intuitive-surgical-and-spdr-sp-regional-bank-etf", "time_published": "20230425T090000", "authors": ["Zacks Investment Research"], "summary": "Nasdaq 100 ETF, Dexcom, Merck, Intuitive Surgical and SPDR S&P Regional Bank ETF have been highlighted in this Investment Ideas article.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/cd/2084.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.714479"}], "overall_sentiment_score": -0.054778, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "WBD", "relevance_score": "0.102888", "ticker_sentiment_score": "-0.108835", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.301933", "ticker_sentiment_score": "0.091551", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.301933", "ticker_sentiment_score": "0.091551", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.301933", "ticker_sentiment_score": "-0.310968", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "What Investors Might Have Missed About Netflix", "url": "https://www.fool.com/investing/2023/04/24/what-investors-might-have-missed-about-netflix/", "time_published": "20230424T210205", "authors": ["Chris Hill"], "summary": "And a look at what makes Monster Beverage such a winner.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727515%2Fsocial-security-options-highway-sign-fork-in-the-road.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.999864"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.928769"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.139802, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.249991", "ticker_sentiment_score": "0.185864", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOOG", "relevance_score": "0.039096", "ticker_sentiment_score": "0.098707", "ticker_sentiment_label": "Neutral"}, {"ticker": "MO", "relevance_score": "0.009778", "ticker_sentiment_score": "-0.009645", "ticker_sentiment_label": "Neutral"}, {"ticker": "KO", "relevance_score": "0.078099", "ticker_sentiment_score": "0.011345", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNST", "relevance_score": "0.039096", "ticker_sentiment_score": "-0.018759", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSCO", "relevance_score": "0.019554", "ticker_sentiment_score": "0.040564", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURN", "relevance_score": "0.009778", "ticker_sentiment_score": "0.091339", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.009778", "ticker_sentiment_score": "0.064785", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZO", "relevance_score": "0.009778", "ticker_sentiment_score": "0.032848", "ticker_sentiment_label": "Neutral"}, {"ticker": "KDP", "relevance_score": "0.019554", "ticker_sentiment_score": "0.02773", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.009778", "ticker_sentiment_score": "-0.009645", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROST", "relevance_score": "0.009778", "ticker_sentiment_score": "0.032848", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEP", "relevance_score": "0.009778", "ticker_sentiment_score": "-0.009645", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.009778", "ticker_sentiment_score": "0.057945", "ticker_sentiment_label": "Neutral"}, {"ticker": "PM", "relevance_score": "0.009778", "ticker_sentiment_score": "-0.009645", "ticker_sentiment_label": "Neutral"}, {"ticker": "ODFL", "relevance_score": "0.019554", "ticker_sentiment_score": "0.01629", "ticker_sentiment_label": "Neutral"}]}, {"title": "Wall Street Headlines, International Investing, and Stocks to Watch", "url": "https://www.fool.com/investing/2023/04/24/wall-street-headlines-international-investing-and/", "time_published": "20230424T194911", "authors": ["Jason Moser", "Bill Mann", "and Dan Boyd", "Andy Cross", "Chris Hill"], "summary": "The \"Motley Fool Money\" crew kicks things off with a look at what's going on with Netflix.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728889%2Fjoe-biden-wh-photo-east-room-deliver-remarks-adam-schultz.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.14175, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.051901", "ticker_sentiment_score": "0.017974", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRHI", "relevance_score": "0.006492", "ticker_sentiment_score": "0.083605", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.090694", "ticker_sentiment_score": "0.023225", "ticker_sentiment_label": "Neutral"}, {"ticker": "GM", "relevance_score": "0.006492", "ticker_sentiment_score": "0.04496", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.006492", "ticker_sentiment_score": "-0.167535", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TWNK", "relevance_score": "0.012984", "ticker_sentiment_score": "0.031977", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.006492", "ticker_sentiment_score": "0.054387", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSCO", "relevance_score": "0.058377", "ticker_sentiment_score": "0.051015", "ticker_sentiment_label": "Neutral"}, {"ticker": "GIS", "relevance_score": "0.012984", "ticker_sentiment_score": "0.031977", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.077782", "ticker_sentiment_score": "0.057029", "ticker_sentiment_label": "Neutral"}, {"ticker": "PG", "relevance_score": "0.019474", "ticker_sentiment_score": "0.015029", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.025964", "ticker_sentiment_score": "0.072754", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.019474", "ticker_sentiment_score": "0.127153", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.025964", "ticker_sentiment_score": "-0.00555", "ticker_sentiment_label": "Neutral"}]}, {"title": "Sell the News? 5 Reasons Tech May Pullback", "url": "https://www.zacks.com/commentary/2083614/sell-the-news-5-reasons-tech-may-pullback", "time_published": "20230424T172300", "authors": ["Zacks Investment Research"], "summary": "Though the medium-term trend remains intact for tech, some subtle signs of weakness are appearing beneath the surface. Andrew Rocco breaks it down.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default270.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.071554, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "WBD", "relevance_score": "0.112532", "ticker_sentiment_score": "-0.181122", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ISRG", "relevance_score": "0.222838", "ticker_sentiment_score": "0.110189", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.222838", "ticker_sentiment_score": "0.110189", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.328819", "ticker_sentiment_score": "-0.330473", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Intuitive Surgical Sees Its Composite Rating Rise To 96", "url": "https://www.investors.com/ibd-data-stories/intuitive-surgical-sees-its-composite-rating-rise-to-96-2/", "time_published": "20230424T070000", "authors": ["INVESTOR'S BUSINESS DAILY", "Investor's Business Daily"], "summary": "Intuitive Surgical ( ISRG ) saw an improvement in its IBD SmartSelect Composite Rating Monday, from 94 to 96. The new score means the company is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria.", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928769"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.313697, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.647749", "ticker_sentiment_score": "0.291121", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "INMD", "relevance_score": "0.358152", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Investing $5,000 in This Stock 20 Years Ago Would Have Made You a Millionaire Today", "url": "https://www.fool.com/investing/2023/04/23/investing-5000-in-this-stock-20-years-ago-would-ha/", "time_published": "20230423T120500", "authors": ["David Jagielski"], "summary": "There's still plenty of growth ahead for the business.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727515%2Fsocial-security-options-highway-sign-fork-in-the-road.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999956"}, {"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.375179, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.052685", "ticker_sentiment_score": "0.14488", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.402941", "ticker_sentiment_score": "0.443967", "ticker_sentiment_label": "Bullish"}]}, {"title": "Market Rally Drifts Lower; Tesla Dives On Margins: Weekly Review", "url": "https://www.investors.com/news/stock-market-rally-drifts-lower-tesla-dives-on-margins-isrg-dhi-lvs-are-winners/", "time_published": "20230421T151600", "authors": ["IBD STAFF", "Investor's Business Daily"], "summary": "Market Rally Drifts Lower. Tesla Dives On Margins: Weekly Review Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2021/01/Stock-Tesla-modelY-01-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.99977"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.09001, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "XPEV", "relevance_score": "0.062271", "ticker_sentiment_score": "-0.003015", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAL", "relevance_score": "0.041538", "ticker_sentiment_score": "0.008941", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.062271", "ticker_sentiment_score": "-0.0486", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVS", "relevance_score": "0.124164", "ticker_sentiment_score": "-0.02055", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLB", "relevance_score": "0.062271", "ticker_sentiment_score": "0.051316", "ticker_sentiment_label": "Neutral"}, {"ticker": "BK", "relevance_score": "0.041538", "ticker_sentiment_score": "0.008941", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.062271", "ticker_sentiment_score": "0.009061", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.041538", "ticker_sentiment_score": "-0.047931", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.185306", "ticker_sentiment_score": "-0.079295", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNP", "relevance_score": "0.062271", "ticker_sentiment_score": "-0.087197", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRCX", "relevance_score": "0.103598", "ticker_sentiment_score": "-0.112153", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPGI", "relevance_score": "0.020776", "ticker_sentiment_score": "-0.013591", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.041538", "ticker_sentiment_score": "-0.060168", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.062271", "ticker_sentiment_score": "-0.087018", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBKR", "relevance_score": "0.062271", "ticker_sentiment_score": "0.003046", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.041538", "ticker_sentiment_score": "0.008941", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.041538", "ticker_sentiment_score": "0.008941", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCA", "relevance_score": "0.041538", "ticker_sentiment_score": "0.08633", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKR", "relevance_score": "0.062271", "ticker_sentiment_score": "0.051316", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.041538", "ticker_sentiment_score": "0.008941", "ticker_sentiment_label": "Neutral"}, {"ticker": "AN", "relevance_score": "0.020776", "ticker_sentiment_score": "-0.109884", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCB", "relevance_score": "0.041538", "ticker_sentiment_score": "0.008941", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSM", "relevance_score": "0.082963", "ticker_sentiment_score": "-0.105451", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMT", "relevance_score": "0.041538", "ticker_sentiment_score": "0.050024", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIO", "relevance_score": "0.062271", "ticker_sentiment_score": "-0.003015", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALB", "relevance_score": "0.062271", "ticker_sentiment_score": "-0.179135", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PG", "relevance_score": "0.062271", "ticker_sentiment_score": "-0.056259", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.041538", "ticker_sentiment_score": "-0.056996", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIO", "relevance_score": "0.041538", "ticker_sentiment_score": "-0.175689", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SCHW", "relevance_score": "0.062271", "ticker_sentiment_score": "0.003046", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCX", "relevance_score": "0.041538", "ticker_sentiment_score": "-0.024978", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.062271", "ticker_sentiment_score": "-0.043466", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.144646", "ticker_sentiment_score": "0.007934", "ticker_sentiment_label": "Neutral"}, {"ticker": "LI", "relevance_score": "0.062271", "ticker_sentiment_score": "-0.003015", "ticker_sentiment_label": "Neutral"}, {"ticker": "KEY", "relevance_score": "0.041538", "ticker_sentiment_score": "0.008941", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Return-to-Normal Healthcare Trade Picks Up Pace", "url": "https://www.wsj.com/articles/the-return-to-normal-healthcare-trade-picks-up-pace-31b00327", "time_published": "20230421T120000", "authors": ["David Wainer"], "summary": "Healthcare is finally getting back to normal, which is good news for medical-device makers and hospitals, but not for insurers.", "banner_image": "https://images.wsj.net/im-767579?width=700&height=466", "source": "Wall Street Journal", "category_within_source": "Markets", "source_domain": "www.wsj.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.292961, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.485711", "ticker_sentiment_score": "0.574667", "ticker_sentiment_label": "Bullish"}]}, {"title": "Zacks Investment Ideas feature highlights: Nvidia, First Solar, Intuitive Surgical, Dexcom and Asure Software", "url": "https://www.zacks.com/stock/news/2082605/zacks-investment-ideas-feature-highlights-nvidia-first-solar-intuitive-surgical-dexcom-and-asure-software", "time_published": "20230421T110500", "authors": ["Zacks Investment Research"], "summary": "Nvidia, First Solar, Intuitive Surgical, Dexcom and Asure Software are part of the Zacks Investment Ideas article.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/1952.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.955357"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.038217, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ASUR", "relevance_score": "0.238133", "ticker_sentiment_score": "-0.043734", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.238133", "ticker_sentiment_score": "-0.164732", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FSLR", "relevance_score": "0.313817", "ticker_sentiment_score": "0.257299", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.238133", "ticker_sentiment_score": "0.145322", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.160099", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Riding the Wave: These 3 Industry Groups are Making a Splash with Expected Money Inflows", "url": "https://www.zacks.com/commentary/2081867/riding-the-wave-these-3-industry-groups-are-making-a-splash-with-expected-money-inflows", "time_published": "20230420T130500", "authors": ["Zacks Investment Research"], "summary": "Markets have been known to have periods of \"nasty\" industry group rotation. Get ahead of the curve with these 3 under-the-radar groups.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default295.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.996718"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.08296, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ASUR", "relevance_score": "0.132368", "ticker_sentiment_score": "0.063911", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.132368", "ticker_sentiment_score": "-0.097047", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLR", "relevance_score": "0.197413", "ticker_sentiment_score": "0.244176", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FSLY", "relevance_score": "0.132368", "ticker_sentiment_score": "0.063911", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.066414", "ticker_sentiment_score": "0.157058", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.132368", "ticker_sentiment_score": "0.087047", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.197413", "ticker_sentiment_score": "0.112757", "ticker_sentiment_label": "Neutral"}, {"ticker": "IOT", "relevance_score": "0.132368", "ticker_sentiment_score": "0.063911", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical  ( NASDAQ:ISRG )  Upgraded by StockNews.com to Buy", "url": "https://www.defenseworld.net/2023/04/20/intuitive-surgical-nasdaqisrg-upgraded-by-stocknews-com-to-buy.html", "time_published": "20230420T095848", "authors": ["Defense World Staff"], "summary": "Intuitive Surgical ( NASDAQ:ISRG ) Upgraded by StockNews.com to ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&Symbol=ISRG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.280042, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.095517", "ticker_sentiment_score": "0.182352", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AB", "relevance_score": "0.095517", "ticker_sentiment_score": "0.182352", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LMT", "relevance_score": "0.047844", "ticker_sentiment_score": "0.185598", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BCS", "relevance_score": "0.047844", "ticker_sentiment_score": "0.11484", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.047844", "ticker_sentiment_score": "0.11484", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.095517", "ticker_sentiment_score": "0.182352", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RBCPF", "relevance_score": "0.047844", "ticker_sentiment_score": "0.11484", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.813165", "ticker_sentiment_score": "0.455531", "ticker_sentiment_label": "Bullish"}, {"ticker": "MULN", "relevance_score": "0.047844", "ticker_sentiment_score": "0.185598", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Stock market today: Asian shares trading mostly lower", "url": "https://apnews.com/article/stock-market-banks-rates-earnings-7578df8f439bfe027890f8268514836c", "time_published": "20230420T070258", "authors": [], "summary": "A currency trader walks by the screen showing the Korea Composite Stock Price Index ( KOSPI ) at a foreign exchange dealing room in Seoul, South Korea, Thursday, April 20, 2023.", "banner_image": "https://storage.googleapis.com/afs-prod/media/95a93639773c47afb331c4105954abc8/2856.webp", "source": "Associated Press", "category_within_source": "Business", "source_domain": "apnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.769861"}, {"topic": "Financial Markets", "relevance_score": "0.999186"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.891286"}], "overall_sentiment_score": -0.151917, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.052112", "ticker_sentiment_score": "-0.121337", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.052112", "ticker_sentiment_score": "0.223659", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.052112", "ticker_sentiment_score": "0.223659", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.155451", "ticker_sentiment_score": "-0.101144", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAL", "relevance_score": "0.052112", "ticker_sentiment_score": "-0.029006", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.052112", "ticker_sentiment_score": "0.263745", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ELV", "relevance_score": "0.052112", "ticker_sentiment_score": "-0.337895", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FOREX:JPY", "relevance_score": "0.104002", "ticker_sentiment_score": "-0.180148", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FOREX:EUR", "relevance_score": "0.052112", "ticker_sentiment_score": "-0.166562", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FOREX:USD", "relevance_score": "0.052112", "ticker_sentiment_score": "-0.166562", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Futures: Tesla Margins Dive; Musk Willing To Push Profit To Zero", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-tesla-falls-as-gross-margins-free-cash-flow-dive/", "time_published": "20230420T015200", "authors": ["Investor's Business Daily", "ED CARSON"], "summary": "Dow Jones Futures: Tesla Falls As Margins Dive. Why Elon Musk Is ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/12/stock-Tesla-Model3-10-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.998645"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": -0.075083, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.134003", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.008929", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.091075", "ticker_sentiment_score": "-0.008393", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.224164", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AAPL", "relevance_score": "0.091075", "ticker_sentiment_score": "-0.009476", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVS", "relevance_score": "0.136242", "ticker_sentiment_score": "0.035889", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.113705", "ticker_sentiment_score": "-0.028359", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXTR", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.23402", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EW", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.099583", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.39329", "ticker_sentiment_score": "-0.055393", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRCX", "relevance_score": "0.180967", "ticker_sentiment_score": "-0.035547", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.099583", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.008929", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.045612", "ticker_sentiment_score": "-0.099583", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow dips, S&P 500 ends flat amid rising fears of economic downturn", "url": "https://www.moneycontrol.com/news/business/markets/dow-dips-sp-500-ends-flat-amid-rising-fears-of-economic-downturn-10443331.html", "time_published": "20230420T004013", "authors": [], "summary": "Investors are looking for signs in corporate results that inflation may be driving up costs or hurting consumer spending, amid fears the economy may be on the cusp of a downturn ...", "banner_image": "https://images.moneycontrol.com/static-mcnews/2021/06/Coffee-cup-and-coffee-beans.jpg?impolicy=website&width=168&height=118", "source": "Money Control", "category_within_source": "Economy", "source_domain": "www.moneycontrol.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.904684"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.075617, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.134968", "ticker_sentiment_score": "0.093927", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.067727", "ticker_sentiment_score": "0.110966", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.134968", "ticker_sentiment_score": "0.084415", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAL", "relevance_score": "0.067727", "ticker_sentiment_score": "0.180705", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.067727", "ticker_sentiment_score": "0.110966", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELV", "relevance_score": "0.067727", "ticker_sentiment_score": "0.112894", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.134968", "ticker_sentiment_score": "0.127051", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Medtronic Stock Soared More Than 4% Higher Today", "url": "https://www.fool.com/investing/2023/04/19/why-medtronic-stock-soared-more-than-4-higher-toda/", "time_published": "20230419T211200", "authors": ["Eric Volkman"], "summary": "The veteran device maker did well on a very good day for stocks in its industry.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728401%2Finvestor-60.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.323754, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.535653", "ticker_sentiment_score": "0.567824", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.285526", "ticker_sentiment_score": "0.182309", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Business Highlights: Nazi-linked accounts, Tesla's earnings", "url": "https://apnews.com/article/business-highlights-73eed916a176448e5029e2514ec1de2b", "time_published": "20230419T210233", "authors": [], "summary": "GENEVA ( AP ) - U.S. lawmakers have accused the embattled Swiss bank Credit Suisse of limiting the scope of an internal investigation into Nazi clients and Nazi-linked accounts.", "banner_image": "https://storage.googleapis.com/afs-prod/media/afs:Medium:751921853724/700.png", "source": "Associated Press", "category_within_source": "Markets", "source_domain": "apnews.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.744043"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": -0.067888, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.036091", "ticker_sentiment_score": "0.024705", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.072108", "ticker_sentiment_score": "0.009101", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.036091", "ticker_sentiment_score": "0.024705", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.036091", "ticker_sentiment_score": "0.024705", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.107978", "ticker_sentiment_score": "0.010218", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.036091", "ticker_sentiment_score": "0.024705", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOX", "relevance_score": "0.036091", "ticker_sentiment_score": "-0.200295", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "How major US stock indexes fared Wednesday 4/19/2023", "url": "https://apnews.com/article/netflix-inc-abbott-laboratories-financial-markets-business-66d2b1a37b0778b207043ef699673de2", "time_published": "20230419T201934", "authors": [], "summary": "Stocks are closing mostly flat on Wall Street Wednesday following mixed earnings reports from big U.S. companies. The S&P 500 was virtually unchanged, the Dow slipped and the Nasdaq gained less than 0.1%. Netflix dropped after reporting weaker revenue than expected.", "banner_image": "https://storage.googleapis.com/afs-prod/media/afs:Medium:751921853724/700.png", "source": "Associated Press", "category_within_source": "Business", "source_domain": "apnews.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Energy & Transportation", "relevance_score": "0.5"}, {"topic": "Life Sciences", "relevance_score": "0.5"}], "overall_sentiment_score": 0.016783, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.220809", "ticker_sentiment_score": "0.13644", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.220809", "ticker_sentiment_score": "0.13644", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.220809", "ticker_sentiment_score": "0.13644", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.220809", "ticker_sentiment_score": "0.13644", "ticker_sentiment_label": "Neutral"}]}, {"title": "Netflix, Tesla fall; United Airlines, Abbott rise", "url": "https://apnews.com/article/financial-markets-stocks-wall-street-60e2d6e619025d07c55c7d7a0b40a456", "time_published": "20230419T201748", "authors": [], "summary": "Netflix, Tesla fall. United Airlines, Abbott rise The Associated Press ...", "banner_image": "https://storage.googleapis.com/afs-prod/media/afs:Medium:751921853724/700.png", "source": "Associated Press", "category_within_source": "Markets", "source_domain": "apnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": -0.033429, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TRV", "relevance_score": "0.258351", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.258351", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.258351", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAD", "relevance_score": "0.258351", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stock Market Today: Stocks Close Mixed After Sizzling U.K. Inflation Update", "url": "https://www.kiplinger.com/investing/stocks/stock-market-today-stocks-close-mixed-after-sizzling-uk-inflation-update", "time_published": "20230419T201458", "authors": ["Karee Venema"], "summary": "Stock Market Today: Stocks Close Mixed After Sizzling U.K. Inflation ... Kiplinger's Personal Finance ...", "banner_image": "https://cdn.mos.cms.futurecdn.net/5NKsh727v32mgprk9eApJK-415-80.jpg", "source": "Kiplinger", "category_within_source": "n/a", "source_domain": "www.kiplinger.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.682689"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.150598, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.300946", "ticker_sentiment_score": "-0.211071", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "META", "relevance_score": "0.24289", "ticker_sentiment_score": "0.093398", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRGLF", "relevance_score": "0.061631", "ticker_sentiment_score": "-0.059008", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.122894", "ticker_sentiment_score": "0.096879", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stock Market Climbs Up From The Depths; Tech Products Stock Down Big", "url": "https://www.investors.com/market-trend/stock-market-today/stock-market-climbs-up-from-the-depths-technology-products-stock-down-big/", "time_published": "20230419T175500", "authors": ["Investor's Business Daily", "KIMBERLEY KOENIG"], "summary": "Stock Market Climbs From Day's Depths. Tech Distributor Plunges ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2023/02/Stock-CDW-building-01-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999819"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.980922"}, {"topic": "Finance", "relevance_score": "0.333333"}, {"topic": "Blockchain", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.176023, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.10607", "ticker_sentiment_score": "0.030739", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBKR", "relevance_score": "0.10607", "ticker_sentiment_score": "0.278733", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.158519", "ticker_sentiment_score": "-0.110208", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAL", "relevance_score": "0.10607", "ticker_sentiment_score": "0.219576", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.10607", "ticker_sentiment_score": "-0.015911", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOUR", "relevance_score": "0.10607", "ticker_sentiment_score": "0.020005", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.053153", "ticker_sentiment_score": "-0.068277", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.158519", "ticker_sentiment_score": "0.262761", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "COIN", "relevance_score": "0.10607", "ticker_sentiment_score": "-0.171433", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.053153", "ticker_sentiment_score": "-0.157687", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Stocks making the biggest moves midday: Rivian, Western Alliance, Peloton and more", "url": "https://www.cnbc.com/2023/04/19/stocks-making-the-biggest-moves-midday-rivn-wal-pton-and-more.html", "time_published": "20230419T170941", "authors": ["Pia Singh"], "summary": "Regional bank stocks gained on Wednesday. Western Alliance led the pack, with its shares jumping 18% after it said deposits have been rebounding in April.", "banner_image": "https://image.cnbcfm.com/api/v1/image/106858065-1616514026299-gettyimages-1230436272-679772-679772-fi-california-blackouts-rooftop-solar7-MAM.jpeg?v=1681914654", "source": "CNBC", "category_within_source": "Market Insider", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.098637, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.1331", "ticker_sentiment_score": "-0.044613", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.044551", "ticker_sentiment_score": "0.040909", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.044551", "ticker_sentiment_score": "0.110112", "ticker_sentiment_label": "Neutral"}, {"ticker": "RF", "relevance_score": "0.044551", "ticker_sentiment_score": "0.112538", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFG", "relevance_score": "0.1331", "ticker_sentiment_score": "-0.064275", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMA", "relevance_score": "0.044551", "ticker_sentiment_score": "0.112538", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.044551", "ticker_sentiment_score": "-0.058875", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZIONL", "relevance_score": "0.044551", "ticker_sentiment_score": "0.112538", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.044551", "ticker_sentiment_score": "0.009", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOWL", "relevance_score": "0.088964", "ticker_sentiment_score": "0.415291", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.088964", "ticker_sentiment_score": "0.088885", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASML", "relevance_score": "0.088964", "ticker_sentiment_score": "0.026303", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.044551", "ticker_sentiment_score": "-0.084375", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Soars On Stellar Q1 Results: Analysts Boost Price Targets Amid Robust Procedure Growth - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/04/31892102/intuitive-surgical-soars-on-stellar-q1-results-analysts-boost-price-targets-amid-ro", "time_published": "20230419T160603", "authors": ["Priya Nigam"], "summary": "Shares of Intuitive Surgical, Inc. ISRG surged in after-hours trading on Tuesday, following the release of the company's upbeat results for the first quarter. Analyst Shagun Singh maintained an Outperform rating, while raising the price target from $305 to $309.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/19/surgery_unsplash.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.25293, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.489659", "ticker_sentiment_score": "0.408411", "ticker_sentiment_label": "Bullish"}]}, {"title": "Stock Market Trims Losses At Midday; This Nasdaq 100 Stock Soars On Earnings", "url": "https://www.investors.com/market-trend/stock-market-today/stock-market-lower-as-bank-other-earnings-pour-in-tesla-falls-after-another-price-cut/", "time_published": "20230419T160100", "authors": ["Investor's Business Daily", "JUAN CARLOS ARANCIBIA"], "summary": "Stock Market Lower As Bank, Other Earnings Pour In. Tesla Falls ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2017/10/stock-WallStreet-03-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.9996"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": -0.007266, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.185306", "ticker_sentiment_score": "-0.165005", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SYF", "relevance_score": "0.093289", "ticker_sentiment_score": "0.242602", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.139534", "ticker_sentiment_score": "-0.185537", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WAL", "relevance_score": "0.093289", "ticker_sentiment_score": "0.175131", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.093289", "ticker_sentiment_score": "-0.25759", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LRCX", "relevance_score": "0.093289", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.185306", "ticker_sentiment_score": "0.012283", "ticker_sentiment_label": "Neutral"}, {"ticker": "STLD", "relevance_score": "0.093289", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Shift4 Stock Plunges On Short Seller Blue Orca's Report", "url": "https://www.investors.com/news/technology/four-stock-shift4-plunges-short-seller-blue-orca-report/", "time_published": "20230419T153300", "authors": ["REINHARDT KRAUSE", "Investor's Business Daily"], "summary": "Short seller Blue Orca Capital on Wednesday issued a report claiming Shift4 ( FOUR ) engaged in \"highly questionable and hyper aggressive accounting maneuvers\" in 2022. FOUR stock plunged on the Blue Orca report. Shift4 stock tumbled 14.6% to 58.52 in morning trades on the stock market today.", "banner_image": "https://www.investors.com/wp-content/uploads/2022/12/Stock-shift4payments-02-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}], "overall_sentiment_score": -0.019268, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.09186", "ticker_sentiment_score": "-0.160696", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Why Intuitive Surgical Stock Is Soaring Today", "url": "https://www.fool.com/investing/2023/04/19/why-intuitive-surgical-stock-is-soaring-today/", "time_published": "20230419T153041", "authors": ["Keith Speights"], "summary": "Intuitive's impressive Q1 results were driven by a surge in procedure volume for its da Vinci robotic surgical system.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728400%2Fbear-market-silhouette-newspaper-stock-market-quotes-invest-crash-plunge-correction-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997902"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.443494, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.337811", "ticker_sentiment_score": "0.219161", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FOREX:USD", "relevance_score": "0.115787", "ticker_sentiment_score": "0.266344", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical  ( ISRG )  Gains Following Q1 Earnings Beat", "url": "https://www.zacks.com/stock/news/2081447/intuitive-surgical-isrg-gains-following-q1-earnings-beat", "time_published": "20230419T153000", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical's (ISRG) first-quarter results reflect healthy demand for procedures, partially offset by unfavorable currency. COVID-19 impacts procedure volume in China.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e7/4322.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997874"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.175587, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MASI", "relevance_score": "0.256719", "ticker_sentiment_score": "0.202823", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMN", "relevance_score": "0.206685", "ticker_sentiment_score": "-0.05337", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVNS", "relevance_score": "0.256719", "ticker_sentiment_score": "0.171196", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.444487", "ticker_sentiment_score": "0.35163", "ticker_sentiment_label": "Bullish"}, {"ticker": "HCSG", "relevance_score": "0.052226", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Stock Soars as Robotic Surgery Grows", "url": "https://www.barrons.com/articles/intuitive-earnings-robotic-surgery-stock-isrg-959141ed", "time_published": "20230419T145900", "authors": ["Karishma Vanjani"], "summary": "Intuitive Impresses Wall Street With Robotic Surgery Resurgence. Stock Soars. ...", "banner_image": "https://images.barrons.com/im-766280/social", "source": "Barrons", "category_within_source": "n/a", "source_domain": "www.barrons.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.378775, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.666827", "ticker_sentiment_score": "0.55574", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Surgical Gets Price Target Bumps By Analysts After Better-Than-Expected Q1 Results - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/23/04/31892280/intuitive-surgical-gets-price-target-bumps-by-analysts-after-better-than-expected-q1-results", "time_published": "20230419T141229", "authors": ["Lisa Levin"], "summary": "Intuitive Surgical posted adjusted earnings of $1.23 per share, beating analysts' estimates of $1.20 per share. The company's sales came in at $1.70 billion, versus expectations of $1.59 billion. Intuitive Surgical shares rose 11.4% to trade at $299.99 on Wednesday", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/19/intuitive_surgical_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.99676"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.13949, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "C", "relevance_score": "0.265378", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.958038", "ticker_sentiment_score": "0.259736", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WFC", "relevance_score": "0.265378", "ticker_sentiment_score": "-0.204424", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JPM", "relevance_score": "0.265378", "ticker_sentiment_score": "-0.034759", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.265378", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Apple To Rally 15%? Here Are 10 Other Analyst Forecasts For Wednesday - Apple  ( NASDAQ:AAPL ) , Align Tech  ( NASDAQ:ALGN ) ", "url": "https://www.benzinga.com/news/23/04/31890413/apple-to-rally-15-here-are-10-other-analyst-forecasts-for-wednesday", "time_published": "20230419T131400", "authors": ["Lisa Levin"], "summary": "Morgan Stanley raised the price target for Align Technology, Inc. ALGN from $314 to $383. Morgan Stanley analyst Erin Wright maintained an Overweight rating. Align Technology shares fell 0.9% to $345.00 in pre-market trading. Goldman Sachs cut the price target for The Mosaic Company MOS from $78 ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/19/apple_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.998682"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}], "overall_sentiment_score": 0.121657, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.277958", "ticker_sentiment_score": "-0.054751", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.187463", "ticker_sentiment_score": "0.025209", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.277958", "ticker_sentiment_score": "-0.080812", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.277958", "ticker_sentiment_score": "0.07407", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.187463", "ticker_sentiment_score": "-0.059594", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.187463", "ticker_sentiment_score": "-0.151018", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALGN", "relevance_score": "0.277958", "ticker_sentiment_score": "-0.2044", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GS", "relevance_score": "0.446742", "ticker_sentiment_score": "-0.051468", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOS", "relevance_score": "0.277958", "ticker_sentiment_score": "-0.177505", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LMT", "relevance_score": "0.277958", "ticker_sentiment_score": "0.008392", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSO", "relevance_score": "0.277958", "ticker_sentiment_score": "0.556454", "ticker_sentiment_label": "Bullish"}, {"ticker": "WFC", "relevance_score": "0.187463", "ticker_sentiment_score": "0.006149", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.277958", "ticker_sentiment_score": "0.468278", "ticker_sentiment_label": "Bullish"}]}, {"title": "What's Behind The Move In Intuitive Surgical Stock? - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/23/04/31888432/whats-behind-the-move-in-intuitive-surgical-stock", "time_published": "20230419T125537", "authors": ["Adam Eckert"], "summary": "Intuitive Surgical Inc ISRG shares are trading higher Wednesday after the company reported better-than-expected financial results. Multiple analysts also raised price targets following the print. Q1 Revenue: $1.7 billion beat estimates of $1.59 billion", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/19/intuitive-da-vinci-sp-surgical-system-patient-cart-front-view-1060863-hi-res.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.157713, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.953293", "ticker_sentiment_score": "0.28054", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WFC", "relevance_score": "0.131643", "ticker_sentiment_score": "-0.151474", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "C", "relevance_score": "0.131643", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Futures Lower As Netflix Drops On Earnings", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-as-netflix-drops-on-earnings-tesla-stock-skids-on-price-cuts-before-earnings/", "time_published": "20230419T123500", "authors": ["SCOTT LEHTONEN", "Investor's Business Daily"], "summary": "Dow Jones Futures Fall: Netflix Drops On Q1 Results, Tesla Skids ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2022/06/Stock-elonmusk-14-shutt.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.999759"}], "overall_sentiment_score": 0.109323, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.101797", "ticker_sentiment_score": "-0.079471", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.025514", "ticker_sentiment_score": "0.142108", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.127052", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBKR", "relevance_score": "0.025514", "ticker_sentiment_score": "-0.072457", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSCO", "relevance_score": "0.127052", "ticker_sentiment_score": "0.064316", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.127052", "ticker_sentiment_score": "0.086975", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.025514", "ticker_sentiment_score": "-0.072457", "ticker_sentiment_label": "Neutral"}, {"ticker": "CROX", "relevance_score": "0.201944", "ticker_sentiment_score": "0.144507", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.076439", "ticker_sentiment_score": "0.065686", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKE", "relevance_score": "0.101797", "ticker_sentiment_score": "0.087508", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.025514", "ticker_sentiment_score": "0.103228", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.101797", "ticker_sentiment_score": "-0.031436", "ticker_sentiment_label": "Neutral"}, {"ticker": "LULU", "relevance_score": "0.051003", "ticker_sentiment_score": "0.099414", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.201944", "ticker_sentiment_score": "-0.139482", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.051003", "ticker_sentiment_score": "-0.047005", "ticker_sentiment_label": "Neutral"}, {"ticker": "V", "relevance_score": "0.127052", "ticker_sentiment_score": "0.058888", "ticker_sentiment_label": "Neutral"}, {"ticker": "HD", "relevance_score": "0.076439", "ticker_sentiment_score": "0.07149", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.051003", "ticker_sentiment_score": "-0.077894", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.076439", "ticker_sentiment_score": "0.07149", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks making the biggest moves premarket: United Airlines, Netflix, Morgan Stanley and more", "url": "https://www.cnbc.com/2023/04/19/stocks-making-the-biggest-moves-premarket-united-airlines-netflix-morgan-stanley-and-more.html", "time_published": "20230419T122703", "authors": ["Hakyung Kim"], "summary": "These are the stocks posting the largest moves in premarket trading.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107186426-1675167989957-gettyimages-1246684316-economou-unitedai230130_npHU1.jpeg?v=1681907223&w=1920&h=1080", "source": "CNBC", "category_within_source": "Market Insider", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.09351, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.036255", "ticker_sentiment_score": "-0.051393", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.036255", "ticker_sentiment_score": "-0.065891", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBKR", "relevance_score": "0.036255", "ticker_sentiment_score": "-0.003935", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFG", "relevance_score": "0.072435", "ticker_sentiment_score": "-0.027483", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLY", "relevance_score": "0.036255", "ticker_sentiment_score": "-0.011677", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.036255", "ticker_sentiment_score": "0.252816", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ZIONL", "relevance_score": "0.036255", "ticker_sentiment_score": "-0.018392", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.036255", "ticker_sentiment_score": "0.077448", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASML", "relevance_score": "0.072435", "ticker_sentiment_score": "0.020487", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.036255", "ticker_sentiment_score": "0.084454", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.072435", "ticker_sentiment_score": "-0.057662", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.072435", "ticker_sentiment_score": "0.121871", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.036255", "ticker_sentiment_score": "-0.030454", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.036255", "ticker_sentiment_score": "0.071536", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nasdaq, S&P Futures Falter As Mixed Earnings Weigh Down On Sentiment - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ", "url": "https://www.benzinga.com/news/earnings/23/04/31885678/nasdaq-s-p-futures-falter-as-mixed-earnings-weigh-down-on-sentiment", "time_published": "20230419T104817", "authors": ["Shanthi Rexaline"], "summary": "Earnings continue to be front and center in the market, with futures trading signaling a negative start on Wednesday. More bellwether names are due to turn in their quarterly scorecard, potentially creating volatility in the market.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/19/shutterstock_1780397543.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.986714"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.089956, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AA", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.164656", "ticker_sentiment_score": "-0.149429", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.110209", "ticker_sentiment_score": "-0.253478", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AAPL", "relevance_score": "0.110209", "ticker_sentiment_score": "-0.176987", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "C", "relevance_score": "0.055236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAL", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.055236", "ticker_sentiment_score": "-0.160886", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MS", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKR", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVS", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.055236", "ticker_sentiment_score": "-0.030005", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFIV", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DFS", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRCX", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRV", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPLA", "relevance_score": "0.055236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.110209", "ticker_sentiment_score": "0.169237", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STLD", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Western Alliance Bancorporation, Intuitive Surgical And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session - Citizens Financial Group  ( NYSE:CFG ) , New Oriental Education  ( NYSE:EDU ) ", "url": "https://www.benzinga.com/news/23/04/31885670/western-alliance-bancorporation-intuitive-surgical-and-other-big-stocks-moving-higher-in-wednesdays", "time_published": "20230419T104258", "authors": ["Lisa Levin"], "summary": "U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today's pre-market trading session. Western Alliance Bancorporation WAL shares jumped 15.4% to $37.50 in pre-market trading after the company reported better-than-expected Q1 earnings.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/19/western_alliance_bancorporation_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}, {"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.306142, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PACW", "relevance_score": "0.431065", "ticker_sentiment_score": "0.244385", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LEGN", "relevance_score": "0.431065", "ticker_sentiment_score": "0.302644", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CFG", "relevance_score": "0.295867", "ticker_sentiment_score": "0.366119", "ticker_sentiment_label": "Bullish"}, {"ticker": "EDU", "relevance_score": "0.295867", "ticker_sentiment_score": "0.407596", "ticker_sentiment_label": "Bullish"}, {"ticker": "VERB", "relevance_score": "0.431065", "ticker_sentiment_score": "0.118207", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.295867", "ticker_sentiment_score": "0.607827", "ticker_sentiment_label": "Bullish"}, {"ticker": "MCB", "relevance_score": "0.295867", "ticker_sentiment_score": "0.496712", "ticker_sentiment_label": "Bullish"}, {"ticker": "MVST", "relevance_score": "0.431065", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Netflix Reports, But Investors Are Happier About These 2 Other Stocks", "url": "https://www.fool.com/investing/2023/04/18/netflix-reports-but-investors-are-happier-about-th/", "time_published": "20230418T222700", "authors": ["Dan Caplinger"], "summary": "The biggest winners after-hours were outside the FAANG stock universe.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728448%2Fprofessional-stock-trader-broker-analyze-stock-chart-invest-retire-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}], "overall_sentiment_score": 0.244282, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.211191", "ticker_sentiment_score": "0.130594", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.344712", "ticker_sentiment_score": "0.329618", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Futures: Netflix Volatile Late; TSLA Eyes 3 Buy Points With Earnings Due", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-netflix-volatile-late-tesla-eyes-3-buy-points-with-earnings-due/", "time_published": "20230418T220800", "authors": ["ED CARSON", "Investor's Business Daily"], "summary": "Futures: Netflix Volatile Late. TSLA Eyes 3 Buy Points With Earnings ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2022/12/Stock-netflixwednesday-01-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.999965"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.0555, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.190793", "ticker_sentiment_score": "-0.031777", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.048133", "ticker_sentiment_score": "-0.067975", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.1437", "ticker_sentiment_score": "0.059759", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBKR", "relevance_score": "0.1437", "ticker_sentiment_score": "-0.168622", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WAL", "relevance_score": "0.096091", "ticker_sentiment_score": "-0.069506", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.048133", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVS", "relevance_score": "0.048133", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.024077", "ticker_sentiment_score": "0.025002", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCB", "relevance_score": "0.072144", "ticker_sentiment_score": "-0.07645", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMT", "relevance_score": "0.048133", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.327366", "ticker_sentiment_score": "-0.009683", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRCX", "relevance_score": "0.048133", "ticker_sentiment_score": "-0.028", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.1437", "ticker_sentiment_score": "-0.028456", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical beats first-quarter sales on higher procedure volumes", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/intuitive-surgical-beats-first-quarter-sales-higher-procedure-volumes-2023-04-18/", "time_published": "20230418T215900", "authors": ["Sriparna Roy"], "summary": "April 18 ( Reuters ) - Intuitive Surgical Inc ( ISRG.O ) beat estimates for first-quarter sales on Tuesday as the surgical robot maker recorded a rise in total procedure volumes. Shares of the Sunnyvale, California-based company rose 9.18% to $294, after the bell.", "banner_image": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=137", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.229459, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.123526", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.123526", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Surpasses Q1 Earnings and Revenue Estimates", "url": "https://www.zacks.com/stock/news/2080696/intuitive-surgical-inc-isrg-surpasses-q1-earnings-and-revenue-estimates", "time_published": "20230418T213507", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 3.36% and 6.88%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default164.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.150851, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "FNA", "relevance_score": "0.207571", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.401331", "ticker_sentiment_score": "0.140756", "ticker_sentiment_label": "Neutral"}]}, {"title": "After-Hours Action: Why Intuitive Surgical Shares Are Surging - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/23/04/31871979/after-hours-action-why-intuitive-surgical-shares-are-surging", "time_published": "20230418T211809", "authors": ["Adam Eckert"], "summary": "Intuitive Surgical Inc ISRG shares are rising in extended trading Tuesday after the company reported better-than-expected financial results. Q1 Revenue: $1.7 billion beat estimates of $1.59 billion", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/18/intuitive-da-vinci-or-staff-with-patient-cart-hi-res.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.303015, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.899125", "ticker_sentiment_score": "0.514277", "ticker_sentiment_label": "Bullish"}]}, {"title": "Stocks making the biggest moves after hours: Netflix, United Airlines, Western Alliance, Interactive Brokers and more", "url": "https://www.cnbc.com/2023/04/18/stocks-moving-big-after-hours-nflx-ual-ibkr-wal.html", "time_published": "20230418T211444", "authors": ["Brian Evans"], "summary": "These are the stocks posting the largest moves in extended trading.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107075690-1655227861488-gettyimages-1240448479-RAFAPRESS_04052022-0494.jpeg?v=1681852484&w=1920&h=1080", "source": "CNBC", "category_within_source": "Market Insider", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.999974"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.205931, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.25168", "ticker_sentiment_score": "0.023178", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.127456", "ticker_sentiment_score": "0.155135", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IBKR", "relevance_score": "0.25168", "ticker_sentiment_score": "0.24323", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WAL", "relevance_score": "0.127456", "ticker_sentiment_score": "0.035879", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHN", "relevance_score": "0.127456", "ticker_sentiment_score": "0.21015", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.25168", "ticker_sentiment_score": "0.216063", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Robotic Surgery Giant Notches Massive Growth; Shares Rocket", "url": "https://www.investors.com/news/technology/isrg-stock-intuitive-surgical-earnings-q1-2023/", "time_published": "20230418T201500", "authors": ["Investor's Business Daily", "ALLISON GATLIN"], "summary": "ISRG Stock Rockets On Massive Growth In Robotic Surgery ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/07/stock-Intuitive-Surgical-05-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.955357"}], "overall_sentiment_score": 0.36848, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "MDGL", "relevance_score": "0.199037", "ticker_sentiment_score": "0.235102", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.922387", "ticker_sentiment_score": "0.43992", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Surgical Unusual Options Activity - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/04/31868664/intuitive-surgical-unusual-options-activity", "time_published": "20230418T194614", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ISRG we detected 17 strange trades.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.174811, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.71032", "ticker_sentiment_score": "0.057325", "ticker_sentiment_label": "Neutral"}]}, {"title": "Tech Futures Lead As Q1 Earnings Heats Up", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-as-goldman-sachs-dives-on-earnings-nvidia-jumps-on-buy-rating/", "time_published": "20230418T130100", "authors": ["Investor's Business Daily", "SCOTT LEHTONEN"], "summary": "Dow Jones Futures Rise As Goldman Sachs Dives On Earnings ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2017/04/stock-wallstreet-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.999336"}], "overall_sentiment_score": 0.145928, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.087931", "ticker_sentiment_score": "0.024683", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.174798", "ticker_sentiment_score": "0.201838", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AAPL", "relevance_score": "0.146025", "ticker_sentiment_score": "0.042276", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSCO", "relevance_score": "0.117057", "ticker_sentiment_score": "0.026338", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.087931", "ticker_sentiment_score": "0.100696", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.146025", "ticker_sentiment_score": "0.091048", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.087931", "ticker_sentiment_score": "0.100696", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.146025", "ticker_sentiment_score": "0.056006", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKE", "relevance_score": "0.117057", "ticker_sentiment_score": "0.090688", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.087931", "ticker_sentiment_score": "0.100696", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.029363", "ticker_sentiment_score": "0.105286", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASML", "relevance_score": "0.058687", "ticker_sentiment_score": "0.274081", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MSFT", "relevance_score": "0.117057", "ticker_sentiment_score": "0.052497", "ticker_sentiment_label": "Neutral"}, {"ticker": "LULU", "relevance_score": "0.058687", "ticker_sentiment_score": "0.097991", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIVE", "relevance_score": "0.203337", "ticker_sentiment_score": "-0.03466", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMT", "relevance_score": "0.058687", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.087931", "ticker_sentiment_score": "0.003173", "ticker_sentiment_label": "Neutral"}, {"ticker": "V", "relevance_score": "0.117057", "ticker_sentiment_score": "0.09857", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBA", "relevance_score": "0.058687", "ticker_sentiment_score": "0.134999", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.058687", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.087931", "ticker_sentiment_score": "0.139511", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why US Stocks Look Poised For A Rally This Earnings Season - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ", "url": "https://www.benzinga.com/news/earnings/23/04/31850201/us-stocks-ready-to-rally-amid-earnings-optimism-analyst-sees-upward-momentum-on-outlier-s-p-500-ret", "time_published": "20230418T105848", "authors": ["Shanthi Rexaline"], "summary": "The positive mood seen in late trading on Monday appears to be spilling over into Tuesday's session, with futures pointing to a higher open. A slew of bank earnings, energy prices and a housing market reading are all in the mix, as traders position themselves for the earnings season.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/18/shutterstock_1604841298.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.955357"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.838487"}], "overall_sentiment_score": 0.021331, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.107978", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.107978", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.107978", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.107978", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.107978", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BK", "relevance_score": "0.107978", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RUN", "relevance_score": "0.107978", "ticker_sentiment_score": "-0.175744", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PLUG", "relevance_score": "0.107978", "ticker_sentiment_score": "-0.288064", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GS", "relevance_score": "0.107978", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.054114", "ticker_sentiment_score": "0.064785", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHN", "relevance_score": "0.107978", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLR", "relevance_score": "0.107978", "ticker_sentiment_score": "-0.288064", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LMT", "relevance_score": "0.107978", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCHW", "relevance_score": "0.107978", "ticker_sentiment_score": "-0.112096", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPLA", "relevance_score": "0.054114", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.107978", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Morning Bid: Global pulse picks up, rates creep higher again", "url": "https://www.reuters.com/markets/us/global-markets-view-usa-2023-04-18/", "time_published": "20230418T100716", "authors": ["Reuters"], "summary": "A look at the day ahead in U.S. and global markets from Mike Dolan With investors largely assuming recession ahead, an accelerating global economic pulse challenges the narrative and is seeing interest rates tick back higher again as the March banking wobble subsides.", "banner_image": "https://fingfx.thomsonreuters.com/gfx/mkt/klvygmrrmvg/Two.PNG", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.905476"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.060475, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.096477", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.048327", "ticker_sentiment_score": "0.148864", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.048327", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAL", "relevance_score": "0.048327", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.096477", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMC", "relevance_score": "0.048327", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.048327", "ticker_sentiment_score": "0.194878", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.048327", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BK", "relevance_score": "0.096477", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLD", "relevance_score": "0.048327", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.144275", "ticker_sentiment_score": "0.119553", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.048327", "ticker_sentiment_score": "0.148864", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMT", "relevance_score": "0.048327", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.048327", "ticker_sentiment_score": "-0.067005", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.048327", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:GBP", "relevance_score": "0.048327", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.048327", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Jones Futures: Netflix, Tesla Earnings On Deck", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-netflix-tesla-earnings-on-deck-what-to-do-now-todays-stock-market/", "time_published": "20230417T205400", "authors": ["SCOTT LEHTONEN", "Investor's Business Daily"], "summary": "Dow Jones futures were little changed ahead of Tuesday's open, with first-quarter earnings season set to heat up this week. Netflix ( NFLX ) earnings are out Tuesday, while Tesla ( TSLA ) earnings are set for Wednesday.", "banner_image": "https://www.investors.com/wp-content/uploads/2020/12/Stock-Teslalogo-01-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.988787"}], "overall_sentiment_score": 0.10629, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.105449", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.105449", "ticker_sentiment_score": "0.055983", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSCO", "relevance_score": "0.14028", "ticker_sentiment_score": "-0.006255", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.070414", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.14028", "ticker_sentiment_score": "0.096368", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.070414", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.17484", "ticker_sentiment_score": "0.062891", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKE", "relevance_score": "0.105449", "ticker_sentiment_score": "0.098205", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.070414", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.105449", "ticker_sentiment_score": "0.073282", "ticker_sentiment_label": "Neutral"}, {"ticker": "LULU", "relevance_score": "0.070414", "ticker_sentiment_score": "0.098464", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIVE", "relevance_score": "0.209064", "ticker_sentiment_score": "-0.063591", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMT", "relevance_score": "0.070414", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.14028", "ticker_sentiment_score": "-0.019143", "ticker_sentiment_label": "Neutral"}, {"ticker": "V", "relevance_score": "0.105449", "ticker_sentiment_score": "0.109059", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBA", "relevance_score": "0.070414", "ticker_sentiment_score": "0.135736", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.070414", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.105449", "ticker_sentiment_score": "0.146038", "ticker_sentiment_label": "Neutral"}]}, {"title": "Investing Action Plan: Tesla, Netflix, Goldman Sachs Earnings Amid Young Uptrend", "url": "https://www.investors.com/research/investing-action-plan/stock-trading-action-plan-tesla-netflix-goldman-sachs-earnings-amid-young-uptrend/", "time_published": "20230414T220300", "authors": ["Investor's Business Daily", "ALAN R. ELLIOTT"], "summary": "Investing Action Plan: Tesla, Netflix, Goldman Sachs Earnings Amid ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/11/stock-NYSE-exterior-04-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.102536, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "XPEV", "relevance_score": "0.042762", "ticker_sentiment_score": "0.123163", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAL", "relevance_score": "0.042762", "ticker_sentiment_score": "-0.056626", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.042762", "ticker_sentiment_score": "0.093831", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.042762", "ticker_sentiment_score": "0.093831", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLB", "relevance_score": "0.042762", "ticker_sentiment_score": "0.097777", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.042762", "ticker_sentiment_score": "0.093831", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASML", "relevance_score": "0.064104", "ticker_sentiment_score": "0.113235", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.148863", "ticker_sentiment_score": "0.057581", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMA", "relevance_score": "0.042762", "ticker_sentiment_score": "-0.056626", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRCX", "relevance_score": "0.042762", "ticker_sentiment_score": "-0.001973", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPGI", "relevance_score": "0.021388", "ticker_sentiment_score": "-0.017343", "ticker_sentiment_label": "Neutral"}, {"ticker": "DKNG", "relevance_score": "0.042762", "ticker_sentiment_score": "0.050026", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.148863", "ticker_sentiment_score": "0.088158", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.042762", "ticker_sentiment_score": "-0.056626", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.042762", "ticker_sentiment_score": "-0.056626", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCA", "relevance_score": "0.064104", "ticker_sentiment_score": "0.061032", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKR", "relevance_score": "0.064104", "ticker_sentiment_score": "0.075667", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.0854", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IOT", "relevance_score": "0.042762", "ticker_sentiment_score": "0.050026", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMT", "relevance_score": "0.064104", "ticker_sentiment_score": "0.051023", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIO", "relevance_score": "0.042762", "ticker_sentiment_score": "0.123163", "ticker_sentiment_label": "Neutral"}, {"ticker": "PG", "relevance_score": "0.042762", "ticker_sentiment_score": "0.093831", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.042762", "ticker_sentiment_score": "0.093831", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCHW", "relevance_score": "0.042762", "ticker_sentiment_score": "-0.056626", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCX", "relevance_score": "0.064104", "ticker_sentiment_score": "-0.075161", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.042762", "ticker_sentiment_score": "0.136375", "ticker_sentiment_label": "Neutral"}, {"ticker": "LI", "relevance_score": "0.064104", "ticker_sentiment_score": "0.125286", "ticker_sentiment_label": "Neutral"}, {"ticker": "KEY", "relevance_score": "0.042762", "ticker_sentiment_score": "-0.056626", "ticker_sentiment_label": "Neutral"}]}, {"title": "Netflix Stock Shows Strength Ahead Of Q1 Results; Intuitive Surgical, Tesla Highlight Earnings Calendar", "url": "https://www.investors.com/research/earnings-preview/netflix-stock-shows-strength-q1-results-intuitive-surgical-tesla-hightlight-earnings-calendar/", "time_published": "20230414T161400", "authors": ["Investor's Business Daily", "KEN SHREVE"], "summary": "Netflix Stock Shows Strength Ahead Of Q1 Results. Intuitive Surgical ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2023/04/EARNwatch041723.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.999953"}], "overall_sentiment_score": 0.109464, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.51165", "ticker_sentiment_score": "0.15347", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.064973", "ticker_sentiment_score": "0.089438", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.064973", "ticker_sentiment_score": "0.146238", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRCX", "relevance_score": "0.064973", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.064973", "ticker_sentiment_score": "0.146238", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCX", "relevance_score": "0.161494", "ticker_sentiment_score": "-0.084876", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCCO", "relevance_score": "0.064973", "ticker_sentiment_score": "-0.100116", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.064973", "ticker_sentiment_score": "0.146238", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.255641", "ticker_sentiment_score": "0.299359", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "TMO vs. ISRG: Which Stock Is the Better Value Option?", "url": "https://www.zacks.com/stock/news/2079008/tmo-vs-isrg-which-stock-is-the-better-value-option", "time_published": "20230414T154015", "authors": ["Zacks Investment Research"], "summary": "Investors interested in stocks from the Medical - Instruments sector have probably already heard of Thermo Fisher Scientific ( TMO Quick QuoteTMO - ) and Intuitive Surgical, Inc. ( ISRG Quick QuoteISRG - ) . But which of these two stocks presents investors with the better value opportunity right ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default196.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.507744, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.66878", "ticker_sentiment_score": "0.59511", "ticker_sentiment_label": "Bullish"}, {"ticker": "TMO", "relevance_score": "0.775472", "ticker_sentiment_score": "0.623947", "ticker_sentiment_label": "Bullish"}]}, {"title": "Dow Jones Slumps 180 Points Despite JPMorgan Earnings Pop; Boeing Dives On 737 MAX Delay; Tesla Drops On More Price Cuts", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-150-point-jpmorgan-earnings-boeing-dives-737-max-news-tesla-drops-price-cuts/", "time_published": "20230414T144900", "authors": ["Investor's Business Daily", "KEN SHREVE"], "summary": "Dow Jones Slumps 180 Points Despite JPMorgan Earnings Pop ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2018/05/Stock-dow-04-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.999896"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.947132"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.019417, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MARA", "relevance_score": "0.122269", "ticker_sentiment_score": "0.096942", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.122269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.182506", "ticker_sentiment_score": "0.083655", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.182506", "ticker_sentiment_score": "-0.26963", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CROX", "relevance_score": "0.122269", "ticker_sentiment_score": "0.244309", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GS", "relevance_score": "0.122269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.122269", "ticker_sentiment_score": "0.264581", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MSFT", "relevance_score": "0.122269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCID", "relevance_score": "0.122269", "ticker_sentiment_score": "-0.170264", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TSLA", "relevance_score": "0.182506", "ticker_sentiment_score": "-0.260927", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SPR", "relevance_score": "0.122269", "ticker_sentiment_score": "-0.393129", "ticker_sentiment_label": "Bearish"}, {"ticker": "WFC", "relevance_score": "0.122269", "ticker_sentiment_score": "0.066024", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.122269", "ticker_sentiment_score": "0.096942", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.122269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.061315", "ticker_sentiment_score": "0.085005", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Medical Stocks With Solid Growth Potential to Keep Track Of", "url": "https://www.zacks.com/stock/news/2078839/3-medical-stocks-with-solid-growth-potential-to-keep-track-of", "time_published": "20230414T132600", "authors": ["Zacks Investment Research"], "summary": "Here we discuss three medical stocks - AXSM, MRNA and ISRG - that have the potential to create wealth for investors over the coming years.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e7/288.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.224894, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.375722", "ticker_sentiment_score": "0.107375", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.331765", "ticker_sentiment_score": "0.305296", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JAZZ", "relevance_score": "0.04882", "ticker_sentiment_score": "0.153715", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AXSM", "relevance_score": "0.193465", "ticker_sentiment_score": "0.075196", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical  ( ISRG )  to Post Q1 Earnings: What's in Store?", "url": "https://www.zacks.com/stock/news/2078831/intuitive-surgical-isrg-to-post-q1-earnings-whats-in-store", "time_published": "20230414T121700", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical's (ISRG) first-quarter results likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs may have hurt margins.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/dc/1107.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.999937"}], "overall_sentiment_score": 0.20928, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MASI", "relevance_score": "0.154455", "ticker_sentiment_score": "0.125292", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.154455", "ticker_sentiment_score": "0.025611", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCK", "relevance_score": "0.154455", "ticker_sentiment_score": "-0.0066", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.396574", "ticker_sentiment_score": "0.20629", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical Stock To See Higher Levels Post Q1?", "url": "https://www.forbes.com/sites/greatspeculations/2023/04/13/intuitive-surgical-stock-to-see-higher-levels-post-q1/", "time_published": "20230413T130000", "authors": ["Trefis Team"], "summary": "We expect Intuitive Surgical to report revenue and earnings slightly above the street estimates, driven by a rise in total procedures volume.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/643763ef25ef3956b46ba1ce/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Markets", "source_domain": "www.forbes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Earnings", "relevance_score": "0.999483"}], "overall_sentiment_score": 0.109671, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.740328", "ticker_sentiment_score": "0.120741", "ticker_sentiment_label": "Neutral"}]}, {"title": "1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy", "url": "https://www.fool.com/investing/2023/04/13/ai-investments-top-stocks-to-buy/", "time_published": "20230413T095000", "authors": ["Keith Speights"], "summary": "These companies are leading the way in using AI in healthcare.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727802%2Fman-pointing-upward-toward-a-rising-red-line-on-a-wall.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.340754, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.201944", "ticker_sentiment_score": "0.154985", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABCL", "relevance_score": "0.101797", "ticker_sentiment_score": "0.260105", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OSCR", "relevance_score": "0.051003", "ticker_sentiment_score": "0.148377", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.051003", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.051003", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAH", "relevance_score": "0.051003", "ticker_sentiment_score": "-0.033105", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.051003", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.101797", "ticker_sentiment_score": "-0.02333", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.250902", "ticker_sentiment_score": "0.22827", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Is SPDR S&P Health Care Equipment ETF  ( XHE )  a Strong ETF Right Now?", "url": "https://www.zacks.com/stock/news/2077297/is-spdr-sp-health-care-equipment-etf-xhe-a-strong-etf-right-now", "time_published": "20230412T102007", "authors": ["Zacks Investment Research"], "summary": "Smart Beta ETF report for ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default199.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999892"}], "overall_sentiment_score": 0.285119, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SEM", "relevance_score": "0.059194", "ticker_sentiment_score": "0.084028", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.059194", "ticker_sentiment_score": "0.118", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.118064", "ticker_sentiment_score": "0.063933", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.118064", "ticker_sentiment_score": "0.063933", "ticker_sentiment_label": "Neutral"}]}, {"title": "Market Fades, But These Stocks Flash Buy Signals; Inflation Report Due", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-fades-4-stocks-flash-buy-signals-cpi-inflation-report-due/", "time_published": "20230411T205200", "authors": ["Investor's Business Daily", "ED CARSON"], "summary": "Market Fades, But These Stocks Flash Buy Signals. Inflation Report ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2017/10/stock-climbingHill-02-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.999937"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.02905, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MTH", "relevance_score": "0.079656", "ticker_sentiment_score": "-0.042603", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.053153", "ticker_sentiment_score": "-0.07405", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBH", "relevance_score": "0.053153", "ticker_sentiment_score": "0.135668", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.079656", "ticker_sentiment_score": "-0.105131", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLDR", "relevance_score": "0.184497", "ticker_sentiment_score": "0.062632", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDOG", "relevance_score": "0.053153", "ticker_sentiment_score": "0.022001", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGN", "relevance_score": "0.053153", "ticker_sentiment_score": "0.135668", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.026591", "ticker_sentiment_score": "0.01841", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPH", "relevance_score": "0.079656", "ticker_sentiment_score": "-0.042603", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.158519", "ticker_sentiment_score": "-0.028354", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.026591", "ticker_sentiment_score": "0.214774", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LEN", "relevance_score": "0.053153", "ticker_sentiment_score": "-0.094671", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.053153", "ticker_sentiment_score": "0.135668", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.10607", "ticker_sentiment_score": "-0.024439", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWAV", "relevance_score": "0.158519", "ticker_sentiment_score": "-0.035212", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Earnings Expected to Grow: Should You Buy?", "url": "https://www.zacks.com/stock/news/2076939/intuitive-surgical-inc-isrg-earnings-expected-to-grow-should-you-buy", "time_published": "20230411T140027", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default92.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.198398, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.295273", "ticker_sentiment_score": "0.245998", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "2 Forever Stocks to Buy No Matter What the Market Is Doing", "url": "https://www.fool.com/investing/2023/04/11/2-forever-stocks-to-buy-no-matter-what-the-market/", "time_published": "20230411T093000", "authors": ["Adria Cimino"], "summary": "These two top stocks are trading at very reasonable prices right now.", "banner_image": "https://media.ycharts.com/charts/e30bd25ea4698bf043e380380903aa4f.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99994"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.119315, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.124809", "ticker_sentiment_score": "0.032147", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.470174", "ticker_sentiment_score": "0.006167", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.062597", "ticker_sentiment_score": "0.122904", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Outpaces Stock Market Gains: What You Should Know", "url": "https://www.zacks.com/stock/news/2076578/intuitive-surgical-inc-isrg-outpaces-stock-market-gains-what-you-should-know", "time_published": "20230410T220023", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed at $258.94 in the latest trading session, marking a +0.79% move from the prior day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default266.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.25643, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.659949", "ticker_sentiment_score": "0.400412", "ticker_sentiment_label": "Bullish"}]}, {"title": "Here's Why You Should Retain Intuitive Surgical  ( ISRG )  Stock Now", "url": "https://www.zacks.com/stock/news/2076345/heres-why-you-should-retain-intuitive-surgical-isrg-stock-now", "time_published": "20230410T144200", "authors": ["Zacks Investment Research"], "summary": "Investors continue to be optimistic about Intuitive Surgical (ISRG) owing to its strength in robotics.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/61/11728.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": 0.274187, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MASI", "relevance_score": "0.212115", "ticker_sentiment_score": "0.046399", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.212115", "ticker_sentiment_score": "0.084122", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSIC", "relevance_score": "0.212115", "ticker_sentiment_score": "-0.051095", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.313484", "ticker_sentiment_score": "0.236335", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Zacks Investment Ideas feature highlights: Nvidia, United Healthcare, Merck, Pfizer and Intuitive Surgical", "url": "https://www.zacks.com/stock/news/2076198/zacks-investment-ideas-feature-highlights-nvidia-united-healthcare-merck-pfizer-and-intuitive-surgical", "time_published": "20230410T121700", "authors": ["Zacks Investment Research"], "summary": "Nvidia, United Healthcare, Merck, Pfizer and Intuitive Surgical are part of the Zacks Investment Ideas article.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/16/2258.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.162515, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.254751", "ticker_sentiment_score": "0.130995", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.33514", "ticker_sentiment_score": "0.107571", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.254751", "ticker_sentiment_score": "0.130995", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 High-Growth Stocks You Can Buy and Hold for Years", "url": "https://www.fool.com/investing/2023/04/09/2-high-growth-stocks-you-can-buy-and-hold-for-year/", "time_published": "20230409T111000", "authors": ["Rachel Warren"], "summary": "A long-term perspective is invaluable, particularly in the current market environment.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727340%2Fperson-looking-at-charts-on-a-computer-screen.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Earnings", "relevance_score": "0.989041"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": 0.169953, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IIPR", "relevance_score": "0.329237", "ticker_sentiment_score": "0.135311", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.191929", "ticker_sentiment_score": "0.116124", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Supercharged Stocks With Multibagger Potential to Buy on the Dip", "url": "https://www.fool.com/investing/2023/04/08/2-supercharged-stocks-with-multibagger-potential/", "time_published": "20230408T134500", "authors": ["Rachel Warren"], "summary": "A volatile market can still be a golden buying moment for long-term investors.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726751%2Fsurprised-young-woman-laptop.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.858979"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.284383, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.1871", "ticker_sentiment_score": "0.160044", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABNB", "relevance_score": "0.1871", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "5 S&P 500 Stocks Showing Strength As Recession Fears Rise", "url": "https://www.investors.com/news/5-sp-500-stocks-showing-strength-as-recession-fears-rise/", "time_published": "20230407T171400", "authors": ["KIT NORTON", "Investor's Business Daily"], "summary": "S&P 500 medical stocks Cardinal Health ( CAH ) , Vertex Pharmaceuticals ( VRTX ) , Merck ( MRK ) , Intuitive Surgical ( ISRG ) and Insulet ( PODD ) are in focus this week. Medical stocks are coming into favor again - with companies involved in biotech, pharmaceuticals, medical products and ...", "banner_image": "https://www.investors.com/wp-content/uploads/2017/10/stock-pharmacy-01-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.101428, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TSLA", "relevance_score": "0.027195", "ticker_sentiment_score": "0.083431", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCK", "relevance_score": "0.054359", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.162073", "ticker_sentiment_score": "0.109066", "ticker_sentiment_label": "Neutral"}, {"ticker": "PODD", "relevance_score": "0.214937", "ticker_sentiment_score": "0.082914", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAH", "relevance_score": "0.29234", "ticker_sentiment_score": "0.155506", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRNA", "relevance_score": "0.054359", "ticker_sentiment_score": "0.241922", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.241018", "ticker_sentiment_score": "0.075299", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Once-in-a-Decade Buying Opportunities in a Growth Stock Bear Market", "url": "https://www.fool.com/investing/2023/04/07/2-once-in-a-decade-buying-opportunities-in-a-bear/", "time_published": "20230407T141500", "authors": ["Rachel Warren"], "summary": "These stocks have growth stories that investors might find too compelling to overlook.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726820%2Fa-dollar-sign-in-cyberspace.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.905476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": 0.241991, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.04912", "ticker_sentiment_score": "0.015924", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.098054", "ticker_sentiment_score": "0.167844", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.288327", "ticker_sentiment_score": "0.13418", "ticker_sentiment_label": "Neutral"}]}, {"title": "Futures: Jobs Report Looms, Tesla Cuts EV Prices Again", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-jobs-report-tesla-cuts-u-s-ev-prices-again/", "time_published": "20230407T100400", "authors": ["Investor's Business Daily", "ED CARSON"], "summary": "Dow Jones futures were about unchanged early Friday, along with S&P 500 futures and Nasdaq futures. The March jobs report looms while Tesla ( TSLA ) cut U.S. prices on all its electric vehicles. But U.S. markets are closed today.", "banner_image": "https://www.investors.com/wp-content/uploads/2021/01/Stock-Tesla-modelY-01-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.495866"}], "overall_sentiment_score": -0.019422, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BABA", "relevance_score": "0.137474", "ticker_sentiment_score": "-0.057578", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.204936", "ticker_sentiment_score": "-0.075189", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.137474", "ticker_sentiment_score": "0.084411", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.068995", "ticker_sentiment_score": "0.114437", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.068995", "ticker_sentiment_score": "0.114437", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.455525", "ticker_sentiment_score": "-0.060654", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.068995", "ticker_sentiment_score": "0.114437", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.068995", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.068995", "ticker_sentiment_score": "0.114437", "ticker_sentiment_label": "Neutral"}]}, {"title": "Futures Fall As Jobs Report Looms; Two Giants Flash Buy Signals", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-rebounds-into-jobs-report-google-alibaba-flash-buy-signals/", "time_published": "20230407T021800", "authors": ["ED CARSON", "Investor's Business Daily"], "summary": "Dow Jones Futures: Market Rally Rebounds Into Jobs Report ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/10/stock-jobs-factory-01-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.495866"}], "overall_sentiment_score": -0.034211, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BABA", "relevance_score": "0.092213", "ticker_sentiment_score": "-0.042947", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.092213", "ticker_sentiment_score": "0.120942", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.046184", "ticker_sentiment_score": "0.154327", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AAPL", "relevance_score": "0.046184", "ticker_sentiment_score": "0.154327", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "C", "relevance_score": "0.046184", "ticker_sentiment_score": "-0.167306", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JPM", "relevance_score": "0.046184", "ticker_sentiment_score": "-0.167306", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MU", "relevance_score": "0.046184", "ticker_sentiment_score": "0.053001", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.046184", "ticker_sentiment_score": "0.154327", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MSFT", "relevance_score": "0.092213", "ticker_sentiment_score": "-0.025767", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSNLF", "relevance_score": "0.023102", "ticker_sentiment_score": "0.050611", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.160633", "ticker_sentiment_score": "-0.021371", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.046184", "ticker_sentiment_score": "-0.167306", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "XOM", "relevance_score": "0.046184", "ticker_sentiment_score": "0.154327", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.046184", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Action Plan: Bank Earnings In Focus; Delta, UnitedHealth On Tap", "url": "https://www.investors.com/research/investing-action-plan/jpmorgan-big-bank-earnings-get-special-attention-delta-unitedhealth-due/", "time_published": "20230406T165500", "authors": ["Investor's Business Daily", "IBD STAFF"], "summary": "JPMorgan and other bank earnings On Tap Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2020/07/Stock-JPmorgan-04-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.983605"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.999336"}], "overall_sentiment_score": -0.009668, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "C", "relevance_score": "0.179121", "ticker_sentiment_score": "-0.074109", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNC", "relevance_score": "0.222838", "ticker_sentiment_score": "-0.087508", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.265859", "ticker_sentiment_score": "-0.100737", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.090134", "ticker_sentiment_score": "-0.020401", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAL", "relevance_score": "0.222838", "ticker_sentiment_score": "0.031412", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.265859", "ticker_sentiment_score": "0.094146", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSM", "relevance_score": "0.090134", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNTH", "relevance_score": "0.090134", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.222838", "ticker_sentiment_score": "-0.087508", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRC", "relevance_score": "0.134841", "ticker_sentiment_score": "-0.061804", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.134841", "ticker_sentiment_score": "-0.024137", "ticker_sentiment_label": "Neutral"}, {"ticker": "PODD", "relevance_score": "0.090134", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAST", "relevance_score": "0.090134", "ticker_sentiment_score": "0.105218", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.134841", "ticker_sentiment_score": "-0.024137", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWAV", "relevance_score": "0.134841", "ticker_sentiment_score": "-0.024137", "ticker_sentiment_label": "Neutral"}]}, {"title": "Prediction: This Could Become a Trillion-Dollar Stock by 2043", "url": "https://www.fool.com/investing/2023/04/06/prediction-this-could-become-trillion-dollar-stock/", "time_published": "20230406T140700", "authors": ["Prosper Junior Bakiny"], "summary": "Demand for robotic-assisted surgery will only grow, and Intuitive Surgical is the leader.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726769%2Fbuy-sell-stock-market-rolling-dice-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.228382, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDT", "relevance_score": "0.090645", "ticker_sentiment_score": "0.093176", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.045396", "ticker_sentiment_score": "0.158084", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.468807", "ticker_sentiment_score": "0.331449", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "3 Reasons to Buy Healthcare Stocks in the Current Market Environment", "url": "https://www.zacks.com/commentary/2075389/3-reasons-to-buy-healthcare-stocks-in-the-current-market-environment", "time_published": "20230406T125900", "authors": ["Zacks Investment Research"], "summary": "Healthcare stocks are currently providing investors with an attractive way to counterbalance a portfolio overexposed to tech. In general, healthcare stocks have lower betas, are more defensive, and have cleaner balance sheets.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.159694, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AMD", "relevance_score": "0.156461", "ticker_sentiment_score": "0.12", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.23281", "ticker_sentiment_score": "0.083054", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.23281", "ticker_sentiment_score": "0.100288", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.156461", "ticker_sentiment_score": "0.074795", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMCI", "relevance_score": "0.156461", "ticker_sentiment_score": "0.12", "ticker_sentiment_label": "Neutral"}]}, {"title": "Urology Devices Market to Reach USD 64 Bn by 2031 Owing to the Rise in the Number of Urology Disorders | TMR Study", "url": "https://www.benzinga.com/pressreleases/23/04/g31685689/urology-devices-market-to-reach-usd-64-bn-by-2031-owing-to-the-rise-in-the-number-of-urology-disor", "time_published": "20230405T183000", "authors": ["Globe Newswire"], "summary": "Wilmington, Delaware, United States, April 06, 2023 ( GLOBE NEWSWIRE ) -- The global urology devices market is estimated to flourish at a CAGR of 5.6% from 2022 to 2031. According to Transparency Market Research, sales of urology devices are slated to total USD 64 billion by the end of the ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.132217, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BAX", "relevance_score": "0.076115", "ticker_sentiment_score": "0.110238", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSNUF", "relevance_score": "0.038101", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.038101", "ticker_sentiment_score": "-0.011836", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMS", "relevance_score": "0.038101", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.038101", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.076115", "ticker_sentiment_score": "0.18525", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "IBD Stock Of The Day: Why 2024 Could Be A Game-Changer", "url": "https://www.investors.com/research/ibd-stock-of-the-day/isrg-stock-why-2024-could-be-a-game-changer-for-robotic-surgery/", "time_published": "20230405T162800", "authors": ["ALLISON GATLIN", "Investor's Business Daily"], "summary": "ISRG Stock: Why 2024 Could Be A Game-Changer For Robotic ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2023/04/ISRG-SOTD-chart1.png", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999365"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.173841, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVR", "relevance_score": "0.068306", "ticker_sentiment_score": "0.097295", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.136113", "ticker_sentiment_score": "0.026971", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.068306", "ticker_sentiment_score": "0.138353", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.734843", "ticker_sentiment_score": "0.231238", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.202932", "ticker_sentiment_score": "0.028709", "ticker_sentiment_label": "Neutral"}]}, {"title": "Minimally Invasive Surgery - This Company's Successful Trial Could Help Eliminate The Need For An Incision In Patients With Back Pain - Globus Medical  ( NYSE:GMED ) , Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/general/biotech/23/04/31676938/minimally-invasive-surgery-this-companys-successful-trial-could-help-eliminate-the-need-for-an-in", "time_published": "20230405T122125", "authors": ["Ernest Dela Aglanu"], "summary": "As medical technology progresses, the world's approach to surgical operations is also advancing and changing significantly. As part of this, minimally invasive surgery ( MIS ) , in recent years, has taken the forefront of the surgical industry, and there are no surprises why.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/05/shutterstock_1762068680.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.143826, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SSTK", "relevance_score": "0.034282", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBH", "relevance_score": "0.068502", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMTC", "relevance_score": "0.068502", "ticker_sentiment_score": "0.116682", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMED", "relevance_score": "0.068502", "ticker_sentiment_score": "0.031375", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.068502", "ticker_sentiment_score": "0.031375", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.068502", "ticker_sentiment_score": "0.031375", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Gains As Market Dips: What You Should Know", "url": "https://www.zacks.com/stock/news/2074573/intuitive-surgical-inc-isrg-gains-as-market-dips-what-you-should-know", "time_published": "20230404T220018", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed at $254.71 in the latest trading session, marking a +0.47% move from the prior day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default296.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.976913"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.174901, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.606946", "ticker_sentiment_score": "0.185638", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "4 Stocks the World's Top-Performing Hedge Fund Is Buying Hand Over Fist", "url": "https://www.fool.com/investing/2023/04/04/4-stocks-worlds-top-performing-hedge-fund-buying/", "time_published": "20230404T092100", "authors": ["Sean Williams"], "summary": "This billionaire-run hedge fund has generated $66 billion in profit since inception. Here are four stocks it's currently piling into.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726861%2Fstock-chart-quote-bear-bull-trading-invest-short-options-getty.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.989041"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.183304, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYPL", "relevance_score": "0.239137", "ticker_sentiment_score": "0.177647", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "META", "relevance_score": "0.205807", "ticker_sentiment_score": "0.174921", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.205807", "ticker_sentiment_score": "0.192349", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.103778", "ticker_sentiment_score": "0.026197", "ticker_sentiment_label": "Neutral"}]}, {"title": "Risk and Reward: A 10-Year Look at Selected Growth Stocks Versus Dividend Champions", "url": "https://www.fool.com/investing/2023/04/03/growth-vs-dividend-stocks-10-year-risk-reward/", "time_published": "20230403T133300", "authors": ["Anders Bylund"], "summary": "Are volatile high-growth stocks really worth the risk? This analysis might surprise you.", "banner_image": "https://media.ycharts.com/charts/11ce1e627a6ce9cce6282e37706dfb10.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.257805, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.190417", "ticker_sentiment_score": "0.237665", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TMUS", "relevance_score": "0.032035", "ticker_sentiment_score": "0.068045", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.032035", "ticker_sentiment_score": "0.001933", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZ", "relevance_score": "0.032035", "ticker_sentiment_score": "0.068045", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.032035", "ticker_sentiment_score": "0.036244", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Unstoppable Growth Stocks That Could Go Parabolic in 2023", "url": "https://www.fool.com/investing/2023/04/02/2-unstoppable-stocks-could-go-parabolic-in-2023/", "time_published": "20230402T134500", "authors": ["Rachel Warren"], "summary": "Don't gloss over these stocks in the current market.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726371%2Fpeople-viewing-a-mobile-device-in-front-of-stacks-of-supercomputers.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.839681"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.318374, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.174587", "ticker_sentiment_score": "0.160629", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABNB", "relevance_score": "0.286864", "ticker_sentiment_score": "0.230649", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "2 All-Weather Stocks to Buy Without Hesitation Right Now", "url": "https://www.fool.com/investing/2023/03/31/2-all-weather-stocks-to-buy-without-hesitation/", "time_published": "20230331T124500", "authors": ["Rachel Warren"], "summary": "Despite near-term economic clouds, long-term investors can still find compelling buying opportunities.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726079%2Fbuffett19-tmf.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.87644"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.284475, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.363768", "ticker_sentiment_score": "0.237935", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DXCM", "relevance_score": "0.363768", "ticker_sentiment_score": "0.346107", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Have $2,000? 2 Exceptional Stocks to Buy In a Bear Market", "url": "https://www.fool.com/investing/2023/03/31/2-exceptional-stocks-to-buy-in-a-bear-market/", "time_published": "20230331T114500", "authors": ["Rachel Warren"], "summary": "The current market is challenging investors' fortitude, but patience can pay off.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726079%2Fbuffett19-tmf.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.282872, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.049221", "ticker_sentiment_score": "0.071285", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.146916", "ticker_sentiment_score": "0.181796", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.288893", "ticker_sentiment_score": "0.295154", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "5 Bargain-Basement Stocks to Buy Right Now", "url": "https://www.fool.com/investing/2023/03/31/5-bargain-basement-stocks-to-buy-right-now/", "time_published": "20230331T093000", "authors": ["Adria Cimino"], "summary": "Down markets offer us something very positive: deals on quality companies.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F725910%2Fstack-of-one-hundred-dollar-bills-cash-money-invest-retire-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.999763"}], "overall_sentiment_score": 0.225152, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.037563", "ticker_sentiment_score": "0.009785", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.186163", "ticker_sentiment_score": "0.154496", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.075043", "ticker_sentiment_score": "0.198401", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMZN", "relevance_score": "0.293653", "ticker_sentiment_score": "0.207025", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Check Out What Whales Are Doing With ISRG - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/markets/options/23/03/31596193/check-out-what-whales-are-doing-with-isrg", "time_published": "20230330T201614", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ISRG we detected 12 strange trades.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.188737, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.71032", "ticker_sentiment_score": "0.057325", "ticker_sentiment_label": "Neutral"}]}, {"title": "5 Artificial Intelligence ETFs For Investors To Ride The AI Wave - Plus One Bonus Alternative", "url": "https://www.forbes.com/sites/qai/2023/03/30/5-artificial-intelligence-etfs-for-investors-to-ride-the-ai-waveplus-one-bonus-alternative/", "time_published": "20230330T161422", "authors": ["Q.ai - Powering a Personal Wealth Movement"], "summary": "For investors looking to invest in AI, we're going to cover a number of the most popular artificial intelligence ETFs out there.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/6425b51751f40621dc8ad237/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Money", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Blockchain", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.248516, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PATH", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TER", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DE", "relevance_score": "0.032513", "ticker_sentiment_score": "0.06848", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "YASKF", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPGP", "relevance_score": "0.032513", "ticker_sentiment_score": "0.159285", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KYCCF", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.032513", "ticker_sentiment_score": "0.06848", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESLT", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KDP", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNS", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCZ", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FANUF", "relevance_score": "0.064973", "ticker_sentiment_score": "0.088092", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.064973", "ticker_sentiment_score": "0.088092", "ticker_sentiment_label": "Neutral"}]}, {"title": "Have $1,500? 2 Explosive Stocks to Add to Your Buy Basket", "url": "https://www.fool.com/investing/2023/03/30/have-1500-2-stocks-to-add-to-your-buy-basket/", "time_published": "20230330T141500", "authors": ["Rachel Warren"], "summary": "These healthcare companies are giants in their respective industries, but each has an untapped growth story to explore.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F725910%2Fstack-of-one-hundred-dollar-bills-cash-money-invest-retire-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99676"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99393"}], "overall_sentiment_score": 0.206053, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.346278", "ticker_sentiment_score": "0.266666", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HCSG", "relevance_score": "0.044718", "ticker_sentiment_score": "-0.106221", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDOC", "relevance_score": "0.089295", "ticker_sentiment_score": "0.062465", "ticker_sentiment_label": "Neutral"}]}, {"title": "EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy", "url": "https://www.globenewswire.com/news-release/2023/03/30/2637451/9622/en/EDAP-Reports-Record-Fourth-Quarter-and-Full-Year-2022-Results-and-Announces-Leadership-Succession-Plan-to-Develop-Global-Group-Strategy.html", "time_published": "20230330T103000", "authors": ["EDAP TMS S.A."], "summary": "LYON, France, March 30, 2023 -- EDAP TMS SA ( Nasdaq: EDAP ) ( the \"Company\" ) , a global leader in robotic energy-based therapies, announced today unaudited financial results for the fourth quarter and full-year 2022 and announced a change in its leadership, effective May 1, 2023.", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/3e934184-5c25-44fd-880b-e10deb63e6e1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.714479"}], "overall_sentiment_score": 0.174893, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VERO", "relevance_score": "0.020491", "ticker_sentiment_score": "0.114063", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.020491", "ticker_sentiment_score": "0.114063", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDAP", "relevance_score": "0.280846", "ticker_sentiment_score": "0.285709", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.020491", "ticker_sentiment_score": "0.114063", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.772642", "ticker_sentiment_score": "0.246071", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Gains But Lags Market: What You Should Know", "url": "https://www.zacks.com/stock/news/2072126/intuitive-surgical-inc-isrg-gains-but-lags-market-what-you-should-know", "time_published": "20230329T220024", "authors": ["Zacks Investment Research"], "summary": "In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $250.76, marking a +0.51% move from the previous day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default285.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.225789, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.546745", "ticker_sentiment_score": "0.244639", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Have $1,000? 2 Smart Stocks to Buy for 2023", "url": "https://www.fool.com/investing/2023/03/29/have-1000-2-smart-stocks-to-buy-for-2023/", "time_published": "20230329T110900", "authors": ["Rachel Warren"], "summary": "Both companies are raking in profits, and even another bear market shouldn't deter these growth stories.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F725950%2Fa-digital-rendering-of-computer-chips-with-one-labelled-ai.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Earnings", "relevance_score": "0.992549"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": 0.186245, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IIPR", "relevance_score": "0.325208", "ticker_sentiment_score": "0.218137", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.246999", "ticker_sentiment_score": "0.112585", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Stock Jumps 4.9%: Will It Continue to Soar?", "url": "https://www.zacks.com/stock/news/2070734/intuitive-surgical-inc-isrg-stock-jumps-49-will-it-continue-to-soar", "time_published": "20230327T120800", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default269.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.983783"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.226968, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.560594", "ticker_sentiment_score": "0.259464", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRCT", "relevance_score": "0.560594", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical Shows Market Leadership With Jump To 83 RS Rating", "url": "https://www.investors.com/ibd-data-stories/intuitive-surgical-shows-market-leadership-with-jump-to-83-rs-rating/", "time_published": "20230327T070000", "authors": ["INVESTOR'S BUSINESS DAILY", "Investor's Business Daily"], "summary": "Intuitive Surgical Shows Market Leadership With Jump To 83 RS ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.380563, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "BRKR", "relevance_score": "0.363388", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDXX", "relevance_score": "0.363388", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.762438", "ticker_sentiment_score": "0.541468", "ticker_sentiment_label": "Bullish"}]}, {"title": "Nasdaq Bear Market: 5 Jaw-Dropping Growth Stocks You'll Regret Not Buying on the Dip", "url": "https://www.fool.com/investing/2023/03/25/nasdaq-bear-market-5-growth-stocks-regret-not-buy/", "time_published": "20230325T090600", "authors": ["Sean Williams"], "summary": "The Nasdaq Composite losing a third of its value is the perfect excuse for opportunistic investors to pounce on high-quality growth stocks.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F725340%2Fbear-market-stocks-plunge-crash-invest-correction-getty.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.995077"}, {"topic": "Earnings", "relevance_score": "0.905476"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.102167, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "FVRR", "relevance_score": "0.160277", "ticker_sentiment_score": "0.126664", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRWD", "relevance_score": "0.133841", "ticker_sentiment_score": "0.055314", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.080548", "ticker_sentiment_score": "0.085408", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIDU", "relevance_score": "0.21258", "ticker_sentiment_score": "0.138706", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stock Market Feeling Gloomy As Banks Are Back In The Hot Seat; Drug Stock Pops", "url": "https://www.investors.com/market-trend/stock-market-today/stock-market-overcomes-bank-gloom-as-s-drug-stock-pops/", "time_published": "20230324T175207", "authors": ["Investor's Business Daily", "KIMBERLEY KOENIG"], "summary": "Stock Market Overcomes Bank Gloom As S&P 500 Turns Positive ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/08/stock-finance-broken-bank-01-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.024399, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MDLZ", "relevance_score": "0.103109", "ticker_sentiment_score": "-0.032719", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.103109", "ticker_sentiment_score": "-0.142926", "ticker_sentiment_label": "Neutral"}, {"ticker": "OXM", "relevance_score": "0.103109", "ticker_sentiment_score": "0.031253", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.103109", "ticker_sentiment_score": "-0.142926", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPGI", "relevance_score": "0.051663", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.051663", "ticker_sentiment_score": "0.098501", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.103109", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.051663", "ticker_sentiment_score": "0.082534", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.154125", "ticker_sentiment_score": "0.281448", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.051663", "ticker_sentiment_score": "-0.357891", "ticker_sentiment_label": "Bearish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Outpaces Stock Market Gains: What You Should Know", "url": "https://www.zacks.com/stock/news/2069925/intuitive-surgical-inc-isrg-outpaces-stock-market-gains-what-you-should-know", "time_published": "20230323T221521", "authors": ["Zacks Investment Research"], "summary": "In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $244.47, marking a +1.52% move from the previous day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default80.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.201671, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.617188", "ticker_sentiment_score": "0.289882", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why This Intuitive Surgical Analyst Is Bullish About 'Durable Growth' - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/03/31474976/why-this-intuitive-surgical-analyst-is-bullish-about-durable-growth", "time_published": "20230323T141841", "authors": ["Priya Nigam"], "summary": "Intuitive Surgical Inc. ISRG shares have been in focus for its short interest. The Sunnyvale, California-based company addresses a large market and has a strong pipeline that can deliver \"durable growth,\" according to William Blair.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/23/stock__chart_image.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.508646, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.858597", "ticker_sentiment_score": "0.735666", "ticker_sentiment_label": "Bullish"}]}, {"title": "This Is My Highest-Conviction Stock to Own in 2023 and Beyond", "url": "https://www.fool.com/investing/2023/03/23/this-is-my-highest-conviction-stock-to-own-in-2023/", "time_published": "20230323T114500", "authors": ["Prosper Junior Bakiny"], "summary": "This company has already delivered market-beating returns, but it's not too late to get in.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F725347%2Fwarren-buffett-motley-fool6-brka-brkb-berkshire.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.187205, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.2872", "ticker_sentiment_score": "0.158054", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.048919", "ticker_sentiment_score": "-0.042012", "ticker_sentiment_label": "Neutral"}]}, {"title": " ( ISRG )  - Analyzing Intuitive Surgical's Short Interest - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/short-sellers/23/03/31461606/isrg-analyzing-intuitive-surgicals-short-interest", "time_published": "20230322T173117", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical's ISRG short percent of float has fallen 6.35% since its last report. The company recently reported that it has 2.05 million shares sold short, which is 0.59% of all regular shares that are available for trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5521.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.259737, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.221819", "ticker_sentiment_score": "0.110774", "ticker_sentiment_label": "Neutral"}]}, {"title": "Should You Invest in the SPDR S&P Health Care Equipment ETF  ( XHE ) ?", "url": "https://www.zacks.com/stock/news/2068832/should-you-invest-in-the-spdr-sp-health-care-equipment-etf-xhe", "time_published": "20230322T102010", "authors": ["Zacks Investment Research"], "summary": "Sector ETF report for ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default131.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.262031, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SEM", "relevance_score": "0.064276", "ticker_sentiment_score": "0.084223", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.064276", "ticker_sentiment_score": "0.082059", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.128135", "ticker_sentiment_score": "0.080304", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.128135", "ticker_sentiment_score": "0.080304", "ticker_sentiment_label": "Neutral"}]}, {"title": "Minerva Surgical Announces the Appointment of Kaile Zagger as Chief Commercial Officer", "url": "https://www.globenewswire.com/news-release/2023/03/21/2631824/0/en/Minerva-Surgical-Announces-the-Appointment-of-Kaile-Zagger-as-Chief-Commercial-Officer.html", "time_published": "20230321T200500", "authors": ["Minerva Surgical", "Inc."], "summary": "SANTA CLARA, Calif., March 21, 2023 ( GLOBE NEWSWIRE ) -- Minerva Surgical, Inc. ( Nasdaq: UTRS ) ( Minerva Surgical ) , a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, announced today the appointment of Kaile Zagger as its new Chief ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/5acffb1f-9c6b-40fe-b206-1b8fe1b8faeb", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.14457, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.056143", "ticker_sentiment_score": "0.167947", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BSX", "relevance_score": "0.056143", "ticker_sentiment_score": "0.167947", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UTRS", "relevance_score": "0.377958", "ticker_sentiment_score": "0.268428", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Minerva Surgical Announces the Appointment of Kaile Zagger as Chief Commercial Officer - Minerva Surgical  ( NASDAQ:UTRS ) ", "url": "https://www.benzinga.com/pressreleases/23/03/g31446380/minerva-surgical-announces-the-appointment-of-kaile-zagger-as-chief-commercial-officer", "time_published": "20230321T200500", "authors": ["Globe Newswire"], "summary": "SANTA CLARA, Calif., March 21, 2023 ( GLOBE NEWSWIRE ) -- Minerva Surgical, Inc. UTRS ( Minerva Surgical ) , a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, announced today the appointment of Kaile Zagger as its new Chief Commercial Officer.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.142107, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.055109", "ticker_sentiment_score": "0.167885", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BSX", "relevance_score": "0.055109", "ticker_sentiment_score": "0.167885", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UTRS", "relevance_score": "0.371523", "ticker_sentiment_score": "0.262618", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ALC vs. ISRG: Which Stock Is the Better Value Option?", "url": "https://www.zacks.com/stock/news/2068061/alc-vs-isrg-which-stock-is-the-better-value-option", "time_published": "20230320T154010", "authors": ["Zacks Investment Research"], "summary": "Investors with an interest in Medical - Instruments stocks have likely encountered both Alcon ( ALC Quick QuoteALC - ) and Intuitive Surgical, Inc. ( ISRG Quick QuoteISRG - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default63.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.466843, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ALC", "relevance_score": "0.783009", "ticker_sentiment_score": "0.5608", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.676678", "ticker_sentiment_score": "0.533582", "ticker_sentiment_label": "Bullish"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Stock Moves -0.47%: What You Should Know", "url": "https://www.zacks.com/stock/news/2066431/intuitive-surgical-inc-isrg-stock-moves--047-what-you-should-know", "time_published": "20230315T220020", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed at $234.18 in the latest trading session, marking a -0.47% move from the prior day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default2.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.104277, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.605266", "ticker_sentiment_score": "0.189019", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "2 Unstoppable Growth Stocks to Buy and Hold Forever", "url": "https://www.fool.com/investing/2023/03/14/2-unstoppable-growth-stocks-to-buy-hold-forever/", "time_published": "20230314T133700", "authors": ["Prosper Junior Bakiny"], "summary": "You can bet the farm on these longtime market winners.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F724094%2Fsmiling-person-at-laptop-making-celebratory-fist_gettyimages-1349311070.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.98396"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.293186, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.370831", "ticker_sentiment_score": "0.342227", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.237204", "ticker_sentiment_score": "0.14254", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Genius Stocks to Buy if the Fed Induces a Recession", "url": "https://www.fool.com/investing/2023/03/09/3-genius-stocks-to-buy-if-fed-induces-a-recession/", "time_published": "20230309T102100", "authors": ["Sean Williams"], "summary": "Three recession-probability indicators that haven't been wrong for over 50 years suggest a recession is coming. These stocks can help you successfully navigate any economic turmoil.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F723667%2Fdollar-bill-stock-chart-plunge-correction-dow-sp-500-invest-getty.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999701"}, {"topic": "Earnings", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.022286, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MA", "relevance_score": "0.271274", "ticker_sentiment_score": "0.055679", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.137671", "ticker_sentiment_score": "0.07585", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Outpaces Stock Market Gains: What You Should Know", "url": "https://www.zacks.com/stock/news/2063224/intuitive-surgical-inc-isrg-outpaces-stock-market-gains-what-you-should-know", "time_published": "20230308T230020", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $231.09, moving +0.16% from the previous trading session.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default300.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.143663, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.659949", "ticker_sentiment_score": "0.336571", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "2 Healthcare Stocks That Could Help Make You a Fortune", "url": "https://www.fool.com/investing/2023/03/08/2-healthcare-stocks-that-could-help-make-you-a-for/", "time_published": "20230308T190000", "authors": ["Adria Cimino"], "summary": "These companies also happen to be a bargain right now.", "banner_image": "https://media.ycharts.com/charts/a5f59d5db2599a2649a192de09d9afde.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.995921"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.281006, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.053271", "ticker_sentiment_score": "0.035812", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.106305", "ticker_sentiment_score": "0.115877", "ticker_sentiment_label": "Neutral"}]}, {"title": "Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade", "url": "https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/", "time_published": "20230307T132000", "authors": ["Rachel Warren"], "summary": "No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F723433%2Fnyse-wall-street-trading-new-york-financial-stock-market-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Earnings", "relevance_score": "0.929393"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.2091, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.218817", "ticker_sentiment_score": "0.115646", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.343279", "ticker_sentiment_score": "0.140711", "ticker_sentiment_label": "Neutral"}]}, {"title": " ( ISRG )  - Analyzing Intuitive Surgical's Short Interest - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/short-sellers/23/03/31222570/isrg-analyzing-intuitive-surgicals-short-interest", "time_published": "20230306T173024", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical's ISRG short percent of float has fallen 12.5% since its last report. The company recently reported that it has 2.21 million shares sold short, which is 0.63% of all regular shares that are available for trading.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.259737, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.221819", "ticker_sentiment_score": "0.110774", "ticker_sentiment_label": "Neutral"}]}, {"title": "Service Robotics Market Size Worth USD 57.35 billion at a CAGR of 16.6% by 2029", "url": "https://www.benzinga.com/pressreleases/23/03/g31211220/service-robotics-market-size-worth-usd-57-35-billion-at-a-cagr-of-16-6-by-2029", "time_published": "20230306T045327", "authors": ["Globe Newswire"], "summary": "Pune, India, March 05, 2023 ( GLOBE NEWSWIRE ) -- The global service robotics market size was USD 16.95 billion in 2021.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.283034, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DFKCY", "relevance_score": "0.050894", "ticker_sentiment_score": "0.030717", "ticker_sentiment_label": "Neutral"}, {"ticker": "RICOF", "relevance_score": "0.050894", "ticker_sentiment_score": "0.090421", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFTBF", "relevance_score": "0.050894", "ticker_sentiment_score": "0.030717", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.050894", "ticker_sentiment_score": "0.030717", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.050894", "ticker_sentiment_score": "0.030717", "ticker_sentiment_label": "Neutral"}, {"ticker": "KUKAF", "relevance_score": "0.050894", "ticker_sentiment_score": "0.030717", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMC", "relevance_score": "0.050894", "ticker_sentiment_score": "0.030717", "ticker_sentiment_label": "Neutral"}]}, {"title": "Guide to Artificial Intelligence ETFs", "url": "https://www.zacks.com/stock/news/2061702/guide-to-artificial-intelligence-etfs", "time_published": "20230303T174300", "authors": ["Zacks Investment Research"], "summary": "The recent success of Chart GPT made the AI space an intriguing investing area. IDC expects the AI market to maintain a year-over-year growth rate in the high teens throughout the five-year forecast.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/21892.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.998663"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}], "overall_sentiment_score": 0.282126, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.087185", "ticker_sentiment_score": "-0.024812", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABB", "relevance_score": "0.043658", "ticker_sentiment_score": "-0.073341", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.087185", "ticker_sentiment_score": "0.03471", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYCCF", "relevance_score": "0.043658", "ticker_sentiment_score": "-0.073341", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.043658", "ticker_sentiment_score": "0.098035", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIDU", "relevance_score": "0.087185", "ticker_sentiment_score": "-0.03651", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.043658", "ticker_sentiment_score": "-0.073341", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.087185", "ticker_sentiment_score": "0.03471", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Gains But Lags Market: What You Should Know", "url": "https://www.zacks.com/stock/news/2061304/intuitive-surgical-inc-isrg-gains-but-lags-market-what-you-should-know", "time_published": "20230302T230011", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed at $228.90 in the latest trading session, marking a +0.69% move from the prior day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default192.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.138612, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.654859", "ticker_sentiment_score": "0.268878", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's How Much $100 Invested In Intuitive Surgical 5 Years Ago Would Be Worth Today - Intuitive Surgical  ( NASDAQ:ISRG ) ", "url": "https://www.benzinga.com/news/earnings/23/03/31177098/heres-how-much-100-invested-in-intuitive-surgical-5-years-ago-would-be-worth-today", "time_published": "20230302T173042", "authors": ["Benzinga Insights"], "summary": "Intuitive Surgical ISRG has outperformed the market over the past 5 years by 29.05% on an annualized basis producing an average annual return of 36.67%. Currently, Intuitive Surgical has a market capitalization of $79.18 billion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.980595", "ticker_sentiment_score": "0.386944", "ticker_sentiment_label": "Bullish"}]}, {"title": "ALC vs. ISRG: Which Stock Should Value Investors Buy Now?", "url": "https://www.zacks.com/stock/news/2061115/alc-vs-isrg-which-stock-should-value-investors-buy-now", "time_published": "20230302T164011", "authors": ["Zacks Investment Research"], "summary": "ALC vs. ISRG: Which Stock Is the Better Value Option?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default253.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.501793, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ALC", "relevance_score": "0.737428", "ticker_sentiment_score": "0.624433", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.616447", "ticker_sentiment_score": "0.563071", "ticker_sentiment_label": "Bullish"}]}, {"title": "2 Stocks Down 12% or More This Year to Buy Hand Over Fist", "url": "https://www.fool.com/investing/2023/03/02/2-stocks-down-10-or-more-this-year-to-buy-hand-ove/", "time_published": "20230302T145500", "authors": ["Prosper Junior Bakiny"], "summary": "Investors might want to act fast before it's too late.", "banner_image": "https://media.ycharts.com/charts/6c0ebe8d14613d787d52ce63f1af5fb3.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.891286"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.15573, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.398148", "ticker_sentiment_score": "0.194589", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.255641", "ticker_sentiment_score": "0.280526", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "3 Top Growth Stocks I'd Buy Right Now Without Any Hesitation", "url": "https://www.fool.com/investing/2023/03/02/3-top-growth-stocks-id-buy-right-now-without-any-h/", "time_published": "20230302T114500", "authors": ["Bradley Guichard"], "summary": "Growth stocks are down, but Alphabet, Palo Alto Networks, and Intuitive Surgical look like compelling long-term investments.", "banner_image": "https://media.ycharts.com/charts/8db58932358a18ace090b2a59e4144a3.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.155777, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.198221", "ticker_sentiment_score": "0.100353", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.149346", "ticker_sentiment_score": "0.152298", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PANW", "relevance_score": "0.149346", "ticker_sentiment_score": "0.130906", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is Medtronic Still a Great Dividend Stock?", "url": "https://www.fool.com/investing/2023/03/01/is-medtronic-still-a-great-dividend-stock/", "time_published": "20230301T131500", "authors": ["Jim Halley"], "summary": "Innovation and consistent dividend increases attract investors.", "banner_image": "https://media.ycharts.com/charts/c5d0f124309c0e01934ddade9969e3b8.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Earnings", "relevance_score": "0.999862"}], "overall_sentiment_score": 0.263258, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CURN", "relevance_score": "0.045396", "ticker_sentiment_score": "-0.156427", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MDT", "relevance_score": "0.309725", "ticker_sentiment_score": "0.292662", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.045396", "ticker_sentiment_score": "0.069719", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.045396", "ticker_sentiment_score": "0.126951", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why Intuitive Surgical Stock Is A Better Pick Over Its Peer", "url": "https://www.forbes.com/sites/greatspeculations/2023/03/01/heres-why-intuitive-surgical-stock-is-a-better-pick-over-its-peer/", "time_published": "20230301T130000", "authors": ["Trefis Team"], "summary": "Although ISRG stock trades at a higher valuation of 13x trailing revenues, compared to just 5x for Stryker, this gap in valuation makes sense, in our view, given Intuitive Surgical's superior revenue growth, profitability, and financial position, as discussed below Looking at stock returns, SYK, ...", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/63fec3826af3169855ec682c/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Markets", "source_domain": "www.forbes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.22789, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SYK", "relevance_score": "0.592285", "ticker_sentiment_score": "0.397014", "ticker_sentiment_label": "Bullish"}, {"ticker": "ISRG", "relevance_score": "0.737342", "ticker_sentiment_score": "0.35514", "ticker_sentiment_label": "Bullish"}, {"ticker": "SYNH", "relevance_score": "0.038843", "ticker_sentiment_score": "0.210987", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Get a Dividend Every Month With These 3 Healthcare Stocks", "url": "https://www.fool.com/investing/2023/03/01/get-a-dividend-every-month-with-these-3-healthcare/", "time_published": "20230301T125900", "authors": ["Jim Halley"], "summary": "With a little planning, you can receive a dependable dividend payout every month.", "banner_image": "https://media.ycharts.com/charts/b92f7825bb2e0e76a1aebdfe1d498fb8.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}], "overall_sentiment_score": 0.186632, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.372139", "ticker_sentiment_score": "0.171914", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.042953", "ticker_sentiment_score": "0.14637", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.253426", "ticker_sentiment_score": "0.169435", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.042953", "ticker_sentiment_score": "0.122553", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.170576", "ticker_sentiment_score": "0.111531", "ticker_sentiment_label": "Neutral"}]}, {"title": "Where to Invest $5,000 in a 2023 Nasdaq Bear Market", "url": "https://www.fool.com/investing/2023/02/26/where-to-invest-5000-in-a-2023-nasdaq-bear-market/", "time_published": "20230226T101000", "authors": ["Rachel Warren"], "summary": "If the market dips into bear territory for a prolonged period again, that doesn't mean investors have to head for the hills.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F722033%2Fgettyimages-1187235213.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.99977"}, {"topic": "Earnings", "relevance_score": "0.999862"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.222266, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.2317", "ticker_sentiment_score": "0.122753", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.19393", "ticker_sentiment_score": "0.052298", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nasdaq Bear Market: 5 Superb Growth Stocks You'll Regret Not Buying on the Dip", "url": "https://www.fool.com/investing/2023/02/25/nasdaq-bear-market-5-growth-stocks-regret-not-buy/", "time_published": "20230225T100600", "authors": ["Sean Williams"], "summary": "A 33% plunge in the Nasdaq Composite is the perfect excuse for opportunistic investors to pounce on innovation-driven businesses.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F721578%2Fbear-market-stocks-plunge-crash-invest-correction-getty.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}, {"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.085053, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.081276", "ticker_sentiment_score": "0.142667", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.188193", "ticker_sentiment_score": "0.102743", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.16171", "ticker_sentiment_score": "0.00429", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.027134", "ticker_sentiment_score": "0.107825", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIDU", "relevance_score": "0.16171", "ticker_sentiment_score": "0.084083", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intuitive Surgical, Inc.  ( ISRG )  Dips More Than Broader Markets: What You Should Know", "url": "https://www.zacks.com/stock/news/2058984/intuitive-surgical-inc-isrg-dips-more-than-broader-markets-what-you-should-know", "time_published": "20230224T230004", "authors": ["Zacks Investment Research"], "summary": "Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $231.05, moving -1.64% from the previous trading session.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default359.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.157553, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.649828", "ticker_sentiment_score": "0.25204", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Artificial Intelligence Companies You May Want To Invest In Now", "url": "https://www.forbes.com/sites/qai/2023/02/24/artificial-intelligence-companies-you-may-want-to-invest-in-now/", "time_published": "20230224T190445", "authors": ["Q.ai - Powering a Personal Wealth Movement"], "summary": "OpenAI's release of ChatGPT and its pending incorporation into Bing have dominated headlines. As artificial intelligence becomes more omnipresent, investors are looking for AI companies with growth potential. Here are some options to consider.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/63f909efaf73498cf7093b40/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Markets", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Blockchain", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.999997"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.938793"}], "overall_sentiment_score": 0.195029, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.1789", "ticker_sentiment_score": "0.059534", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.14947", "ticker_sentiment_score": "0.088294", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.208081", "ticker_sentiment_score": "0.063164", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.030064", "ticker_sentiment_score": "0.069547", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRK-A", "relevance_score": "0.030064", "ticker_sentiment_score": "0.069547", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADBE", "relevance_score": "0.090021", "ticker_sentiment_score": "0.121113", "ticker_sentiment_label": "Neutral"}, {"ticker": "MU", "relevance_score": "0.060085", "ticker_sentiment_score": "0.114434", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.060085", "ticker_sentiment_score": "0.114434", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why AI stocks could return outsized performance in the next 18 months, and 7 leading names with direct exposure, according to an ETFs analyst", "url": "https://www.businessinsider.com/why-ai-stocks-could-return-outsized-performance-2023-2", "time_published": "20230223T100000", "authors": ["Laila Maidan"], "summary": "AI Stocks: Sector Could Return Outsized Performance in 18 Months - Business Insider ...", "banner_image": null, "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "www.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.986564"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.145237, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DT", "relevance_score": "0.085936", "ticker_sentiment_score": "0.135829", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.212674", "ticker_sentiment_score": "0.158997", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABB", "relevance_score": "0.085936", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGNX", "relevance_score": "0.085936", "ticker_sentiment_score": "0.135829", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.04303", "ticker_sentiment_score": "0.166297", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVDA", "relevance_score": "0.085936", "ticker_sentiment_score": "0.226665", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KYCCF", "relevance_score": "0.085936", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FANUF", "relevance_score": "0.04303", "ticker_sentiment_score": "0.129516", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.085936", "ticker_sentiment_score": "0.135829", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Healthcare Stocks You Can Buy and Hold for the Next Decade", "url": "https://www.fool.com/investing/2023/02/19/2-healthcare-stocks-you-can-buy-and-hold-for-the-n/", "time_published": "20230219T132500", "authors": ["Rachel Warren"], "summary": "This healthcare space is bursting with opportunity for long-term investors.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F720437%2Fpipeline-worker.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.260878, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.270274", "ticker_sentiment_score": "0.194076", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DXCM", "relevance_score": "0.137148", "ticker_sentiment_score": "0.193571", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "3 Stocks Ready to Bounce Back", "url": "https://www.fool.com/investing/2023/02/19/3-stocks-ready-to-bounce-back/", "time_published": "20230219T103000", "authors": ["Adria Cimino"], "summary": "These stocks could deliver explosive gains -- and gains that should last.", "banner_image": "https://media.ycharts.com/charts/dfe1ec182395fdaae90906376479979a.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.221305, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.101367", "ticker_sentiment_score": "-0.012006", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCS", "relevance_score": "0.433523", "ticker_sentiment_score": "0.363162", "ticker_sentiment_label": "Bullish"}, {"ticker": "TDOC", "relevance_score": "0.101367", "ticker_sentiment_score": "-0.091921", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Growth Stocks With Multi-Bagger Potential to Buy for 2023", "url": "https://www.fool.com/investing/2023/02/17/2-growth-stocks-with-multi-bagger-potential-to-buy/", "time_published": "20230217T134500", "authors": ["Rachel Warren"], "summary": "The market may have more volatility in store for investors in the coming months, but wonderful stocks can soar over the long haul.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F720872%2Fslide-1-warren-buffett-source-motley-fool.jpeg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.998682"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.22148, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.221212", "ticker_sentiment_score": "0.008836", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABNB", "relevance_score": "0.263942", "ticker_sentiment_score": "0.135102", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Patent Cliff Is Coming For Bristol Myers - Here's What It's Planning For 2023", "url": "https://www.investors.com/news/technology/bmy-stock-can-its-new-products-fill-the-looming-patent-cliff-gap/", "time_published": "20230217T130000", "authors": ["ALLISON GATLIN", "Investor's Business Daily"], "summary": "BMY Stock: Can Its New Products Fill The Looming Patent-Cliff Gap? Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2023/02/TECJ1_Eliquis_021723_shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.123738, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CYTK", "relevance_score": "0.081691", "ticker_sentiment_score": "0.103263", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.040899", "ticker_sentiment_score": "-0.351902", "ticker_sentiment_label": "Bearish"}, {"ticker": "INMD", "relevance_score": "0.040899", "ticker_sentiment_score": "-0.351902", "ticker_sentiment_label": "Bearish"}, {"ticker": "PFE", "relevance_score": "0.081691", "ticker_sentiment_score": "-0.156708", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BMY", "relevance_score": "0.280386", "ticker_sentiment_score": "-0.055651", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Powerhouse Stocks to Buy in 2023 That Are Ready for a Bull Run", "url": "https://www.fool.com/investing/2023/02/16/2-powerhouse-stocks-to-buy-in-2023-that-are-ready/", "time_published": "20230216T131500", "authors": ["Rachel Warren"], "summary": "A prolonged bull market could see these stocks soar.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F720483%2F2022-rivian-r1t-22.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.995077"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.998947"}], "overall_sentiment_score": 0.179747, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.238523", "ticker_sentiment_score": "0.108123", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.040348", "ticker_sentiment_score": "-0.119588", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.422126", "ticker_sentiment_score": "0.117675", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Vicarious Surgical Stock Just Popped 10%", "url": "https://www.fool.com/investing/2023/02/14/why-vicarious-surgical-stock-just-popped-10/", "time_published": "20230214T175410", "authors": ["Rich Smith"], "summary": "Is this stock the next Intuitive Surgical? Maybe. We won't know for sure, though, until it has something to sell.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F720735%2Fchalkboard-drawing-of-stock-chart-arrow-going-up-being-erased-and-pointing-back-down.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.94762"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": 0.041255, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.09989", "ticker_sentiment_score": "0.10194", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBOT", "relevance_score": "0.469744", "ticker_sentiment_score": "0.204657", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Moderna, Cirrus Logic And Other Balance Sheet Powerhouses", "url": "https://www.forbes.com/sites/johndorfman/2023/02/13/moderna-cirrus-logic-and-other-balance-sheet-powerhouses/", "time_published": "20230213T190639", "authors": ["John Dorfman"], "summary": "These U.S. companies with market caps of at least $5 billion have earnings of at least 20 cents a share in the latest fiscal year, debt no more than 10% of stockholders' equity and assets at least two times current liabilities.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/63e9de5780475dd711d77e9c/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Money", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.155348, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANET", "relevance_score": "0.060236", "ticker_sentiment_score": "0.151016", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GGG", "relevance_score": "0.12013", "ticker_sentiment_score": "0.211595", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VEEV", "relevance_score": "0.060236", "ticker_sentiment_score": "0.181038", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GNTX", "relevance_score": "0.12013", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEIC", "relevance_score": "0.060236", "ticker_sentiment_score": "0.151016", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ALGM", "relevance_score": "0.12013", "ticker_sentiment_score": "0.211595", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SNDR", "relevance_score": "0.12013", "ticker_sentiment_score": "0.142517", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPRT", "relevance_score": "0.060236", "ticker_sentiment_score": "0.186043", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MSFT", "relevance_score": "0.060236", "ticker_sentiment_score": "0.181038", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRUS", "relevance_score": "0.060236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLR", "relevance_score": "0.12013", "ticker_sentiment_score": "0.115576", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPGP", "relevance_score": "0.060236", "ticker_sentiment_score": "0.151016", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EPAM", "relevance_score": "0.12013", "ticker_sentiment_score": "0.205872", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DLB", "relevance_score": "0.12013", "ticker_sentiment_score": "0.068932", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCS", "relevance_score": "0.060236", "ticker_sentiment_score": "0.186043", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRNA", "relevance_score": "0.294446", "ticker_sentiment_score": "0.185696", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.060236", "ticker_sentiment_score": "0.151016", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "2 Growth Stocks That Could Help Make You a Fortune", "url": "https://www.fool.com/investing/2023/02/13/2-growth-stocks-that-could-help-make-you-a-fortune/", "time_published": "20230213T135300", "authors": ["Rachel Warren"], "summary": "These companies have what it takes to deliver outsized returns over the long haul.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F720214%2Fa-person-making-financial-calculations.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.98396"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.263598, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.272788", "ticker_sentiment_score": "0.108948", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.206392", "ticker_sentiment_score": "0.066398", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Top Stocks to Buy in February and Hold Forever", "url": "https://www.fool.com/investing/2023/02/13/2-top-stocks-to-buy-in-february-and-hold-forever/", "time_published": "20230213T102500", "authors": ["Rachel Warren"], "summary": "These healthcare giants are profitable and have wide moats.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F718958%2Fkid-jumping-in-rain-puddles.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.796627"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.342463, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.297301", "ticker_sentiment_score": "0.315938", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.239895", "ticker_sentiment_score": "0.141997", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Smart Stocks to Buy and Hold for Years", "url": "https://www.fool.com/investing/2023/02/09/2-smart-stocks-to-buy-and-hold-for-years/", "time_published": "20230209T151100", "authors": ["Rachel Warren"], "summary": "A long-term investment in these stocks could yield generous returns in the years to come.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F719380%2Ftwo-people-looking-at-a-phone-in-a-cafe.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.976913"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}], "overall_sentiment_score": 0.275976, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.231332", "ticker_sentiment_score": "0.243427", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABNB", "relevance_score": "0.393241", "ticker_sentiment_score": "0.370115", "ticker_sentiment_label": "Bullish"}]}, {"title": "Why Things Could Get Worse Before They Get Better for This Growth Stock", "url": "https://www.fool.com/investing/2023/02/09/why-things-could-get-worse-before-they-get-better/", "time_published": "20230209T140000", "authors": ["David Jagielski"], "summary": "Should you buy Intuitive Surgical despite the headwinds it's facing right now?", "banner_image": "https://media.ycharts.com/charts/794f3c1107c02af8c7c53ecbeeafe555.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.082576, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.370418", "ticker_sentiment_score": "0.18232", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "4 Best Artificial Intelligence  ( AI )  ETFs in 2023", "url": "https://www.fool.com/investing/stock-market/market-sectors/information-technology/ai-stocks/ai-etfs/", "time_published": "20230208T162156", "authors": ["Jeremy Bowman"], "summary": "There are several options for investors looking to diversify in AI.", "banner_image": "https://m.foolcdn.com/media/dubs/images/original_imageshttpsg.foolcdn.comeditorialimag.width-880_tt3GXMg.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.999998"}, {"topic": "Manufacturing", "relevance_score": "0.2"}], "overall_sentiment_score": 0.273965, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DT", "relevance_score": "0.039353", "ticker_sentiment_score": "0.067716", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.039353", "ticker_sentiment_score": "0.148866", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.039353", "ticker_sentiment_score": "0.125885", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYCCF", "relevance_score": "0.039353", "ticker_sentiment_score": "0.125885", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEMTF", "relevance_score": "0.039353", "ticker_sentiment_score": "0.166802", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMBA", "relevance_score": "0.078611", "ticker_sentiment_score": "0.121744", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESLT", "relevance_score": "0.039353", "ticker_sentiment_score": "0.067716", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNS", "relevance_score": "0.039353", "ticker_sentiment_score": "0.067716", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPLK", "relevance_score": "0.039353", "ticker_sentiment_score": "0.166802", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UPST", "relevance_score": "0.039353", "ticker_sentiment_score": "0.125885", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.078611", "ticker_sentiment_score": "0.096769", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.039353", "ticker_sentiment_score": "0.148866", "ticker_sentiment_label": "Neutral"}]}, {"title": "2 Stocks to Buy No Matter What Happens This Year", "url": "https://www.fool.com/investing/2023/02/08/2-stocks-to-buy-no-matter-what-happens-this-year/", "time_published": "20230208T145300", "authors": ["Prosper Junior Bakiny"], "summary": "These two companies have historically delivered market-beating returns. They can do the same in the future.", "banner_image": "https://media.ycharts.com/charts/c48e5fc3b2c406f28990fad5700f4e08.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.938793"}, {"topic": "Earnings", "relevance_score": "0.980716"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.099011, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ISRG", "relevance_score": "0.28387", "ticker_sentiment_score": "-0.015155", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.495015", "ticker_sentiment_score": "0.154457", "ticker_sentiment_label": "Somewhat-Bullish"}]}]}